<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Report for na_pos 1439144934464 [GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.broadinstitute.org/gsea/images/XBench.gif' rel='shortcut icon'></head><body><div class='richTable'><table cols='11' border='1'><th class='richTable'></th><th class='richTable'>GS<br> follow link to MSigDB</th><th class='richTable'>GS DETAILS</th><th class='richTable'>SIZE</th><th class='richTable'>ES</th><th class='richTable'>NES</th><th class='richTable'>NOM p-val</th><th class='richTable'>FDR q-val</th><th class='richTable'>FWER p-val</th><th class='richTable'>RANK AT MAX</th><th class='richTable'>LEADING EDGE</th><tr><td class='lessen'>1</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/LANDIS_ERBB2_BREAST_TUMORS_324_DN'>LANDIS_ERBB2_BREAST_TUMORS_324_DN</a></td><td><a href='LANDIS_ERBB2_BREAST_TUMORS_324_DN.html'>Details ...</a></td><td>136</td><td>0.72</td><td>2.80</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2487</td><td>tags=71%, list=19%, signal=87%</td></tr><tr><td class='lessen'>2</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP'>SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP</a></td><td><a href='SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP.html'>Details ...</a></td><td>287</td><td>0.65</td><td>2.79</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2343</td><td>tags=63%, list=18%, signal=75%</td></tr><tr><td class='lessen'>3</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/LANDIS_BREAST_CANCER_PROGRESSION_DN'>LANDIS_BREAST_CANCER_PROGRESSION_DN</a></td><td><a href='LANDIS_BREAST_CANCER_PROGRESSION_DN.html'>Details ...</a></td><td>67</td><td>0.77</td><td>2.75</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1962</td><td>tags=76%, list=15%, signal=89%</td></tr><tr><td class='lessen'>4</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/RUAN_RESPONSE_TO_TNF_DN'>RUAN_RESPONSE_TO_TNF_DN</a></td><td><a href='RUAN_RESPONSE_TO_TNF_DN.html'>Details ...</a></td><td>79</td><td>0.73</td><td>2.69</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2540</td><td>tags=73%, list=20%, signal=91%</td></tr><tr><td class='lessen'>5</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN'>NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN</a></td><td><a href='NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN.html'>Details ...</a></td><td>59</td><td>0.77</td><td>2.67</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1929</td><td>tags=71%, list=15%, signal=83%</td></tr><tr><td class='lessen'>6</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_6'>BURTON_ADIPOGENESIS_6</a></td><td><a href='BURTON_ADIPOGENESIS_6.html'>Details ...</a></td><td>165</td><td>0.65</td><td>2.67</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2312</td><td>tags=45%, list=18%, signal=55%</td></tr><tr><td class='lessen'>7</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_BREAST_4_5WK_DN'>MCBRYAN_PUBERTAL_BREAST_4_5WK_DN</a></td><td><a href='MCBRYAN_PUBERTAL_BREAST_4_5WK_DN.html'>Details ...</a></td><td>164</td><td>0.63</td><td>2.64</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2007</td><td>tags=46%, list=16%, signal=53%</td></tr><tr><td class='lessen'>8</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/IGLESIAS_E2F_TARGETS_UP'>IGLESIAS_E2F_TARGETS_UP</a></td><td><a href='IGLESIAS_E2F_TARGETS_UP.html'>Details ...</a></td><td>137</td><td>0.64</td><td>2.58</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2840</td><td>tags=56%, list=22%, signal=71%</td></tr><tr><td class='lessen'>9</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SWEET_LUNG_CANCER_KRAS_DN'>SWEET_LUNG_CANCER_KRAS_DN</a></td><td><a href='SWEET_LUNG_CANCER_KRAS_DN.html'>Details ...</a></td><td>383</td><td>0.55</td><td>2.53</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2078</td><td>tags=47%, list=16%, signal=55%</td></tr><tr><td class='lessen'>10</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE'>ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE</a></td><td><a href='ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE.html'>Details ...</a></td><td>59</td><td>0.70</td><td>2.49</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2329</td><td>tags=73%, list=18%, signal=88%</td></tr><tr><td class='lessen'>11</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/LIM_MAMMARY_LUMINAL_MATURE_DN'>LIM_MAMMARY_LUMINAL_MATURE_DN</a></td><td><a href='LIM_MAMMARY_LUMINAL_MATURE_DN.html'>Details ...</a></td><td>88</td><td>0.65</td><td>2.48</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2052</td><td>tags=56%, list=16%, signal=66%</td></tr><tr><td class='lessen'>12</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK'>WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK</a></td><td><a href='WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK.html'>Details ...</a></td><td>114</td><td>0.62</td><td>2.47</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2312</td><td>tags=46%, list=18%, signal=55%</td></tr><tr><td class='lessen'>13</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/NAKAMURA_ADIPOGENESIS_LATE_UP'>NAKAMURA_ADIPOGENESIS_LATE_UP</a></td><td><a href='NAKAMURA_ADIPOGENESIS_LATE_UP.html'>Details ...</a></td><td>89</td><td>0.66</td><td>2.46</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2249</td><td>tags=46%, list=17%, signal=55%</td></tr><tr><td class='lessen'>14</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN'>LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN</a></td><td><a href='LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN.html'>Details ...</a></td><td>48</td><td>0.73</td><td>2.46</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1784</td><td>tags=65%, list=14%, signal=75%</td></tr><tr><td class='lessen'>15</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/GAURNIER_PSMD4_TARGETS'>GAURNIER_PSMD4_TARGETS</a></td><td><a href='GAURNIER_PSMD4_TARGETS.html'>Details ...</a></td><td>44</td><td>0.74</td><td>2.45</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1977</td><td>tags=59%, list=15%, signal=70%</td></tr><tr><td class='lessen'>16</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/LENAOUR_DENDRITIC_CELL_MATURATION_DN'>LENAOUR_DENDRITIC_CELL_MATURATION_DN</a></td><td><a href='LENAOUR_DENDRITIC_CELL_MATURATION_DN.html'>Details ...</a></td><td>108</td><td>0.61</td><td>2.44</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1726</td><td>tags=44%, list=13%, signal=50%</td></tr><tr><td class='lessen'>17</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/VERHAAK_GLIOBLASTOMA_MESENCHYMAL'>VERHAAK_GLIOBLASTOMA_MESENCHYMAL</a></td><td><a href='VERHAAK_GLIOBLASTOMA_MESENCHYMAL.html'>Details ...</a></td><td>183</td><td>0.59</td><td>2.42</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2758</td><td>tags=58%, list=21%, signal=73%</td></tr><tr><td class='lessen'>18</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP'>PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP</a></td><td><a href='PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP.html'>Details ...</a></td><td>177</td><td>0.58</td><td>2.41</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2443</td><td>tags=51%, list=19%, signal=63%</td></tr><tr><td class='lessen'>19</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/LIAN_LIPA_TARGETS_3M'>LIAN_LIPA_TARGETS_3M</a></td><td><a href='LIAN_LIPA_TARGETS_3M.html'>Details ...</a></td><td>53</td><td>0.67</td><td>2.41</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2136</td><td>tags=60%, list=17%, signal=72%</td></tr><tr><td class='lessen'>20</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/GERHOLD_ADIPOGENESIS_UP'>GERHOLD_ADIPOGENESIS_UP</a></td><td><a href='GERHOLD_ADIPOGENESIS_UP.html'>Details ...</a></td><td>45</td><td>0.70</td><td>2.38</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2528</td><td>tags=56%, list=20%, signal=69%</td></tr><tr><td class='lessen'>21</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BOQUEST_STEM_CELL_DN'>BOQUEST_STEM_CELL_DN</a></td><td><a href='BOQUEST_STEM_CELL_DN.html'>Details ...</a></td><td>173</td><td>0.56</td><td>2.38</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2360</td><td>tags=53%, list=18%, signal=63%</td></tr><tr><td class='lessen'>22</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/LINDGREN_BLADDER_CANCER_CLUSTER_2B'>LINDGREN_BLADDER_CANCER_CLUSTER_2B</a></td><td><a href='LINDGREN_BLADDER_CANCER_CLUSTER_2B.html'>Details ...</a></td><td>326</td><td>0.54</td><td>2.37</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2136</td><td>tags=44%, list=17%, signal=51%</td></tr><tr><td class='lessen'>23</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WINTER_HYPOXIA_DN'>WINTER_HYPOXIA_DN</a></td><td><a href='WINTER_HYPOXIA_DN.html'>Details ...</a></td><td>39</td><td>0.72</td><td>2.36</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1331</td><td>tags=54%, list=10%, signal=60%</td></tr><tr><td class='lessen'>24</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN'>RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN</a></td><td><a href='RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN.html'>Details ...</a></td><td>40</td><td>0.71</td><td>2.35</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2369</td><td>tags=65%, list=18%, signal=79%</td></tr><tr><td class='lessen'>25</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BOQUEST_STEM_CELL_UP'>BOQUEST_STEM_CELL_UP</a></td><td><a href='BOQUEST_STEM_CELL_UP.html'>Details ...</a></td><td>225</td><td>0.55</td><td>2.35</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2249</td><td>tags=52%, list=17%, signal=62%</td></tr><tr><td class='lessen'>26</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_5'>BURTON_ADIPOGENESIS_5</a></td><td><a href='BURTON_ADIPOGENESIS_5.html'>Details ...</a></td><td>98</td><td>0.62</td><td>2.35</td><td>0.000</td><td>0.000</td><td>0.000</td><td>3002</td><td>tags=49%, list=23%, signal=63%</td></tr><tr><td class='lessen'>27</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/REN_ALVEOLAR_RHABDOMYOSARCOMA_DN'>REN_ALVEOLAR_RHABDOMYOSARCOMA_DN</a></td><td><a href='REN_ALVEOLAR_RHABDOMYOSARCOMA_DN.html'>Details ...</a></td><td>384</td><td>0.51</td><td>2.35</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2522</td><td>tags=36%, list=19%, signal=44%</td></tr><tr><td class='lessen'>28</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/VERNOCHET_ADIPOGENESIS'>VERNOCHET_ADIPOGENESIS</a></td><td><a href='VERNOCHET_ADIPOGENESIS.html'>Details ...</a></td><td>18</td><td>0.86</td><td>2.34</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1664</td><td>tags=89%, list=13%, signal=102%</td></tr><tr><td class='lessen'>29</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG'>WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG</a></td><td><a href='WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG.html'>Details ...</a></td><td>25</td><td>0.80</td><td>2.33</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1909</td><td>tags=72%, list=15%, signal=84%</td></tr><tr><td class='lessen'>30</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_BREAST_6_7WK_UP'>MCBRYAN_PUBERTAL_BREAST_6_7WK_UP</a></td><td><a href='MCBRYAN_PUBERTAL_BREAST_6_7WK_UP.html'>Details ...</a></td><td>168</td><td>0.56</td><td>2.33</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2124</td><td>tags=34%, list=16%, signal=40%</td></tr><tr><td class='lessen'>31</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN'>HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN</a></td><td><a href='HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN.html'>Details ...</a></td><td>68</td><td>0.63</td><td>2.32</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2854</td><td>tags=69%, list=22%, signal=88%</td></tr><tr><td class='lessen'>32</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16'>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16</a></td><td><a href='YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16.html'>Details ...</a></td><td>68</td><td>0.62</td><td>2.31</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1889</td><td>tags=46%, list=15%, signal=53%</td></tr><tr><td class='lessen'>33</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/NADLER_OBESITY_DN'>NADLER_OBESITY_DN</a></td><td><a href='NADLER_OBESITY_DN.html'>Details ...</a></td><td>45</td><td>0.71</td><td>2.31</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1613</td><td>tags=47%, list=12%, signal=53%</td></tr><tr><td class='lessen'>34</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/VERRECCHIA_EARLY_RESPONSE_TO_TGFB1'>VERRECCHIA_EARLY_RESPONSE_TO_TGFB1</a></td><td><a href='VERRECCHIA_EARLY_RESPONSE_TO_TGFB1.html'>Details ...</a></td><td>55</td><td>0.67</td><td>2.31</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2225</td><td>tags=51%, list=17%, signal=61%</td></tr><tr><td class='lessen'>35</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/STEGER_ADIPOGENESIS_UP'>STEGER_ADIPOGENESIS_UP</a></td><td><a href='STEGER_ADIPOGENESIS_UP.html'>Details ...</a></td><td>20</td><td>0.84</td><td>2.30</td><td>0.000</td><td>0.000</td><td>0.000</td><td>665</td><td>tags=65%, list=5%, signal=68%</td></tr><tr><td class='lessen'>36</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SCHRAETS_MLL_TARGETS_DN'>SCHRAETS_MLL_TARGETS_DN</a></td><td><a href='SCHRAETS_MLL_TARGETS_DN.html'>Details ...</a></td><td>31</td><td>0.75</td><td>2.30</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1918</td><td>tags=61%, list=15%, signal=72%</td></tr><tr><td class='lessen'>37</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WALLACE_PROSTATE_CANCER_RACE_UP'>WALLACE_PROSTATE_CANCER_RACE_UP</a></td><td><a href='WALLACE_PROSTATE_CANCER_RACE_UP.html'>Details ...</a></td><td>225</td><td>0.54</td><td>2.28</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2399</td><td>tags=54%, list=19%, signal=65%</td></tr><tr><td class='lessen'>38</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/LIU_VAV3_PROSTATE_CARCINOGENESIS_UP'>LIU_VAV3_PROSTATE_CARCINOGENESIS_UP</a></td><td><a href='LIU_VAV3_PROSTATE_CARCINOGENESIS_UP.html'>Details ...</a></td><td>79</td><td>0.64</td><td>2.28</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2168</td><td>tags=62%, list=17%, signal=74%</td></tr><tr><td class='lessen'>39</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/CROONQUIST_STROMAL_STIMULATION_UP'>CROONQUIST_STROMAL_STIMULATION_UP</a></td><td><a href='CROONQUIST_STROMAL_STIMULATION_UP.html'>Details ...</a></td><td>53</td><td>0.66</td><td>2.28</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2105</td><td>tags=62%, list=16%, signal=74%</td></tr><tr><td class='lessen'>40</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/LIEN_BREAST_CARCINOMA_METAPLASTIC'>LIEN_BREAST_CARCINOMA_METAPLASTIC</a></td><td><a href='LIEN_BREAST_CARCINOMA_METAPLASTIC.html'>Details ...</a></td><td>32</td><td>0.72</td><td>2.28</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2306</td><td>tags=59%, list=18%, signal=72%</td></tr><tr><td class='lessen'>41</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/PETRETTO_CARDIAC_HYPERTROPHY'>PETRETTO_CARDIAC_HYPERTROPHY</a></td><td><a href='PETRETTO_CARDIAC_HYPERTROPHY.html'>Details ...</a></td><td>31</td><td>0.73</td><td>2.27</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2200</td><td>tags=55%, list=17%, signal=66%</td></tr><tr><td class='lessen'>42</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/LI_ADIPOGENESIS_BY_ACTIVATED_PPARG'>LI_ADIPOGENESIS_BY_ACTIVATED_PPARG</a></td><td><a href='LI_ADIPOGENESIS_BY_ACTIVATED_PPARG.html'>Details ...</a></td><td>16</td><td>0.86</td><td>2.27</td><td>0.000</td><td>0.000</td><td>0.000</td><td>664</td><td>tags=69%, list=5%, signal=72%</td></tr><tr><td class='lessen'>43</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_CLUSTER_5'>FARMER_BREAST_CANCER_CLUSTER_5</a></td><td><a href='FARMER_BREAST_CANCER_CLUSTER_5.html'>Details ...</a></td><td>18</td><td>0.86</td><td>2.27</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1371</td><td>tags=83%, list=11%, signal=93%</td></tr><tr><td class='lessen'>44</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/ROY_WOUND_BLOOD_VESSEL_UP'>ROY_WOUND_BLOOD_VESSEL_UP</a></td><td><a href='ROY_WOUND_BLOOD_VESSEL_UP.html'>Details ...</a></td><td>41</td><td>0.67</td><td>2.26</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2360</td><td>tags=63%, list=18%, signal=77%</td></tr><tr><td class='lessen'>45</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SIMBULAN_PARP1_TARGETS_UP'>SIMBULAN_PARP1_TARGETS_UP</a></td><td><a href='SIMBULAN_PARP1_TARGETS_UP.html'>Details ...</a></td><td>31</td><td>0.73</td><td>2.26</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1717</td><td>tags=58%, list=13%, signal=67%</td></tr><tr><td class='lessen'>46</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/RASHI_RESPONSE_TO_IONIZING_RADIATION_6'>RASHI_RESPONSE_TO_IONIZING_RADIATION_6</a></td><td><a href='RASHI_RESPONSE_TO_IONIZING_RADIATION_6.html'>Details ...</a></td><td>74</td><td>0.63</td><td>2.26</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1776</td><td>tags=43%, list=14%, signal=50%</td></tr><tr><td class='lessen'>47</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_NORMAL_LIKE_UP'>SMID_BREAST_CANCER_NORMAL_LIKE_UP</a></td><td><a href='SMID_BREAST_CANCER_NORMAL_LIKE_UP.html'>Details ...</a></td><td>377</td><td>0.50</td><td>2.26</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2399</td><td>tags=53%, list=19%, signal=63%</td></tr><tr><td class='lessen'>48</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP'>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP</a></td><td><a href='FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP.html'>Details ...</a></td><td>75</td><td>0.62</td><td>2.26</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2167</td><td>tags=53%, list=17%, signal=64%</td></tr><tr><td class='lessen'>49</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP'>NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP</a></td><td><a href='NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP.html'>Details ...</a></td><td>59</td><td>0.64</td><td>2.25</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1751</td><td>tags=53%, list=14%, signal=60%</td></tr><tr><td class='lessen'>50</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MARKEY_RB1_ACUTE_LOF_UP'>MARKEY_RB1_ACUTE_LOF_UP</a></td><td><a href='MARKEY_RB1_ACUTE_LOF_UP.html'>Details ...</a></td><td>182</td><td>0.54</td><td>2.25</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2399</td><td>tags=47%, list=19%, signal=57%</td></tr><tr><td class='lessen'>51</td><td>ZHU_CMV_24_HR_DN</td><td></td><td>80</td><td>0.60</td><td>2.24</td><td>0.000</td><td>0.000</td><td>0.001</td><td>2547</td><td>tags=54%, list=20%, signal=67%</td></tr><tr><td class='lessen'>52</td><td>LIM_MAMMARY_STEM_CELL_UP</td><td></td><td>424</td><td>0.48</td><td>2.24</td><td>0.000</td><td>0.000</td><td>0.001</td><td>2290</td><td>tags=43%, list=18%, signal=51%</td></tr><tr><td class='lessen'>53</td><td>HUMMERICH_BENIGN_SKIN_TUMOR_DN</td><td></td><td>18</td><td>0.85</td><td>2.24</td><td>0.000</td><td>0.000</td><td>0.001</td><td>958</td><td>tags=61%, list=7%, signal=66%</td></tr><tr><td class='lessen'>54</td><td>HUANG_GATA2_TARGETS_UP</td><td></td><td>123</td><td>0.56</td><td>2.24</td><td>0.000</td><td>0.000</td><td>0.001</td><td>2285</td><td>tags=44%, list=18%, signal=53%</td></tr><tr><td class='lessen'>55</td><td>YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP</td><td></td><td>70</td><td>0.62</td><td>2.24</td><td>0.000</td><td>0.000</td><td>0.001</td><td>2083</td><td>tags=47%, list=16%, signal=56%</td></tr><tr><td class='lessen'>56</td><td>JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP</td><td></td><td>68</td><td>0.64</td><td>2.23</td><td>0.000</td><td>0.000</td><td>0.001</td><td>1875</td><td>tags=50%, list=14%, signal=58%</td></tr><tr><td class='lessen'>57</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN</td><td></td><td>136</td><td>0.55</td><td>2.23</td><td>0.000</td><td>0.000</td><td>0.001</td><td>2770</td><td>tags=49%, list=21%, signal=61%</td></tr><tr><td class='lessen'>58</td><td>TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP</td><td></td><td>57</td><td>0.63</td><td>2.22</td><td>0.000</td><td>0.000</td><td>0.001</td><td>2196</td><td>tags=56%, list=17%, signal=67%</td></tr><tr><td class='lessen'>59</td><td>LIAN_LIPA_TARGETS_6M</td><td></td><td>67</td><td>0.61</td><td>2.22</td><td>0.000</td><td>0.000</td><td>0.001</td><td>2136</td><td>tags=55%, list=17%, signal=66%</td></tr><tr><td class='lessen'>60</td><td>KIM_GLIS2_TARGETS_UP</td><td></td><td>73</td><td>0.60</td><td>2.22</td><td>0.000</td><td>0.000</td><td>0.001</td><td>2145</td><td>tags=58%, list=17%, signal=69%</td></tr><tr><td class='lessen'>61</td><td>LANDIS_ERBB2_BREAST_TUMORS_65_DN</td><td></td><td>34</td><td>0.70</td><td>2.21</td><td>0.000</td><td>0.000</td><td>0.001</td><td>1470</td><td>tags=53%, list=11%, signal=60%</td></tr><tr><td class='lessen'>62</td><td>ZHU_CMV_ALL_DN</td><td></td><td>113</td><td>0.58</td><td>2.21</td><td>0.000</td><td>0.000</td><td>0.001</td><td>2547</td><td>tags=50%, list=20%, signal=61%</td></tr><tr><td class='lessen'>63</td><td>RUAN_RESPONSE_TO_TROGLITAZONE_UP</td><td></td><td>23</td><td>0.77</td><td>2.21</td><td>0.000</td><td>0.000</td><td>0.002</td><td>2693</td><td>tags=87%, list=21%, signal=110%</td></tr><tr><td class='lessen'>64</td><td>HUMMERICH_SKIN_CANCER_PROGRESSION_DN</td><td></td><td>95</td><td>0.58</td><td>2.21</td><td>0.000</td><td>0.000</td><td>0.002</td><td>2295</td><td>tags=34%, list=18%, signal=41%</td></tr><tr><td class='lessen'>65</td><td>TSENG_ADIPOGENIC_POTENTIAL_DN</td><td></td><td>43</td><td>0.66</td><td>2.21</td><td>0.000</td><td>0.000</td><td>0.002</td><td>2122</td><td>tags=60%, list=16%, signal=72%</td></tr><tr><td class='lessen'>66</td><td>TSENG_IRS1_TARGETS_DN</td><td></td><td>115</td><td>0.56</td><td>2.21</td><td>0.000</td><td>0.000</td><td>0.002</td><td>2151</td><td>tags=46%, list=17%, signal=55%</td></tr><tr><td class='lessen'>67</td><td>LINDVALL_IMMORTALIZED_BY_TERT_DN</td><td></td><td>71</td><td>0.59</td><td>2.19</td><td>0.000</td><td>0.000</td><td>0.003</td><td>2500</td><td>tags=48%, list=19%, signal=59%</td></tr><tr><td class='lessen'>68</td><td>BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN</td><td></td><td>42</td><td>0.67</td><td>2.19</td><td>0.000</td><td>0.000</td><td>0.003</td><td>1962</td><td>tags=48%, list=15%, signal=56%</td></tr><tr><td class='lessen'>69</td><td>LINDSTEDT_DENDRITIC_CELL_MATURATION_D</td><td></td><td>57</td><td>0.63</td><td>2.19</td><td>0.000</td><td>0.000</td><td>0.003</td><td>2120</td><td>tags=47%, list=16%, signal=56%</td></tr><tr><td class='lessen'>70</td><td>HUANG_DASATINIB_RESISTANCE_UP</td><td></td><td>69</td><td>0.60</td><td>2.17</td><td>0.000</td><td>0.000</td><td>0.005</td><td>2501</td><td>tags=58%, list=19%, signal=71%</td></tr><tr><td class='lessen'>71</td><td>BURTON_ADIPOGENESIS_PEAK_AT_0HR</td><td></td><td>55</td><td>0.61</td><td>2.17</td><td>0.000</td><td>0.000</td><td>0.005</td><td>2167</td><td>tags=45%, list=17%, signal=54%</td></tr><tr><td class='lessen'>72</td><td>PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP</td><td></td><td>108</td><td>0.55</td><td>2.16</td><td>0.000</td><td>0.000</td><td>0.009</td><td>2180</td><td>tags=47%, list=17%, signal=56%</td></tr><tr><td class='lessen'>73</td><td>ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION</td><td></td><td>107</td><td>0.58</td><td>2.16</td><td>0.000</td><td>0.000</td><td>0.009</td><td>2382</td><td>tags=52%, list=18%, signal=64%</td></tr><tr><td class='lessen'>74</td><td>GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP</td><td></td><td>171</td><td>0.52</td><td>2.15</td><td>0.000</td><td>0.001</td><td>0.011</td><td>2544</td><td>tags=47%, list=20%, signal=58%</td></tr><tr><td class='lessen'>75</td><td>VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1</td><td></td><td>38</td><td>0.66</td><td>2.14</td><td>0.000</td><td>0.001</td><td>0.012</td><td>2455</td><td>tags=53%, list=19%, signal=65%</td></tr><tr><td class='lessen'>76</td><td>FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN</td><td></td><td>327</td><td>0.48</td><td>2.13</td><td>0.000</td><td>0.001</td><td>0.012</td><td>2438</td><td>tags=38%, list=19%, signal=46%</td></tr><tr><td class='lessen'>77</td><td>ROZANOV_MMP14_TARGETS_SUBSET</td><td></td><td>31</td><td>0.71</td><td>2.13</td><td>0.000</td><td>0.001</td><td>0.013</td><td>1998</td><td>tags=68%, list=15%, signal=80%</td></tr><tr><td class='lessen'>78</td><td>LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE</td><td></td><td>41</td><td>0.66</td><td>2.13</td><td>0.000</td><td>0.001</td><td>0.013</td><td>1441</td><td>tags=41%, list=11%, signal=47%</td></tr><tr><td class='lessen'>79</td><td>NADLER_OBESITY_UP</td><td></td><td>53</td><td>0.63</td><td>2.13</td><td>0.000</td><td>0.001</td><td>0.013</td><td>2302</td><td>tags=49%, list=18%, signal=59%</td></tr><tr><td class='lessen'>80</td><td>BERENJENO_TRANSFORMED_BY_RHOA_DN</td><td></td><td>339</td><td>0.49</td><td>2.12</td><td>0.000</td><td>0.001</td><td>0.015</td><td>2468</td><td>tags=36%, list=19%, signal=43%</td></tr><tr><td class='lessen'>81</td><td>THUM_SYSTOLIC_HEART_FAILURE_UP</td><td></td><td>340</td><td>0.50</td><td>2.11</td><td>0.000</td><td>0.001</td><td>0.018</td><td>2576</td><td>tags=37%, list=20%, signal=45%</td></tr><tr><td class='lessen'>82</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN</td><td></td><td>383</td><td>0.49</td><td>2.11</td><td>0.000</td><td>0.001</td><td>0.018</td><td>2443</td><td>tags=44%, list=19%, signal=52%</td></tr><tr><td class='lessen'>83</td><td>WESTON_VEGFA_TARGETS_12HR</td><td></td><td>35</td><td>0.67</td><td>2.10</td><td>0.000</td><td>0.001</td><td>0.023</td><td>2052</td><td>tags=60%, list=16%, signal=71%</td></tr><tr><td class='lessen'>84</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN</td><td></td><td>36</td><td>0.67</td><td>2.09</td><td>0.000</td><td>0.001</td><td>0.024</td><td>2379</td><td>tags=58%, list=18%, signal=71%</td></tr><tr><td class='lessen'>85</td><td>SMID_BREAST_CANCER_LUMINAL_A_UP</td><td></td><td>75</td><td>0.57</td><td>2.09</td><td>0.000</td><td>0.001</td><td>0.025</td><td>1547</td><td>tags=43%, list=12%, signal=48%</td></tr><tr><td class='lessen'>86</td><td>HOSHIDA_LIVER_CANCER_SUBCLASS_S1</td><td></td><td>214</td><td>0.48</td><td>2.09</td><td>0.000</td><td>0.001</td><td>0.029</td><td>2302</td><td>tags=41%, list=18%, signal=49%</td></tr><tr><td class='lessen'>87</td><td>CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN</td><td></td><td>19</td><td>0.76</td><td>2.08</td><td>0.000</td><td>0.001</td><td>0.029</td><td>958</td><td>tags=37%, list=7%, signal=40%</td></tr><tr><td class='lessen'>88</td><td>SWEET_KRAS_TARGETS_UP</td><td></td><td>72</td><td>0.56</td><td>2.08</td><td>0.000</td><td>0.001</td><td>0.029</td><td>2590</td><td>tags=44%, list=20%, signal=55%</td></tr><tr><td class='lessen'>89</td><td>WESTON_VEGFA_TARGETS</td><td></td><td>97</td><td>0.55</td><td>2.08</td><td>0.000</td><td>0.001</td><td>0.029</td><td>2277</td><td>tags=49%, list=18%, signal=60%</td></tr><tr><td class='lessen'>90</td><td>WILENSKY_RESPONSE_TO_DARAPLADIB</td><td></td><td>26</td><td>0.70</td><td>2.07</td><td>0.000</td><td>0.001</td><td>0.031</td><td>2302</td><td>tags=62%, list=18%, signal=75%</td></tr><tr><td class='lessen'>91</td><td>MCLACHLAN_DENTAL_CARIES_UP</td><td></td><td>188</td><td>0.50</td><td>2.07</td><td>0.000</td><td>0.001</td><td>0.032</td><td>1868</td><td>tags=46%, list=14%, signal=53%</td></tr><tr><td class='lessen'>92</td><td>DURAND_STROMA_S_UP</td><td></td><td>249</td><td>0.49</td><td>2.07</td><td>0.000</td><td>0.001</td><td>0.035</td><td>2388</td><td>tags=48%, list=18%, signal=57%</td></tr><tr><td class='lessen'>93</td><td>WESTON_VEGFA_TARGETS_6HR</td><td></td><td>56</td><td>0.59</td><td>2.07</td><td>0.000</td><td>0.001</td><td>0.038</td><td>2080</td><td>tags=54%, list=16%, signal=64%</td></tr><tr><td class='lessen'>94</td><td>DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP</td><td></td><td>38</td><td>0.65</td><td>2.07</td><td>0.000</td><td>0.002</td><td>0.039</td><td>2058</td><td>tags=58%, list=16%, signal=69%</td></tr><tr><td class='lessen'>95</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP</td><td></td><td>137</td><td>0.52</td><td>2.06</td><td>0.000</td><td>0.002</td><td>0.045</td><td>1743</td><td>tags=28%, list=13%, signal=32%</td></tr><tr><td class='lessen'>96</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN</td><td></td><td>48</td><td>0.62</td><td>2.05</td><td>0.000</td><td>0.002</td><td>0.053</td><td>2268</td><td>tags=52%, list=18%, signal=63%</td></tr><tr><td class='lessen'>97</td><td>QI_PLASMACYTOMA_UP</td><td></td><td>239</td><td>0.46</td><td>2.05</td><td>0.000</td><td>0.002</td><td>0.055</td><td>2438</td><td>tags=44%, list=19%, signal=54%</td></tr><tr><td class='lessen'>98</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN</td><td></td><td>138</td><td>0.53</td><td>2.05</td><td>0.000</td><td>0.002</td><td>0.055</td><td>2153</td><td>tags=41%, list=17%, signal=49%</td></tr><tr><td class='lessen'>99</td><td>PASINI_SUZ12_TARGETS_DN</td><td></td><td>288</td><td>0.48</td><td>2.05</td><td>0.000</td><td>0.002</td><td>0.055</td><td>2374</td><td>tags=38%, list=18%, signal=45%</td></tr><tr><td class='lessen'>100</td><td>FARMER_BREAST_CANCER_CLUSTER_1</td><td></td><td>33</td><td>0.64</td><td>2.04</td><td>0.000</td><td>0.002</td><td>0.057</td><td>2386</td><td>tags=58%, list=18%, signal=70%</td></tr><tr><td class='lessen'>101</td><td>MIKKELSEN_MEF_LCP_WITH_H3K4ME3</td><td></td><td>105</td><td>0.52</td><td>2.04</td><td>0.000</td><td>0.002</td><td>0.057</td><td>1642</td><td>tags=38%, list=13%, signal=43%</td></tr><tr><td class='lessen'>102</td><td>CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN</td><td></td><td>32</td><td>0.66</td><td>2.04</td><td>0.000</td><td>0.002</td><td>0.060</td><td>1170</td><td>tags=47%, list=9%, signal=51%</td></tr><tr><td class='lessen'>103</td><td>SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION</td><td></td><td>48</td><td>0.63</td><td>2.04</td><td>0.000</td><td>0.002</td><td>0.061</td><td>2003</td><td>tags=54%, list=15%, signal=64%</td></tr><tr><td class='lessen'>104</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN</td><td></td><td>366</td><td>0.45</td><td>2.04</td><td>0.000</td><td>0.002</td><td>0.062</td><td>2293</td><td>tags=38%, list=18%, signal=45%</td></tr><tr><td class='lessen'>105</td><td>MARKEY_RB1_CHRONIC_LOF_DN</td><td></td><td>97</td><td>0.53</td><td>2.03</td><td>0.000</td><td>0.002</td><td>0.070</td><td>2302</td><td>tags=44%, list=18%, signal=54%</td></tr><tr><td class='lessen'>106</td><td>GOLUB_ALL_VS_AML_DN</td><td></td><td>20</td><td>0.72</td><td>2.03</td><td>0.000</td><td>0.002</td><td>0.071</td><td>2574</td><td>tags=60%, list=20%, signal=75%</td></tr><tr><td class='lessen'>107</td><td>RODWELL_AGING_KIDNEY_UP</td><td></td><td>363</td><td>0.45</td><td>2.03</td><td>0.000</td><td>0.002</td><td>0.072</td><td>2766</td><td>tags=46%, list=21%, signal=57%</td></tr><tr><td class='lessen'>108</td><td>DASU_IL6_SIGNALING_SCAR_DN</td><td></td><td>13</td><td>0.79</td><td>2.03</td><td>0.000</td><td>0.002</td><td>0.072</td><td>1905</td><td>tags=69%, list=15%, signal=81%</td></tr><tr><td class='lessen'>109</td><td>RAMALHO_STEMNESS_DN</td><td></td><td>63</td><td>0.56</td><td>2.02</td><td>0.000</td><td>0.003</td><td>0.075</td><td>2302</td><td>tags=52%, list=18%, signal=63%</td></tr><tr><td class='lessen'>110</td><td>MARTINEZ_RB1_AND_TP53_TARGETS_UP</td><td></td><td>505</td><td>0.44</td><td>2.02</td><td>0.000</td><td>0.003</td><td>0.077</td><td>2007</td><td>tags=29%, list=16%, signal=33%</td></tr><tr><td class='lessen'>111</td><td>ZHAN_LATE_DIFFERENTIATION_GENES_UP</td><td></td><td>32</td><td>0.64</td><td>2.02</td><td>0.000</td><td>0.003</td><td>0.080</td><td>1461</td><td>tags=44%, list=11%, signal=49%</td></tr><tr><td class='lessen'>112</td><td>HUMMERICH_MALIGNANT_SKIN_TUMOR_DN</td><td></td><td>15</td><td>0.80</td><td>2.02</td><td>0.000</td><td>0.003</td><td>0.082</td><td>641</td><td>tags=53%, list=5%, signal=56%</td></tr><tr><td class='lessen'>113</td><td>ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP</td><td></td><td>29</td><td>0.67</td><td>2.01</td><td>0.000</td><td>0.003</td><td>0.086</td><td>2206</td><td>tags=59%, list=17%, signal=71%</td></tr><tr><td class='lessen'>114</td><td>VERHAAK_AML_WITH_NPM1_MUTATED_DN</td><td></td><td>205</td><td>0.47</td><td>2.01</td><td>0.000</td><td>0.003</td><td>0.094</td><td>1614</td><td>tags=34%, list=12%, signal=38%</td></tr><tr><td class='lessen'>115</td><td>WONG_ENDMETRIUM_CANCER_DN</td><td></td><td>71</td><td>0.55</td><td>2.00</td><td>0.000</td><td>0.004</td><td>0.110</td><td>2114</td><td>tags=54%, list=16%, signal=64%</td></tr><tr><td class='lessen'>116</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN</td><td></td><td>154</td><td>0.49</td><td>2.00</td><td>0.000</td><td>0.004</td><td>0.110</td><td>1712</td><td>tags=40%, list=13%, signal=46%</td></tr><tr><td class='lessen'>117</td><td>VALK_AML_WITH_EVI1</td><td></td><td>18</td><td>0.75</td><td>2.00</td><td>0.003</td><td>0.004</td><td>0.114</td><td>1115</td><td>tags=44%, list=9%, signal=49%</td></tr><tr><td class='lessen'>118</td><td>CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN</td><td></td><td>36</td><td>0.64</td><td>2.00</td><td>0.000</td><td>0.004</td><td>0.117</td><td>1956</td><td>tags=64%, list=15%, signal=75%</td></tr><tr><td class='lessen'>119</td><td>OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP</td><td></td><td>22</td><td>0.68</td><td>2.00</td><td>0.000</td><td>0.004</td><td>0.118</td><td>1177</td><td>tags=36%, list=9%, signal=40%</td></tr><tr><td class='lessen'>120</td><td>GERHOLD_ADIPOGENESIS_DN</td><td></td><td>55</td><td>0.57</td><td>1.99</td><td>0.000</td><td>0.004</td><td>0.125</td><td>1939</td><td>tags=36%, list=15%, signal=43%</td></tr><tr><td class='lessen'>121</td><td>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP</td><td></td><td>110</td><td>0.51</td><td>1.99</td><td>0.000</td><td>0.004</td><td>0.127</td><td>1776</td><td>tags=44%, list=14%, signal=50%</td></tr><tr><td class='lessen'>122</td><td>TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN</td><td></td><td>64</td><td>0.57</td><td>1.99</td><td>0.000</td><td>0.004</td><td>0.129</td><td>2011</td><td>tags=53%, list=16%, signal=63%</td></tr><tr><td class='lessen'>123</td><td>MCDOWELL_ACUTE_LUNG_INJURY_DN</td><td></td><td>37</td><td>0.61</td><td>1.99</td><td>0.000</td><td>0.004</td><td>0.129</td><td>2508</td><td>tags=54%, list=19%, signal=67%</td></tr><tr><td class='lessen'>124</td><td>DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN</td><td></td><td>100</td><td>0.51</td><td>1.99</td><td>0.000</td><td>0.004</td><td>0.130</td><td>2419</td><td>tags=44%, list=19%, signal=54%</td></tr><tr><td class='lessen'>125</td><td>AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP</td><td></td><td>97</td><td>0.51</td><td>1.98</td><td>0.000</td><td>0.005</td><td>0.150</td><td>1488</td><td>tags=31%, list=12%, signal=35%</td></tr><tr><td class='lessen'>126</td><td>STEGER_ADIPOGENESIS_DN</td><td></td><td>25</td><td>0.67</td><td>1.98</td><td>0.000</td><td>0.005</td><td>0.150</td><td>1484</td><td>tags=44%, list=11%, signal=50%</td></tr><tr><td class='lessen'>127</td><td>TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN</td><td></td><td>30</td><td>0.65</td><td>1.98</td><td>0.000</td><td>0.005</td><td>0.152</td><td>2719</td><td>tags=60%, list=21%, signal=76%</td></tr><tr><td class='lessen'>128</td><td>VERRECCHIA_RESPONSE_TO_TGFB1_C2</td><td></td><td>24</td><td>0.69</td><td>1.97</td><td>0.000</td><td>0.005</td><td>0.159</td><td>1718</td><td>tags=46%, list=13%, signal=53%</td></tr><tr><td class='lessen'>129</td><td>WIERENGA_STAT5A_TARGETS_DN</td><td></td><td>162</td><td>0.50</td><td>1.97</td><td>0.000</td><td>0.005</td><td>0.164</td><td>2761</td><td>tags=48%, list=21%, signal=60%</td></tr><tr><td class='lessen'>130</td><td>AZARE_STAT3_TARGETS</td><td></td><td>19</td><td>0.73</td><td>1.97</td><td>0.004</td><td>0.005</td><td>0.169</td><td>1228</td><td>tags=37%, list=9%, signal=41%</td></tr><tr><td class='lessen'>131</td><td>MCBRYAN_PUBERTAL_BREAST_5_6WK_DN</td><td></td><td>114</td><td>0.50</td><td>1.96</td><td>0.000</td><td>0.006</td><td>0.182</td><td>2124</td><td>tags=27%, list=16%, signal=32%</td></tr><tr><td class='lessen'>132</td><td>CHIBA_RESPONSE_TO_TSA_UP</td><td></td><td>46</td><td>0.59</td><td>1.95</td><td>0.000</td><td>0.006</td><td>0.203</td><td>1488</td><td>tags=41%, list=12%, signal=47%</td></tr><tr><td class='lessen'>133</td><td>HECKER_IFNB1_TARGETS</td><td></td><td>69</td><td>0.54</td><td>1.95</td><td>0.000</td><td>0.006</td><td>0.210</td><td>2388</td><td>tags=46%, list=18%, signal=57%</td></tr><tr><td class='lessen'>134</td><td>URS_ADIPOCYTE_DIFFERENTIATION_DN</td><td></td><td>26</td><td>0.67</td><td>1.95</td><td>0.000</td><td>0.007</td><td>0.220</td><td>1472</td><td>tags=50%, list=11%, signal=56%</td></tr><tr><td class='lessen'>135</td><td>MORI_MATURE_B_LYMPHOCYTE_UP</td><td></td><td>70</td><td>0.52</td><td>1.95</td><td>0.000</td><td>0.007</td><td>0.225</td><td>2392</td><td>tags=37%, list=18%, signal=45%</td></tr><tr><td class='lessen'>136</td><td>BAELDE_DIABETIC_NEPHROPATHY_UP</td><td></td><td>69</td><td>0.54</td><td>1.95</td><td>0.000</td><td>0.007</td><td>0.225</td><td>1962</td><td>tags=42%, list=15%, signal=49%</td></tr><tr><td class='lessen'>137</td><td>KEEN_RESPONSE_TO_ROSIGLITAZONE_DN</td><td></td><td>94</td><td>0.51</td><td>1.94</td><td>0.000</td><td>0.007</td><td>0.237</td><td>1969</td><td>tags=32%, list=15%, signal=37%</td></tr><tr><td class='lessen'>138</td><td>IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN</td><td></td><td>88</td><td>0.52</td><td>1.94</td><td>0.000</td><td>0.007</td><td>0.237</td><td>1572</td><td>tags=40%, list=12%, signal=45%</td></tr><tr><td class='lessen'>139</td><td>HAN_JNK_SINGALING_UP</td><td></td><td>32</td><td>0.64</td><td>1.94</td><td>0.000</td><td>0.007</td><td>0.237</td><td>2168</td><td>tags=47%, list=17%, signal=56%</td></tr><tr><td class='lessen'>140</td><td>KEEN_RESPONSE_TO_ROSIGLITAZONE_UP</td><td></td><td>32</td><td>0.63</td><td>1.94</td><td>0.005</td><td>0.007</td><td>0.238</td><td>874</td><td>tags=31%, list=7%, signal=33%</td></tr><tr><td class='lessen'>141</td><td>PARK_APL_PATHOGENESIS_DN</td><td></td><td>39</td><td>0.60</td><td>1.94</td><td>0.000</td><td>0.007</td><td>0.239</td><td>2065</td><td>tags=41%, list=16%, signal=49%</td></tr><tr><td class='lessen'>142</td><td>BASSO_CD40_SIGNALING_UP</td><td></td><td>83</td><td>0.52</td><td>1.94</td><td>0.000</td><td>0.007</td><td>0.245</td><td>2854</td><td>tags=53%, list=22%, signal=68%</td></tr><tr><td class='lessen'>143</td><td>VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP</td><td></td><td>148</td><td>0.48</td><td>1.94</td><td>0.000</td><td>0.007</td><td>0.255</td><td>2230</td><td>tags=49%, list=17%, signal=59%</td></tr><tr><td class='lessen'>144</td><td>DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN</td><td></td><td>17</td><td>0.72</td><td>1.93</td><td>0.000</td><td>0.007</td><td>0.264</td><td>2109</td><td>tags=59%, list=16%, signal=70%</td></tr><tr><td class='lessen'>145</td><td>HOSHIDA_LIVER_CANCER_SURVIVAL_UP</td><td></td><td>68</td><td>0.54</td><td>1.93</td><td>0.000</td><td>0.008</td><td>0.268</td><td>2127</td><td>tags=38%, list=16%, signal=46%</td></tr><tr><td class='lessen'>146</td><td>INAMURA_LUNG_CANCER_SCC_DN</td><td></td><td>12</td><td>0.79</td><td>1.93</td><td>0.003</td><td>0.008</td><td>0.278</td><td>1837</td><td>tags=50%, list=14%, signal=58%</td></tr><tr><td class='lessen'>147</td><td>GERHOLD_RESPONSE_TO_TZD_DN</td><td></td><td>13</td><td>0.77</td><td>1.93</td><td>0.000</td><td>0.008</td><td>0.278</td><td>1775</td><td>tags=54%, list=14%, signal=62%</td></tr><tr><td class='lessen'>148</td><td>JAATINEN_HEMATOPOIETIC_STEM_CELL_DN</td><td></td><td>175</td><td>0.47</td><td>1.93</td><td>0.000</td><td>0.008</td><td>0.278</td><td>2225</td><td>tags=52%, list=17%, signal=62%</td></tr><tr><td class='lessen'>149</td><td>JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN</td><td></td><td>16</td><td>0.72</td><td>1.92</td><td>0.003</td><td>0.008</td><td>0.282</td><td>732</td><td>tags=50%, list=6%, signal=53%</td></tr><tr><td class='lessen'>150</td><td>YU_MYC_TARGETS_DN</td><td></td><td>42</td><td>0.58</td><td>1.92</td><td>0.000</td><td>0.008</td><td>0.285</td><td>1828</td><td>tags=52%, list=14%, signal=61%</td></tr><tr><td class='lessen'>151</td><td>THUM_MIR21_TARGETS_HEART_DISEASE_UP</td><td></td><td>15</td><td>0.75</td><td>1.92</td><td>0.000</td><td>0.008</td><td>0.290</td><td>2011</td><td>tags=80%, list=16%, signal=95%</td></tr><tr><td class='lessen'>152</td><td>RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP</td><td></td><td>15</td><td>0.76</td><td>1.92</td><td>0.000</td><td>0.008</td><td>0.291</td><td>2540</td><td>tags=73%, list=20%, signal=91%</td></tr><tr><td class='lessen'>153</td><td>DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN</td><td></td><td>59</td><td>0.55</td><td>1.92</td><td>0.000</td><td>0.008</td><td>0.294</td><td>2186</td><td>tags=44%, list=17%, signal=53%</td></tr><tr><td class='lessen'>154</td><td>ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN</td><td></td><td>15</td><td>0.75</td><td>1.92</td><td>0.003</td><td>0.008</td><td>0.298</td><td>1833</td><td>tags=53%, list=14%, signal=62%</td></tr><tr><td class='lessen'>155</td><td>SCHOEN_NFKB_SIGNALING</td><td></td><td>30</td><td>0.63</td><td>1.92</td><td>0.000</td><td>0.008</td><td>0.299</td><td>2758</td><td>tags=63%, list=21%, signal=80%</td></tr><tr><td class='lessen'>156</td><td>SANA_TNF_SIGNALING_UP</td><td></td><td>59</td><td>0.55</td><td>1.91</td><td>0.000</td><td>0.009</td><td>0.323</td><td>2497</td><td>tags=44%, list=19%, signal=54%</td></tr><tr><td class='lessen'>157</td><td>SEKI_INFLAMMATORY_RESPONSE_LPS_DN</td><td></td><td>23</td><td>0.67</td><td>1.91</td><td>0.000</td><td>0.009</td><td>0.325</td><td>2180</td><td>tags=61%, list=17%, signal=73%</td></tr><tr><td class='lessen'>158</td><td>RUAN_RESPONSE_TO_TROGLITAZONE_DN</td><td></td><td>18</td><td>0.71</td><td>1.91</td><td>0.000</td><td>0.009</td><td>0.328</td><td>2273</td><td>tags=61%, list=18%, signal=74%</td></tr><tr><td class='lessen'>159</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0</td><td></td><td>64</td><td>0.53</td><td>1.91</td><td>0.000</td><td>0.009</td><td>0.335</td><td>2221</td><td>tags=38%, list=17%, signal=45%</td></tr><tr><td class='lessen'>160</td><td>CROONQUIST_NRAS_SIGNALING_UP</td><td></td><td>34</td><td>0.60</td><td>1.91</td><td>0.000</td><td>0.009</td><td>0.336</td><td>1693</td><td>tags=41%, list=13%, signal=47%</td></tr><tr><td class='lessen'>161</td><td>PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN</td><td></td><td>139</td><td>0.48</td><td>1.91</td><td>0.000</td><td>0.009</td><td>0.337</td><td>2330</td><td>tags=42%, list=18%, signal=51%</td></tr><tr><td class='lessen'>162</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP</td><td></td><td>154</td><td>0.47</td><td>1.91</td><td>0.000</td><td>0.009</td><td>0.345</td><td>2549</td><td>tags=42%, list=20%, signal=51%</td></tr><tr><td class='lessen'>163</td><td>PETROVA_PROX1_TARGETS_DN</td><td></td><td>56</td><td>0.53</td><td>1.90</td><td>0.000</td><td>0.010</td><td>0.357</td><td>2329</td><td>tags=57%, list=18%, signal=69%</td></tr><tr><td class='lessen'>164</td><td>ONDER_CDH1_TARGETS_2_UP</td><td></td><td>216</td><td>0.46</td><td>1.90</td><td>0.000</td><td>0.010</td><td>0.357</td><td>2443</td><td>tags=44%, list=19%, signal=53%</td></tr><tr><td class='lessen'>165</td><td>NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP</td><td></td><td>18</td><td>0.71</td><td>1.90</td><td>0.000</td><td>0.010</td><td>0.358</td><td>1267</td><td>tags=50%, list=10%, signal=55%</td></tr><tr><td class='lessen'>166</td><td>BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN</td><td></td><td>28</td><td>0.63</td><td>1.90</td><td>0.004</td><td>0.010</td><td>0.363</td><td>2135</td><td>tags=39%, list=17%, signal=47%</td></tr><tr><td class='lessen'>167</td><td>BURTON_ADIPOGENESIS_4</td><td></td><td>39</td><td>0.58</td><td>1.90</td><td>0.000</td><td>0.010</td><td>0.374</td><td>1688</td><td>tags=33%, list=13%, signal=38%</td></tr><tr><td class='lessen'>168</td><td>ROSS_AML_WITH_CBFB_MYH11_FUSION</td><td></td><td>43</td><td>0.57</td><td>1.90</td><td>0.000</td><td>0.010</td><td>0.380</td><td>1918</td><td>tags=44%, list=15%, signal=52%</td></tr><tr><td class='lessen'>169</td><td>CROMER_TUMORIGENESIS_UP</td><td></td><td>55</td><td>0.55</td><td>1.90</td><td>0.000</td><td>0.010</td><td>0.385</td><td>1568</td><td>tags=42%, list=12%, signal=47%</td></tr><tr><td class='lessen'>170</td><td>VERRECCHIA_RESPONSE_TO_TGFB1_C1</td><td></td><td>18</td><td>0.70</td><td>1.89</td><td>0.000</td><td>0.011</td><td>0.401</td><td>2052</td><td>tags=50%, list=16%, signal=59%</td></tr><tr><td class='lessen'>171</td><td>WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER</td><td></td><td>45</td><td>0.57</td><td>1.89</td><td>0.000</td><td>0.011</td><td>0.408</td><td>1432</td><td>tags=42%, list=11%, signal=47%</td></tr><tr><td class='lessen'>172</td><td>BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN</td><td></td><td>137</td><td>0.47</td><td>1.89</td><td>0.000</td><td>0.011</td><td>0.422</td><td>2434</td><td>tags=42%, list=19%, signal=51%</td></tr><tr><td class='lessen'>173</td><td>DELACROIX_RAR_TARGETS_DN</td><td></td><td>22</td><td>0.67</td><td>1.88</td><td>0.000</td><td>0.012</td><td>0.436</td><td>1586</td><td>tags=41%, list=12%, signal=47%</td></tr><tr><td class='lessen'>174</td><td>WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2</td><td></td><td>50</td><td>0.56</td><td>1.88</td><td>0.000</td><td>0.012</td><td>0.437</td><td>2161</td><td>tags=46%, list=17%, signal=55%</td></tr><tr><td class='lessen'>175</td><td>FOSTER_TOLERANT_MACROPHAGE_DN</td><td></td><td>339</td><td>0.41</td><td>1.88</td><td>0.000</td><td>0.012</td><td>0.442</td><td>2750</td><td>tags=36%, list=21%, signal=44%</td></tr><tr><td class='lessen'>176</td><td>CHEN_ETV5_TARGETS_SERTOLI</td><td></td><td>17</td><td>0.71</td><td>1.88</td><td>0.000</td><td>0.012</td><td>0.448</td><td>1775</td><td>tags=65%, list=14%, signal=75%</td></tr><tr><td class='lessen'>177</td><td>LEE_NEURAL_CREST_STEM_CELL_UP</td><td></td><td>128</td><td>0.47</td><td>1.88</td><td>0.000</td><td>0.012</td><td>0.449</td><td>1354</td><td>tags=31%, list=10%, signal=35%</td></tr><tr><td class='lessen'>178</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP</td><td></td><td>106</td><td>0.50</td><td>1.88</td><td>0.000</td><td>0.012</td><td>0.455</td><td>1998</td><td>tags=34%, list=15%, signal=40%</td></tr><tr><td class='lessen'>179</td><td>SHIN_B_CELL_LYMPHOMA_CLUSTER_3</td><td></td><td>26</td><td>0.64</td><td>1.88</td><td>0.000</td><td>0.012</td><td>0.456</td><td>2003</td><td>tags=46%, list=15%, signal=55%</td></tr><tr><td class='lessen'>180</td><td>KHETCHOUMIAN_TRIM24_TARGETS_UP</td><td></td><td>44</td><td>0.55</td><td>1.88</td><td>0.000</td><td>0.012</td><td>0.459</td><td>2104</td><td>tags=52%, list=16%, signal=62%</td></tr><tr><td class='lessen'>181</td><td>HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN</td><td></td><td>19</td><td>0.67</td><td>1.88</td><td>0.004</td><td>0.012</td><td>0.461</td><td>1859</td><td>tags=58%, list=14%, signal=68%</td></tr><tr><td class='lessen'>182</td><td>NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN</td><td></td><td>18</td><td>0.69</td><td>1.88</td><td>0.004</td><td>0.012</td><td>0.461</td><td>2814</td><td>tags=83%, list=22%, signal=106%</td></tr><tr><td class='lessen'>183</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN</td><td></td><td>15</td><td>0.74</td><td>1.88</td><td>0.006</td><td>0.012</td><td>0.462</td><td>2094</td><td>tags=60%, list=16%, signal=72%</td></tr><tr><td class='lessen'>184</td><td>SANA_RESPONSE_TO_IFNG_UP</td><td></td><td>47</td><td>0.56</td><td>1.88</td><td>0.000</td><td>0.012</td><td>0.470</td><td>2497</td><td>tags=49%, list=19%, signal=60%</td></tr><tr><td class='lessen'>185</td><td>YAMAZAKI_TCEB3_TARGETS_UP</td><td></td><td>158</td><td>0.45</td><td>1.87</td><td>0.000</td><td>0.012</td><td>0.474</td><td>1988</td><td>tags=31%, list=15%, signal=36%</td></tr><tr><td class='lessen'>186</td><td>WANG_MLL_TARGETS</td><td></td><td>253</td><td>0.42</td><td>1.87</td><td>0.000</td><td>0.012</td><td>0.474</td><td>2136</td><td>tags=41%, list=17%, signal=48%</td></tr><tr><td class='lessen'>187</td><td>VALK_AML_CLUSTER_10</td><td></td><td>28</td><td>0.63</td><td>1.87</td><td>0.000</td><td>0.012</td><td>0.478</td><td>1237</td><td>tags=32%, list=10%, signal=35%</td></tr><tr><td class='lessen'>188</td><td>ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN</td><td></td><td>47</td><td>0.56</td><td>1.87</td><td>0.000</td><td>0.012</td><td>0.481</td><td>2355</td><td>tags=49%, list=18%, signal=60%</td></tr><tr><td class='lessen'>189</td><td>KAMIKUBO_MYELOID_CEBPA_NETWORK</td><td></td><td>26</td><td>0.62</td><td>1.87</td><td>0.004</td><td>0.012</td><td>0.482</td><td>2120</td><td>tags=50%, list=16%, signal=60%</td></tr><tr><td class='lessen'>190</td><td>AMIT_SERUM_RESPONSE_40_MCF10A</td><td></td><td>27</td><td>0.64</td><td>1.87</td><td>0.000</td><td>0.012</td><td>0.484</td><td>2152</td><td>tags=56%, list=17%, signal=67%</td></tr><tr><td class='lessen'>191</td><td>STREICHER_LSM1_TARGETS_DN</td><td></td><td>17</td><td>0.71</td><td>1.87</td><td>0.000</td><td>0.012</td><td>0.484</td><td>1202</td><td>tags=53%, list=9%, signal=58%</td></tr><tr><td class='lessen'>192</td><td>HUPER_BREAST_BASAL_VS_LUMINAL_UP</td><td></td><td>41</td><td>0.58</td><td>1.87</td><td>0.000</td><td>0.012</td><td>0.484</td><td>2011</td><td>tags=46%, list=16%, signal=55%</td></tr><tr><td class='lessen'>193</td><td>YAMASHITA_METHYLATED_IN_PROSTATE_CANCER</td><td></td><td>48</td><td>0.55</td><td>1.87</td><td>0.000</td><td>0.012</td><td>0.484</td><td>1426</td><td>tags=42%, list=11%, signal=47%</td></tr><tr><td class='lessen'>194</td><td>GUO_HEX_TARGETS_DN</td><td></td><td>55</td><td>0.54</td><td>1.87</td><td>0.000</td><td>0.013</td><td>0.509</td><td>1508</td><td>tags=38%, list=12%, signal=43%</td></tr><tr><td class='lessen'>195</td><td>NAKAMURA_ADIPOGENESIS_EARLY_UP</td><td></td><td>48</td><td>0.55</td><td>1.87</td><td>0.000</td><td>0.013</td><td>0.515</td><td>2249</td><td>tags=42%, list=17%, signal=50%</td></tr><tr><td class='lessen'>196</td><td>GROSS_HYPOXIA_VIA_ELK3_ONLY_DN</td><td></td><td>39</td><td>0.58</td><td>1.86</td><td>0.000</td><td>0.013</td><td>0.518</td><td>2476</td><td>tags=51%, list=19%, signal=63%</td></tr><tr><td class='lessen'>197</td><td>GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP</td><td></td><td>66</td><td>0.52</td><td>1.86</td><td>0.000</td><td>0.013</td><td>0.524</td><td>2083</td><td>tags=35%, list=16%, signal=41%</td></tr><tr><td class='lessen'>198</td><td>ZHANG_TLX_TARGETS_DN</td><td></td><td>96</td><td>0.49</td><td>1.86</td><td>0.000</td><td>0.013</td><td>0.529</td><td>2146</td><td>tags=39%, list=17%, signal=46%</td></tr><tr><td class='lessen'>199</td><td>WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN</td><td></td><td>54</td><td>0.53</td><td>1.86</td><td>0.000</td><td>0.013</td><td>0.529</td><td>2155</td><td>tags=39%, list=17%, signal=46%</td></tr><tr><td class='lessen'>200</td><td>FERRANDO_LYL1_NEIGHBORS</td><td></td><td>15</td><td>0.71</td><td>1.86</td><td>0.000</td><td>0.014</td><td>0.537</td><td>2003</td><td>tags=60%, list=15%, signal=71%</td></tr><tr><td class='lessen'>201</td><td>MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP</td><td></td><td>18</td><td>0.70</td><td>1.86</td><td>0.003</td><td>0.014</td><td>0.538</td><td>609</td><td>tags=44%, list=5%, signal=47%</td></tr><tr><td class='lessen'>202</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP</td><td></td><td>15</td><td>0.72</td><td>1.86</td><td>0.000</td><td>0.014</td><td>0.543</td><td>1564</td><td>tags=40%, list=12%, signal=45%</td></tr><tr><td class='lessen'>203</td><td>MCLACHLAN_DENTAL_CARIES_DN</td><td></td><td>185</td><td>0.46</td><td>1.85</td><td>0.000</td><td>0.014</td><td>0.557</td><td>1868</td><td>tags=41%, list=14%, signal=47%</td></tr><tr><td class='lessen'>204</td><td>DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN</td><td></td><td>31</td><td>0.60</td><td>1.85</td><td>0.000</td><td>0.014</td><td>0.566</td><td>1998</td><td>tags=48%, list=15%, signal=57%</td></tr><tr><td class='lessen'>205</td><td>LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP</td><td></td><td>65</td><td>0.52</td><td>1.85</td><td>0.000</td><td>0.014</td><td>0.567</td><td>2455</td><td>tags=42%, list=19%, signal=51%</td></tr><tr><td class='lessen'>206</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP</td><td></td><td>132</td><td>0.46</td><td>1.85</td><td>0.000</td><td>0.016</td><td>0.596</td><td>2479</td><td>tags=40%, list=19%, signal=49%</td></tr><tr><td class='lessen'>207</td><td>SANA_TNF_SIGNALING_DN</td><td></td><td>76</td><td>0.50</td><td>1.84</td><td>0.000</td><td>0.016</td><td>0.600</td><td>2120</td><td>tags=45%, list=16%, signal=53%</td></tr><tr><td class='lessen'>208</td><td>BASSO_HAIRY_CELL_LEUKEMIA_DN</td><td></td><td>73</td><td>0.51</td><td>1.84</td><td>0.000</td><td>0.016</td><td>0.611</td><td>1364</td><td>tags=34%, list=11%, signal=38%</td></tr><tr><td class='lessen'>209</td><td>DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP</td><td></td><td>221</td><td>0.45</td><td>1.84</td><td>0.000</td><td>0.016</td><td>0.614</td><td>2419</td><td>tags=41%, list=19%, signal=49%</td></tr><tr><td class='lessen'>210</td><td>BROWNE_HCMV_INFECTION_18HR_DN</td><td></td><td>147</td><td>0.45</td><td>1.84</td><td>0.000</td><td>0.016</td><td>0.614</td><td>2550</td><td>tags=42%, list=20%, signal=52%</td></tr><tr><td class='lessen'>211</td><td>BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP</td><td></td><td>358</td><td>0.43</td><td>1.84</td><td>0.000</td><td>0.016</td><td>0.614</td><td>2524</td><td>tags=42%, list=20%, signal=50%</td></tr><tr><td class='lessen'>212</td><td>HAN_JNK_SINGALING_DN</td><td></td><td>35</td><td>0.59</td><td>1.84</td><td>0.000</td><td>0.016</td><td>0.620</td><td>2048</td><td>tags=43%, list=16%, signal=51%</td></tr><tr><td class='lessen'>213</td><td>MANALO_HYPOXIA_UP</td><td></td><td>178</td><td>0.45</td><td>1.84</td><td>0.000</td><td>0.017</td><td>0.635</td><td>2614</td><td>tags=46%, list=20%, signal=56%</td></tr><tr><td class='lessen'>214</td><td>ZHANG_TLX_TARGETS_36HR_UP</td><td></td><td>191</td><td>0.45</td><td>1.84</td><td>0.000</td><td>0.017</td><td>0.635</td><td>2165</td><td>tags=34%, list=17%, signal=40%</td></tr><tr><td class='lessen'>215</td><td>NAKAMURA_ADIPOGENESIS_EARLY_DN</td><td></td><td>37</td><td>0.56</td><td>1.84</td><td>0.000</td><td>0.017</td><td>0.648</td><td>2052</td><td>tags=49%, list=16%, signal=58%</td></tr><tr><td class='lessen'>216</td><td>LIU_SMARCA4_TARGETS</td><td></td><td>51</td><td>0.54</td><td>1.84</td><td>0.000</td><td>0.017</td><td>0.650</td><td>1432</td><td>tags=43%, list=11%, signal=48%</td></tr><tr><td class='lessen'>217</td><td>KRASNOSELSKAYA_ILF3_TARGETS_UP</td><td></td><td>29</td><td>0.59</td><td>1.83</td><td>0.000</td><td>0.017</td><td>0.653</td><td>2864</td><td>tags=55%, list=22%, signal=71%</td></tr><tr><td class='lessen'>218</td><td>ZHANG_ADIPOGENESIS_BY_BMP7</td><td></td><td>13</td><td>0.74</td><td>1.83</td><td>0.000</td><td>0.017</td><td>0.654</td><td>1033</td><td>tags=46%, list=8%, signal=50%</td></tr><tr><td class='lessen'>219</td><td>HOWLIN_PUBERTAL_MAMMARY_GLAND</td><td></td><td>61</td><td>0.52</td><td>1.83</td><td>0.000</td><td>0.017</td><td>0.668</td><td>1939</td><td>tags=41%, list=15%, signal=48%</td></tr><tr><td class='lessen'>220</td><td>RICKMAN_HEAD_AND_NECK_CANCER_F</td><td></td><td>48</td><td>0.55</td><td>1.83</td><td>0.000</td><td>0.017</td><td>0.670</td><td>1432</td><td>tags=40%, list=11%, signal=44%</td></tr><tr><td class='lessen'>221</td><td>BURTON_ADIPOGENESIS_PEAK_AT_2HR</td><td></td><td>48</td><td>0.56</td><td>1.83</td><td>0.000</td><td>0.018</td><td>0.685</td><td>2230</td><td>tags=48%, list=17%, signal=58%</td></tr><tr><td class='lessen'>222</td><td>ROSS_AML_WITH_MLL_FUSIONS</td><td></td><td>63</td><td>0.51</td><td>1.83</td><td>0.000</td><td>0.019</td><td>0.689</td><td>2550</td><td>tags=40%, list=20%, signal=49%</td></tr><tr><td class='lessen'>223</td><td>WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN</td><td></td><td>22</td><td>0.64</td><td>1.83</td><td>0.000</td><td>0.019</td><td>0.693</td><td>2512</td><td>tags=64%, list=19%, signal=79%</td></tr><tr><td class='lessen'>224</td><td>AMIT_EGF_RESPONSE_20_HELA</td><td></td><td>10</td><td>0.78</td><td>1.82</td><td>0.003</td><td>0.019</td><td>0.698</td><td>2062</td><td>tags=60%, list=16%, signal=71%</td></tr><tr><td class='lessen'>225</td><td>GOUYER_TATI_TARGETS_DN</td><td></td><td>16</td><td>0.70</td><td>1.82</td><td>0.000</td><td>0.019</td><td>0.703</td><td>1876</td><td>tags=63%, list=15%, signal=73%</td></tr><tr><td class='lessen'>226</td><td>DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN</td><td></td><td>150</td><td>0.44</td><td>1.82</td><td>0.000</td><td>0.019</td><td>0.708</td><td>2655</td><td>tags=44%, list=21%, signal=55%</td></tr><tr><td class='lessen'>227</td><td>RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP</td><td></td><td>326</td><td>0.42</td><td>1.82</td><td>0.000</td><td>0.019</td><td>0.713</td><td>2438</td><td>tags=33%, list=19%, signal=39%</td></tr><tr><td class='lessen'>228</td><td>MORI_LARGE_PRE_BII_LYMPHOCYTE_DN</td><td></td><td>46</td><td>0.54</td><td>1.82</td><td>0.000</td><td>0.020</td><td>0.722</td><td>3051</td><td>tags=57%, list=24%, signal=74%</td></tr><tr><td class='lessen'>229</td><td>CHAN_INTERFERON_PRODUCING_DENDRITIC_CELL</td><td></td><td>11</td><td>0.76</td><td>1.82</td><td>0.006</td><td>0.020</td><td>0.723</td><td>1620</td><td>tags=73%, list=13%, signal=83%</td></tr><tr><td class='lessen'>230</td><td>VERRECCHIA_RESPONSE_TO_TGFB1_C4</td><td></td><td>12</td><td>0.73</td><td>1.82</td><td>0.006</td><td>0.020</td><td>0.730</td><td>1224</td><td>tags=42%, list=9%, signal=46%</td></tr><tr><td class='lessen'>231</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP</td><td></td><td>136</td><td>0.47</td><td>1.82</td><td>0.000</td><td>0.020</td><td>0.731</td><td>2425</td><td>tags=43%, list=19%, signal=52%</td></tr><tr><td class='lessen'>232</td><td>DANG_MYC_TARGETS_DN</td><td></td><td>31</td><td>0.59</td><td>1.82</td><td>0.004</td><td>0.020</td><td>0.736</td><td>2135</td><td>tags=39%, list=17%, signal=46%</td></tr><tr><td class='lessen'>233</td><td>DAIRKEE_CANCER_PRONE_RESPONSE_E2</td><td></td><td>27</td><td>0.61</td><td>1.82</td><td>0.000</td><td>0.020</td><td>0.737</td><td>1722</td><td>tags=37%, list=13%, signal=43%</td></tr><tr><td class='lessen'>234</td><td>GROSS_HYPOXIA_VIA_HIF1A_DN</td><td></td><td>93</td><td>0.48</td><td>1.81</td><td>0.000</td><td>0.020</td><td>0.740</td><td>2438</td><td>tags=34%, list=19%, signal=42%</td></tr><tr><td class='lessen'>235</td><td>LEE_AGING_CEREBELLUM_UP</td><td></td><td>76</td><td>0.50</td><td>1.81</td><td>0.000</td><td>0.020</td><td>0.741</td><td>2766</td><td>tags=46%, list=21%, signal=58%</td></tr><tr><td class='lessen'>236</td><td>SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN</td><td></td><td>24</td><td>0.64</td><td>1.81</td><td>0.004</td><td>0.020</td><td>0.744</td><td>2325</td><td>tags=50%, list=18%, signal=61%</td></tr><tr><td class='lessen'>237</td><td>LINDSTEDT_DENDRITIC_CELL_MATURATION_A</td><td></td><td>60</td><td>0.51</td><td>1.81</td><td>0.000</td><td>0.020</td><td>0.744</td><td>1868</td><td>tags=38%, list=14%, signal=45%</td></tr><tr><td class='lessen'>238</td><td>CHANG_POU5F1_TARGETS_UP</td><td></td><td>13</td><td>0.73</td><td>1.81</td><td>0.006</td><td>0.021</td><td>0.747</td><td>1905</td><td>tags=62%, list=15%, signal=72%</td></tr><tr><td class='lessen'>239</td><td>BOYLAN_MULTIPLE_MYELOMA_C_D_DN</td><td></td><td>216</td><td>0.43</td><td>1.81</td><td>0.000</td><td>0.021</td><td>0.747</td><td>2186</td><td>tags=35%, list=17%, signal=41%</td></tr><tr><td class='lessen'>240</td><td>SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP</td><td></td><td>30</td><td>0.60</td><td>1.81</td><td>0.000</td><td>0.021</td><td>0.755</td><td>1441</td><td>tags=23%, list=11%, signal=26%</td></tr><tr><td class='lessen'>241</td><td>DER_IFN_ALPHA_RESPONSE_UP</td><td></td><td>61</td><td>0.51</td><td>1.81</td><td>0.000</td><td>0.021</td><td>0.758</td><td>3606</td><td>tags=46%, list=28%, signal=63%</td></tr><tr><td class='lessen'>242</td><td>VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP</td><td></td><td>152</td><td>0.44</td><td>1.81</td><td>0.000</td><td>0.021</td><td>0.760</td><td>1940</td><td>tags=43%, list=15%, signal=50%</td></tr><tr><td class='lessen'>243</td><td>RUTELLA_RESPONSE_TO_HGF_DN</td><td></td><td>188</td><td>0.44</td><td>1.80</td><td>0.000</td><td>0.022</td><td>0.765</td><td>2152</td><td>tags=32%, list=17%, signal=38%</td></tr><tr><td class='lessen'>244</td><td>NADERI_BREAST_CANCER_PROGNOSIS_DN</td><td></td><td>17</td><td>0.68</td><td>1.80</td><td>0.003</td><td>0.022</td><td>0.773</td><td>1657</td><td>tags=53%, list=13%, signal=61%</td></tr><tr><td class='lessen'>245</td><td>ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN</td><td></td><td>84</td><td>0.47</td><td>1.80</td><td>0.000</td><td>0.022</td><td>0.776</td><td>2117</td><td>tags=39%, list=16%, signal=47%</td></tr><tr><td class='lessen'>246</td><td>GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN</td><td></td><td>74</td><td>0.49</td><td>1.80</td><td>0.000</td><td>0.022</td><td>0.776</td><td>1692</td><td>tags=31%, list=13%, signal=36%</td></tr><tr><td class='lessen'>247</td><td>BROWNE_HCMV_INFECTION_24HR_DN</td><td></td><td>126</td><td>0.46</td><td>1.80</td><td>0.000</td><td>0.022</td><td>0.776</td><td>2468</td><td>tags=45%, list=19%, signal=55%</td></tr><tr><td class='lessen'>248</td><td>RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN</td><td></td><td>135</td><td>0.45</td><td>1.80</td><td>0.000</td><td>0.022</td><td>0.778</td><td>1787</td><td>tags=27%, list=14%, signal=31%</td></tr><tr><td class='lessen'>249</td><td>VALK_AML_CLUSTER_11</td><td></td><td>34</td><td>0.57</td><td>1.80</td><td>0.005</td><td>0.023</td><td>0.798</td><td>2524</td><td>tags=53%, list=20%, signal=66%</td></tr><tr><td class='lessen'>250</td><td>VERHAAK_AML_WITH_NPM1_MUTATED_UP</td><td></td><td>152</td><td>0.44</td><td>1.80</td><td>0.000</td><td>0.023</td><td>0.798</td><td>2320</td><td>tags=43%, list=18%, signal=51%</td></tr><tr><td class='lessen'>251</td><td>LEE_DIFFERENTIATING_T_LYMPHOCYTE</td><td></td><td>148</td><td>0.43</td><td>1.79</td><td>0.000</td><td>0.023</td><td>0.800</td><td>2545</td><td>tags=40%, list=20%, signal=49%</td></tr><tr><td class='lessen'>252</td><td>SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN</td><td></td><td>16</td><td>0.68</td><td>1.79</td><td>0.003</td><td>0.023</td><td>0.803</td><td>1328</td><td>tags=38%, list=10%, signal=42%</td></tr><tr><td class='lessen'>253</td><td>DEMAGALHAES_AGING_UP</td><td></td><td>43</td><td>0.54</td><td>1.79</td><td>0.000</td><td>0.023</td><td>0.803</td><td>2365</td><td>tags=49%, list=18%, signal=60%</td></tr><tr><td class='lessen'>254</td><td>BURTON_ADIPOGENESIS_7</td><td></td><td>47</td><td>0.54</td><td>1.79</td><td>0.005</td><td>0.023</td><td>0.805</td><td>2123</td><td>tags=43%, list=16%, signal=51%</td></tr><tr><td class='lessen'>255</td><td>CAIRO_LIVER_DEVELOPMENT_UP</td><td></td><td>141</td><td>0.45</td><td>1.79</td><td>0.000</td><td>0.023</td><td>0.806</td><td>2391</td><td>tags=36%, list=18%, signal=44%</td></tr><tr><td class='lessen'>256</td><td>LI_INDUCED_T_TO_NATURAL_KILLER_UP</td><td></td><td>247</td><td>0.42</td><td>1.79</td><td>0.000</td><td>0.023</td><td>0.811</td><td>2705</td><td>tags=42%, list=21%, signal=52%</td></tr><tr><td class='lessen'>257</td><td>WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN</td><td></td><td>44</td><td>0.52</td><td>1.79</td><td>0.000</td><td>0.023</td><td>0.811</td><td>1905</td><td>tags=41%, list=15%, signal=48%</td></tr><tr><td class='lessen'>258</td><td>RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN</td><td></td><td>245</td><td>0.41</td><td>1.79</td><td>0.000</td><td>0.023</td><td>0.811</td><td>2574</td><td>tags=36%, list=20%, signal=44%</td></tr><tr><td class='lessen'>259</td><td>BIDUS_METASTASIS_DN</td><td></td><td>119</td><td>0.46</td><td>1.79</td><td>0.000</td><td>0.023</td><td>0.812</td><td>2359</td><td>tags=37%, list=18%, signal=45%</td></tr><tr><td class='lessen'>260</td><td>NAKAJIMA_MAST_CELL</td><td></td><td>41</td><td>0.56</td><td>1.79</td><td>0.000</td><td>0.024</td><td>0.816</td><td>2606</td><td>tags=51%, list=20%, signal=64%</td></tr><tr><td class='lessen'>261</td><td>EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION</td><td></td><td>49</td><td>0.53</td><td>1.79</td><td>0.000</td><td>0.023</td><td>0.816</td><td>898</td><td>tags=31%, list=7%, signal=33%</td></tr><tr><td class='lessen'>262</td><td>LEE_BMP2_TARGETS_UP</td><td></td><td>605</td><td>0.38</td><td>1.79</td><td>0.000</td><td>0.024</td><td>0.826</td><td>2800</td><td>tags=36%, list=22%, signal=43%</td></tr><tr><td class='lessen'>263</td><td>EHRLICH_ICF_SYNDROM_DN</td><td></td><td>12</td><td>0.72</td><td>1.79</td><td>0.014</td><td>0.024</td><td>0.826</td><td>1885</td><td>tags=58%, list=15%, signal=68%</td></tr><tr><td class='lessen'>264</td><td>GU_PDEF_TARGETS_UP</td><td></td><td>67</td><td>0.50</td><td>1.78</td><td>0.000</td><td>0.024</td><td>0.832</td><td>1918</td><td>tags=37%, list=15%, signal=44%</td></tr><tr><td class='lessen'>265</td><td>CLAUS_PGR_POSITIVE_MENINGIOMA_DN</td><td></td><td>12</td><td>0.74</td><td>1.78</td><td>0.015</td><td>0.025</td><td>0.844</td><td>2767</td><td>tags=75%, list=21%, signal=95%</td></tr><tr><td class='lessen'>266</td><td>WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC</td><td></td><td>20</td><td>0.64</td><td>1.78</td><td>0.003</td><td>0.025</td><td>0.844</td><td>2359</td><td>tags=65%, list=18%, signal=79%</td></tr><tr><td class='lessen'>267</td><td>FRIDMAN_SENESCENCE_UP</td><td></td><td>70</td><td>0.49</td><td>1.78</td><td>0.000</td><td>0.025</td><td>0.846</td><td>2547</td><td>tags=47%, list=20%, signal=58%</td></tr><tr><td class='lessen'>268</td><td>MILI_PSEUDOPODIA_CHEMOTAXIS_DN</td><td></td><td>379</td><td>0.38</td><td>1.78</td><td>0.000</td><td>0.026</td><td>0.849</td><td>2969</td><td>tags=29%, list=23%, signal=36%</td></tr><tr><td class='lessen'>269</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6</td><td></td><td>60</td><td>0.51</td><td>1.78</td><td>0.000</td><td>0.026</td><td>0.854</td><td>2240</td><td>tags=40%, list=17%, signal=48%</td></tr><tr><td class='lessen'>270</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN</td><td></td><td>19</td><td>0.65</td><td>1.78</td><td>0.011</td><td>0.026</td><td>0.857</td><td>3313</td><td>tags=84%, list=26%, signal=113%</td></tr><tr><td class='lessen'>271</td><td>KIM_HYPOXIA</td><td></td><td>21</td><td>0.63</td><td>1.77</td><td>0.007</td><td>0.027</td><td>0.864</td><td>2509</td><td>tags=52%, list=19%, signal=65%</td></tr><tr><td class='lessen'>272</td><td>DANG_REGULATED_BY_MYC_DN</td><td></td><td>230</td><td>0.41</td><td>1.77</td><td>0.000</td><td>0.027</td><td>0.868</td><td>2501</td><td>tags=35%, list=19%, signal=42%</td></tr><tr><td class='lessen'>273</td><td>RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP</td><td></td><td>59</td><td>0.52</td><td>1.77</td><td>0.000</td><td>0.027</td><td>0.871</td><td>3020</td><td>tags=53%, list=23%, signal=68%</td></tr><tr><td class='lessen'>274</td><td>CHYLA_CBFA2T3_TARGETS_UP</td><td></td><td>316</td><td>0.40</td><td>1.77</td><td>0.000</td><td>0.027</td><td>0.874</td><td>2477</td><td>tags=42%, list=19%, signal=51%</td></tr><tr><td class='lessen'>275</td><td>MOSERLE_IFNA_RESPONSE</td><td></td><td>19</td><td>0.65</td><td>1.77</td><td>0.007</td><td>0.027</td><td>0.876</td><td>3534</td><td>tags=74%, list=27%, signal=101%</td></tr><tr><td class='lessen'>276</td><td>KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN</td><td></td><td>256</td><td>0.41</td><td>1.77</td><td>0.000</td><td>0.027</td><td>0.876</td><td>2217</td><td>tags=35%, list=17%, signal=41%</td></tr><tr><td class='lessen'>277</td><td>ONO_AML1_TARGETS_DN</td><td></td><td>34</td><td>0.56</td><td>1.77</td><td>0.009</td><td>0.027</td><td>0.881</td><td>1559</td><td>tags=41%, list=12%, signal=47%</td></tr><tr><td class='lessen'>278</td><td>RUAN_RESPONSE_TO_TNF_UP</td><td></td><td>10</td><td>0.77</td><td>1.77</td><td>0.003</td><td>0.028</td><td>0.886</td><td>2382</td><td>tags=70%, list=18%, signal=86%</td></tr><tr><td class='lessen'>279</td><td>KANG_GIST_WITH_PDGFRA_UP</td><td></td><td>45</td><td>0.53</td><td>1.77</td><td>0.000</td><td>0.028</td><td>0.890</td><td>2255</td><td>tags=42%, list=17%, signal=51%</td></tr><tr><td class='lessen'>280</td><td>KAYO_CALORIE_RESTRICTION_MUSCLE_UP</td><td></td><td>83</td><td>0.48</td><td>1.76</td><td>0.000</td><td>0.029</td><td>0.897</td><td>1889</td><td>tags=37%, list=15%, signal=43%</td></tr><tr><td class='lessen'>281</td><td>WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP</td><td></td><td>104</td><td>0.45</td><td>1.76</td><td>0.000</td><td>0.029</td><td>0.902</td><td>2201</td><td>tags=43%, list=17%, signal=52%</td></tr><tr><td class='lessen'>282</td><td>LE_EGR2_TARGETS_DN</td><td></td><td>95</td><td>0.45</td><td>1.76</td><td>0.000</td><td>0.030</td><td>0.906</td><td>1521</td><td>tags=28%, list=12%, signal=32%</td></tr><tr><td class='lessen'>283</td><td>CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP</td><td></td><td>85</td><td>0.48</td><td>1.76</td><td>0.000</td><td>0.030</td><td>0.907</td><td>2434</td><td>tags=41%, list=19%, signal=50%</td></tr><tr><td class='lessen'>284</td><td>WANG_LSD1_TARGETS_UP</td><td></td><td>18</td><td>0.67</td><td>1.75</td><td>0.004</td><td>0.031</td><td>0.912</td><td>1711</td><td>tags=44%, list=13%, signal=51%</td></tr><tr><td class='lessen'>285</td><td>MARZEC_IL2_SIGNALING_UP</td><td></td><td>106</td><td>0.45</td><td>1.75</td><td>0.000</td><td>0.031</td><td>0.913</td><td>2353</td><td>tags=29%, list=18%, signal=35%</td></tr><tr><td class='lessen'>286</td><td>WIELAND_UP_BY_HBV_INFECTION</td><td></td><td>75</td><td>0.48</td><td>1.75</td><td>0.000</td><td>0.031</td><td>0.915</td><td>2382</td><td>tags=47%, list=18%, signal=57%</td></tr><tr><td class='lessen'>287</td><td>ZHU_CMV_8_HR_DN</td><td></td><td>47</td><td>0.52</td><td>1.75</td><td>0.000</td><td>0.031</td><td>0.915</td><td>2894</td><td>tags=47%, list=22%, signal=60%</td></tr><tr><td class='lessen'>288</td><td>WIERENGA_STAT5A_TARGETS_GROUP2</td><td></td><td>45</td><td>0.51</td><td>1.75</td><td>0.000</td><td>0.032</td><td>0.922</td><td>2048</td><td>tags=38%, list=16%, signal=45%</td></tr><tr><td class='lessen'>289</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP</td><td></td><td>29</td><td>0.57</td><td>1.75</td><td>0.016</td><td>0.032</td><td>0.923</td><td>1855</td><td>tags=34%, list=14%, signal=40%</td></tr><tr><td class='lessen'>290</td><td>PHONG_TNF_RESPONSE_VIA_P38_PARTIAL</td><td></td><td>145</td><td>0.42</td><td>1.75</td><td>0.000</td><td>0.032</td><td>0.923</td><td>2604</td><td>tags=39%, list=20%, signal=48%</td></tr><tr><td class='lessen'>291</td><td>NEMETH_INFLAMMATORY_RESPONSE_LPS_UP</td><td></td><td>79</td><td>0.47</td><td>1.75</td><td>0.000</td><td>0.032</td><td>0.926</td><td>3181</td><td>tags=49%, list=25%, signal=65%</td></tr><tr><td class='lessen'>292</td><td>ROZANOV_MMP14_TARGETS_UP</td><td></td><td>213</td><td>0.42</td><td>1.75</td><td>0.000</td><td>0.032</td><td>0.926</td><td>1998</td><td>tags=37%, list=15%, signal=43%</td></tr><tr><td class='lessen'>293</td><td>GILDEA_METASTASIS</td><td></td><td>23</td><td>0.62</td><td>1.75</td><td>0.004</td><td>0.032</td><td>0.926</td><td>2255</td><td>tags=52%, list=17%, signal=63%</td></tr><tr><td class='lessen'>294</td><td>GRABARCZYK_BCL11B_TARGETS_UP</td><td></td><td>58</td><td>0.49</td><td>1.75</td><td>0.000</td><td>0.032</td><td>0.926</td><td>1444</td><td>tags=28%, list=11%, signal=31%</td></tr><tr><td class='lessen'>295</td><td>BOWIE_RESPONSE_TO_TAMOXIFEN</td><td></td><td>14</td><td>0.69</td><td>1.75</td><td>0.012</td><td>0.032</td><td>0.926</td><td>3524</td><td>tags=79%, list=27%, signal=108%</td></tr><tr><td class='lessen'>296</td><td>KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS</td><td></td><td>38</td><td>0.56</td><td>1.74</td><td>0.000</td><td>0.033</td><td>0.929</td><td>1828</td><td>tags=63%, list=14%, signal=73%</td></tr><tr><td class='lessen'>297</td><td>WANG_TNF_TARGETS</td><td></td><td>22</td><td>0.61</td><td>1.74</td><td>0.000</td><td>0.033</td><td>0.929</td><td>2493</td><td>tags=68%, list=19%, signal=84%</td></tr><tr><td class='lessen'>298</td><td>VERRECCHIA_RESPONSE_TO_TGFB1_C5</td><td></td><td>21</td><td>0.64</td><td>1.74</td><td>0.008</td><td>0.033</td><td>0.929</td><td>3039</td><td>tags=62%, list=23%, signal=81%</td></tr><tr><td class='lessen'>299</td><td>VALK_AML_CLUSTER_5</td><td></td><td>21</td><td>0.63</td><td>1.74</td><td>0.000</td><td>0.034</td><td>0.936</td><td>2765</td><td>tags=62%, list=21%, signal=79%</td></tr><tr><td class='lessen'>300</td><td>VANHARANTA_UTERINE_FIBROID_DN</td><td></td><td>53</td><td>0.50</td><td>1.74</td><td>0.000</td><td>0.034</td><td>0.936</td><td>2235</td><td>tags=43%, list=17%, signal=52%</td></tr><tr><td class='lessen'>301</td><td>BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP</td><td></td><td>17</td><td>0.65</td><td>1.74</td><td>0.010</td><td>0.035</td><td>0.937</td><td>2443</td><td>tags=65%, list=19%, signal=80%</td></tr><tr><td class='lessen'>302</td><td>NAKAMURA_ADIPOGENESIS_LATE_DN</td><td></td><td>35</td><td>0.54</td><td>1.73</td><td>0.020</td><td>0.035</td><td>0.939</td><td>2255</td><td>tags=49%, list=17%, signal=59%</td></tr><tr><td class='lessen'>303</td><td>AMIT_EGF_RESPONSE_120_HELA</td><td></td><td>58</td><td>0.50</td><td>1.73</td><td>0.000</td><td>0.036</td><td>0.940</td><td>3150</td><td>tags=55%, list=24%, signal=73%</td></tr><tr><td class='lessen'>304</td><td>WESTON_VEGFA_TARGETS_3HR</td><td></td><td>65</td><td>0.48</td><td>1.73</td><td>0.000</td><td>0.037</td><td>0.952</td><td>2557</td><td>tags=48%, list=20%, signal=59%</td></tr><tr><td class='lessen'>305</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN</td><td></td><td>362</td><td>0.35</td><td>1.73</td><td>0.000</td><td>0.037</td><td>0.952</td><td>2082</td><td>tags=31%, list=16%, signal=36%</td></tr><tr><td class='lessen'>306</td><td>SABATES_COLORECTAL_ADENOMA_SIZE_UP</td><td></td><td>15</td><td>0.67</td><td>1.73</td><td>0.013</td><td>0.037</td><td>0.952</td><td>1604</td><td>tags=33%, list=12%, signal=38%</td></tr><tr><td class='lessen'>307</td><td>LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP</td><td></td><td>166</td><td>0.43</td><td>1.73</td><td>0.000</td><td>0.037</td><td>0.952</td><td>2329</td><td>tags=35%, list=18%, signal=42%</td></tr><tr><td class='lessen'>308</td><td>SIMBULAN_UV_RESPONSE_NORMAL_DN</td><td></td><td>28</td><td>0.58</td><td>1.72</td><td>0.008</td><td>0.038</td><td>0.953</td><td>1427</td><td>tags=36%, list=11%, signal=40%</td></tr><tr><td class='lessen'>309</td><td>BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX</td><td></td><td>14</td><td>0.68</td><td>1.72</td><td>0.006</td><td>0.038</td><td>0.957</td><td>3524</td><td>tags=79%, list=27%, signal=108%</td></tr><tr><td class='lessen'>310</td><td>MARTINEZ_TP53_TARGETS_UP</td><td></td><td>504</td><td>0.43</td><td>1.72</td><td>0.000</td><td>0.039</td><td>0.957</td><td>2007</td><td>tags=27%, list=16%, signal=31%</td></tr><tr><td class='lessen'>311</td><td>BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP</td><td></td><td>25</td><td>0.57</td><td>1.72</td><td>0.000</td><td>0.039</td><td>0.960</td><td>1979</td><td>tags=40%, list=15%, signal=47%</td></tr><tr><td class='lessen'>312</td><td>AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G</td><td></td><td>87</td><td>0.46</td><td>1.72</td><td>0.000</td><td>0.039</td><td>0.960</td><td>2416</td><td>tags=36%, list=19%, signal=44%</td></tr><tr><td class='lessen'>313</td><td>ZHENG_RESPONSE_TO_ARSENITE_DN</td><td></td><td>17</td><td>0.63</td><td>1.72</td><td>0.006</td><td>0.039</td><td>0.960</td><td>2358</td><td>tags=47%, list=18%, signal=57%</td></tr><tr><td class='lessen'>314</td><td>TSAI_RESPONSE_TO_RADIATION_THERAPY</td><td></td><td>29</td><td>0.56</td><td>1.72</td><td>0.013</td><td>0.039</td><td>0.960</td><td>2121</td><td>tags=55%, list=16%, signal=66%</td></tr><tr><td class='lessen'>315</td><td>GRUETZMANN_PANCREATIC_CANCER_UP</td><td></td><td>307</td><td>0.38</td><td>1.72</td><td>0.000</td><td>0.040</td><td>0.963</td><td>2528</td><td>tags=30%, list=20%, signal=37%</td></tr><tr><td class='lessen'>316</td><td>KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP</td><td></td><td>111</td><td>0.43</td><td>1.72</td><td>0.000</td><td>0.040</td><td>0.963</td><td>2499</td><td>tags=41%, list=19%, signal=50%</td></tr><tr><td class='lessen'>317</td><td>CROONQUIST_IL6_DEPRIVATION_UP</td><td></td><td>17</td><td>0.65</td><td>1.71</td><td>0.018</td><td>0.040</td><td>0.966</td><td>1852</td><td>tags=53%, list=14%, signal=62%</td></tr><tr><td class='lessen'>318</td><td>VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP</td><td></td><td>11</td><td>0.73</td><td>1.71</td><td>0.014</td><td>0.040</td><td>0.967</td><td>1954</td><td>tags=55%, list=15%, signal=64%</td></tr><tr><td class='lessen'>319</td><td>MULLIGHAN_MLL_SIGNATURE_1_UP</td><td></td><td>304</td><td>0.39</td><td>1.71</td><td>0.000</td><td>0.040</td><td>0.967</td><td>2040</td><td>tags=26%, list=16%, signal=30%</td></tr><tr><td class='lessen'>320</td><td>PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION</td><td></td><td>30</td><td>0.56</td><td>1.71</td><td>0.004</td><td>0.040</td><td>0.967</td><td>2165</td><td>tags=53%, list=17%, signal=64%</td></tr><tr><td class='lessen'>321</td><td>PLASARI_TGFB1_TARGETS_10HR_DN</td><td></td><td>218</td><td>0.41</td><td>1.71</td><td>0.000</td><td>0.041</td><td>0.969</td><td>2597</td><td>tags=44%, list=20%, signal=54%</td></tr><tr><td class='lessen'>322</td><td>KANG_IMMORTALIZED_BY_TERT_UP</td><td></td><td>80</td><td>0.45</td><td>1.71</td><td>0.000</td><td>0.041</td><td>0.970</td><td>2089</td><td>tags=34%, list=16%, signal=40%</td></tr><tr><td class='lessen'>323</td><td>MCDOWELL_ACUTE_LUNG_INJURY_UP</td><td></td><td>41</td><td>0.51</td><td>1.71</td><td>0.000</td><td>0.041</td><td>0.970</td><td>2452</td><td>tags=49%, list=19%, signal=60%</td></tr><tr><td class='lessen'>324</td><td>MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH</td><td></td><td>15</td><td>0.65</td><td>1.71</td><td>0.013</td><td>0.041</td><td>0.970</td><td>717</td><td>tags=27%, list=6%, signal=28%</td></tr><tr><td class='lessen'>325</td><td>BOYLAN_MULTIPLE_MYELOMA_PCA1_UP</td><td></td><td>87</td><td>0.46</td><td>1.71</td><td>0.000</td><td>0.041</td><td>0.970</td><td>2125</td><td>tags=41%, list=16%, signal=49%</td></tr><tr><td class='lessen'>326</td><td>BROWNE_INTERFERON_RESPONSIVE_GENES</td><td></td><td>53</td><td>0.51</td><td>1.71</td><td>0.000</td><td>0.042</td><td>0.970</td><td>2833</td><td>tags=51%, list=22%, signal=65%</td></tr><tr><td class='lessen'>327</td><td>GENTLES_LEUKEMIC_STEM_CELL_UP</td><td></td><td>22</td><td>0.61</td><td>1.71</td><td>0.003</td><td>0.042</td><td>0.971</td><td>2118</td><td>tags=50%, list=16%, signal=60%</td></tr><tr><td class='lessen'>328</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN</td><td></td><td>107</td><td>0.44</td><td>1.71</td><td>0.000</td><td>0.042</td><td>0.971</td><td>1918</td><td>tags=43%, list=15%, signal=50%</td></tr><tr><td class='lessen'>329</td><td>RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP</td><td></td><td>282</td><td>0.39</td><td>1.71</td><td>0.000</td><td>0.042</td><td>0.971</td><td>2842</td><td>tags=35%, list=22%, signal=44%</td></tr><tr><td class='lessen'>330</td><td>SMID_BREAST_CANCER_LUMINAL_B_DN</td><td></td><td>444</td><td>0.40</td><td>1.70</td><td>0.000</td><td>0.044</td><td>0.976</td><td>2411</td><td>tags=41%, list=19%, signal=49%</td></tr><tr><td class='lessen'>331</td><td>THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN</td><td></td><td>198</td><td>0.41</td><td>1.70</td><td>0.000</td><td>0.044</td><td>0.976</td><td>3504</td><td>tags=38%, list=27%, signal=52%</td></tr><tr><td class='lessen'>332</td><td>BRACHAT_RESPONSE_TO_CISPLATIN</td><td></td><td>16</td><td>0.64</td><td>1.70</td><td>0.020</td><td>0.044</td><td>0.976</td><td>2990</td><td>tags=69%, list=23%, signal=89%</td></tr><tr><td class='lessen'>333</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP</td><td></td><td>132</td><td>0.44</td><td>1.70</td><td>0.000</td><td>0.044</td><td>0.976</td><td>1300</td><td>tags=29%, list=10%, signal=32%</td></tr><tr><td class='lessen'>334</td><td>RODWELL_AGING_KIDNEY_NO_BLOOD_UP</td><td></td><td>173</td><td>0.41</td><td>1.70</td><td>0.000</td><td>0.045</td><td>0.977</td><td>1759</td><td>tags=31%, list=14%, signal=36%</td></tr><tr><td class='lessen'>335</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_1_DN</td><td></td><td>33</td><td>0.53</td><td>1.70</td><td>0.014</td><td>0.045</td><td>0.977</td><td>3037</td><td>tags=48%, list=23%, signal=63%</td></tr><tr><td class='lessen'>336</td><td>CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN</td><td></td><td>42</td><td>0.52</td><td>1.70</td><td>0.000</td><td>0.045</td><td>0.977</td><td>1880</td><td>tags=40%, list=15%, signal=47%</td></tr><tr><td class='lessen'>337</td><td>WEST_ADRENOCORTICAL_TUMOR_DN</td><td></td><td>458</td><td>0.39</td><td>1.70</td><td>0.000</td><td>0.045</td><td>0.977</td><td>2416</td><td>tags=34%, list=19%, signal=41%</td></tr><tr><td class='lessen'>338</td><td>NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN</td><td></td><td>105</td><td>0.46</td><td>1.70</td><td>0.000</td><td>0.045</td><td>0.978</td><td>1889</td><td>tags=21%, list=15%, signal=24%</td></tr><tr><td class='lessen'>339</td><td>GAJATE_RESPONSE_TO_TRABECTEDIN_UP</td><td></td><td>56</td><td>0.49</td><td>1.69</td><td>0.000</td><td>0.045</td><td>0.978</td><td>2470</td><td>tags=45%, list=19%, signal=55%</td></tr><tr><td class='lessen'>340</td><td>TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN</td><td></td><td>264</td><td>0.38</td><td>1.69</td><td>0.000</td><td>0.046</td><td>0.981</td><td>2517</td><td>tags=34%, list=19%, signal=42%</td></tr><tr><td class='lessen'>341</td><td>HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP</td><td></td><td>60</td><td>0.49</td><td>1.69</td><td>0.007</td><td>0.046</td><td>0.981</td><td>1862</td><td>tags=37%, list=14%, signal=43%</td></tr><tr><td class='lessen'>342</td><td>GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN</td><td></td><td>69</td><td>0.47</td><td>1.69</td><td>0.000</td><td>0.046</td><td>0.981</td><td>2472</td><td>tags=42%, list=19%, signal=52%</td></tr><tr><td class='lessen'>343</td><td>KATSANOU_ELAVL1_TARGETS_UP</td><td></td><td>143</td><td>0.42</td><td>1.69</td><td>0.000</td><td>0.047</td><td>0.983</td><td>2343</td><td>tags=40%, list=18%, signal=48%</td></tr><tr><td class='lessen'>344</td><td>HINATA_NFKB_TARGETS_KERATINOCYTE_UP</td><td></td><td>81</td><td>0.46</td><td>1.69</td><td>0.009</td><td>0.047</td><td>0.983</td><td>2771</td><td>tags=42%, list=21%, signal=53%</td></tr><tr><td class='lessen'>345</td><td>SHIN_B_CELL_LYMPHOMA_CLUSTER_1</td><td></td><td>10</td><td>0.74</td><td>1.68</td><td>0.017</td><td>0.048</td><td>0.984</td><td>1283</td><td>tags=40%, list=10%, signal=44%</td></tr><tr><td class='lessen'>346</td><td>KIM_LRRC3B_TARGETS</td><td></td><td>17</td><td>0.65</td><td>1.68</td><td>0.010</td><td>0.048</td><td>0.985</td><td>1356</td><td>tags=29%, list=10%, signal=33%</td></tr><tr><td class='lessen'>347</td><td>CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP</td><td></td><td>30</td><td>0.55</td><td>1.68</td><td>0.013</td><td>0.048</td><td>0.986</td><td>1373</td><td>tags=37%, list=11%, signal=41%</td></tr><tr><td class='lessen'>348</td><td>SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP</td><td></td><td>134</td><td>0.42</td><td>1.68</td><td>0.000</td><td>0.048</td><td>0.986</td><td>2083</td><td>tags=37%, list=16%, signal=43%</td></tr><tr><td class='lessen'>349</td><td>WANG_NFKB_TARGETS</td><td></td><td>22</td><td>0.58</td><td>1.68</td><td>0.011</td><td>0.049</td><td>0.987</td><td>2106</td><td>tags=36%, list=16%, signal=43%</td></tr><tr><td class='lessen'>350</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP</td><td></td><td>47</td><td>0.50</td><td>1.68</td><td>0.000</td><td>0.049</td><td>0.987</td><td>1472</td><td>tags=28%, list=11%, signal=31%</td></tr><tr><td class='lessen'>351</td><td>WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP</td><td></td><td>28</td><td>0.56</td><td>1.68</td><td>0.009</td><td>0.049</td><td>0.987</td><td>1993</td><td>tags=61%, list=15%, signal=72%</td></tr><tr><td class='lessen'>352</td><td>MORI_PRE_BI_LYMPHOCYTE_DN</td><td></td><td>66</td><td>0.49</td><td>1.68</td><td>0.008</td><td>0.049</td><td>0.987</td><td>2152</td><td>tags=35%, list=17%, signal=42%</td></tr><tr><td class='lessen'>353</td><td>WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN</td><td></td><td>17</td><td>0.64</td><td>1.68</td><td>0.019</td><td>0.049</td><td>0.988</td><td>1824</td><td>tags=47%, list=14%, signal=55%</td></tr><tr><td class='lessen'>354</td><td>WOO_LIVER_CANCER_RECURRENCE_UP</td><td></td><td>93</td><td>0.44</td><td>1.68</td><td>0.011</td><td>0.049</td><td>0.988</td><td>2606</td><td>tags=41%, list=20%, signal=51%</td></tr><tr><td class='lessen'>355</td><td>GAVIN_PDE3B_TARGETS</td><td></td><td>20</td><td>0.61</td><td>1.68</td><td>0.004</td><td>0.049</td><td>0.988</td><td>1605</td><td>tags=40%, list=12%, signal=46%</td></tr><tr><td class='lessen'>356</td><td>HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP</td><td></td><td>56</td><td>0.48</td><td>1.68</td><td>0.000</td><td>0.050</td><td>0.988</td><td>2049</td><td>tags=36%, list=16%, signal=42%</td></tr><tr><td class='lessen'>357</td><td>ELVIDGE_HYPOXIA_UP</td><td></td><td>140</td><td>0.41</td><td>1.68</td><td>0.000</td><td>0.050</td><td>0.989</td><td>2117</td><td>tags=36%, list=16%, signal=42%</td></tr><tr><td class='lessen'>358</td><td>DELACROIX_RAR_TARGETS_UP</td><td></td><td>44</td><td>0.50</td><td>1.67</td><td>0.005</td><td>0.050</td><td>0.991</td><td>1759</td><td>tags=34%, list=14%, signal=39%</td></tr><tr><td class='lessen'>359</td><td>VERRECCHIA_RESPONSE_TO_TGFB1_C3</td><td></td><td>13</td><td>0.68</td><td>1.67</td><td>0.015</td><td>0.051</td><td>0.994</td><td>2225</td><td>tags=62%, list=17%, signal=74%</td></tr><tr><td class='lessen'>360</td><td>GREENBAUM_E2A_TARGETS_DN</td><td></td><td>16</td><td>0.64</td><td>1.67</td><td>0.015</td><td>0.051</td><td>0.994</td><td>1388</td><td>tags=31%, list=11%, signal=35%</td></tr><tr><td class='lessen'>361</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP</td><td></td><td>154</td><td>0.40</td><td>1.67</td><td>0.000</td><td>0.051</td><td>0.994</td><td>2145</td><td>tags=30%, list=17%, signal=35%</td></tr><tr><td class='lessen'>362</td><td>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP</td><td></td><td>88</td><td>0.44</td><td>1.67</td><td>0.000</td><td>0.051</td><td>0.995</td><td>2766</td><td>tags=51%, list=21%, signal=65%</td></tr><tr><td class='lessen'>363</td><td>DASU_IL6_SIGNALING_UP</td><td></td><td>51</td><td>0.49</td><td>1.67</td><td>0.000</td><td>0.052</td><td>0.995</td><td>2524</td><td>tags=39%, list=20%, signal=49%</td></tr><tr><td class='lessen'>364</td><td>HARRIS_BRAIN_CANCER_PROGENITORS</td><td></td><td>37</td><td>0.51</td><td>1.67</td><td>0.005</td><td>0.053</td><td>0.996</td><td>1834</td><td>tags=46%, list=14%, signal=53%</td></tr><tr><td class='lessen'>365</td><td>JEON_SMAD6_TARGETS_UP</td><td></td><td>21</td><td>0.59</td><td>1.67</td><td>0.011</td><td>0.053</td><td>0.996</td><td>2062</td><td>tags=48%, list=16%, signal=57%</td></tr><tr><td class='lessen'>366</td><td>HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP</td><td></td><td>65</td><td>0.47</td><td>1.67</td><td>0.000</td><td>0.053</td><td>0.996</td><td>2403</td><td>tags=40%, list=19%, signal=49%</td></tr><tr><td class='lessen'>367</td><td>ZHENG_IL22_SIGNALING_UP</td><td></td><td>44</td><td>0.50</td><td>1.67</td><td>0.005</td><td>0.053</td><td>0.996</td><td>972</td><td>tags=25%, list=8%, signal=27%</td></tr><tr><td class='lessen'>368</td><td>PHONG_TNF_TARGETS_UP</td><td></td><td>58</td><td>0.47</td><td>1.67</td><td>0.000</td><td>0.053</td><td>0.996</td><td>3154</td><td>tags=55%, list=24%, signal=73%</td></tr><tr><td class='lessen'>369</td><td>CADWELL_ATG16L1_TARGETS_UP</td><td></td><td>78</td><td>0.46</td><td>1.66</td><td>0.008</td><td>0.053</td><td>0.996</td><td>870</td><td>tags=28%, list=7%, signal=30%</td></tr><tr><td class='lessen'>370</td><td>ZIRN_TRETINOIN_RESPONSE_UP</td><td></td><td>17</td><td>0.63</td><td>1.66</td><td>0.010</td><td>0.053</td><td>0.996</td><td>1608</td><td>tags=47%, list=12%, signal=54%</td></tr><tr><td class='lessen'>371</td><td>CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP</td><td></td><td>19</td><td>0.60</td><td>1.66</td><td>0.011</td><td>0.053</td><td>0.996</td><td>2256</td><td>tags=47%, list=17%, signal=57%</td></tr><tr><td class='lessen'>372</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN</td><td></td><td>160</td><td>0.41</td><td>1.66</td><td>0.000</td><td>0.053</td><td>0.996</td><td>2115</td><td>tags=39%, list=16%, signal=46%</td></tr><tr><td class='lessen'>373</td><td>WU_HBX_TARGETS_2_DN</td><td></td><td>14</td><td>0.67</td><td>1.66</td><td>0.016</td><td>0.053</td><td>0.996</td><td>1244</td><td>tags=36%, list=10%, signal=39%</td></tr><tr><td class='lessen'>374</td><td>ZHENG_GLIOBLASTOMA_PLASTICITY_DN</td><td></td><td>55</td><td>0.49</td><td>1.66</td><td>0.007</td><td>0.053</td><td>0.996</td><td>1905</td><td>tags=35%, list=15%, signal=40%</td></tr><tr><td class='lessen'>375</td><td>BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN</td><td></td><td>39</td><td>0.51</td><td>1.66</td><td>0.000</td><td>0.053</td><td>0.996</td><td>3526</td><td>tags=62%, list=27%, signal=84%</td></tr><tr><td class='lessen'>376</td><td>CHICAS_RB1_TARGETS_CONFLUENT</td><td></td><td>457</td><td>0.37</td><td>1.66</td><td>0.000</td><td>0.054</td><td>0.996</td><td>2286</td><td>tags=33%, list=18%, signal=39%</td></tr><tr><td class='lessen'>377</td><td>BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN</td><td></td><td>42</td><td>0.52</td><td>1.66</td><td>0.005</td><td>0.054</td><td>0.996</td><td>2502</td><td>tags=43%, list=19%, signal=53%</td></tr><tr><td class='lessen'>378</td><td>WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN</td><td></td><td>14</td><td>0.67</td><td>1.66</td><td>0.031</td><td>0.055</td><td>0.996</td><td>2371</td><td>tags=57%, list=18%, signal=70%</td></tr><tr><td class='lessen'>379</td><td>COWLING_MYCN_TARGETS</td><td></td><td>34</td><td>0.52</td><td>1.66</td><td>0.005</td><td>0.055</td><td>0.996</td><td>2378</td><td>tags=38%, list=18%, signal=47%</td></tr><tr><td class='lessen'>380</td><td>LEE_CALORIE_RESTRICTION_MUSCLE_DN</td><td></td><td>49</td><td>0.48</td><td>1.66</td><td>0.000</td><td>0.054</td><td>0.996</td><td>1293</td><td>tags=18%, list=10%, signal=20%</td></tr><tr><td class='lessen'>381</td><td>JIANG_TIP30_TARGETS_UP</td><td></td><td>38</td><td>0.52</td><td>1.66</td><td>0.000</td><td>0.054</td><td>0.996</td><td>2161</td><td>tags=39%, list=17%, signal=47%</td></tr><tr><td class='lessen'>382</td><td>KANG_AR_TARGETS_DN</td><td></td><td>17</td><td>0.63</td><td>1.65</td><td>0.019</td><td>0.056</td><td>0.996</td><td>2820</td><td>tags=71%, list=22%, signal=90%</td></tr><tr><td class='lessen'>383</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN</td><td></td><td>44</td><td>0.51</td><td>1.65</td><td>0.000</td><td>0.056</td><td>0.996</td><td>2485</td><td>tags=43%, list=19%, signal=53%</td></tr><tr><td class='lessen'>384</td><td>VARELA_ZMPSTE24_TARGETS_UP</td><td></td><td>34</td><td>0.53</td><td>1.65</td><td>0.000</td><td>0.056</td><td>0.996</td><td>2785</td><td>tags=50%, list=22%, signal=64%</td></tr><tr><td class='lessen'>385</td><td>RADMACHER_AML_PROGNOSIS</td><td></td><td>66</td><td>0.46</td><td>1.65</td><td>0.000</td><td>0.056</td><td>0.996</td><td>2150</td><td>tags=32%, list=17%, signal=38%</td></tr><tr><td class='lessen'>386</td><td>DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN</td><td></td><td>24</td><td>0.57</td><td>1.65</td><td>0.022</td><td>0.056</td><td>0.996</td><td>2124</td><td>tags=33%, list=16%, signal=40%</td></tr><tr><td class='lessen'>387</td><td>BILBAN_B_CLL_LPL_UP</td><td></td><td>52</td><td>0.47</td><td>1.65</td><td>0.000</td><td>0.056</td><td>0.996</td><td>1187</td><td>tags=19%, list=9%, signal=21%</td></tr><tr><td class='lessen'>388</td><td>VILIMAS_NOTCH1_TARGETS_DN</td><td></td><td>20</td><td>0.59</td><td>1.65</td><td>0.026</td><td>0.056</td><td>0.996</td><td>2322</td><td>tags=65%, list=18%, signal=79%</td></tr><tr><td class='lessen'>389</td><td>DER_IFN_GAMMA_RESPONSE_UP</td><td></td><td>62</td><td>0.46</td><td>1.65</td><td>0.007</td><td>0.056</td><td>0.996</td><td>3277</td><td>tags=45%, list=25%, signal=60%</td></tr><tr><td class='lessen'>390</td><td>LEE_INTRATHYMIC_T_PROGENITOR</td><td></td><td>15</td><td>0.63</td><td>1.65</td><td>0.026</td><td>0.057</td><td>0.996</td><td>1282</td><td>tags=40%, list=10%, signal=44%</td></tr><tr><td class='lessen'>391</td><td>KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN</td><td></td><td>11</td><td>0.69</td><td>1.65</td><td>0.027</td><td>0.058</td><td>0.996</td><td>1805</td><td>tags=36%, list=14%, signal=42%</td></tr><tr><td class='lessen'>392</td><td>DIRMEIER_LMP1_RESPONSE_EARLY</td><td></td><td>60</td><td>0.47</td><td>1.64</td><td>0.000</td><td>0.059</td><td>0.998</td><td>2425</td><td>tags=35%, list=19%, signal=43%</td></tr><tr><td class='lessen'>393</td><td>POOLA_INVASIVE_BREAST_CANCER_UP</td><td></td><td>227</td><td>0.39</td><td>1.64</td><td>0.000</td><td>0.059</td><td>0.998</td><td>1868</td><td>tags=39%, list=14%, signal=45%</td></tr><tr><td class='lessen'>394</td><td>KANG_IMMORTALIZED_BY_TERT_DN</td><td></td><td>94</td><td>0.43</td><td>1.64</td><td>0.000</td><td>0.060</td><td>0.998</td><td>1609</td><td>tags=37%, list=12%, signal=42%</td></tr><tr><td class='lessen'>395</td><td>KANG_CISPLATIN_RESISTANCE_UP</td><td></td><td>16</td><td>0.61</td><td>1.64</td><td>0.023</td><td>0.061</td><td>0.999</td><td>2388</td><td>tags=50%, list=18%, signal=61%</td></tr><tr><td class='lessen'>396</td><td>DELYS_THYROID_CANCER_UP</td><td></td><td>391</td><td>0.31</td><td>1.64</td><td>0.000</td><td>0.061</td><td>0.999</td><td>2302</td><td>tags=30%, list=18%, signal=36%</td></tr><tr><td class='lessen'>397</td><td>DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP</td><td></td><td>104</td><td>0.42</td><td>1.64</td><td>0.000</td><td>0.061</td><td>0.999</td><td>2532</td><td>tags=35%, list=20%, signal=43%</td></tr><tr><td class='lessen'>398</td><td>BRIDEAU_IMPRINTED_GENES</td><td></td><td>58</td><td>0.46</td><td>1.64</td><td>0.000</td><td>0.062</td><td>0.999</td><td>987</td><td>tags=28%, list=8%, signal=30%</td></tr><tr><td class='lessen'>399</td><td>CORRE_MULTIPLE_MYELOMA_UP</td><td></td><td>57</td><td>0.46</td><td>1.64</td><td>0.007</td><td>0.062</td><td>0.999</td><td>1982</td><td>tags=42%, list=15%, signal=50%</td></tr><tr><td class='lessen'>400</td><td>MURATA_VIRULENCE_OF_H_PILORI</td><td></td><td>21</td><td>0.59</td><td>1.63</td><td>0.022</td><td>0.063</td><td>0.999</td><td>1671</td><td>tags=48%, list=13%, signal=55%</td></tr><tr><td class='lessen'>401</td><td>GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN</td><td></td><td>24</td><td>0.56</td><td>1.63</td><td>0.025</td><td>0.063</td><td>0.999</td><td>3088</td><td>tags=63%, list=24%, signal=82%</td></tr><tr><td class='lessen'>402</td><td>CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP</td><td></td><td>35</td><td>0.51</td><td>1.63</td><td>0.018</td><td>0.063</td><td>0.999</td><td>3020</td><td>tags=54%, list=23%, signal=71%</td></tr><tr><td class='lessen'>403</td><td>ELVIDGE_HYPOXIA_BY_DMOG_UP</td><td></td><td>108</td><td>0.42</td><td>1.63</td><td>0.000</td><td>0.063</td><td>0.999</td><td>2117</td><td>tags=38%, list=16%, signal=45%</td></tr><tr><td class='lessen'>404</td><td>ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF</td><td></td><td>181</td><td>0.40</td><td>1.63</td><td>0.000</td><td>0.063</td><td>0.999</td><td>2423</td><td>tags=33%, list=19%, signal=40%</td></tr><tr><td class='lessen'>405</td><td>ONO_FOXP3_TARGETS_DN</td><td></td><td>35</td><td>0.51</td><td>1.63</td><td>0.005</td><td>0.063</td><td>0.999</td><td>2113</td><td>tags=40%, list=16%, signal=48%</td></tr><tr><td class='lessen'>406</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_T7</td><td></td><td>82</td><td>0.44</td><td>1.63</td><td>0.000</td><td>0.063</td><td>0.999</td><td>2761</td><td>tags=33%, list=21%, signal=42%</td></tr><tr><td class='lessen'>407</td><td>YAGI_AML_RELAPSE_PROGNOSIS</td><td></td><td>30</td><td>0.53</td><td>1.63</td><td>0.004</td><td>0.064</td><td>0.999</td><td>2320</td><td>tags=30%, list=18%, signal=36%</td></tr><tr><td class='lessen'>408</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP</td><td></td><td>33</td><td>0.51</td><td>1.63</td><td>0.021</td><td>0.064</td><td>0.999</td><td>1696</td><td>tags=15%, list=13%, signal=17%</td></tr><tr><td class='lessen'>409</td><td>WINTER_HYPOXIA_METAGENE</td><td></td><td>202</td><td>0.39</td><td>1.63</td><td>0.000</td><td>0.064</td><td>0.999</td><td>2250</td><td>tags=34%, list=17%, signal=40%</td></tr><tr><td class='lessen'>410</td><td>RUTELLA_RESPONSE_TO_HGF_UP</td><td></td><td>339</td><td>0.37</td><td>1.63</td><td>0.000</td><td>0.064</td><td>0.999</td><td>2604</td><td>tags=32%, list=20%, signal=39%</td></tr><tr><td class='lessen'>411</td><td>FOSTER_TOLERANT_MACROPHAGE_UP</td><td></td><td>136</td><td>0.40</td><td>1.63</td><td>0.000</td><td>0.064</td><td>0.999</td><td>2290</td><td>tags=38%, list=18%, signal=46%</td></tr><tr><td class='lessen'>412</td><td>SEKI_INFLAMMATORY_RESPONSE_LPS_UP</td><td></td><td>69</td><td>0.46</td><td>1.63</td><td>0.000</td><td>0.064</td><td>0.999</td><td>2493</td><td>tags=43%, list=19%, signal=54%</td></tr><tr><td class='lessen'>413</td><td>PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN</td><td></td><td>38</td><td>0.50</td><td>1.63</td><td>0.000</td><td>0.064</td><td>0.999</td><td>1956</td><td>tags=32%, list=15%, signal=37%</td></tr><tr><td class='lessen'>414</td><td>INGRAM_SHH_TARGETS_DN</td><td></td><td>50</td><td>0.49</td><td>1.63</td><td>0.006</td><td>0.065</td><td>0.999</td><td>2079</td><td>tags=36%, list=16%, signal=43%</td></tr><tr><td class='lessen'>415</td><td>APPEL_IMATINIB_RESPONSE</td><td></td><td>30</td><td>0.53</td><td>1.63</td><td>0.004</td><td>0.065</td><td>0.999</td><td>2641</td><td>tags=40%, list=20%, signal=50%</td></tr><tr><td class='lessen'>416</td><td>SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN</td><td></td><td>126</td><td>0.40</td><td>1.63</td><td>0.000</td><td>0.065</td><td>0.999</td><td>2468</td><td>tags=32%, list=19%, signal=39%</td></tr><tr><td class='lessen'>417</td><td>DIRMEIER_LMP1_RESPONSE_LATE_UP</td><td></td><td>50</td><td>0.47</td><td>1.62</td><td>0.006</td><td>0.065</td><td>0.999</td><td>2746</td><td>tags=42%, list=21%, signal=53%</td></tr><tr><td class='lessen'>418</td><td>HASLINGER_B_CLL_WITH_11Q23_DELETION</td><td></td><td>20</td><td>0.59</td><td>1.62</td><td>0.031</td><td>0.065</td><td>0.999</td><td>2865</td><td>tags=40%, list=22%, signal=51%</td></tr><tr><td class='lessen'>419</td><td>GOLDRATH_IMMUNE_MEMORY</td><td></td><td>57</td><td>0.47</td><td>1.62</td><td>0.006</td><td>0.065</td><td>0.999</td><td>2240</td><td>tags=35%, list=17%, signal=42%</td></tr><tr><td class='lessen'>420</td><td>BURTON_ADIPOGENESIS_11</td><td></td><td>45</td><td>0.48</td><td>1.62</td><td>0.005</td><td>0.065</td><td>0.999</td><td>3007</td><td>tags=38%, list=23%, signal=49%</td></tr><tr><td class='lessen'>421</td><td>TSAI_DNAJB4_TARGETS_UP</td><td></td><td>11</td><td>0.70</td><td>1.62</td><td>0.032</td><td>0.065</td><td>0.999</td><td>3395</td><td>tags=73%, list=26%, signal=99%</td></tr><tr><td class='lessen'>422</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP</td><td></td><td>123</td><td>0.42</td><td>1.62</td><td>0.000</td><td>0.066</td><td>0.999</td><td>2230</td><td>tags=34%, list=17%, signal=41%</td></tr><tr><td class='lessen'>423</td><td>HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS</td><td></td><td>65</td><td>0.47</td><td>1.62</td><td>0.000</td><td>0.066</td><td>0.999</td><td>1618</td><td>tags=35%, list=13%, signal=40%</td></tr><tr><td class='lessen'>424</td><td>KUNINGER_IGF1_VS_PDGFB_TARGETS_UP</td><td></td><td>68</td><td>0.45</td><td>1.62</td><td>0.000</td><td>0.067</td><td>0.999</td><td>1045</td><td>tags=28%, list=8%, signal=30%</td></tr><tr><td class='lessen'>425</td><td>MARSON_FOXP3_TARGETS_UP</td><td></td><td>57</td><td>0.47</td><td>1.62</td><td>0.006</td><td>0.067</td><td>0.999</td><td>3051</td><td>tags=51%, list=24%, signal=66%</td></tr><tr><td class='lessen'>426</td><td>GROSS_ELK3_TARGETS_UP</td><td></td><td>26</td><td>0.54</td><td>1.62</td><td>0.017</td><td>0.068</td><td>0.999</td><td>2895</td><td>tags=58%, list=22%, signal=74%</td></tr><tr><td class='lessen'>427</td><td>FALVELLA_SMOKERS_WITH_LUNG_CANCER</td><td></td><td>63</td><td>0.45</td><td>1.62</td><td>0.000</td><td>0.068</td><td>0.999</td><td>2221</td><td>tags=30%, list=17%, signal=36%</td></tr><tr><td class='lessen'>428</td><td>VALK_AML_WITH_CEBPA</td><td></td><td>32</td><td>0.52</td><td>1.62</td><td>0.009</td><td>0.068</td><td>0.999</td><td>2392</td><td>tags=38%, list=18%, signal=46%</td></tr><tr><td class='lessen'>429</td><td>ELVIDGE_HIF1A_TARGETS_DN</td><td></td><td>77</td><td>0.45</td><td>1.61</td><td>0.000</td><td>0.068</td><td>0.999</td><td>2117</td><td>tags=40%, list=16%, signal=48%</td></tr><tr><td class='lessen'>430</td><td>BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS</td><td></td><td>21</td><td>0.57</td><td>1.61</td><td>0.012</td><td>0.068</td><td>0.999</td><td>2382</td><td>tags=33%, list=18%, signal=41%</td></tr><tr><td class='lessen'>431</td><td>BAKER_HEMATOPOESIS_STAT1_TARGETS</td><td></td><td>10</td><td>0.71</td><td>1.61</td><td>0.027</td><td>0.068</td><td>0.999</td><td>1218</td><td>tags=50%, list=9%, signal=55%</td></tr><tr><td class='lessen'>432</td><td>PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION</td><td></td><td>22</td><td>0.56</td><td>1.61</td><td>0.026</td><td>0.068</td><td>0.999</td><td>2165</td><td>tags=55%, list=17%, signal=65%</td></tr><tr><td class='lessen'>433</td><td>WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN</td><td></td><td>17</td><td>0.59</td><td>1.61</td><td>0.014</td><td>0.068</td><td>0.999</td><td>1714</td><td>tags=53%, list=13%, signal=61%</td></tr><tr><td class='lessen'>434</td><td>FRIDMAN_IMMORTALIZATION_DN</td><td></td><td>29</td><td>0.53</td><td>1.61</td><td>0.022</td><td>0.068</td><td>0.999</td><td>2507</td><td>tags=55%, list=19%, signal=68%</td></tr><tr><td class='lessen'>435</td><td>GAJATE_RESPONSE_TO_TRABECTEDIN_DN</td><td></td><td>18</td><td>0.59</td><td>1.61</td><td>0.023</td><td>0.069</td><td>0.999</td><td>650</td><td>tags=17%, list=5%, signal=18%</td></tr><tr><td class='lessen'>436</td><td>ONDER_CDH1_SIGNALING_VIA_CTNNB1</td><td></td><td>67</td><td>0.45</td><td>1.61</td><td>0.000</td><td>0.069</td><td>0.999</td><td>2500</td><td>tags=43%, list=19%, signal=53%</td></tr><tr><td class='lessen'>437</td><td>DORSEY_GAB2_TARGETS</td><td></td><td>27</td><td>0.53</td><td>1.61</td><td>0.017</td><td>0.071</td><td>0.999</td><td>2309</td><td>tags=59%, list=18%, signal=72%</td></tr><tr><td class='lessen'>438</td><td>VALK_AML_CLUSTER_9</td><td></td><td>28</td><td>0.55</td><td>1.61</td><td>0.011</td><td>0.071</td><td>0.999</td><td>2046</td><td>tags=43%, list=16%, signal=51%</td></tr><tr><td class='lessen'>439</td><td>PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2</td><td></td><td>63</td><td>0.45</td><td>1.61</td><td>0.000</td><td>0.071</td><td>0.999</td><td>1757</td><td>tags=29%, list=14%, signal=33%</td></tr><tr><td class='lessen'>440</td><td>KUMAR_TARGETS_OF_MLL_AF9_FUSION</td><td></td><td>334</td><td>0.37</td><td>1.60</td><td>0.000</td><td>0.072</td><td>1.000</td><td>2512</td><td>tags=35%, list=19%, signal=42%</td></tr><tr><td class='lessen'>441</td><td>ZHANG_RESPONSE_TO_CANTHARIDIN_UP</td><td></td><td>17</td><td>0.60</td><td>1.60</td><td>0.023</td><td>0.072</td><td>1.000</td><td>2311</td><td>tags=41%, list=18%, signal=50%</td></tr><tr><td class='lessen'>442</td><td>NEWMAN_ERCC6_TARGETS_DN</td><td></td><td>30</td><td>0.54</td><td>1.60</td><td>0.014</td><td>0.072</td><td>1.000</td><td>1531</td><td>tags=40%, list=12%, signal=45%</td></tr><tr><td class='lessen'>443</td><td>MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP</td><td></td><td>213</td><td>0.38</td><td>1.60</td><td>0.000</td><td>0.074</td><td>1.000</td><td>2505</td><td>tags=36%, list=19%, signal=44%</td></tr><tr><td class='lessen'>444</td><td>INGA_TP53_TARGETS</td><td></td><td>15</td><td>0.63</td><td>1.60</td><td>0.036</td><td>0.075</td><td>1.000</td><td>2052</td><td>tags=47%, list=16%, signal=55%</td></tr><tr><td class='lessen'>445</td><td>PHONG_TNF_RESPONSE_NOT_VIA_P38</td><td></td><td>289</td><td>0.36</td><td>1.60</td><td>0.000</td><td>0.075</td><td>1.000</td><td>2655</td><td>tags=33%, list=21%, signal=40%</td></tr><tr><td class='lessen'>446</td><td>REN_ALVEOLAR_RHABDOMYOSARCOMA_UP</td><td></td><td>88</td><td>0.42</td><td>1.60</td><td>0.000</td><td>0.075</td><td>1.000</td><td>1837</td><td>tags=31%, list=14%, signal=36%</td></tr><tr><td class='lessen'>447</td><td>PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN</td><td></td><td>138</td><td>0.40</td><td>1.60</td><td>0.000</td><td>0.075</td><td>1.000</td><td>2156</td><td>tags=29%, list=17%, signal=34%</td></tr><tr><td class='lessen'>448</td><td>COATES_MACROPHAGE_M1_VS_M2_UP</td><td></td><td>65</td><td>0.45</td><td>1.60</td><td>0.000</td><td>0.075</td><td>1.000</td><td>2646</td><td>tags=40%, list=20%, signal=50%</td></tr><tr><td class='lessen'>449</td><td>DELACROIX_RARG_BOUND_MEF</td><td></td><td>311</td><td>0.37</td><td>1.59</td><td>0.000</td><td>0.075</td><td>1.000</td><td>1898</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>450</td><td>TRAYNOR_RETT_SYNDROM_UP</td><td></td><td>35</td><td>0.52</td><td>1.59</td><td>0.010</td><td>0.075</td><td>1.000</td><td>2833</td><td>tags=51%, list=22%, signal=66%</td></tr><tr><td class='lessen'>451</td><td>WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN</td><td></td><td>154</td><td>0.40</td><td>1.59</td><td>0.000</td><td>0.075</td><td>1.000</td><td>2353</td><td>tags=36%, list=18%, signal=43%</td></tr><tr><td class='lessen'>452</td><td>ROSS_LEUKEMIA_WITH_MLL_FUSIONS</td><td></td><td>62</td><td>0.45</td><td>1.59</td><td>0.000</td><td>0.075</td><td>1.000</td><td>1550</td><td>tags=27%, list=12%, signal=31%</td></tr><tr><td class='lessen'>453</td><td>BAELDE_DIABETIC_NEPHROPATHY_DN</td><td></td><td>373</td><td>0.34</td><td>1.59</td><td>0.000</td><td>0.075</td><td>1.000</td><td>2621</td><td>tags=27%, list=20%, signal=33%</td></tr><tr><td class='lessen'>454</td><td>JOHNSTONE_PARVB_TARGETS_3_UP</td><td></td><td>344</td><td>0.38</td><td>1.59</td><td>0.000</td><td>0.075</td><td>1.000</td><td>2754</td><td>tags=34%, list=21%, signal=42%</td></tr><tr><td class='lessen'>455</td><td>BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE</td><td></td><td>57</td><td>0.46</td><td>1.59</td><td>0.007</td><td>0.075</td><td>1.000</td><td>1437</td><td>tags=28%, list=11%, signal=31%</td></tr><tr><td class='lessen'>456</td><td>CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN</td><td></td><td>88</td><td>0.42</td><td>1.59</td><td>0.000</td><td>0.075</td><td>1.000</td><td>2394</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>457</td><td>HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN</td><td></td><td>226</td><td>0.37</td><td>1.59</td><td>0.000</td><td>0.075</td><td>1.000</td><td>2138</td><td>tags=29%, list=17%, signal=34%</td></tr><tr><td class='lessen'>458</td><td>BURTON_ADIPOGENESIS_8</td><td></td><td>77</td><td>0.43</td><td>1.59</td><td>0.016</td><td>0.076</td><td>1.000</td><td>3093</td><td>tags=39%, list=24%, signal=51%</td></tr><tr><td class='lessen'>459</td><td>HUMMERICH_BENIGN_SKIN_TUMOR_UP</td><td></td><td>15</td><td>0.62</td><td>1.59</td><td>0.033</td><td>0.077</td><td>1.000</td><td>489</td><td>tags=27%, list=4%, signal=28%</td></tr><tr><td class='lessen'>460</td><td>JOHNSTONE_PARVB_TARGETS_2_UP</td><td></td><td>118</td><td>0.41</td><td>1.58</td><td>0.000</td><td>0.079</td><td>1.000</td><td>2522</td><td>tags=31%, list=19%, signal=38%</td></tr><tr><td class='lessen'>461</td><td>THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP</td><td></td><td>65</td><td>0.44</td><td>1.58</td><td>0.000</td><td>0.080</td><td>1.000</td><td>2355</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>462</td><td>SHI_SPARC_TARGETS_UP</td><td></td><td>21</td><td>0.56</td><td>1.58</td><td>0.016</td><td>0.081</td><td>1.000</td><td>1728</td><td>tags=33%, list=13%, signal=38%</td></tr><tr><td class='lessen'>463</td><td>INGRAM_SHH_TARGETS_UP</td><td></td><td>109</td><td>0.40</td><td>1.58</td><td>0.000</td><td>0.081</td><td>1.000</td><td>2854</td><td>tags=44%, list=22%, signal=56%</td></tr><tr><td class='lessen'>464</td><td>LEI_HOXC8_TARGETS_UP</td><td></td><td>12</td><td>0.64</td><td>1.58</td><td>0.031</td><td>0.081</td><td>1.000</td><td>1295</td><td>tags=42%, list=10%, signal=46%</td></tr><tr><td class='lessen'>465</td><td>PENG_GLUCOSE_DEPRIVATION_UP</td><td></td><td>40</td><td>0.48</td><td>1.58</td><td>0.009</td><td>0.083</td><td>1.000</td><td>1999</td><td>tags=25%, list=15%, signal=29%</td></tr><tr><td class='lessen'>466</td><td>DER_IFN_BETA_RESPONSE_UP</td><td></td><td>85</td><td>0.41</td><td>1.58</td><td>0.000</td><td>0.083</td><td>1.000</td><td>3277</td><td>tags=38%, list=25%, signal=50%</td></tr><tr><td class='lessen'>467</td><td>MORI_IMMATURE_B_LYMPHOCYTE_UP</td><td></td><td>45</td><td>0.48</td><td>1.58</td><td>0.015</td><td>0.083</td><td>1.000</td><td>2302</td><td>tags=36%, list=18%, signal=43%</td></tr><tr><td class='lessen'>468</td><td>MULLIGHAN_MLL_SIGNATURE_1_DN</td><td></td><td>197</td><td>0.37</td><td>1.57</td><td>0.000</td><td>0.083</td><td>1.000</td><td>2334</td><td>tags=32%, list=18%, signal=39%</td></tr><tr><td class='lessen'>469</td><td>LU_AGING_BRAIN_UP</td><td></td><td>219</td><td>0.38</td><td>1.57</td><td>0.000</td><td>0.084</td><td>1.000</td><td>2785</td><td>tags=35%, list=22%, signal=44%</td></tr><tr><td class='lessen'>470</td><td>PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP</td><td></td><td>42</td><td>0.49</td><td>1.57</td><td>0.011</td><td>0.085</td><td>1.000</td><td>2302</td><td>tags=38%, list=18%, signal=46%</td></tr><tr><td class='lessen'>471</td><td>MATZUK_POST-IMPLANTATION_AND_POST-PARTUM</td><td></td><td>13</td><td>0.65</td><td>1.57</td><td>0.049</td><td>0.085</td><td>1.000</td><td>2048</td><td>tags=38%, list=16%, signal=46%</td></tr><tr><td class='lessen'>472</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN</td><td></td><td>25</td><td>0.55</td><td>1.57</td><td>0.020</td><td>0.086</td><td>1.000</td><td>2136</td><td>tags=52%, list=17%, signal=62%</td></tr><tr><td class='lessen'>473</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1</td><td></td><td>63</td><td>0.46</td><td>1.57</td><td>0.000</td><td>0.087</td><td>1.000</td><td>2792</td><td>tags=43%, list=22%, signal=54%</td></tr><tr><td class='lessen'>474</td><td>MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS</td><td></td><td>31</td><td>0.51</td><td>1.56</td><td>0.018</td><td>0.088</td><td>1.000</td><td>2136</td><td>tags=45%, list=17%, signal=54%</td></tr><tr><td class='lessen'>475</td><td>SABATES_COLORECTAL_ADENOMA_DN</td><td></td><td>212</td><td>0.37</td><td>1.56</td><td>0.000</td><td>0.088</td><td>1.000</td><td>1897</td><td>tags=38%, list=15%, signal=43%</td></tr><tr><td class='lessen'>476</td><td>MORI_PLASMA_CELL_DN</td><td></td><td>28</td><td>0.52</td><td>1.56</td><td>0.021</td><td>0.088</td><td>1.000</td><td>2047</td><td>tags=50%, list=16%, signal=59%</td></tr><tr><td class='lessen'>477</td><td>HUMMERICH_SKIN_CANCER_PROGRESSION_UP</td><td></td><td>78</td><td>0.42</td><td>1.56</td><td>0.000</td><td>0.089</td><td>1.000</td><td>2135</td><td>tags=38%, list=17%, signal=46%</td></tr><tr><td class='lessen'>478</td><td>LANG_MYB_FAMILY_TARGETS</td><td></td><td>28</td><td>0.52</td><td>1.56</td><td>0.017</td><td>0.089</td><td>1.000</td><td>1382</td><td>tags=18%, list=11%, signal=20%</td></tr><tr><td class='lessen'>479</td><td>WU_CELL_MIGRATION</td><td></td><td>156</td><td>0.38</td><td>1.56</td><td>0.000</td><td>0.090</td><td>1.000</td><td>2161</td><td>tags=35%, list=17%, signal=42%</td></tr><tr><td class='lessen'>480</td><td>RODRIGUES_DCC_TARGETS_DN</td><td></td><td>107</td><td>0.41</td><td>1.56</td><td>0.000</td><td>0.091</td><td>1.000</td><td>3167</td><td>tags=43%, list=24%, signal=56%</td></tr><tr><td class='lessen'>481</td><td>MARKS_HDAC_TARGETS_UP</td><td></td><td>18</td><td>0.58</td><td>1.56</td><td>0.043</td><td>0.091</td><td>1.000</td><td>3110</td><td>tags=56%, list=24%, signal=73%</td></tr><tr><td class='lessen'>482</td><td>ZHANG_INTERFERON_RESPONSE</td><td></td><td>18</td><td>0.58</td><td>1.56</td><td>0.029</td><td>0.091</td><td>1.000</td><td>2915</td><td>tags=50%, list=23%, signal=64%</td></tr><tr><td class='lessen'>483</td><td>TSUNODA_CISPLATIN_RESISTANCE_UP</td><td></td><td>13</td><td>0.64</td><td>1.56</td><td>0.031</td><td>0.091</td><td>1.000</td><td>2329</td><td>tags=54%, list=18%, signal=66%</td></tr><tr><td class='lessen'>484</td><td>ZHANG_TLX_TARGETS_60HR_UP</td><td></td><td>261</td><td>0.37</td><td>1.56</td><td>0.000</td><td>0.091</td><td>1.000</td><td>2785</td><td>tags=40%, list=22%, signal=50%</td></tr><tr><td class='lessen'>485</td><td>BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE</td><td></td><td>125</td><td>0.40</td><td>1.56</td><td>0.000</td><td>0.092</td><td>1.000</td><td>2439</td><td>tags=34%, list=19%, signal=42%</td></tr><tr><td class='lessen'>486</td><td>SCHRAETS_MLL_TARGETS_UP</td><td></td><td>31</td><td>0.51</td><td>1.56</td><td>0.025</td><td>0.091</td><td>1.000</td><td>1962</td><td>tags=42%, list=15%, signal=49%</td></tr><tr><td class='lessen'>487</td><td>SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN</td><td></td><td>29</td><td>0.51</td><td>1.56</td><td>0.018</td><td>0.091</td><td>1.000</td><td>540</td><td>tags=31%, list=4%, signal=32%</td></tr><tr><td class='lessen'>488</td><td>NIELSEN_GIST</td><td></td><td>77</td><td>0.44</td><td>1.56</td><td>0.000</td><td>0.091</td><td>1.000</td><td>2047</td><td>tags=31%, list=16%, signal=37%</td></tr><tr><td class='lessen'>489</td><td>BURTON_ADIPOGENESIS_1</td><td></td><td>31</td><td>0.50</td><td>1.55</td><td>0.015</td><td>0.091</td><td>1.000</td><td>2135</td><td>tags=32%, list=17%, signal=39%</td></tr><tr><td class='lessen'>490</td><td>LUI_THYROID_CANCER_CLUSTER_1</td><td></td><td>44</td><td>0.46</td><td>1.55</td><td>0.010</td><td>0.091</td><td>1.000</td><td>2534</td><td>tags=36%, list=20%, signal=45%</td></tr><tr><td class='lessen'>491</td><td>LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN</td><td></td><td>49</td><td>0.47</td><td>1.55</td><td>0.006</td><td>0.092</td><td>1.000</td><td>2135</td><td>tags=39%, list=17%, signal=46%</td></tr><tr><td class='lessen'>492</td><td>POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN</td><td></td><td>54</td><td>0.44</td><td>1.55</td><td>0.012</td><td>0.092</td><td>1.000</td><td>2231</td><td>tags=30%, list=17%, signal=36%</td></tr><tr><td class='lessen'>493</td><td>WANG_SMARCE1_TARGETS_UP</td><td></td><td>234</td><td>0.36</td><td>1.55</td><td>0.000</td><td>0.092</td><td>1.000</td><td>2256</td><td>tags=35%, list=17%, signal=41%</td></tr><tr><td class='lessen'>494</td><td>PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN</td><td></td><td>19</td><td>0.58</td><td>1.55</td><td>0.021</td><td>0.092</td><td>1.000</td><td>831</td><td>tags=42%, list=6%, signal=45%</td></tr><tr><td class='lessen'>495</td><td>ENGELMANN_CANCER_PROGENITORS_UP</td><td></td><td>44</td><td>0.48</td><td>1.55</td><td>0.020</td><td>0.094</td><td>1.000</td><td>2767</td><td>tags=48%, list=21%, signal=61%</td></tr><tr><td class='lessen'>496</td><td>HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP</td><td></td><td>53</td><td>0.45</td><td>1.55</td><td>0.012</td><td>0.095</td><td>1.000</td><td>2120</td><td>tags=38%, list=16%, signal=45%</td></tr><tr><td class='lessen'>497</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_UP</td><td></td><td>40</td><td>0.48</td><td>1.55</td><td>0.026</td><td>0.095</td><td>1.000</td><td>1080</td><td>tags=25%, list=8%, signal=27%</td></tr><tr><td class='lessen'>498</td><td>EINAV_INTERFERON_SIGNATURE_IN_CANCER</td><td></td><td>20</td><td>0.57</td><td>1.55</td><td>0.020</td><td>0.095</td><td>1.000</td><td>3277</td><td>tags=55%, list=25%, signal=74%</td></tr><tr><td class='lessen'>499</td><td>MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP</td><td></td><td>22</td><td>0.54</td><td>1.55</td><td>0.027</td><td>0.095</td><td>1.000</td><td>1757</td><td>tags=41%, list=14%, signal=47%</td></tr><tr><td class='lessen'>500</td><td>NIELSEN_LEIOMYOSARCOMA_UP</td><td></td><td>15</td><td>0.60</td><td>1.54</td><td>0.034</td><td>0.096</td><td>1.000</td><td>1794</td><td>tags=53%, list=14%, signal=62%</td></tr><tr><td class='lessen'>501</td><td>LEE_TARGETS_OF_PTCH1_AND_SUFU_UP</td><td></td><td>46</td><td>0.46</td><td>1.54</td><td>0.015</td><td>0.096</td><td>1.000</td><td>2302</td><td>tags=39%, list=18%, signal=47%</td></tr><tr><td class='lessen'>502</td><td>SANSOM_APC_TARGETS_DN</td><td></td><td>331</td><td>0.34</td><td>1.54</td><td>0.000</td><td>0.096</td><td>1.000</td><td>2298</td><td>tags=34%, list=18%, signal=40%</td></tr><tr><td class='lessen'>503</td><td>MARCHINI_TRABECTEDIN_RESISTANCE_DN</td><td></td><td>46</td><td>0.46</td><td>1.54</td><td>0.011</td><td>0.097</td><td>1.000</td><td>1988</td><td>tags=37%, list=15%, signal=44%</td></tr><tr><td class='lessen'>504</td><td>ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP</td><td></td><td>62</td><td>0.42</td><td>1.54</td><td>0.026</td><td>0.097</td><td>1.000</td><td>2557</td><td>tags=44%, list=20%, signal=54%</td></tr><tr><td class='lessen'>505</td><td>CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN</td><td></td><td>140</td><td>0.38</td><td>1.54</td><td>0.000</td><td>0.098</td><td>1.000</td><td>2049</td><td>tags=40%, list=16%, signal=47%</td></tr><tr><td class='lessen'>506</td><td>LIU_PROSTATE_CANCER_DN</td><td></td><td>390</td><td>0.35</td><td>1.54</td><td>0.000</td><td>0.098</td><td>1.000</td><td>2123</td><td>tags=33%, list=16%, signal=38%</td></tr><tr><td class='lessen'>507</td><td>GROSS_HYPOXIA_VIA_ELK3_DN</td><td></td><td>138</td><td>0.40</td><td>1.54</td><td>0.000</td><td>0.098</td><td>1.000</td><td>2165</td><td>tags=27%, list=17%, signal=32%</td></tr><tr><td class='lessen'>508</td><td>NATSUME_RESPONSE_TO_INTERFERON_BETA_UP</td><td></td><td>59</td><td>0.44</td><td>1.54</td><td>0.006</td><td>0.098</td><td>1.000</td><td>2498</td><td>tags=36%, list=19%, signal=44%</td></tr><tr><td class='lessen'>509</td><td>LEE_LIVER_CANCER_CIPROFIBRATE_UP</td><td></td><td>55</td><td>0.44</td><td>1.54</td><td>0.007</td><td>0.098</td><td>1.000</td><td>1012</td><td>tags=25%, list=8%, signal=27%</td></tr><tr><td class='lessen'>510</td><td>SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE</td><td></td><td>61</td><td>0.44</td><td>1.54</td><td>0.027</td><td>0.098</td><td>1.000</td><td>2355</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>511</td><td>MCBRYAN_PUBERTAL_BREAST_6_7WK_DN</td><td></td><td>64</td><td>0.43</td><td>1.54</td><td>0.013</td><td>0.100</td><td>1.000</td><td>1461</td><td>tags=23%, list=11%, signal=26%</td></tr><tr><td class='lessen'>512</td><td>JISON_SICKLE_CELL_DISEASE_UP</td><td></td><td>154</td><td>0.37</td><td>1.53</td><td>0.000</td><td>0.101</td><td>1.000</td><td>3290</td><td>tags=44%, list=25%, signal=59%</td></tr><tr><td class='lessen'>513</td><td>HORIUCHI_WTAP_TARGETS_UP</td><td></td><td>240</td><td>0.37</td><td>1.53</td><td>0.000</td><td>0.102</td><td>1.000</td><td>2942</td><td>tags=42%, list=23%, signal=53%</td></tr><tr><td class='lessen'>514</td><td>OLSSON_E2F3_TARGETS_UP</td><td></td><td>22</td><td>0.55</td><td>1.53</td><td>0.040</td><td>0.102</td><td>1.000</td><td>602</td><td>tags=18%, list=5%, signal=19%</td></tr><tr><td class='lessen'>515</td><td>BROCKE_APOPTOSIS_REVERSED_BY_IL6</td><td></td><td>115</td><td>0.40</td><td>1.53</td><td>0.000</td><td>0.102</td><td>1.000</td><td>2382</td><td>tags=33%, list=18%, signal=40%</td></tr><tr><td class='lessen'>516</td><td>VANHARANTA_UTERINE_FIBROID_UP</td><td></td><td>41</td><td>0.47</td><td>1.53</td><td>0.005</td><td>0.102</td><td>1.000</td><td>1352</td><td>tags=29%, list=10%, signal=33%</td></tr><tr><td class='lessen'>517</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP</td><td></td><td>59</td><td>0.44</td><td>1.53</td><td>0.021</td><td>0.102</td><td>1.000</td><td>2064</td><td>tags=36%, list=16%, signal=42%</td></tr><tr><td class='lessen'>518</td><td>KORKOLA_SEMINOMA_UP</td><td></td><td>35</td><td>0.48</td><td>1.53</td><td>0.023</td><td>0.102</td><td>1.000</td><td>841</td><td>tags=17%, list=7%, signal=18%</td></tr><tr><td class='lessen'>519</td><td>MOOTHA_FFA_OXYDATION</td><td></td><td>19</td><td>0.56</td><td>1.53</td><td>0.028</td><td>0.103</td><td>1.000</td><td>3119</td><td>tags=68%, list=24%, signal=90%</td></tr><tr><td class='lessen'>520</td><td>LU_EZH2_TARGETS_UP</td><td></td><td>197</td><td>0.35</td><td>1.53</td><td>0.000</td><td>0.104</td><td>1.000</td><td>2322</td><td>tags=21%, list=18%, signal=26%</td></tr><tr><td class='lessen'>521</td><td>TOMLINS_PROSTATE_CANCER_DN</td><td></td><td>36</td><td>0.48</td><td>1.53</td><td>0.024</td><td>0.104</td><td>1.000</td><td>2000</td><td>tags=36%, list=15%, signal=43%</td></tr><tr><td class='lessen'>522</td><td>SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN</td><td></td><td>30</td><td>0.51</td><td>1.53</td><td>0.021</td><td>0.104</td><td>1.000</td><td>1275</td><td>tags=27%, list=10%, signal=30%</td></tr><tr><td class='lessen'>523</td><td>CHANG_CORE_SERUM_RESPONSE_DN</td><td></td><td>155</td><td>0.38</td><td>1.53</td><td>0.000</td><td>0.104</td><td>1.000</td><td>2786</td><td>tags=30%, list=22%, signal=38%</td></tr><tr><td class='lessen'>524</td><td>TSAI_RESPONSE_TO_IONIZING_RADIATION</td><td></td><td>131</td><td>0.39</td><td>1.52</td><td>0.017</td><td>0.105</td><td>1.000</td><td>2419</td><td>tags=35%, list=19%, signal=43%</td></tr><tr><td class='lessen'>525</td><td>DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN</td><td></td><td>13</td><td>0.62</td><td>1.52</td><td>0.043</td><td>0.106</td><td>1.000</td><td>2052</td><td>tags=46%, list=16%, signal=55%</td></tr><tr><td class='lessen'>526</td><td>TAGHAVI_NEOPLASTIC_TRANSFORMATION</td><td></td><td>10</td><td>0.65</td><td>1.52</td><td>0.049</td><td>0.106</td><td>1.000</td><td>2795</td><td>tags=70%, list=22%, signal=89%</td></tr><tr><td class='lessen'>527</td><td>MILI_PSEUDOPODIA</td><td></td><td>32</td><td>0.50</td><td>1.52</td><td>0.013</td><td>0.107</td><td>1.000</td><td>2688</td><td>tags=34%, list=21%, signal=43%</td></tr><tr><td class='lessen'>528</td><td>WILLIAMS_ESR2_TARGETS_DN</td><td></td><td>10</td><td>0.66</td><td>1.52</td><td>0.056</td><td>0.107</td><td>1.000</td><td>3060</td><td>tags=50%, list=24%, signal=65%</td></tr><tr><td class='lessen'>529</td><td>YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP</td><td></td><td>16</td><td>0.58</td><td>1.52</td><td>0.037</td><td>0.108</td><td>1.000</td><td>1571</td><td>tags=38%, list=12%, signal=43%</td></tr><tr><td class='lessen'>530</td><td>DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN</td><td></td><td>17</td><td>0.57</td><td>1.52</td><td>0.058</td><td>0.108</td><td>1.000</td><td>1962</td><td>tags=41%, list=15%, signal=48%</td></tr><tr><td class='lessen'>531</td><td>LIU_NASOPHARYNGEAL_CARCINOMA</td><td></td><td>56</td><td>0.44</td><td>1.52</td><td>0.000</td><td>0.109</td><td>1.000</td><td>1224</td><td>tags=14%, list=9%, signal=16%</td></tr><tr><td class='lessen'>532</td><td>CHEOK_RESPONSE_TO_HD_MTX_UP</td><td></td><td>18</td><td>0.56</td><td>1.52</td><td>0.044</td><td>0.109</td><td>1.000</td><td>1449</td><td>tags=39%, list=11%, signal=44%</td></tr><tr><td class='lessen'>533</td><td>LU_IL4_SIGNALING</td><td></td><td>79</td><td>0.41</td><td>1.52</td><td>0.009</td><td>0.109</td><td>1.000</td><td>2779</td><td>tags=41%, list=21%, signal=51%</td></tr><tr><td class='lessen'>534</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9</td><td></td><td>64</td><td>0.43</td><td>1.52</td><td>0.008</td><td>0.110</td><td>1.000</td><td>2312</td><td>tags=31%, list=18%, signal=38%</td></tr><tr><td class='lessen'>535</td><td>TOOKER_GEMCITABINE_RESISTANCE_DN</td><td></td><td>107</td><td>0.39</td><td>1.52</td><td>0.000</td><td>0.110</td><td>1.000</td><td>2286</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>536</td><td>HUMMEL_BURKITTS_LYMPHOMA_DN</td><td></td><td>13</td><td>0.61</td><td>1.52</td><td>0.045</td><td>0.110</td><td>1.000</td><td>2477</td><td>tags=62%, list=19%, signal=76%</td></tr><tr><td class='lessen'>537</td><td>PARK_HSC_MARKERS</td><td></td><td>39</td><td>0.46</td><td>1.52</td><td>0.026</td><td>0.110</td><td>1.000</td><td>1829</td><td>tags=23%, list=14%, signal=27%</td></tr><tr><td class='lessen'>538</td><td>LEE_LIVER_CANCER_HEPATOBLAST</td><td></td><td>13</td><td>0.61</td><td>1.51</td><td>0.085</td><td>0.111</td><td>1.000</td><td>1484</td><td>tags=54%, list=11%, signal=61%</td></tr><tr><td class='lessen'>539</td><td>SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN</td><td></td><td>16</td><td>0.59</td><td>1.51</td><td>0.038</td><td>0.111</td><td>1.000</td><td>2771</td><td>tags=56%, list=21%, signal=71%</td></tr><tr><td class='lessen'>540</td><td>HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN</td><td></td><td>52</td><td>0.45</td><td>1.51</td><td>0.027</td><td>0.111</td><td>1.000</td><td>2109</td><td>tags=44%, list=16%, signal=53%</td></tr><tr><td class='lessen'>541</td><td>DELASERNA_MYOD_TARGETS_UP</td><td></td><td>81</td><td>0.40</td><td>1.51</td><td>0.009</td><td>0.112</td><td>1.000</td><td>1876</td><td>tags=35%, list=15%, signal=40%</td></tr><tr><td class='lessen'>542</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP</td><td></td><td>152</td><td>0.38</td><td>1.51</td><td>0.000</td><td>0.112</td><td>1.000</td><td>1936</td><td>tags=28%, list=15%, signal=32%</td></tr><tr><td class='lessen'>543</td><td>WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP</td><td></td><td>17</td><td>0.57</td><td>1.51</td><td>0.045</td><td>0.113</td><td>1.000</td><td>1136</td><td>tags=35%, list=9%, signal=39%</td></tr><tr><td class='lessen'>544</td><td>MARTINEZ_RB1_TARGETS_UP</td><td></td><td>564</td><td>0.36</td><td>1.51</td><td>0.000</td><td>0.113</td><td>1.000</td><td>1929</td><td>tags=24%, list=15%, signal=27%</td></tr><tr><td class='lessen'>545</td><td>SCHURINGA_STAT5A_TARGETS_DN</td><td></td><td>14</td><td>0.61</td><td>1.51</td><td>0.058</td><td>0.113</td><td>1.000</td><td>1484</td><td>tags=64%, list=11%, signal=73%</td></tr><tr><td class='lessen'>546</td><td>WOTTON_RUNX_TARGETS_UP</td><td></td><td>16</td><td>0.57</td><td>1.51</td><td>0.043</td><td>0.113</td><td>1.000</td><td>2367</td><td>tags=44%, list=18%, signal=53%</td></tr><tr><td class='lessen'>547</td><td>RUIZ_TNC_TARGETS_UP</td><td></td><td>131</td><td>0.37</td><td>1.51</td><td>0.000</td><td>0.113</td><td>1.000</td><td>2845</td><td>tags=40%, list=22%, signal=50%</td></tr><tr><td class='lessen'>548</td><td>SERVITJA_ISLET_HNF1A_TARGETS_UP</td><td></td><td>151</td><td>0.38</td><td>1.51</td><td>0.000</td><td>0.113</td><td>1.000</td><td>2270</td><td>tags=46%, list=18%, signal=56%</td></tr><tr><td class='lessen'>549</td><td>NIELSEN_LIPOSARCOMA_UP</td><td></td><td>17</td><td>0.59</td><td>1.51</td><td>0.037</td><td>0.113</td><td>1.000</td><td>1063</td><td>tags=47%, list=8%, signal=51%</td></tr><tr><td class='lessen'>550</td><td>HELLER_HDAC_TARGETS_DN</td><td></td><td>239</td><td>0.34</td><td>1.51</td><td>0.000</td><td>0.113</td><td>1.000</td><td>2355</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>551</td><td>XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR</td><td></td><td>24</td><td>0.52</td><td>1.51</td><td>0.050</td><td>0.113</td><td>1.000</td><td>2655</td><td>tags=54%, list=21%, signal=68%</td></tr><tr><td class='lessen'>552</td><td>ONO_AML1_TARGETS_UP</td><td></td><td>23</td><td>0.51</td><td>1.50</td><td>0.043</td><td>0.114</td><td>1.000</td><td>2113</td><td>tags=39%, list=16%, signal=47%</td></tr><tr><td class='lessen'>553</td><td>ZHAN_MULTIPLE_MYELOMA_SPIKED</td><td></td><td>20</td><td>0.52</td><td>1.50</td><td>0.037</td><td>0.114</td><td>1.000</td><td>2168</td><td>tags=50%, list=17%, signal=60%</td></tr><tr><td class='lessen'>554</td><td>JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN</td><td></td><td>35</td><td>0.47</td><td>1.50</td><td>0.047</td><td>0.115</td><td>1.000</td><td>1267</td><td>tags=31%, list=10%, signal=35%</td></tr><tr><td class='lessen'>555</td><td>RIGGI_EWING_SARCOMA_PROGENITOR_DN</td><td></td><td>145</td><td>0.37</td><td>1.50</td><td>0.000</td><td>0.114</td><td>1.000</td><td>1878</td><td>tags=37%, list=15%, signal=42%</td></tr><tr><td class='lessen'>556</td><td>MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP</td><td></td><td>157</td><td>0.37</td><td>1.50</td><td>0.000</td><td>0.114</td><td>1.000</td><td>2124</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>557</td><td>DAUER_STAT3_TARGETS_DN</td><td></td><td>40</td><td>0.47</td><td>1.50</td><td>0.005</td><td>0.114</td><td>1.000</td><td>2833</td><td>tags=45%, list=22%, signal=57%</td></tr><tr><td class='lessen'>558</td><td>WILCOX_RESPONSE_TO_PROGESTERONE_DN</td><td></td><td>55</td><td>0.43</td><td>1.50</td><td>0.013</td><td>0.114</td><td>1.000</td><td>2411</td><td>tags=38%, list=19%, signal=47%</td></tr><tr><td class='lessen'>559</td><td>MAHADEVAN_IMATINIB_RESISTANCE_DN</td><td></td><td>15</td><td>0.59</td><td>1.50</td><td>0.046</td><td>0.115</td><td>1.000</td><td>1956</td><td>tags=60%, list=15%, signal=71%</td></tr><tr><td class='lessen'>560</td><td>BRUECKNER_TARGETS_OF_MIRLET7A3_DN</td><td></td><td>61</td><td>0.42</td><td>1.50</td><td>0.020</td><td>0.115</td><td>1.000</td><td>2282</td><td>tags=34%, list=18%, signal=42%</td></tr><tr><td class='lessen'>561</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN</td><td></td><td>42</td><td>0.46</td><td>1.50</td><td>0.032</td><td>0.115</td><td>1.000</td><td>2094</td><td>tags=33%, list=16%, signal=40%</td></tr><tr><td class='lessen'>562</td><td>MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP</td><td></td><td>20</td><td>0.56</td><td>1.50</td><td>0.045</td><td>0.116</td><td>1.000</td><td>1820</td><td>tags=50%, list=14%, signal=58%</td></tr><tr><td class='lessen'>563</td><td>HUMMERICH_MALIGNANT_SKIN_TUMOR_UP</td><td></td><td>15</td><td>0.59</td><td>1.50</td><td>0.050</td><td>0.115</td><td>1.000</td><td>1170</td><td>tags=33%, list=9%, signal=37%</td></tr><tr><td class='lessen'>564</td><td>KIM_WT1_TARGETS_12HR_UP</td><td></td><td>129</td><td>0.37</td><td>1.50</td><td>0.000</td><td>0.115</td><td>1.000</td><td>2555</td><td>tags=36%, list=20%, signal=44%</td></tr><tr><td class='lessen'>565</td><td>KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN</td><td></td><td>45</td><td>0.45</td><td>1.50</td><td>0.027</td><td>0.116</td><td>1.000</td><td>1843</td><td>tags=36%, list=14%, signal=41%</td></tr><tr><td class='lessen'>566</td><td>ZHAN_MULTIPLE_MYELOMA_HP_UP</td><td></td><td>39</td><td>0.47</td><td>1.50</td><td>0.042</td><td>0.116</td><td>1.000</td><td>1300</td><td>tags=26%, list=10%, signal=28%</td></tr><tr><td class='lessen'>567</td><td>STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN</td><td></td><td>52</td><td>0.44</td><td>1.50</td><td>0.030</td><td>0.116</td><td>1.000</td><td>2574</td><td>tags=38%, list=20%, signal=48%</td></tr><tr><td class='lessen'>568</td><td>BRUNO_HEMATOPOIESIS</td><td></td><td>57</td><td>0.42</td><td>1.50</td><td>0.014</td><td>0.118</td><td>1.000</td><td>2270</td><td>tags=33%, list=18%, signal=40%</td></tr><tr><td class='lessen'>569</td><td>PLASARI_TGFB1_TARGETS_10HR_UP</td><td></td><td>176</td><td>0.37</td><td>1.49</td><td>0.000</td><td>0.118</td><td>1.000</td><td>2143</td><td>tags=33%, list=17%, signal=39%</td></tr><tr><td class='lessen'>570</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_T4</td><td></td><td>78</td><td>0.41</td><td>1.49</td><td>0.017</td><td>0.118</td><td>1.000</td><td>3159</td><td>tags=40%, list=24%, signal=52%</td></tr><tr><td class='lessen'>571</td><td>BROWNE_HCMV_INFECTION_20HR_DN</td><td></td><td>89</td><td>0.39</td><td>1.49</td><td>0.000</td><td>0.119</td><td>1.000</td><td>2161</td><td>tags=28%, list=17%, signal=33%</td></tr><tr><td class='lessen'>572</td><td>LINDSTEDT_DENDRITIC_CELL_MATURATION_B</td><td></td><td>49</td><td>0.45</td><td>1.49</td><td>0.006</td><td>0.119</td><td>1.000</td><td>3118</td><td>tags=51%, list=24%, signal=67%</td></tr><tr><td class='lessen'>573</td><td>SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP</td><td></td><td>60</td><td>0.42</td><td>1.49</td><td>0.000</td><td>0.120</td><td>1.000</td><td>2833</td><td>tags=48%, list=22%, signal=62%</td></tr><tr><td class='lessen'>574</td><td>PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN</td><td></td><td>106</td><td>0.39</td><td>1.49</td><td>0.011</td><td>0.121</td><td>1.000</td><td>3051</td><td>tags=38%, list=24%, signal=49%</td></tr><tr><td class='lessen'>575</td><td>NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP</td><td></td><td>18</td><td>0.56</td><td>1.49</td><td>0.038</td><td>0.122</td><td>1.000</td><td>1833</td><td>tags=50%, list=14%, signal=58%</td></tr><tr><td class='lessen'>576</td><td>LOPES_METHYLATED_IN_COLON_CANCER_DN</td><td></td><td>27</td><td>0.51</td><td>1.49</td><td>0.042</td><td>0.122</td><td>1.000</td><td>976</td><td>tags=26%, list=8%, signal=28%</td></tr><tr><td class='lessen'>577</td><td>MARSON_FOXP3_TARGETS_DN</td><td></td><td>45</td><td>0.45</td><td>1.49</td><td>0.026</td><td>0.123</td><td>1.000</td><td>2539</td><td>tags=33%, list=20%, signal=41%</td></tr><tr><td class='lessen'>578</td><td>OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN</td><td></td><td>201</td><td>0.36</td><td>1.48</td><td>0.000</td><td>0.124</td><td>1.000</td><td>2296</td><td>tags=24%, list=18%, signal=29%</td></tr><tr><td class='lessen'>579</td><td>LEE_LIVER_CANCER_ACOX1_UP</td><td></td><td>56</td><td>0.44</td><td>1.48</td><td>0.022</td><td>0.128</td><td>1.000</td><td>1012</td><td>tags=20%, list=8%, signal=21%</td></tr><tr><td class='lessen'>580</td><td>SENESE_HDAC2_TARGETS_UP</td><td></td><td>95</td><td>0.39</td><td>1.48</td><td>0.000</td><td>0.128</td><td>1.000</td><td>2399</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>581</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP</td><td></td><td>134</td><td>0.37</td><td>1.48</td><td>0.000</td><td>0.129</td><td>1.000</td><td>2548</td><td>tags=37%, list=20%, signal=46%</td></tr><tr><td class='lessen'>582</td><td>DARWICHE_PAPILLOMA_RISK_HIGH_UP</td><td></td><td>105</td><td>0.38</td><td>1.48</td><td>0.000</td><td>0.131</td><td>1.000</td><td>2532</td><td>tags=31%, list=20%, signal=39%</td></tr><tr><td class='lessen'>583</td><td>GEISS_RESPONSE_TO_DSRNA_UP</td><td></td><td>33</td><td>0.48</td><td>1.47</td><td>0.033</td><td>0.131</td><td>1.000</td><td>3147</td><td>tags=52%, list=24%, signal=68%</td></tr><tr><td class='lessen'>584</td><td>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP</td><td></td><td>450</td><td>0.34</td><td>1.47</td><td>0.000</td><td>0.131</td><td>1.000</td><td>2522</td><td>tags=21%, list=19%, signal=25%</td></tr><tr><td class='lessen'>585</td><td>HUANG_FOXA2_TARGETS_DN</td><td></td><td>34</td><td>0.46</td><td>1.47</td><td>0.034</td><td>0.131</td><td>1.000</td><td>2099</td><td>tags=47%, list=16%, signal=56%</td></tr><tr><td class='lessen'>586</td><td>PECE_MAMMARY_STEM_CELL_DN</td><td></td><td>108</td><td>0.38</td><td>1.47</td><td>0.000</td><td>0.131</td><td>1.000</td><td>2820</td><td>tags=32%, list=22%, signal=41%</td></tr><tr><td class='lessen'>587</td><td>TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN</td><td></td><td>17</td><td>0.57</td><td>1.47</td><td>0.078</td><td>0.131</td><td>1.000</td><td>2455</td><td>tags=41%, list=19%, signal=51%</td></tr><tr><td class='lessen'>588</td><td>WEINMANN_ADAPTATION_TO_HYPOXIA_DN</td><td></td><td>37</td><td>0.45</td><td>1.47</td><td>0.028</td><td>0.132</td><td>1.000</td><td>2052</td><td>tags=46%, list=16%, signal=54%</td></tr><tr><td class='lessen'>589</td><td>PRAMOONJAGO_SOX4_TARGETS_UP</td><td></td><td>45</td><td>0.44</td><td>1.47</td><td>0.028</td><td>0.133</td><td>1.000</td><td>3020</td><td>tags=47%, list=23%, signal=61%</td></tr><tr><td class='lessen'>590</td><td>HOEBEKE_LYMPHOID_STEM_CELL_DN</td><td></td><td>78</td><td>0.40</td><td>1.47</td><td>0.008</td><td>0.133</td><td>1.000</td><td>2028</td><td>tags=26%, list=16%, signal=30%</td></tr><tr><td class='lessen'>591</td><td>XU_RESPONSE_TO_TRETINOIN_UP</td><td></td><td>14</td><td>0.59</td><td>1.47</td><td>0.087</td><td>0.134</td><td>1.000</td><td>2549</td><td>tags=57%, list=20%, signal=71%</td></tr><tr><td class='lessen'>592</td><td>RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN</td><td></td><td>201</td><td>0.37</td><td>1.47</td><td>0.000</td><td>0.134</td><td>1.000</td><td>2797</td><td>tags=36%, list=22%, signal=45%</td></tr><tr><td class='lessen'>593</td><td>GEORGANTAS_HSC_MARKERS</td><td></td><td>55</td><td>0.42</td><td>1.46</td><td>0.014</td><td>0.137</td><td>1.000</td><td>1525</td><td>tags=31%, list=12%, signal=35%</td></tr><tr><td class='lessen'>594</td><td>DARWICHE_PAPILLOMA_RISK_LOW_UP</td><td></td><td>117</td><td>0.38</td><td>1.46</td><td>0.000</td><td>0.137</td><td>1.000</td><td>1363</td><td>tags=21%, list=11%, signal=24%</td></tr><tr><td class='lessen'>595</td><td>BOYLAN_MULTIPLE_MYELOMA_D_DN</td><td></td><td>60</td><td>0.42</td><td>1.46</td><td>0.015</td><td>0.138</td><td>1.000</td><td>2148</td><td>tags=38%, list=17%, signal=46%</td></tr><tr><td class='lessen'>596</td><td>DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4</td><td></td><td>11</td><td>0.62</td><td>1.46</td><td>0.076</td><td>0.138</td><td>1.000</td><td>634</td><td>tags=55%, list=5%, signal=57%</td></tr><tr><td class='lessen'>597</td><td>SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP</td><td></td><td>16</td><td>0.56</td><td>1.46</td><td>0.069</td><td>0.138</td><td>1.000</td><td>2371</td><td>tags=44%, list=18%, signal=54%</td></tr><tr><td class='lessen'>598</td><td>SAGIV_CD24_TARGETS_DN</td><td></td><td>42</td><td>0.45</td><td>1.46</td><td>0.037</td><td>0.140</td><td>1.000</td><td>2476</td><td>tags=33%, list=19%, signal=41%</td></tr><tr><td class='lessen'>599</td><td>ONO_FOXP3_TARGETS_UP</td><td></td><td>21</td><td>0.53</td><td>1.46</td><td>0.052</td><td>0.140</td><td>1.000</td><td>2062</td><td>tags=38%, list=16%, signal=45%</td></tr><tr><td class='lessen'>600</td><td>MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN</td><td></td><td>174</td><td>0.35</td><td>1.46</td><td>0.000</td><td>0.140</td><td>1.000</td><td>2052</td><td>tags=34%, list=16%, signal=40%</td></tr><tr><td class='lessen'>601</td><td>LIU_TARGETS_OF_VMYB_VS_CMYB_DN</td><td></td><td>36</td><td>0.45</td><td>1.46</td><td>0.019</td><td>0.140</td><td>1.000</td><td>1752</td><td>tags=42%, list=14%, signal=48%</td></tr><tr><td class='lessen'>602</td><td>CUI_TCF21_TARGETS_UP</td><td></td><td>33</td><td>0.47</td><td>1.46</td><td>0.045</td><td>0.140</td><td>1.000</td><td>1118</td><td>tags=27%, list=9%, signal=30%</td></tr><tr><td class='lessen'>603</td><td>HASINA_NOL7_TARGETS_DN</td><td></td><td>10</td><td>0.64</td><td>1.46</td><td>0.092</td><td>0.140</td><td>1.000</td><td>3099</td><td>tags=70%, list=24%, signal=92%</td></tr><tr><td class='lessen'>604</td><td>DELYS_THYROID_CANCER_DN</td><td></td><td>199</td><td>0.35</td><td>1.46</td><td>0.000</td><td>0.140</td><td>1.000</td><td>1988</td><td>tags=33%, list=15%, signal=39%</td></tr><tr><td class='lessen'>605</td><td>DORSAM_HOXA9_TARGETS_DN</td><td></td><td>30</td><td>0.47</td><td>1.46</td><td>0.050</td><td>0.140</td><td>1.000</td><td>2135</td><td>tags=30%, list=17%, signal=36%</td></tr><tr><td class='lessen'>606</td><td>HUTTMANN_B_CLL_POOR_SURVIVAL_UP</td><td></td><td>226</td><td>0.33</td><td>1.46</td><td>0.000</td><td>0.140</td><td>1.000</td><td>2251</td><td>tags=27%, list=17%, signal=32%</td></tr><tr><td class='lessen'>607</td><td>BURTON_ADIPOGENESIS_9</td><td></td><td>83</td><td>0.39</td><td>1.46</td><td>0.021</td><td>0.141</td><td>1.000</td><td>2659</td><td>tags=36%, list=21%, signal=45%</td></tr><tr><td class='lessen'>608</td><td>BOSCO_TH1_CYTOTOXIC_MODULE</td><td></td><td>91</td><td>0.38</td><td>1.45</td><td>0.010</td><td>0.143</td><td>1.000</td><td>1424</td><td>tags=31%, list=11%, signal=34%</td></tr><tr><td class='lessen'>609</td><td>BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP</td><td></td><td>26</td><td>0.50</td><td>1.45</td><td>0.064</td><td>0.142</td><td>1.000</td><td>657</td><td>tags=19%, list=5%, signal=20%</td></tr><tr><td class='lessen'>610</td><td>HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP</td><td></td><td>16</td><td>0.56</td><td>1.45</td><td>0.078</td><td>0.143</td><td>1.000</td><td>2236</td><td>tags=63%, list=17%, signal=75%</td></tr><tr><td class='lessen'>611</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_P3</td><td></td><td>133</td><td>0.37</td><td>1.45</td><td>0.000</td><td>0.143</td><td>1.000</td><td>2491</td><td>tags=32%, list=19%, signal=40%</td></tr><tr><td class='lessen'>612</td><td>RODRIGUES_THYROID_CARCINOMA_DN</td><td></td><td>57</td><td>0.42</td><td>1.45</td><td>0.040</td><td>0.144</td><td>1.000</td><td>1484</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>613</td><td>VALK_AML_CLUSTER_4</td><td></td><td>20</td><td>0.52</td><td>1.45</td><td>0.065</td><td>0.145</td><td>1.000</td><td>1936</td><td>tags=40%, list=15%, signal=47%</td></tr><tr><td class='lessen'>614</td><td>OZANNE_AP1_TARGETS_UP</td><td></td><td>13</td><td>0.60</td><td>1.45</td><td>0.064</td><td>0.145</td><td>1.000</td><td>1484</td><td>tags=38%, list=11%, signal=43%</td></tr><tr><td class='lessen'>615</td><td>LU_TUMOR_ENDOTHELIAL_MARKERS_UP</td><td></td><td>16</td><td>0.55</td><td>1.45</td><td>0.080</td><td>0.146</td><td>1.000</td><td>2230</td><td>tags=44%, list=17%, signal=53%</td></tr><tr><td class='lessen'>616</td><td>GERY_CEBP_TARGETS</td><td></td><td>110</td><td>0.38</td><td>1.45</td><td>0.024</td><td>0.146</td><td>1.000</td><td>2507</td><td>tags=42%, list=19%, signal=51%</td></tr><tr><td class='lessen'>617</td><td>IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN</td><td></td><td>285</td><td>0.34</td><td>1.45</td><td>0.000</td><td>0.146</td><td>1.000</td><td>2191</td><td>tags=31%, list=17%, signal=37%</td></tr><tr><td class='lessen'>618</td><td>KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD</td><td></td><td>18</td><td>0.54</td><td>1.45</td><td>0.061</td><td>0.146</td><td>1.000</td><td>1283</td><td>tags=56%, list=10%, signal=62%</td></tr><tr><td class='lessen'>619</td><td>SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER</td><td></td><td>77</td><td>0.39</td><td>1.45</td><td>0.009</td><td>0.146</td><td>1.000</td><td>2064</td><td>tags=43%, list=16%, signal=51%</td></tr><tr><td class='lessen'>620</td><td>NUTT_GBM_VS_AO_GLIOMA_UP</td><td></td><td>41</td><td>0.43</td><td>1.45</td><td>0.026</td><td>0.146</td><td>1.000</td><td>2416</td><td>tags=34%, list=19%, signal=42%</td></tr><tr><td class='lessen'>621</td><td>PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP</td><td></td><td>27</td><td>0.49</td><td>1.45</td><td>0.043</td><td>0.146</td><td>1.000</td><td>1807</td><td>tags=44%, list=14%, signal=52%</td></tr><tr><td class='lessen'>622</td><td>PODAR_RESPONSE_TO_ADAPHOSTIN_UP</td><td></td><td>121</td><td>0.37</td><td>1.45</td><td>0.013</td><td>0.146</td><td>1.000</td><td>2854</td><td>tags=37%, list=22%, signal=47%</td></tr><tr><td class='lessen'>623</td><td>COATES_MACROPHAGE_M1_VS_M2_DN</td><td></td><td>59</td><td>0.41</td><td>1.45</td><td>0.027</td><td>0.146</td><td>1.000</td><td>2225</td><td>tags=34%, list=17%, signal=41%</td></tr><tr><td class='lessen'>624</td><td>AKL_HTLV1_INFECTION_UP</td><td></td><td>23</td><td>0.51</td><td>1.44</td><td>0.076</td><td>0.146</td><td>1.000</td><td>2146</td><td>tags=35%, list=17%, signal=42%</td></tr><tr><td class='lessen'>625</td><td>HOEGERKORP_CD44_TARGETS_DIRECT_DN</td><td></td><td>12</td><td>0.60</td><td>1.44</td><td>0.109</td><td>0.146</td><td>1.000</td><td>1553</td><td>tags=25%, list=12%, signal=28%</td></tr><tr><td class='lessen'>626</td><td>SHIN_B_CELL_LYMPHOMA_CLUSTER_8</td><td></td><td>35</td><td>0.46</td><td>1.44</td><td>0.046</td><td>0.147</td><td>1.000</td><td>2423</td><td>tags=51%, list=19%, signal=63%</td></tr><tr><td class='lessen'>627</td><td>ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP</td><td></td><td>175</td><td>0.35</td><td>1.44</td><td>0.000</td><td>0.147</td><td>1.000</td><td>2825</td><td>tags=38%, list=22%, signal=48%</td></tr><tr><td class='lessen'>628</td><td>LAIHO_COLORECTAL_CANCER_SERRATED_UP</td><td></td><td>95</td><td>0.39</td><td>1.44</td><td>0.000</td><td>0.147</td><td>1.000</td><td>2240</td><td>tags=29%, list=17%, signal=35%</td></tr><tr><td class='lessen'>629</td><td>GROSS_HYPOXIA_VIA_ELK3_ONLY_UP</td><td></td><td>32</td><td>0.47</td><td>1.44</td><td>0.057</td><td>0.148</td><td>1.000</td><td>2555</td><td>tags=47%, list=20%, signal=58%</td></tr><tr><td class='lessen'>630</td><td>LIU_CDX2_TARGETS_UP</td><td></td><td>32</td><td>0.45</td><td>1.44</td><td>0.064</td><td>0.148</td><td>1.000</td><td>1633</td><td>tags=38%, list=13%, signal=43%</td></tr><tr><td class='lessen'>631</td><td>RAGHAVACHARI_PLATELET_SPECIFIC_GENES</td><td></td><td>61</td><td>0.41</td><td>1.44</td><td>0.016</td><td>0.149</td><td>1.000</td><td>2106</td><td>tags=33%, list=16%, signal=39%</td></tr><tr><td class='lessen'>632</td><td>DAZARD_UV_RESPONSE_CLUSTER_G24</td><td></td><td>21</td><td>0.51</td><td>1.44</td><td>0.068</td><td>0.149</td><td>1.000</td><td>1088</td><td>tags=29%, list=8%, signal=31%</td></tr><tr><td class='lessen'>633</td><td>COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP</td><td></td><td>28</td><td>0.48</td><td>1.44</td><td>0.051</td><td>0.149</td><td>1.000</td><td>1571</td><td>tags=29%, list=12%, signal=32%</td></tr><tr><td class='lessen'>634</td><td>AMIT_SERUM_RESPONSE_240_MCF10A</td><td></td><td>51</td><td>0.43</td><td>1.44</td><td>0.035</td><td>0.149</td><td>1.000</td><td>1088</td><td>tags=25%, list=8%, signal=28%</td></tr><tr><td class='lessen'>635</td><td>LI_PROSTATE_CANCER_EPIGENETIC</td><td></td><td>29</td><td>0.47</td><td>1.44</td><td>0.050</td><td>0.149</td><td>1.000</td><td>1608</td><td>tags=34%, list=12%, signal=39%</td></tr><tr><td class='lessen'>636</td><td>ROSS_ACUTE_MYELOID_LEUKEMIA_CBF</td><td></td><td>67</td><td>0.40</td><td>1.44</td><td>0.024</td><td>0.149</td><td>1.000</td><td>2123</td><td>tags=31%, list=16%, signal=37%</td></tr><tr><td class='lessen'>637</td><td>LEE_CALORIE_RESTRICTION_MUSCLE_UP</td><td></td><td>35</td><td>0.46</td><td>1.44</td><td>0.036</td><td>0.150</td><td>1.000</td><td>1045</td><td>tags=26%, list=8%, signal=28%</td></tr><tr><td class='lessen'>638</td><td>WINZEN_DEGRADED_VIA_KHSRP</td><td></td><td>92</td><td>0.37</td><td>1.44</td><td>0.000</td><td>0.150</td><td>1.000</td><td>2152</td><td>tags=36%, list=17%, signal=43%</td></tr><tr><td class='lessen'>639</td><td>AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G</td><td></td><td>140</td><td>0.35</td><td>1.44</td><td>0.018</td><td>0.150</td><td>1.000</td><td>2820</td><td>tags=34%, list=22%, signal=42%</td></tr><tr><td class='lessen'>640</td><td>ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP</td><td></td><td>25</td><td>0.49</td><td>1.44</td><td>0.062</td><td>0.150</td><td>1.000</td><td>2295</td><td>tags=52%, list=18%, signal=63%</td></tr><tr><td class='lessen'>641</td><td>TIAN_TNF_SIGNALING_VIA_NFKB</td><td></td><td>25</td><td>0.48</td><td>1.44</td><td>0.047</td><td>0.151</td><td>1.000</td><td>2473</td><td>tags=48%, list=19%, signal=59%</td></tr><tr><td class='lessen'>642</td><td>YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN</td><td></td><td>15</td><td>0.53</td><td>1.43</td><td>0.063</td><td>0.151</td><td>1.000</td><td>854</td><td>tags=33%, list=7%, signal=36%</td></tr><tr><td class='lessen'>643</td><td>DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS</td><td></td><td>18</td><td>0.53</td><td>1.43</td><td>0.065</td><td>0.151</td><td>1.000</td><td>1356</td><td>tags=39%, list=10%, signal=43%</td></tr><tr><td class='lessen'>644</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP</td><td></td><td>48</td><td>0.43</td><td>1.43</td><td>0.012</td><td>0.151</td><td>1.000</td><td>2165</td><td>tags=35%, list=17%, signal=42%</td></tr><tr><td class='lessen'>645</td><td>HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP</td><td></td><td>145</td><td>0.35</td><td>1.43</td><td>0.000</td><td>0.151</td><td>1.000</td><td>2697</td><td>tags=29%, list=21%, signal=36%</td></tr><tr><td class='lessen'>646</td><td>SUNG_METASTASIS_STROMA_UP</td><td></td><td>89</td><td>0.38</td><td>1.43</td><td>0.009</td><td>0.151</td><td>1.000</td><td>2433</td><td>tags=31%, list=19%, signal=38%</td></tr><tr><td class='lessen'>647</td><td>IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN</td><td></td><td>16</td><td>0.54</td><td>1.43</td><td>0.080</td><td>0.151</td><td>1.000</td><td>3039</td><td>tags=50%, list=23%, signal=65%</td></tr><tr><td class='lessen'>648</td><td>NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN</td><td></td><td>12</td><td>0.60</td><td>1.43</td><td>0.086</td><td>0.152</td><td>1.000</td><td>2503</td><td>tags=42%, list=19%, signal=52%</td></tr><tr><td class='lessen'>649</td><td>NOJIMA_SFRP2_TARGETS_UP</td><td></td><td>27</td><td>0.49</td><td>1.43</td><td>0.082</td><td>0.152</td><td>1.000</td><td>2140</td><td>tags=37%, list=17%, signal=44%</td></tr><tr><td class='lessen'>650</td><td>GAL_LEUKEMIC_STEM_CELL_DN</td><td></td><td>189</td><td>0.35</td><td>1.43</td><td>0.000</td><td>0.153</td><td>1.000</td><td>1390</td><td>tags=27%, list=11%, signal=30%</td></tr><tr><td class='lessen'>651</td><td>TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN</td><td></td><td>50</td><td>0.42</td><td>1.43</td><td>0.033</td><td>0.154</td><td>1.000</td><td>1373</td><td>tags=24%, list=11%, signal=27%</td></tr><tr><td class='lessen'>652</td><td>CASTELLANO_NRAS_TARGETS_UP</td><td></td><td>58</td><td>0.41</td><td>1.43</td><td>0.019</td><td>0.154</td><td>1.000</td><td>1159</td><td>tags=21%, list=9%, signal=23%</td></tr><tr><td class='lessen'>653</td><td>MULLIGHAN_MLL_SIGNATURE_2_DN</td><td></td><td>230</td><td>0.34</td><td>1.43</td><td>0.000</td><td>0.154</td><td>1.000</td><td>2283</td><td>tags=29%, list=18%, signal=35%</td></tr><tr><td class='lessen'>654</td><td>BURTON_ADIPOGENESIS_2</td><td></td><td>69</td><td>0.39</td><td>1.43</td><td>0.014</td><td>0.156</td><td>1.000</td><td>2733</td><td>tags=39%, list=21%, signal=49%</td></tr><tr><td class='lessen'>655</td><td>ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN</td><td></td><td>98</td><td>0.38</td><td>1.42</td><td>0.000</td><td>0.157</td><td>1.000</td><td>2135</td><td>tags=34%, list=17%, signal=40%</td></tr><tr><td class='lessen'>656</td><td>LINDSTEDT_DENDRITIC_CELL_MATURATION_C</td><td></td><td>56</td><td>0.41</td><td>1.42</td><td>0.012</td><td>0.160</td><td>1.000</td><td>3273</td><td>tags=46%, list=25%, signal=62%</td></tr><tr><td class='lessen'>657</td><td>KATSANOU_ELAVL1_TARGETS_DN</td><td></td><td>118</td><td>0.36</td><td>1.42</td><td>0.015</td><td>0.159</td><td>1.000</td><td>2268</td><td>tags=33%, list=18%, signal=40%</td></tr><tr><td class='lessen'>658</td><td>BORCZUK_MALIGNANT_MESOTHELIOMA_DN</td><td></td><td>78</td><td>0.38</td><td>1.42</td><td>0.000</td><td>0.160</td><td>1.000</td><td>2523</td><td>tags=44%, list=20%, signal=54%</td></tr><tr><td class='lessen'>659</td><td>IRITANI_MAD1_TARGETS_UP</td><td></td><td>11</td><td>0.61</td><td>1.42</td><td>0.097</td><td>0.161</td><td>1.000</td><td>1828</td><td>tags=45%, list=14%, signal=53%</td></tr><tr><td class='lessen'>660</td><td>STEARMAN_TUMOR_FIELD_EFFECT_UP</td><td></td><td>31</td><td>0.47</td><td>1.42</td><td>0.052</td><td>0.163</td><td>1.000</td><td>2574</td><td>tags=52%, list=20%, signal=64%</td></tr><tr><td class='lessen'>661</td><td>VANLOO_SP3_TARGETS_DN</td><td></td><td>73</td><td>0.39</td><td>1.42</td><td>0.010</td><td>0.163</td><td>1.000</td><td>2696</td><td>tags=41%, list=21%, signal=52%</td></tr><tr><td class='lessen'>662</td><td>GRADE_COLON_VS_RECTAL_CANCER_UP</td><td></td><td>29</td><td>0.46</td><td>1.42</td><td>0.077</td><td>0.164</td><td>1.000</td><td>1962</td><td>tags=34%, list=15%, signal=41%</td></tr><tr><td class='lessen'>663</td><td>KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN</td><td></td><td>71</td><td>0.38</td><td>1.41</td><td>0.024</td><td>0.164</td><td>1.000</td><td>1668</td><td>tags=35%, list=13%, signal=40%</td></tr><tr><td class='lessen'>664</td><td>TERAMOTO_OPN_TARGETS_CLUSTER_6</td><td></td><td>25</td><td>0.48</td><td>1.41</td><td>0.083</td><td>0.164</td><td>1.000</td><td>1158</td><td>tags=20%, list=9%, signal=22%</td></tr><tr><td class='lessen'>665</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2</td><td></td><td>135</td><td>0.36</td><td>1.41</td><td>0.000</td><td>0.164</td><td>1.000</td><td>2215</td><td>tags=36%, list=17%, signal=43%</td></tr><tr><td class='lessen'>666</td><td>ABBUD_LIF_SIGNALING_1_DN</td><td></td><td>22</td><td>0.48</td><td>1.41</td><td>0.060</td><td>0.164</td><td>1.000</td><td>1949</td><td>tags=32%, list=15%, signal=37%</td></tr><tr><td class='lessen'>667</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_4_DN</td><td></td><td>10</td><td>0.62</td><td>1.41</td><td>0.116</td><td>0.166</td><td>1.000</td><td>2008</td><td>tags=50%, list=16%, signal=59%</td></tr><tr><td class='lessen'>668</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_P7</td><td></td><td>77</td><td>0.38</td><td>1.41</td><td>0.018</td><td>0.166</td><td>1.000</td><td>2240</td><td>tags=35%, list=17%, signal=42%</td></tr><tr><td class='lessen'>669</td><td>PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP</td><td></td><td>10</td><td>0.64</td><td>1.41</td><td>0.107</td><td>0.166</td><td>1.000</td><td>1074</td><td>tags=40%, list=8%, signal=44%</td></tr><tr><td class='lessen'>670</td><td>RASHI_RESPONSE_TO_IONIZING_RADIATION_2</td><td></td><td>113</td><td>0.37</td><td>1.41</td><td>0.000</td><td>0.168</td><td>1.000</td><td>2586</td><td>tags=29%, list=20%, signal=36%</td></tr><tr><td class='lessen'>671</td><td>KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP</td><td></td><td>544</td><td>0.31</td><td>1.41</td><td>0.000</td><td>0.168</td><td>1.000</td><td>2993</td><td>tags=32%, list=23%, signal=39%</td></tr><tr><td class='lessen'>672</td><td>NIELSEN_LEIOMYOSARCOMA_CNN1_DN</td><td></td><td>18</td><td>0.52</td><td>1.41</td><td>0.069</td><td>0.168</td><td>1.000</td><td>2443</td><td>tags=44%, list=19%, signal=55%</td></tr><tr><td class='lessen'>673</td><td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN</td><td></td><td>296</td><td>0.32</td><td>1.41</td><td>0.000</td><td>0.168</td><td>1.000</td><td>2437</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>674</td><td>VALK_AML_CLUSTER_2</td><td></td><td>22</td><td>0.49</td><td>1.41</td><td>0.074</td><td>0.168</td><td>1.000</td><td>1607</td><td>tags=45%, list=12%, signal=52%</td></tr><tr><td class='lessen'>675</td><td>GRADE_COLON_AND_RECTAL_CANCER_DN</td><td></td><td>79</td><td>0.39</td><td>1.41</td><td>0.029</td><td>0.168</td><td>1.000</td><td>1682</td><td>tags=24%, list=13%, signal=27%</td></tr><tr><td class='lessen'>676</td><td>BROWNE_HCMV_INFECTION_16HR_DN</td><td></td><td>68</td><td>0.40</td><td>1.41</td><td>0.015</td><td>0.168</td><td>1.000</td><td>1307</td><td>tags=24%, list=10%, signal=26%</td></tr><tr><td class='lessen'>677</td><td>BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP</td><td></td><td>54</td><td>0.41</td><td>1.41</td><td>0.026</td><td>0.168</td><td>1.000</td><td>1807</td><td>tags=33%, list=14%, signal=39%</td></tr><tr><td class='lessen'>678</td><td>TAVOR_CEBPA_TARGETS_DN</td><td></td><td>26</td><td>0.47</td><td>1.41</td><td>0.075</td><td>0.168</td><td>1.000</td><td>2135</td><td>tags=50%, list=17%, signal=60%</td></tr><tr><td class='lessen'>679</td><td>KIM_WT1_TARGETS_8HR_UP</td><td></td><td>145</td><td>0.35</td><td>1.41</td><td>0.020</td><td>0.169</td><td>1.000</td><td>2394</td><td>tags=30%, list=19%, signal=36%</td></tr><tr><td class='lessen'>680</td><td>AMIT_EGF_RESPONSE_60_MCF10A</td><td></td><td>34</td><td>0.45</td><td>1.41</td><td>0.044</td><td>0.169</td><td>1.000</td><td>2771</td><td>tags=44%, list=21%, signal=56%</td></tr><tr><td class='lessen'>681</td><td>EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP</td><td></td><td>177</td><td>0.34</td><td>1.41</td><td>0.000</td><td>0.169</td><td>1.000</td><td>2099</td><td>tags=34%, list=16%, signal=41%</td></tr><tr><td class='lessen'>682</td><td>IKEDA_MIR30_TARGETS_UP</td><td></td><td>107</td><td>0.37</td><td>1.41</td><td>0.012</td><td>0.169</td><td>1.000</td><td>2501</td><td>tags=28%, list=19%, signal=34%</td></tr><tr><td class='lessen'>683</td><td>XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP</td><td></td><td>15</td><td>0.55</td><td>1.41</td><td>0.093</td><td>0.169</td><td>1.000</td><td>2534</td><td>tags=47%, list=20%, signal=58%</td></tr><tr><td class='lessen'>684</td><td>TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP</td><td></td><td>69</td><td>0.39</td><td>1.40</td><td>0.026</td><td>0.169</td><td>1.000</td><td>1988</td><td>tags=25%, list=15%, signal=29%</td></tr><tr><td class='lessen'>685</td><td>WIERENGA_STAT5A_TARGETS_UP</td><td></td><td>161</td><td>0.34</td><td>1.40</td><td>0.000</td><td>0.171</td><td>1.000</td><td>2099</td><td>tags=33%, list=16%, signal=39%</td></tr><tr><td class='lessen'>686</td><td>LEE_LIVER_CANCER_DENA_UP</td><td></td><td>55</td><td>0.41</td><td>1.40</td><td>0.025</td><td>0.171</td><td>1.000</td><td>1757</td><td>tags=33%, list=14%, signal=38%</td></tr><tr><td class='lessen'>687</td><td>MOOTHA_TCA</td><td></td><td>15</td><td>0.56</td><td>1.40</td><td>0.097</td><td>0.173</td><td>1.000</td><td>4027</td><td>tags=73%, list=31%, signal=106%</td></tr><tr><td class='lessen'>688</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP</td><td></td><td>105</td><td>0.36</td><td>1.40</td><td>0.000</td><td>0.173</td><td>1.000</td><td>2500</td><td>tags=37%, list=19%, signal=46%</td></tr><tr><td class='lessen'>689</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN</td><td></td><td>30</td><td>0.46</td><td>1.40</td><td>0.077</td><td>0.173</td><td>1.000</td><td>1791</td><td>tags=43%, list=14%, signal=50%</td></tr><tr><td class='lessen'>690</td><td>ONDER_CDH1_TARGETS_3_DN</td><td></td><td>39</td><td>0.43</td><td>1.40</td><td>0.054</td><td>0.173</td><td>1.000</td><td>917</td><td>tags=26%, list=7%, signal=28%</td></tr><tr><td class='lessen'>691</td><td>SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN</td><td></td><td>41</td><td>0.42</td><td>1.40</td><td>0.035</td><td>0.174</td><td>1.000</td><td>1571</td><td>tags=29%, list=12%, signal=33%</td></tr><tr><td class='lessen'>692</td><td>NATSUME_RESPONSE_TO_INTERFERON_BETA_DN</td><td></td><td>44</td><td>0.42</td><td>1.40</td><td>0.038</td><td>0.174</td><td>1.000</td><td>2442</td><td>tags=27%, list=19%, signal=34%</td></tr><tr><td class='lessen'>693</td><td>ZHANG_PROLIFERATING_VS_QUIESCENT</td><td></td><td>49</td><td>0.41</td><td>1.40</td><td>0.034</td><td>0.173</td><td>1.000</td><td>2161</td><td>tags=31%, list=17%, signal=37%</td></tr><tr><td class='lessen'>694</td><td>CHEN_LIVER_METABOLISM_QTL_CIS</td><td></td><td>79</td><td>0.38</td><td>1.40</td><td>0.015</td><td>0.173</td><td>1.000</td><td>1764</td><td>tags=23%, list=14%, signal=26%</td></tr><tr><td class='lessen'>695</td><td>BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP</td><td></td><td>17</td><td>0.52</td><td>1.40</td><td>0.061</td><td>0.175</td><td>1.000</td><td>2771</td><td>tags=47%, list=21%, signal=60%</td></tr><tr><td class='lessen'>696</td><td>QI_PLASMACYTOMA_DN</td><td></td><td>92</td><td>0.36</td><td>1.39</td><td>0.011</td><td>0.176</td><td>1.000</td><td>2145</td><td>tags=27%, list=17%, signal=32%</td></tr><tr><td class='lessen'>697</td><td>BOUDOUKHA_BOUND_BY_IGF2BP2</td><td></td><td>92</td><td>0.36</td><td>1.39</td><td>0.040</td><td>0.176</td><td>1.000</td><td>3164</td><td>tags=29%, list=24%, signal=39%</td></tr><tr><td class='lessen'>698</td><td>TENEDINI_MEGAKARYOCYTE_MARKERS</td><td></td><td>60</td><td>0.40</td><td>1.39</td><td>0.043</td><td>0.175</td><td>1.000</td><td>2427</td><td>tags=37%, list=19%, signal=45%</td></tr><tr><td class='lessen'>699</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_P4</td><td></td><td>85</td><td>0.38</td><td>1.39</td><td>0.000</td><td>0.176</td><td>1.000</td><td>2370</td><td>tags=38%, list=18%, signal=46%</td></tr><tr><td class='lessen'>700</td><td>YAGI_AML_FAB_MARKERS</td><td></td><td>165</td><td>0.34</td><td>1.39</td><td>0.026</td><td>0.176</td><td>1.000</td><td>2523</td><td>tags=32%, list=20%, signal=39%</td></tr><tr><td class='lessen'>701</td><td>LY_AGING_MIDDLE_UP</td><td></td><td>11</td><td>0.59</td><td>1.39</td><td>0.124</td><td>0.176</td><td>1.000</td><td>1098</td><td>tags=55%, list=8%, signal=60%</td></tr><tr><td class='lessen'>702</td><td>GUILLAUMOND_KLF10_TARGETS_DN</td><td></td><td>24</td><td>0.48</td><td>1.39</td><td>0.079</td><td>0.176</td><td>1.000</td><td>2302</td><td>tags=42%, list=18%, signal=51%</td></tr><tr><td class='lessen'>703</td><td>HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP</td><td></td><td>200</td><td>0.34</td><td>1.39</td><td>0.000</td><td>0.177</td><td>1.000</td><td>2743</td><td>tags=31%, list=21%, signal=39%</td></tr><tr><td class='lessen'>704</td><td>RICKMAN_METASTASIS_DN</td><td></td><td>212</td><td>0.34</td><td>1.39</td><td>0.000</td><td>0.177</td><td>1.000</td><td>2504</td><td>tags=29%, list=19%, signal=36%</td></tr><tr><td class='lessen'>705</td><td>BRACHAT_RESPONSE_TO_METHOTREXATE_UP</td><td></td><td>19</td><td>0.50</td><td>1.39</td><td>0.086</td><td>0.177</td><td>1.000</td><td>1758</td><td>tags=42%, list=14%, signal=49%</td></tr><tr><td class='lessen'>706</td><td>LENAOUR_DENDRITIC_CELL_MATURATION_UP</td><td></td><td>97</td><td>0.37</td><td>1.39</td><td>0.000</td><td>0.177</td><td>1.000</td><td>2286</td><td>tags=43%, list=18%, signal=52%</td></tr><tr><td class='lessen'>707</td><td>MCBRYAN_PUBERTAL_BREAST_3_4WK_DN</td><td></td><td>31</td><td>0.46</td><td>1.39</td><td>0.047</td><td>0.177</td><td>1.000</td><td>2052</td><td>tags=42%, list=16%, signal=50%</td></tr><tr><td class='lessen'>708</td><td>WANG_TARGETS_OF_MLL_CBP_FUSION_DN</td><td></td><td>39</td><td>0.43</td><td>1.39</td><td>0.037</td><td>0.178</td><td>1.000</td><td>2396</td><td>tags=28%, list=19%, signal=35%</td></tr><tr><td class='lessen'>709</td><td>BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING</td><td></td><td>414</td><td>0.31</td><td>1.39</td><td>0.000</td><td>0.178</td><td>1.000</td><td>2579</td><td>tags=26%, list=20%, signal=31%</td></tr><tr><td class='lessen'>710</td><td>RASHI_RESPONSE_TO_IONIZING_RADIATION_1</td><td></td><td>37</td><td>0.44</td><td>1.39</td><td>0.053</td><td>0.178</td><td>1.000</td><td>2152</td><td>tags=35%, list=17%, signal=42%</td></tr><tr><td class='lessen'>711</td><td>GENTILE_UV_LOW_DOSE_DN</td><td></td><td>56</td><td>0.39</td><td>1.39</td><td>0.006</td><td>0.178</td><td>1.000</td><td>2827</td><td>tags=39%, list=22%, signal=50%</td></tr><tr><td class='lessen'>712</td><td>MA_MYELOID_DIFFERENTIATION_UP</td><td></td><td>37</td><td>0.43</td><td>1.39</td><td>0.063</td><td>0.178</td><td>1.000</td><td>3355</td><td>tags=46%, list=26%, signal=62%</td></tr><tr><td class='lessen'>713</td><td>KARLSSON_TGFB1_TARGETS_DN</td><td></td><td>177</td><td>0.33</td><td>1.39</td><td>0.000</td><td>0.178</td><td>1.000</td><td>2266</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>714</td><td>GRANDVAUX_IRF3_TARGETS_UP</td><td></td><td>14</td><td>0.54</td><td>1.39</td><td>0.086</td><td>0.179</td><td>1.000</td><td>2168</td><td>tags=43%, list=17%, signal=51%</td></tr><tr><td class='lessen'>715</td><td>WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN</td><td></td><td>82</td><td>0.38</td><td>1.39</td><td>0.025</td><td>0.179</td><td>1.000</td><td>2147</td><td>tags=23%, list=17%, signal=28%</td></tr><tr><td class='lessen'>716</td><td>PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN</td><td></td><td>24</td><td>0.47</td><td>1.38</td><td>0.064</td><td>0.181</td><td>1.000</td><td>1690</td><td>tags=42%, list=13%, signal=48%</td></tr><tr><td class='lessen'>717</td><td>HEIDENBLAD_AMPLICON_8Q24_DN</td><td></td><td>37</td><td>0.43</td><td>1.38</td><td>0.053</td><td>0.182</td><td>1.000</td><td>2285</td><td>tags=24%, list=18%, signal=29%</td></tr><tr><td class='lessen'>718</td><td>LEIN_ASTROCYTE_MARKERS</td><td></td><td>37</td><td>0.43</td><td>1.38</td><td>0.045</td><td>0.182</td><td>1.000</td><td>2180</td><td>tags=46%, list=17%, signal=55%</td></tr><tr><td class='lessen'>719</td><td>MULLIGHAN_MLL_SIGNATURE_2_UP</td><td></td><td>330</td><td>0.32</td><td>1.38</td><td>0.000</td><td>0.183</td><td>1.000</td><td>2225</td><td>tags=23%, list=17%, signal=27%</td></tr><tr><td class='lessen'>720</td><td>GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP</td><td></td><td>17</td><td>0.52</td><td>1.38</td><td>0.104</td><td>0.183</td><td>1.000</td><td>1357</td><td>tags=35%, list=10%, signal=39%</td></tr><tr><td class='lessen'>721</td><td>ZHAN_MULTIPLE_MYELOMA_LB_DN</td><td></td><td>31</td><td>0.45</td><td>1.38</td><td>0.049</td><td>0.182</td><td>1.000</td><td>2544</td><td>tags=35%, list=20%, signal=44%</td></tr><tr><td class='lessen'>722</td><td>WORSCHECH_TUMOR_REJECTION_UP</td><td></td><td>49</td><td>0.40</td><td>1.38</td><td>0.053</td><td>0.182</td><td>1.000</td><td>1356</td><td>tags=29%, list=10%, signal=32%</td></tr><tr><td class='lessen'>723</td><td>MARSON_FOXP3_CORE_DIRECT_TARGETS</td><td></td><td>16</td><td>0.53</td><td>1.38</td><td>0.113</td><td>0.183</td><td>1.000</td><td>2719</td><td>tags=50%, list=21%, signal=63%</td></tr><tr><td class='lessen'>724</td><td>YAGI_AML_WITH_11Q23_REARRANGED</td><td></td><td>301</td><td>0.32</td><td>1.38</td><td>0.000</td><td>0.183</td><td>1.000</td><td>2146</td><td>tags=24%, list=17%, signal=28%</td></tr><tr><td class='lessen'>725</td><td>BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP</td><td></td><td>29</td><td>0.44</td><td>1.38</td><td>0.082</td><td>0.183</td><td>1.000</td><td>652</td><td>tags=17%, list=5%, signal=18%</td></tr><tr><td class='lessen'>726</td><td>NIKOLSKY_BREAST_CANCER_7P15_AMPLICON</td><td></td><td>11</td><td>0.58</td><td>1.38</td><td>0.132</td><td>0.184</td><td>1.000</td><td>2178</td><td>tags=55%, list=17%, signal=66%</td></tr><tr><td class='lessen'>727</td><td>HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP</td><td></td><td>66</td><td>0.38</td><td>1.38</td><td>0.026</td><td>0.186</td><td>1.000</td><td>2845</td><td>tags=35%, list=22%, signal=44%</td></tr><tr><td class='lessen'>728</td><td>KLEIN_TARGETS_OF_BCR_ABL1_FUSION</td><td></td><td>44</td><td>0.42</td><td>1.37</td><td>0.055</td><td>0.187</td><td>1.000</td><td>2427</td><td>tags=48%, list=19%, signal=59%</td></tr><tr><td class='lessen'>729</td><td>MCGOWAN_RSP6_TARGETS_UP</td><td></td><td>16</td><td>0.53</td><td>1.37</td><td>0.120</td><td>0.192</td><td>1.000</td><td>1434</td><td>tags=31%, list=11%, signal=35%</td></tr><tr><td class='lessen'>730</td><td>MATTHEWS_AP1_TARGETS</td><td></td><td>15</td><td>0.53</td><td>1.37</td><td>0.129</td><td>0.194</td><td>1.000</td><td>378</td><td>tags=27%, list=3%, signal=27%</td></tr><tr><td class='lessen'>731</td><td>MARTENS_BOUND_BY_PML_RARA_FUSION</td><td></td><td>369</td><td>0.32</td><td>1.37</td><td>0.000</td><td>0.194</td><td>1.000</td><td>2594</td><td>tags=29%, list=20%, signal=35%</td></tr><tr><td class='lessen'>732</td><td>KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP</td><td></td><td>119</td><td>0.35</td><td>1.37</td><td>0.000</td><td>0.194</td><td>1.000</td><td>2779</td><td>tags=39%, list=21%, signal=50%</td></tr><tr><td class='lessen'>733</td><td>WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1</td><td></td><td>23</td><td>0.48</td><td>1.37</td><td>0.072</td><td>0.194</td><td>1.000</td><td>1979</td><td>tags=30%, list=15%, signal=36%</td></tr><tr><td class='lessen'>734</td><td>STOSSI_RESPONSE_TO_ESTRADIOL</td><td></td><td>40</td><td>0.42</td><td>1.37</td><td>0.042</td><td>0.194</td><td>1.000</td><td>2140</td><td>tags=35%, list=17%, signal=42%</td></tr><tr><td class='lessen'>735</td><td>SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM</td><td></td><td>33</td><td>0.43</td><td>1.37</td><td>0.084</td><td>0.194</td><td>1.000</td><td>2355</td><td>tags=36%, list=18%, signal=44%</td></tr><tr><td class='lessen'>736</td><td>MOOTHA_VOXPHOS</td><td></td><td>79</td><td>0.37</td><td>1.36</td><td>0.027</td><td>0.201</td><td>1.000</td><td>4087</td><td>tags=42%, list=32%, signal=61%</td></tr><tr><td class='lessen'>737</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP</td><td></td><td>164</td><td>0.33</td><td>1.36</td><td>0.000</td><td>0.201</td><td>1.000</td><td>2250</td><td>tags=24%, list=17%, signal=28%</td></tr><tr><td class='lessen'>738</td><td>LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK</td><td></td><td>13</td><td>0.57</td><td>1.36</td><td>0.118</td><td>0.202</td><td>1.000</td><td>2213</td><td>tags=62%, list=17%, signal=74%</td></tr><tr><td class='lessen'>739</td><td>AMIT_EGF_RESPONSE_120_MCF10A</td><td></td><td>38</td><td>0.42</td><td>1.36</td><td>0.054</td><td>0.203</td><td>1.000</td><td>2008</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>740</td><td>FERRANDO_TAL1_NEIGHBORS</td><td></td><td>17</td><td>0.52</td><td>1.36</td><td>0.122</td><td>0.203</td><td>1.000</td><td>1499</td><td>tags=35%, list=12%, signal=40%</td></tr><tr><td class='lessen'>741</td><td>FEVR_CTNNB1_TARGETS_UP</td><td></td><td>533</td><td>0.28</td><td>1.36</td><td>0.000</td><td>0.205</td><td>1.000</td><td>2169</td><td>tags=23%, list=17%, signal=26%</td></tr><tr><td class='lessen'>742</td><td>ZHENG_FOXP3_TARGETS_IN_THYMUS_UP</td><td></td><td>156</td><td>0.33</td><td>1.36</td><td>0.000</td><td>0.205</td><td>1.000</td><td>2930</td><td>tags=32%, list=23%, signal=41%</td></tr><tr><td class='lessen'>743</td><td>BOYLAN_MULTIPLE_MYELOMA_D_UP</td><td></td><td>72</td><td>0.37</td><td>1.36</td><td>0.015</td><td>0.205</td><td>1.000</td><td>1598</td><td>tags=22%, list=12%, signal=25%</td></tr><tr><td class='lessen'>744</td><td>BAKER_HEMATOPOIESIS_STAT3_TARGETS</td><td></td><td>15</td><td>0.53</td><td>1.36</td><td>0.105</td><td>0.204</td><td>1.000</td><td>3088</td><td>tags=60%, list=24%, signal=79%</td></tr><tr><td class='lessen'>745</td><td>WANG_TARGETS_OF_MLL_CBP_FUSION_UP</td><td></td><td>35</td><td>0.43</td><td>1.35</td><td>0.077</td><td>0.204</td><td>1.000</td><td>1615</td><td>tags=29%, list=12%, signal=33%</td></tr><tr><td class='lessen'>746</td><td>ZHAN_MULTIPLE_MYELOMA_MF_UP</td><td></td><td>38</td><td>0.43</td><td>1.35</td><td>0.055</td><td>0.204</td><td>1.000</td><td>2359</td><td>tags=39%, list=18%, signal=48%</td></tr><tr><td class='lessen'>747</td><td>EHRLICH_ICF_SYNDROM_UP</td><td></td><td>13</td><td>0.55</td><td>1.35</td><td>0.139</td><td>0.206</td><td>1.000</td><td>1798</td><td>tags=54%, list=14%, signal=62%</td></tr><tr><td class='lessen'>748</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP</td><td></td><td>40</td><td>0.42</td><td>1.35</td><td>0.059</td><td>0.206</td><td>1.000</td><td>1347</td><td>tags=25%, list=10%, signal=28%</td></tr><tr><td class='lessen'>749</td><td>LU_TUMOR_ANGIOGENESIS_UP</td><td></td><td>22</td><td>0.48</td><td>1.35</td><td>0.109</td><td>0.208</td><td>1.000</td><td>2789</td><td>tags=45%, list=22%, signal=58%</td></tr><tr><td class='lessen'>750</td><td>SENESE_HDAC1_AND_HDAC2_TARGETS_DN</td><td></td><td>179</td><td>0.32</td><td>1.35</td><td>0.000</td><td>0.208</td><td>1.000</td><td>1344</td><td>tags=22%, list=10%, signal=24%</td></tr><tr><td class='lessen'>751</td><td>GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP</td><td></td><td>17</td><td>0.50</td><td>1.35</td><td>0.111</td><td>0.208</td><td>1.000</td><td>2324</td><td>tags=47%, list=18%, signal=57%</td></tr><tr><td class='lessen'>752</td><td>AMUNDSON_GAMMA_RADIATION_RESISTANCE</td><td></td><td>15</td><td>0.52</td><td>1.35</td><td>0.136</td><td>0.208</td><td>1.000</td><td>1276</td><td>tags=47%, list=10%, signal=52%</td></tr><tr><td class='lessen'>753</td><td>GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP</td><td></td><td>443</td><td>0.32</td><td>1.35</td><td>0.000</td><td>0.209</td><td>1.000</td><td>2497</td><td>tags=30%, list=19%, signal=36%</td></tr><tr><td class='lessen'>754</td><td>PENG_RAPAMYCIN_RESPONSE_UP</td><td></td><td>170</td><td>0.32</td><td>1.35</td><td>0.000</td><td>0.211</td><td>1.000</td><td>2385</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>755</td><td>TRACEY_RESISTANCE_TO_IFNA2_DN</td><td></td><td>23</td><td>0.48</td><td>1.34</td><td>0.108</td><td>0.214</td><td>1.000</td><td>2491</td><td>tags=30%, list=19%, signal=38%</td></tr><tr><td class='lessen'>756</td><td>OXFORD_RALA_OR_RALB_TARGETS_DN</td><td></td><td>18</td><td>0.49</td><td>1.34</td><td>0.103</td><td>0.214</td><td>1.000</td><td>1799</td><td>tags=33%, list=14%, signal=39%</td></tr><tr><td class='lessen'>757</td><td>BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP</td><td></td><td>18</td><td>0.49</td><td>1.34</td><td>0.129</td><td>0.214</td><td>1.000</td><td>484</td><td>tags=17%, list=4%, signal=17%</td></tr><tr><td class='lessen'>758</td><td>NIELSEN_LEIOMYOSARCOMA_DN</td><td></td><td>13</td><td>0.55</td><td>1.34</td><td>0.153</td><td>0.215</td><td>1.000</td><td>2894</td><td>tags=46%, list=22%, signal=59%</td></tr><tr><td class='lessen'>759</td><td>HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN</td><td></td><td>14</td><td>0.53</td><td>1.34</td><td>0.111</td><td>0.217</td><td>1.000</td><td>2366</td><td>tags=29%, list=18%, signal=35%</td></tr><tr><td class='lessen'>760</td><td>MILI_PSEUDOPODIA_CHEMOTAXIS_UP</td><td></td><td>51</td><td>0.39</td><td>1.34</td><td>0.055</td><td>0.217</td><td>1.000</td><td>2688</td><td>tags=27%, list=21%, signal=35%</td></tr><tr><td class='lessen'>761</td><td>RIGGI_EWING_SARCOMA_PROGENITOR_UP</td><td></td><td>351</td><td>0.30</td><td>1.34</td><td>0.000</td><td>0.219</td><td>1.000</td><td>1779</td><td>tags=25%, list=14%, signal=29%</td></tr><tr><td class='lessen'>762</td><td>UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN</td><td></td><td>32</td><td>0.42</td><td>1.34</td><td>0.083</td><td>0.219</td><td>1.000</td><td>2419</td><td>tags=50%, list=19%, signal=61%</td></tr><tr><td class='lessen'>763</td><td>WANG_TUMOR_INVASIVENESS_DN</td><td></td><td>183</td><td>0.32</td><td>1.33</td><td>0.000</td><td>0.222</td><td>1.000</td><td>2376</td><td>tags=18%, list=18%, signal=22%</td></tr><tr><td class='lessen'>764</td><td>ALCALA_APOPTOSIS</td><td></td><td>74</td><td>0.37</td><td>1.33</td><td>0.038</td><td>0.222</td><td>1.000</td><td>3306</td><td>tags=43%, list=26%, signal=58%</td></tr><tr><td class='lessen'>765</td><td>WINNEPENNINCKX_MELANOMA_METASTASIS_DN</td><td></td><td>32</td><td>0.42</td><td>1.33</td><td>0.105</td><td>0.224</td><td>1.000</td><td>1353</td><td>tags=28%, list=10%, signal=31%</td></tr><tr><td class='lessen'>766</td><td>KUNINGER_IGF1_VS_PDGFB_TARGETS_DN</td><td></td><td>37</td><td>0.41</td><td>1.33</td><td>0.073</td><td>0.224</td><td>1.000</td><td>510</td><td>tags=19%, list=4%, signal=20%</td></tr><tr><td class='lessen'>767</td><td>WIKMAN_ASBESTOS_LUNG_CANCER_DN</td><td></td><td>25</td><td>0.45</td><td>1.33</td><td>0.103</td><td>0.224</td><td>1.000</td><td>848</td><td>tags=24%, list=7%, signal=26%</td></tr><tr><td class='lessen'>768</td><td>HAHTOLA_CTCL_CUTANEOUS</td><td></td><td>23</td><td>0.47</td><td>1.33</td><td>0.112</td><td>0.224</td><td>1.000</td><td>960</td><td>tags=22%, list=7%, signal=23%</td></tr><tr><td class='lessen'>769</td><td>ZHU_SKIL_TARGETS_UP</td><td></td><td>19</td><td>0.49</td><td>1.33</td><td>0.141</td><td>0.225</td><td>1.000</td><td>1521</td><td>tags=26%, list=12%, signal=30%</td></tr><tr><td class='lessen'>770</td><td>WANG_METHYLATED_IN_BREAST_CANCER</td><td></td><td>31</td><td>0.43</td><td>1.33</td><td>0.095</td><td>0.226</td><td>1.000</td><td>2165</td><td>tags=35%, list=17%, signal=43%</td></tr><tr><td class='lessen'>771</td><td>TSUDA_ALVEOLAR_SOFT_PART_SARCOMA</td><td></td><td>10</td><td>0.57</td><td>1.33</td><td>0.152</td><td>0.228</td><td>1.000</td><td>3509</td><td>tags=70%, list=27%, signal=96%</td></tr><tr><td class='lessen'>772</td><td>WOTTON_RUNX_TARGETS_DN</td><td></td><td>25</td><td>0.45</td><td>1.33</td><td>0.110</td><td>0.228</td><td>1.000</td><td>1922</td><td>tags=36%, list=15%, signal=42%</td></tr><tr><td class='lessen'>773</td><td>DING_LUNG_CANCER_MUTATED_FREQUENTLY</td><td></td><td>11</td><td>0.56</td><td>1.33</td><td>0.151</td><td>0.228</td><td>1.000</td><td>3347</td><td>tags=45%, list=26%, signal=61%</td></tr><tr><td class='lessen'>774</td><td>SCHRAMM_INHBA_TARGETS_DN</td><td></td><td>24</td><td>0.47</td><td>1.33</td><td>0.117</td><td>0.228</td><td>1.000</td><td>3560</td><td>tags=46%, list=28%, signal=63%</td></tr><tr><td class='lessen'>775</td><td>MENSE_HYPOXIA_UP</td><td></td><td>75</td><td>0.36</td><td>1.33</td><td>0.048</td><td>0.228</td><td>1.000</td><td>2419</td><td>tags=29%, list=19%, signal=36%</td></tr><tr><td class='lessen'>776</td><td>GENTILE_UV_RESPONSE_CLUSTER_D8</td><td></td><td>34</td><td>0.41</td><td>1.33</td><td>0.100</td><td>0.229</td><td>1.000</td><td>2894</td><td>tags=38%, list=22%, signal=49%</td></tr><tr><td class='lessen'>777</td><td>NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP</td><td></td><td>139</td><td>0.34</td><td>1.33</td><td>0.033</td><td>0.229</td><td>1.000</td><td>1905</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>778</td><td>MORI_SMALL_PRE_BII_LYMPHOCYTE_UP</td><td></td><td>76</td><td>0.35</td><td>1.32</td><td>0.054</td><td>0.232</td><td>1.000</td><td>2197</td><td>tags=24%, list=17%, signal=28%</td></tr><tr><td class='lessen'>779</td><td>CHANDRAN_METASTASIS_DN</td><td></td><td>235</td><td>0.32</td><td>1.32</td><td>0.000</td><td>0.232</td><td>1.000</td><td>1897</td><td>tags=25%, list=15%, signal=28%</td></tr><tr><td class='lessen'>780</td><td>LEIN_MIDBRAIN_MARKERS</td><td></td><td>69</td><td>0.36</td><td>1.32</td><td>0.055</td><td>0.232</td><td>1.000</td><td>1089</td><td>tags=20%, list=8%, signal=22%</td></tr><tr><td class='lessen'>781</td><td>DELASERNA_MYOD_TARGETS_DN</td><td></td><td>50</td><td>0.39</td><td>1.32</td><td>0.076</td><td>0.232</td><td>1.000</td><td>3383</td><td>tags=44%, list=26%, signal=59%</td></tr><tr><td class='lessen'>782</td><td>GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP</td><td></td><td>45</td><td>0.40</td><td>1.32</td><td>0.072</td><td>0.232</td><td>1.000</td><td>2324</td><td>tags=36%, list=18%, signal=43%</td></tr><tr><td class='lessen'>783</td><td>BASSO_CD40_SIGNALING_DN</td><td></td><td>59</td><td>0.37</td><td>1.32</td><td>0.057</td><td>0.234</td><td>1.000</td><td>2272</td><td>tags=46%, list=18%, signal=55%</td></tr><tr><td class='lessen'>784</td><td>BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP</td><td></td><td>22</td><td>0.47</td><td>1.32</td><td>0.119</td><td>0.234</td><td>1.000</td><td>1758</td><td>tags=36%, list=14%, signal=42%</td></tr><tr><td class='lessen'>785</td><td>BAUS_TFF2_TARGETS_DN</td><td></td><td>10</td><td>0.56</td><td>1.32</td><td>0.154</td><td>0.234</td><td>1.000</td><td>2270</td><td>tags=50%, list=18%, signal=61%</td></tr><tr><td class='lessen'>786</td><td>WU_ALZHEIMER_DISEASE_DN</td><td></td><td>15</td><td>0.51</td><td>1.32</td><td>0.143</td><td>0.235</td><td>1.000</td><td>1181</td><td>tags=33%, list=9%, signal=37%</td></tr><tr><td class='lessen'>787</td><td>SHIN_B_CELL_LYMPHOMA_CLUSTER_5</td><td></td><td>18</td><td>0.49</td><td>1.32</td><td>0.142</td><td>0.236</td><td>1.000</td><td>2371</td><td>tags=44%, list=18%, signal=54%</td></tr><tr><td class='lessen'>788</td><td>STREICHER_LSM1_TARGETS_UP</td><td></td><td>40</td><td>0.40</td><td>1.32</td><td>0.077</td><td>0.237</td><td>1.000</td><td>3086</td><td>tags=43%, list=24%, signal=56%</td></tr><tr><td class='lessen'>789</td><td>WANG_RESPONSE_TO_BEXAROTENE_DN</td><td></td><td>25</td><td>0.45</td><td>1.32</td><td>0.133</td><td>0.237</td><td>1.000</td><td>2501</td><td>tags=40%, list=19%, signal=49%</td></tr><tr><td class='lessen'>790</td><td>VECCHI_GASTRIC_CANCER_EARLY_DN</td><td></td><td>271</td><td>0.31</td><td>1.31</td><td>0.000</td><td>0.239</td><td>1.000</td><td>2016</td><td>tags=31%, list=16%, signal=36%</td></tr><tr><td class='lessen'>791</td><td>OHM_METHYLATED_IN_ADULT_CANCERS</td><td></td><td>26</td><td>0.44</td><td>1.31</td><td>0.090</td><td>0.239</td><td>1.000</td><td>1608</td><td>tags=35%, list=12%, signal=39%</td></tr><tr><td class='lessen'>792</td><td>FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP</td><td></td><td>72</td><td>0.36</td><td>1.31</td><td>0.057</td><td>0.240</td><td>1.000</td><td>1962</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>793</td><td>MARTINEZ_RESPONSE_TO_TRABECTEDIN</td><td></td><td>44</td><td>0.40</td><td>1.31</td><td>0.077</td><td>0.241</td><td>1.000</td><td>1691</td><td>tags=16%, list=13%, signal=18%</td></tr><tr><td class='lessen'>794</td><td>KASLER_HDAC7_TARGETS_1_DN</td><td></td><td>16</td><td>0.50</td><td>1.31</td><td>0.114</td><td>0.242</td><td>1.000</td><td>2225</td><td>tags=44%, list=17%, signal=53%</td></tr><tr><td class='lessen'>795</td><td>MARZEC_IL2_SIGNALING_DN</td><td></td><td>32</td><td>0.43</td><td>1.31</td><td>0.115</td><td>0.242</td><td>1.000</td><td>2089</td><td>tags=38%, list=16%, signal=45%</td></tr><tr><td class='lessen'>796</td><td>BAE_BRCA1_TARGETS_UP</td><td></td><td>68</td><td>0.36</td><td>1.31</td><td>0.085</td><td>0.242</td><td>1.000</td><td>2964</td><td>tags=32%, list=23%, signal=42%</td></tr><tr><td class='lessen'>797</td><td>CAIRO_HEPATOBLASTOMA_CLASSES_DN</td><td></td><td>170</td><td>0.32</td><td>1.31</td><td>0.026</td><td>0.243</td><td>1.000</td><td>1671</td><td>tags=25%, list=13%, signal=29%</td></tr><tr><td class='lessen'>798</td><td>BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN</td><td></td><td>46</td><td>0.39</td><td>1.31</td><td>0.085</td><td>0.243</td><td>1.000</td><td>2077</td><td>tags=33%, list=16%, signal=39%</td></tr><tr><td class='lessen'>799</td><td>HAN_SATB1_TARGETS_DN</td><td></td><td>345</td><td>0.30</td><td>1.31</td><td>0.000</td><td>0.244</td><td>1.000</td><td>2597</td><td>tags=30%, list=20%, signal=36%</td></tr><tr><td class='lessen'>800</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN</td><td></td><td>99</td><td>0.34</td><td>1.31</td><td>0.030</td><td>0.245</td><td>1.000</td><td>1908</td><td>tags=27%, list=15%, signal=32%</td></tr><tr><td class='lessen'>801</td><td>MUNSHI_MULTIPLE_MYELOMA_UP</td><td></td><td>76</td><td>0.35</td><td>1.31</td><td>0.068</td><td>0.246</td><td>1.000</td><td>2355</td><td>tags=26%, list=18%, signal=32%</td></tr><tr><td class='lessen'>802</td><td>FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP</td><td></td><td>40</td><td>0.42</td><td>1.30</td><td>0.126</td><td>0.247</td><td>1.000</td><td>2593</td><td>tags=38%, list=20%, signal=47%</td></tr><tr><td class='lessen'>803</td><td>TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP</td><td></td><td>32</td><td>0.42</td><td>1.30</td><td>0.104</td><td>0.247</td><td>1.000</td><td>2079</td><td>tags=47%, list=16%, signal=56%</td></tr><tr><td class='lessen'>804</td><td>BEIER_GLIOMA_STEM_CELL_DN</td><td></td><td>46</td><td>0.39</td><td>1.30</td><td>0.084</td><td>0.247</td><td>1.000</td><td>2052</td><td>tags=33%, list=16%, signal=39%</td></tr><tr><td class='lessen'>805</td><td>WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR</td><td></td><td>118</td><td>0.33</td><td>1.30</td><td>0.000</td><td>0.248</td><td>1.000</td><td>2721</td><td>tags=37%, list=21%, signal=47%</td></tr><tr><td class='lessen'>806</td><td>MATTIOLI_MGUS_VS_PCL</td><td></td><td>84</td><td>0.34</td><td>1.30</td><td>0.030</td><td>0.248</td><td>1.000</td><td>1487</td><td>tags=13%, list=11%, signal=15%</td></tr><tr><td class='lessen'>807</td><td>KRISHNAN_FURIN_TARGETS_UP</td><td></td><td>10</td><td>0.57</td><td>1.30</td><td>0.168</td><td>0.251</td><td>1.000</td><td>2099</td><td>tags=60%, list=16%, signal=72%</td></tr><tr><td class='lessen'>808</td><td>CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP</td><td></td><td>135</td><td>0.32</td><td>1.30</td><td>0.018</td><td>0.253</td><td>1.000</td><td>2412</td><td>tags=36%, list=19%, signal=44%</td></tr><tr><td class='lessen'>809</td><td>DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN</td><td></td><td>238</td><td>0.30</td><td>1.30</td><td>0.000</td><td>0.253</td><td>1.000</td><td>2979</td><td>tags=35%, list=23%, signal=44%</td></tr><tr><td class='lessen'>810</td><td>WANG_BARRETTS_ESOPHAGUS_DN</td><td></td><td>21</td><td>0.45</td><td>1.30</td><td>0.141</td><td>0.254</td><td>1.000</td><td>2388</td><td>tags=33%, list=18%, signal=41%</td></tr><tr><td class='lessen'>811</td><td>YAGI_AML_WITH_T_8_21_TRANSLOCATION</td><td></td><td>293</td><td>0.30</td><td>1.30</td><td>0.000</td><td>0.254</td><td>1.000</td><td>1574</td><td>tags=19%, list=12%, signal=21%</td></tr><tr><td class='lessen'>812</td><td>MCBRYAN_PUBERTAL_BREAST_5_6WK_UP</td><td></td><td>102</td><td>0.35</td><td>1.30</td><td>0.011</td><td>0.255</td><td>1.000</td><td>2119</td><td>tags=26%, list=16%, signal=31%</td></tr><tr><td class='lessen'>813</td><td>LEI_MYB_TARGETS</td><td></td><td>276</td><td>0.30</td><td>1.30</td><td>0.000</td><td>0.256</td><td>1.000</td><td>2586</td><td>tags=29%, list=20%, signal=35%</td></tr><tr><td class='lessen'>814</td><td>HOELZEL_NF1_TARGETS_DN</td><td></td><td>86</td><td>0.35</td><td>1.30</td><td>0.042</td><td>0.256</td><td>1.000</td><td>2274</td><td>tags=38%, list=18%, signal=46%</td></tr><tr><td class='lessen'>815</td><td>POS_HISTAMINE_RESPONSE_NETWORK</td><td></td><td>29</td><td>0.43</td><td>1.29</td><td>0.129</td><td>0.258</td><td>1.000</td><td>2470</td><td>tags=45%, list=19%, signal=55%</td></tr><tr><td class='lessen'>816</td><td>NIELSEN_SYNOVIAL_SARCOMA_DN</td><td></td><td>16</td><td>0.49</td><td>1.29</td><td>0.159</td><td>0.258</td><td>1.000</td><td>1605</td><td>tags=44%, list=12%, signal=50%</td></tr><tr><td class='lessen'>817</td><td>DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP</td><td></td><td>54</td><td>0.37</td><td>1.29</td><td>0.045</td><td>0.259</td><td>1.000</td><td>1811</td><td>tags=30%, list=14%, signal=34%</td></tr><tr><td class='lessen'>818</td><td>FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN</td><td></td><td>23</td><td>0.47</td><td>1.29</td><td>0.122</td><td>0.259</td><td>1.000</td><td>1085</td><td>tags=35%, list=8%, signal=38%</td></tr><tr><td class='lessen'>819</td><td>ZHAN_MULTIPLE_MYELOMA_LB_UP</td><td></td><td>33</td><td>0.42</td><td>1.29</td><td>0.116</td><td>0.260</td><td>1.000</td><td>2564</td><td>tags=36%, list=20%, signal=45%</td></tr><tr><td class='lessen'>820</td><td>DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP</td><td></td><td>12</td><td>0.52</td><td>1.29</td><td>0.178</td><td>0.261</td><td>1.000</td><td>562</td><td>tags=25%, list=4%, signal=26%</td></tr><tr><td class='lessen'>821</td><td>PLASARI_NFIC_TARGETS_BASAL_DN</td><td></td><td>18</td><td>0.47</td><td>1.29</td><td>0.160</td><td>0.262</td><td>1.000</td><td>584</td><td>tags=28%, list=5%, signal=29%</td></tr><tr><td class='lessen'>822</td><td>MALONEY_RESPONSE_TO_17AAG_UP</td><td></td><td>36</td><td>0.41</td><td>1.29</td><td>0.098</td><td>0.262</td><td>1.000</td><td>1027</td><td>tags=14%, list=8%, signal=15%</td></tr><tr><td class='lessen'>823</td><td>GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP</td><td></td><td>123</td><td>0.33</td><td>1.29</td><td>0.029</td><td>0.263</td><td>1.000</td><td>2813</td><td>tags=30%, list=22%, signal=38%</td></tr><tr><td class='lessen'>824</td><td>ISSAEVA_MLL2_TARGETS</td><td></td><td>55</td><td>0.37</td><td>1.29</td><td>0.072</td><td>0.265</td><td>1.000</td><td>1597</td><td>tags=33%, list=12%, signal=37%</td></tr><tr><td class='lessen'>825</td><td>CAIRO_PML_TARGETS_BOUND_BY_MYC_DN</td><td></td><td>13</td><td>0.51</td><td>1.29</td><td>0.172</td><td>0.266</td><td>1.000</td><td>2104</td><td>tags=46%, list=16%, signal=55%</td></tr><tr><td class='lessen'>826</td><td>TING_SILENCED_BY_DICER</td><td></td><td>25</td><td>0.44</td><td>1.29</td><td>0.123</td><td>0.266</td><td>1.000</td><td>1905</td><td>tags=48%, list=15%, signal=56%</td></tr><tr><td class='lessen'>827</td><td>DAUER_STAT3_TARGETS_UP</td><td></td><td>43</td><td>0.39</td><td>1.28</td><td>0.096</td><td>0.267</td><td>1.000</td><td>2152</td><td>tags=37%, list=17%, signal=44%</td></tr><tr><td class='lessen'>828</td><td>RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP</td><td></td><td>99</td><td>0.33</td><td>1.28</td><td>0.010</td><td>0.268</td><td>1.000</td><td>1779</td><td>tags=22%, list=14%, signal=26%</td></tr><tr><td class='lessen'>829</td><td>BILBAN_B_CLL_LPL_DN</td><td></td><td>33</td><td>0.41</td><td>1.28</td><td>0.112</td><td>0.269</td><td>1.000</td><td>2505</td><td>tags=39%, list=19%, signal=49%</td></tr><tr><td class='lessen'>830</td><td>XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR</td><td></td><td>16</td><td>0.49</td><td>1.28</td><td>0.140</td><td>0.271</td><td>1.000</td><td>1905</td><td>tags=25%, list=15%, signal=29%</td></tr><tr><td class='lessen'>831</td><td>NAKAMURA_CANCER_MICROENVIRONMENT_UP</td><td></td><td>14</td><td>0.50</td><td>1.28</td><td>0.156</td><td>0.271</td><td>1.000</td><td>2079</td><td>tags=50%, list=16%, signal=60%</td></tr><tr><td class='lessen'>832</td><td>PAL_PRMT5_TARGETS_DN</td><td></td><td>28</td><td>0.43</td><td>1.28</td><td>0.140</td><td>0.271</td><td>1.000</td><td>379</td><td>tags=21%, list=3%, signal=22%</td></tr><tr><td class='lessen'>833</td><td>ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN</td><td></td><td>261</td><td>0.31</td><td>1.28</td><td>0.000</td><td>0.272</td><td>1.000</td><td>2000</td><td>tags=25%, list=15%, signal=29%</td></tr><tr><td class='lessen'>834</td><td>VERNELL_RETINOBLASTOMA_PATHWAY_DN</td><td></td><td>14</td><td>0.52</td><td>1.28</td><td>0.159</td><td>0.274</td><td>1.000</td><td>1988</td><td>tags=29%, list=15%, signal=34%</td></tr><tr><td class='lessen'>835</td><td>FRASOR_RESPONSE_TO_ESTRADIOL_DN</td><td></td><td>74</td><td>0.35</td><td>1.28</td><td>0.053</td><td>0.274</td><td>1.000</td><td>1979</td><td>tags=31%, list=15%, signal=36%</td></tr><tr><td class='lessen'>836</td><td>KORKOLA_EMBRYONAL_CARCINOMA_UP</td><td></td><td>35</td><td>0.41</td><td>1.28</td><td>0.105</td><td>0.275</td><td>1.000</td><td>1527</td><td>tags=23%, list=12%, signal=26%</td></tr><tr><td class='lessen'>837</td><td>YOSHIMURA_MAPK8_TARGETS_DN</td><td></td><td>317</td><td>0.29</td><td>1.28</td><td>0.000</td><td>0.275</td><td>1.000</td><td>2559</td><td>tags=24%, list=20%, signal=29%</td></tr><tr><td class='lessen'>838</td><td>HINATA_NFKB_TARGETS_KERATINOCYTE_DN</td><td></td><td>15</td><td>0.49</td><td>1.28</td><td>0.179</td><td>0.276</td><td>1.000</td><td>1757</td><td>tags=33%, list=14%, signal=39%</td></tr><tr><td class='lessen'>839</td><td>VERHAAK_GLIOBLASTOMA_CLASSICAL</td><td></td><td>132</td><td>0.32</td><td>1.27</td><td>0.017</td><td>0.276</td><td>1.000</td><td>2484</td><td>tags=33%, list=19%, signal=40%</td></tr><tr><td class='lessen'>840</td><td>APRELIKOVA_BRCA1_TARGETS</td><td></td><td>45</td><td>0.38</td><td>1.27</td><td>0.101</td><td>0.277</td><td>1.000</td><td>1045</td><td>tags=16%, list=8%, signal=17%</td></tr><tr><td class='lessen'>841</td><td>AMIT_SERUM_RESPONSE_120_MCF10A</td><td></td><td>54</td><td>0.38</td><td>1.27</td><td>0.097</td><td>0.276</td><td>1.000</td><td>3151</td><td>tags=52%, list=24%, signal=68%</td></tr><tr><td class='lessen'>842</td><td>PARK_TRETINOIN_RESPONSE</td><td></td><td>12</td><td>0.53</td><td>1.27</td><td>0.199</td><td>0.278</td><td>1.000</td><td>1979</td><td>tags=67%, list=15%, signal=79%</td></tr><tr><td class='lessen'>843</td><td>KAAB_HEART_ATRIUM_VS_VENTRICLE_UP</td><td></td><td>217</td><td>0.31</td><td>1.27</td><td>0.000</td><td>0.279</td><td>1.000</td><td>2045</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>844</td><td>GROSS_HYPOXIA_VIA_ELK3_UP</td><td></td><td>181</td><td>0.31</td><td>1.27</td><td>0.000</td><td>0.278</td><td>1.000</td><td>2589</td><td>tags=32%, list=20%, signal=40%</td></tr><tr><td class='lessen'>845</td><td>GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP</td><td></td><td>55</td><td>0.37</td><td>1.27</td><td>0.092</td><td>0.279</td><td>1.000</td><td>2472</td><td>tags=42%, list=19%, signal=51%</td></tr><tr><td class='lessen'>846</td><td>HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP</td><td></td><td>21</td><td>0.46</td><td>1.27</td><td>0.130</td><td>0.280</td><td>1.000</td><td>1467</td><td>tags=24%, list=11%, signal=27%</td></tr><tr><td class='lessen'>847</td><td>MAINA_VHL_TARGETS_DN</td><td></td><td>14</td><td>0.49</td><td>1.27</td><td>0.185</td><td>0.281</td><td>1.000</td><td>1784</td><td>tags=43%, list=14%, signal=50%</td></tr><tr><td class='lessen'>848</td><td>CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN</td><td></td><td>18</td><td>0.47</td><td>1.27</td><td>0.166</td><td>0.281</td><td>1.000</td><td>1446</td><td>tags=17%, list=11%, signal=19%</td></tr><tr><td class='lessen'>849</td><td>BROWNE_HCMV_INFECTION_12HR_DN</td><td></td><td>79</td><td>0.34</td><td>1.27</td><td>0.080</td><td>0.281</td><td>1.000</td><td>2656</td><td>tags=33%, list=21%, signal=41%</td></tr><tr><td class='lessen'>850</td><td>UDAYAKUMAR_MED1_TARGETS_DN</td><td></td><td>201</td><td>0.30</td><td>1.27</td><td>0.040</td><td>0.283</td><td>1.000</td><td>2549</td><td>tags=27%, list=20%, signal=34%</td></tr><tr><td class='lessen'>851</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15</td><td></td><td>30</td><td>0.42</td><td>1.27</td><td>0.126</td><td>0.283</td><td>1.000</td><td>2080</td><td>tags=27%, list=16%, signal=32%</td></tr><tr><td class='lessen'>852</td><td>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP</td><td></td><td>34</td><td>0.40</td><td>1.27</td><td>0.106</td><td>0.284</td><td>1.000</td><td>1280</td><td>tags=24%, list=10%, signal=26%</td></tr><tr><td class='lessen'>853</td><td>LEE_EARLY_T_LYMPHOCYTE_DN</td><td></td><td>36</td><td>0.41</td><td>1.27</td><td>0.126</td><td>0.285</td><td>1.000</td><td>1590</td><td>tags=42%, list=12%, signal=47%</td></tr><tr><td class='lessen'>854</td><td>FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN</td><td></td><td>55</td><td>0.37</td><td>1.26</td><td>0.049</td><td>0.285</td><td>1.000</td><td>2146</td><td>tags=35%, list=17%, signal=41%</td></tr><tr><td class='lessen'>855</td><td>TAKAO_RESPONSE_TO_UVB_RADIATION_DN</td><td></td><td>83</td><td>0.34</td><td>1.26</td><td>0.070</td><td>0.287</td><td>1.000</td><td>3150</td><td>tags=36%, list=24%, signal=47%</td></tr><tr><td class='lessen'>856</td><td>ZIRN_TRETINOIN_RESPONSE_WT1_UP</td><td></td><td>20</td><td>0.46</td><td>1.26</td><td>0.141</td><td>0.289</td><td>1.000</td><td>2052</td><td>tags=40%, list=16%, signal=47%</td></tr><tr><td class='lessen'>857</td><td>LEONARD_HYPOXIA</td><td></td><td>37</td><td>0.39</td><td>1.26</td><td>0.119</td><td>0.290</td><td>1.000</td><td>1884</td><td>tags=30%, list=15%, signal=35%</td></tr><tr><td class='lessen'>858</td><td>JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN</td><td></td><td>54</td><td>0.36</td><td>1.26</td><td>0.086</td><td>0.291</td><td>1.000</td><td>2286</td><td>tags=31%, list=18%, signal=38%</td></tr><tr><td class='lessen'>859</td><td>KANG_AR_TARGETS_UP</td><td></td><td>17</td><td>0.47</td><td>1.26</td><td>0.158</td><td>0.291</td><td>1.000</td><td>1407</td><td>tags=47%, list=11%, signal=53%</td></tr><tr><td class='lessen'>860</td><td>RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN</td><td></td><td>570</td><td>0.27</td><td>1.26</td><td>0.000</td><td>0.293</td><td>1.000</td><td>2859</td><td>tags=26%, list=22%, signal=32%</td></tr><tr><td class='lessen'>861</td><td>BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN</td><td></td><td>26</td><td>0.42</td><td>1.26</td><td>0.169</td><td>0.293</td><td>1.000</td><td>1432</td><td>tags=46%, list=11%, signal=52%</td></tr><tr><td class='lessen'>862</td><td>SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN</td><td></td><td>30</td><td>0.41</td><td>1.26</td><td>0.106</td><td>0.294</td><td>1.000</td><td>2382</td><td>tags=47%, list=18%, signal=57%</td></tr><tr><td class='lessen'>863</td><td>RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP</td><td></td><td>26</td><td>0.42</td><td>1.25</td><td>0.119</td><td>0.297</td><td>1.000</td><td>2135</td><td>tags=35%, list=17%, signal=41%</td></tr><tr><td class='lessen'>864</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP</td><td></td><td>64</td><td>0.35</td><td>1.25</td><td>0.064</td><td>0.298</td><td>1.000</td><td>2355</td><td>tags=31%, list=18%, signal=38%</td></tr><tr><td class='lessen'>865</td><td>KIM_WT1_TARGETS_UP</td><td></td><td>179</td><td>0.30</td><td>1.25</td><td>0.000</td><td>0.298</td><td>1.000</td><td>2434</td><td>tags=26%, list=19%, signal=31%</td></tr><tr><td class='lessen'>866</td><td>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN</td><td></td><td>27</td><td>0.42</td><td>1.25</td><td>0.183</td><td>0.298</td><td>1.000</td><td>839</td><td>tags=22%, list=6%, signal=24%</td></tr><tr><td class='lessen'>867</td><td>GENTILE_UV_RESPONSE_CLUSTER_D1</td><td></td><td>15</td><td>0.48</td><td>1.25</td><td>0.180</td><td>0.298</td><td>1.000</td><td>2785</td><td>tags=47%, list=22%, signal=59%</td></tr><tr><td class='lessen'>868</td><td>NUMATA_CSF3_SIGNALING_VIA_STAT3</td><td></td><td>20</td><td>0.45</td><td>1.25</td><td>0.144</td><td>0.298</td><td>1.000</td><td>1055</td><td>tags=25%, list=8%, signal=27%</td></tr><tr><td class='lessen'>869</td><td>NAKAMURA_METASTASIS_MODEL_DN</td><td></td><td>35</td><td>0.40</td><td>1.25</td><td>0.152</td><td>0.299</td><td>1.000</td><td>2000</td><td>tags=34%, list=15%, signal=40%</td></tr><tr><td class='lessen'>870</td><td>GESERICK_TERT_TARGETS_DN</td><td></td><td>20</td><td>0.45</td><td>1.25</td><td>0.145</td><td>0.301</td><td>1.000</td><td>2419</td><td>tags=45%, list=19%, signal=55%</td></tr><tr><td class='lessen'>871</td><td>MAHAJAN_RESPONSE_TO_IL1A_UP</td><td></td><td>73</td><td>0.34</td><td>1.25</td><td>0.065</td><td>0.301</td><td>1.000</td><td>2423</td><td>tags=45%, list=19%, signal=55%</td></tr><tr><td class='lessen'>872</td><td>YAN_ESCAPE_FROM_ANOIKIS</td><td></td><td>19</td><td>0.47</td><td>1.25</td><td>0.148</td><td>0.303</td><td>1.000</td><td>2915</td><td>tags=47%, list=23%, signal=61%</td></tr><tr><td class='lessen'>873</td><td>ZHANG_GATA6_TARGETS_UP</td><td></td><td>13</td><td>0.50</td><td>1.25</td><td>0.207</td><td>0.304</td><td>1.000</td><td>846</td><td>tags=23%, list=7%, signal=25%</td></tr><tr><td class='lessen'>874</td><td>GENTILE_UV_RESPONSE_CLUSTER_D2</td><td></td><td>36</td><td>0.39</td><td>1.25</td><td>0.135</td><td>0.304</td><td>1.000</td><td>2704</td><td>tags=28%, list=21%, signal=35%</td></tr><tr><td class='lessen'>875</td><td>MIKKELSEN_MCV6_LCP_WITH_H3K4ME3</td><td></td><td>131</td><td>0.32</td><td>1.25</td><td>0.048</td><td>0.307</td><td>1.000</td><td>1642</td><td>tags=28%, list=13%, signal=32%</td></tr><tr><td class='lessen'>876</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23</td><td></td><td>17</td><td>0.45</td><td>1.24</td><td>0.192</td><td>0.310</td><td>1.000</td><td>2519</td><td>tags=24%, list=19%, signal=29%</td></tr><tr><td class='lessen'>877</td><td>MULLIGHAN_NPM1_SIGNATURE_3_DN</td><td></td><td>130</td><td>0.31</td><td>1.24</td><td>0.016</td><td>0.310</td><td>1.000</td><td>2726</td><td>tags=33%, list=21%, signal=41%</td></tr><tr><td class='lessen'>878</td><td>BECKER_TAMOXIFEN_RESISTANCE_UP</td><td></td><td>45</td><td>0.37</td><td>1.24</td><td>0.115</td><td>0.310</td><td>1.000</td><td>544</td><td>tags=16%, list=4%, signal=16%</td></tr><tr><td class='lessen'>879</td><td>BILD_HRAS_ONCOGENIC_SIGNATURE</td><td></td><td>211</td><td>0.29</td><td>1.24</td><td>0.000</td><td>0.311</td><td>1.000</td><td>2655</td><td>tags=32%, list=21%, signal=39%</td></tr><tr><td class='lessen'>880</td><td>WACKER_HYPOXIA_TARGETS_OF_VHL</td><td></td><td>11</td><td>0.52</td><td>1.24</td><td>0.181</td><td>0.311</td><td>1.000</td><td>2394</td><td>tags=45%, list=19%, signal=56%</td></tr><tr><td class='lessen'>881</td><td>MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN</td><td></td><td>58</td><td>0.36</td><td>1.24</td><td>0.119</td><td>0.311</td><td>1.000</td><td>2168</td><td>tags=33%, list=17%, signal=39%</td></tr><tr><td class='lessen'>882</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12</td><td></td><td>72</td><td>0.34</td><td>1.24</td><td>0.096</td><td>0.310</td><td>1.000</td><td>1956</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>883</td><td>BROWN_MYELOID_CELL_DEVELOPMENT_UP</td><td></td><td>129</td><td>0.32</td><td>1.24</td><td>0.017</td><td>0.311</td><td>1.000</td><td>2392</td><td>tags=43%, list=18%, signal=53%</td></tr><tr><td class='lessen'>884</td><td>HINATA_NFKB_TARGETS_FIBROBLAST_UP</td><td></td><td>75</td><td>0.35</td><td>1.24</td><td>0.092</td><td>0.314</td><td>1.000</td><td>1322</td><td>tags=21%, list=10%, signal=24%</td></tr><tr><td class='lessen'>885</td><td>LI_WILMS_TUMOR</td><td></td><td>24</td><td>0.42</td><td>1.24</td><td>0.146</td><td>0.314</td><td>1.000</td><td>768</td><td>tags=25%, list=6%, signal=27%</td></tr><tr><td class='lessen'>886</td><td>SCHURINGA_STAT5A_TARGETS_UP</td><td></td><td>15</td><td>0.49</td><td>1.24</td><td>0.175</td><td>0.315</td><td>1.000</td><td>1863</td><td>tags=27%, list=14%, signal=31%</td></tr><tr><td class='lessen'>887</td><td>WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP</td><td></td><td>21</td><td>0.44</td><td>1.24</td><td>0.174</td><td>0.315</td><td>1.000</td><td>1159</td><td>tags=29%, list=9%, signal=31%</td></tr><tr><td class='lessen'>888</td><td>COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP</td><td></td><td>91</td><td>0.33</td><td>1.24</td><td>0.065</td><td>0.318</td><td>1.000</td><td>3020</td><td>tags=33%, list=23%, signal=43%</td></tr><tr><td class='lessen'>889</td><td>LIANG_SILENCED_BY_METHYLATION_UP</td><td></td><td>25</td><td>0.41</td><td>1.23</td><td>0.130</td><td>0.318</td><td>1.000</td><td>879</td><td>tags=32%, list=7%, signal=34%</td></tr><tr><td class='lessen'>890</td><td>LOPES_METHYLATED_IN_COLON_CANCER_UP</td><td></td><td>23</td><td>0.42</td><td>1.23</td><td>0.186</td><td>0.321</td><td>1.000</td><td>1608</td><td>tags=35%, list=12%, signal=40%</td></tr><tr><td class='lessen'>891</td><td>KYNG_DNA_DAMAGE_DN</td><td></td><td>170</td><td>0.30</td><td>1.23</td><td>0.020</td><td>0.321</td><td>1.000</td><td>2944</td><td>tags=34%, list=23%, signal=43%</td></tr><tr><td class='lessen'>892</td><td>FUKUSHIMA_TNFSF11_TARGETS</td><td></td><td>15</td><td>0.47</td><td>1.23</td><td>0.209</td><td>0.322</td><td>1.000</td><td>1690</td><td>tags=40%, list=13%, signal=46%</td></tr><tr><td class='lessen'>893</td><td>HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN</td><td></td><td>67</td><td>0.34</td><td>1.23</td><td>0.090</td><td>0.322</td><td>1.000</td><td>2293</td><td>tags=43%, list=18%, signal=52%</td></tr><tr><td class='lessen'>894</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN</td><td></td><td>11</td><td>0.51</td><td>1.23</td><td>0.219</td><td>0.323</td><td>1.000</td><td>419</td><td>tags=18%, list=3%, signal=19%</td></tr><tr><td class='lessen'>895</td><td>KENNY_CTNNB1_TARGETS_UP</td><td></td><td>45</td><td>0.37</td><td>1.23</td><td>0.134</td><td>0.323</td><td>1.000</td><td>1088</td><td>tags=18%, list=8%, signal=19%</td></tr><tr><td class='lessen'>896</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN</td><td></td><td>14</td><td>0.48</td><td>1.23</td><td>0.216</td><td>0.323</td><td>1.000</td><td>1894</td><td>tags=36%, list=15%, signal=42%</td></tr><tr><td class='lessen'>897</td><td>DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN</td><td></td><td>409</td><td>0.27</td><td>1.23</td><td>0.000</td><td>0.324</td><td>1.000</td><td>3020</td><td>tags=35%, list=23%, signal=44%</td></tr><tr><td class='lessen'>898</td><td>OLSSON_E2F3_TARGETS_DN</td><td></td><td>41</td><td>0.38</td><td>1.23</td><td>0.112</td><td>0.325</td><td>1.000</td><td>781</td><td>tags=17%, list=6%, signal=18%</td></tr><tr><td class='lessen'>899</td><td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS</td><td></td><td>26</td><td>0.43</td><td>1.23</td><td>0.158</td><td>0.327</td><td>1.000</td><td>2934</td><td>tags=42%, list=23%, signal=55%</td></tr><tr><td class='lessen'>900</td><td>DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP</td><td></td><td>51</td><td>0.36</td><td>1.23</td><td>0.134</td><td>0.327</td><td>1.000</td><td>2251</td><td>tags=39%, list=17%, signal=47%</td></tr><tr><td class='lessen'>901</td><td>BROWNE_HCMV_INFECTION_2HR_UP</td><td></td><td>28</td><td>0.41</td><td>1.23</td><td>0.175</td><td>0.327</td><td>1.000</td><td>3163</td><td>tags=57%, list=24%, signal=75%</td></tr><tr><td class='lessen'>902</td><td>LI_LUNG_CANCER</td><td></td><td>40</td><td>0.38</td><td>1.23</td><td>0.175</td><td>0.327</td><td>1.000</td><td>456</td><td>tags=10%, list=4%, signal=10%</td></tr><tr><td class='lessen'>903</td><td>DOANE_RESPONSE_TO_ANDROGEN_DN</td><td></td><td>204</td><td>0.28</td><td>1.22</td><td>0.031</td><td>0.329</td><td>1.000</td><td>2060</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>904</td><td>NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN</td><td></td><td>15</td><td>0.47</td><td>1.22</td><td>0.214</td><td>0.329</td><td>1.000</td><td>1891</td><td>tags=47%, list=15%, signal=55%</td></tr><tr><td class='lessen'>905</td><td>GENTILE_UV_HIGH_DOSE_UP</td><td></td><td>21</td><td>0.45</td><td>1.22</td><td>0.198</td><td>0.330</td><td>1.000</td><td>1832</td><td>tags=29%, list=14%, signal=33%</td></tr><tr><td class='lessen'>906</td><td>WANG_CISPLATIN_RESPONSE_AND_XPC_DN</td><td></td><td>183</td><td>0.30</td><td>1.22</td><td>0.056</td><td>0.330</td><td>1.000</td><td>2382</td><td>tags=27%, list=18%, signal=32%</td></tr><tr><td class='lessen'>907</td><td>MOOTHA_GLYCOGEN_METABOLISM</td><td></td><td>18</td><td>0.45</td><td>1.22</td><td>0.181</td><td>0.330</td><td>1.000</td><td>1678</td><td>tags=33%, list=13%, signal=38%</td></tr><tr><td class='lessen'>908</td><td>OSMAN_BLADDER_CANCER_UP</td><td></td><td>326</td><td>0.28</td><td>1.22</td><td>0.000</td><td>0.331</td><td>1.000</td><td>3218</td><td>tags=29%, list=25%, signal=37%</td></tr><tr><td class='lessen'>909</td><td>VALK_AML_CLUSTER_8</td><td></td><td>22</td><td>0.43</td><td>1.22</td><td>0.173</td><td>0.331</td><td>1.000</td><td>1881</td><td>tags=27%, list=15%, signal=32%</td></tr><tr><td class='lessen'>910</td><td>AMIT_EGF_RESPONSE_240_HELA</td><td></td><td>55</td><td>0.35</td><td>1.22</td><td>0.126</td><td>0.331</td><td>1.000</td><td>2399</td><td>tags=31%, list=19%, signal=38%</td></tr><tr><td class='lessen'>911</td><td>NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON</td><td></td><td>11</td><td>0.52</td><td>1.22</td><td>0.214</td><td>0.332</td><td>1.000</td><td>2194</td><td>tags=45%, list=17%, signal=55%</td></tr><tr><td class='lessen'>912</td><td>LEE_SP4_THYMOCYTE</td><td></td><td>11</td><td>0.53</td><td>1.22</td><td>0.222</td><td>0.335</td><td>1.000</td><td>1564</td><td>tags=36%, list=12%, signal=41%</td></tr><tr><td class='lessen'>913</td><td>MARKS_HDAC_TARGETS_DN</td><td></td><td>13</td><td>0.50</td><td>1.22</td><td>0.217</td><td>0.336</td><td>1.000</td><td>2767</td><td>tags=38%, list=21%, signal=49%</td></tr><tr><td class='lessen'>914</td><td>MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN</td><td></td><td>16</td><td>0.48</td><td>1.22</td><td>0.204</td><td>0.337</td><td>1.000</td><td>2376</td><td>tags=44%, list=18%, signal=54%</td></tr><tr><td class='lessen'>915</td><td>SEIDEN_ONCOGENESIS_BY_MET</td><td></td><td>73</td><td>0.33</td><td>1.22</td><td>0.101</td><td>0.339</td><td>1.000</td><td>1824</td><td>tags=15%, list=14%, signal=17%</td></tr><tr><td class='lessen'>916</td><td>SHI_SPARC_TARGETS_DN</td><td></td><td>11</td><td>0.52</td><td>1.21</td><td>0.227</td><td>0.340</td><td>1.000</td><td>2843</td><td>tags=55%, list=22%, signal=70%</td></tr><tr><td class='lessen'>917</td><td>SUZUKI_RESPONSE_TO_TSA</td><td></td><td>14</td><td>0.48</td><td>1.21</td><td>0.238</td><td>0.339</td><td>1.000</td><td>1343</td><td>tags=14%, list=10%, signal=16%</td></tr><tr><td class='lessen'>918</td><td>SAGIV_CD24_TARGETS_UP</td><td></td><td>22</td><td>0.42</td><td>1.21</td><td>0.192</td><td>0.340</td><td>1.000</td><td>628</td><td>tags=14%, list=5%, signal=14%</td></tr><tr><td class='lessen'>919</td><td>HOWLIN_CITED1_TARGETS_2_DN</td><td></td><td>15</td><td>0.47</td><td>1.21</td><td>0.220</td><td>0.340</td><td>1.000</td><td>626</td><td>tags=20%, list=5%, signal=21%</td></tr><tr><td class='lessen'>920</td><td>SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP</td><td></td><td>17</td><td>0.45</td><td>1.21</td><td>0.206</td><td>0.340</td><td>1.000</td><td>2813</td><td>tags=35%, list=22%, signal=45%</td></tr><tr><td class='lessen'>921</td><td>BYSTROEM_CORRELATED_WITH_IL5_DN</td><td></td><td>59</td><td>0.33</td><td>1.21</td><td>0.103</td><td>0.340</td><td>1.000</td><td>3010</td><td>tags=31%, list=23%, signal=40%</td></tr><tr><td class='lessen'>922</td><td>KONDO_EZH2_TARGETS</td><td></td><td>176</td><td>0.30</td><td>1.21</td><td>0.026</td><td>0.340</td><td>1.000</td><td>2413</td><td>tags=34%, list=19%, signal=41%</td></tr><tr><td class='lessen'>923</td><td>HE_PTEN_TARGETS_UP</td><td></td><td>15</td><td>0.48</td><td>1.21</td><td>0.218</td><td>0.340</td><td>1.000</td><td>2179</td><td>tags=40%, list=17%, signal=48%</td></tr><tr><td class='lessen'>924</td><td>WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP</td><td></td><td>28</td><td>0.41</td><td>1.21</td><td>0.193</td><td>0.340</td><td>1.000</td><td>1705</td><td>tags=39%, list=13%, signal=45%</td></tr><tr><td class='lessen'>925</td><td>MATSUDA_NATURAL_KILLER_DIFFERENTIATION</td><td></td><td>414</td><td>0.29</td><td>1.21</td><td>0.000</td><td>0.341</td><td>1.000</td><td>1752</td><td>tags=21%, list=14%, signal=24%</td></tr><tr><td class='lessen'>926</td><td>VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN</td><td></td><td>126</td><td>0.30</td><td>1.21</td><td>0.036</td><td>0.340</td><td>1.000</td><td>2090</td><td>tags=33%, list=16%, signal=38%</td></tr><tr><td class='lessen'>927</td><td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD</td><td></td><td>26</td><td>0.41</td><td>1.21</td><td>0.172</td><td>0.343</td><td>1.000</td><td>2896</td><td>tags=46%, list=22%, signal=59%</td></tr><tr><td class='lessen'>928</td><td>MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP</td><td></td><td>63</td><td>0.33</td><td>1.21</td><td>0.098</td><td>0.343</td><td>1.000</td><td>2099</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>929</td><td>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B</td><td></td><td>446</td><td>0.28</td><td>1.21</td><td>0.000</td><td>0.343</td><td>1.000</td><td>1759</td><td>tags=22%, list=14%, signal=25%</td></tr><tr><td class='lessen'>930</td><td>AMIT_EGF_RESPONSE_480_HELA</td><td></td><td>138</td><td>0.31</td><td>1.21</td><td>0.034</td><td>0.344</td><td>1.000</td><td>2519</td><td>tags=29%, list=19%, signal=36%</td></tr><tr><td class='lessen'>931</td><td>LIU_IL13_MEMORY_MODEL_UP</td><td></td><td>15</td><td>0.46</td><td>1.21</td><td>0.213</td><td>0.344</td><td>1.000</td><td>2687</td><td>tags=47%, list=21%, signal=59%</td></tr><tr><td class='lessen'>932</td><td>AMIT_SERUM_RESPONSE_20_MCF10A</td><td></td><td>18</td><td>0.46</td><td>1.21</td><td>0.229</td><td>0.344</td><td>1.000</td><td>2062</td><td>tags=22%, list=16%, signal=26%</td></tr><tr><td class='lessen'>933</td><td>BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER</td><td></td><td>22</td><td>0.43</td><td>1.21</td><td>0.198</td><td>0.346</td><td>1.000</td><td>2704</td><td>tags=41%, list=21%, signal=52%</td></tr><tr><td class='lessen'>934</td><td>ENK_UV_RESPONSE_EPIDERMIS_UP</td><td></td><td>249</td><td>0.28</td><td>1.21</td><td>0.000</td><td>0.347</td><td>1.000</td><td>2165</td><td>tags=20%, list=17%, signal=23%</td></tr><tr><td class='lessen'>935</td><td>NAKAYAMA_FGF2_TARGETS</td><td></td><td>24</td><td>0.42</td><td>1.21</td><td>0.215</td><td>0.348</td><td>1.000</td><td>1889</td><td>tags=33%, list=15%, signal=39%</td></tr><tr><td class='lessen'>936</td><td>IVANOVA_HEMATOPOIESIS_MATURE_CELL</td><td></td><td>223</td><td>0.28</td><td>1.20</td><td>0.000</td><td>0.349</td><td>1.000</td><td>1908</td><td>tags=21%, list=15%, signal=24%</td></tr><tr><td class='lessen'>937</td><td>HOWLIN_CITED1_TARGETS_1_DN</td><td></td><td>31</td><td>0.39</td><td>1.20</td><td>0.204</td><td>0.351</td><td>1.000</td><td>2443</td><td>tags=29%, list=19%, signal=36%</td></tr><tr><td class='lessen'>938</td><td>CHUNG_BLISTER_CYTOTOXICITY_DN</td><td></td><td>32</td><td>0.39</td><td>1.20</td><td>0.178</td><td>0.351</td><td>1.000</td><td>3174</td><td>tags=47%, list=25%, signal=62%</td></tr><tr><td class='lessen'>939</td><td>BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP</td><td></td><td>315</td><td>0.28</td><td>1.20</td><td>0.000</td><td>0.352</td><td>1.000</td><td>2505</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>940</td><td>GOZGIT_ESR1_TARGETS_UP</td><td></td><td>111</td><td>0.31</td><td>1.20</td><td>0.070</td><td>0.352</td><td>1.000</td><td>1373</td><td>tags=24%, list=11%, signal=27%</td></tr><tr><td class='lessen'>941</td><td>DARWICHE_SKIN_TUMOR_PROMOTER_UP</td><td></td><td>107</td><td>0.31</td><td>1.20</td><td>0.083</td><td>0.352</td><td>1.000</td><td>2171</td><td>tags=23%, list=17%, signal=28%</td></tr><tr><td class='lessen'>942</td><td>KIM_GERMINAL_CENTER_T_HELPER_UP</td><td></td><td>51</td><td>0.35</td><td>1.20</td><td>0.180</td><td>0.352</td><td>1.000</td><td>1388</td><td>tags=20%, list=11%, signal=22%</td></tr><tr><td class='lessen'>943</td><td>SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4</td><td></td><td>155</td><td>0.30</td><td>1.20</td><td>0.059</td><td>0.353</td><td>1.000</td><td>2352</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>944</td><td>PEDRIOLI_MIR31_TARGETS_DN</td><td></td><td>305</td><td>0.28</td><td>1.20</td><td>0.000</td><td>0.354</td><td>1.000</td><td>1886</td><td>tags=24%, list=15%, signal=27%</td></tr><tr><td class='lessen'>945</td><td>HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP</td><td></td><td>58</td><td>0.34</td><td>1.20</td><td>0.133</td><td>0.354</td><td>1.000</td><td>504</td><td>tags=10%, list=4%, signal=11%</td></tr><tr><td class='lessen'>946</td><td>SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE</td><td></td><td>70</td><td>0.33</td><td>1.20</td><td>0.112</td><td>0.355</td><td>1.000</td><td>2825</td><td>tags=27%, list=22%, signal=35%</td></tr><tr><td class='lessen'>947</td><td>XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP</td><td></td><td>31</td><td>0.40</td><td>1.20</td><td>0.172</td><td>0.355</td><td>1.000</td><td>2962</td><td>tags=52%, list=23%, signal=67%</td></tr><tr><td class='lessen'>948</td><td>ONDER_CDH1_TARGETS_1_DN</td><td></td><td>132</td><td>0.30</td><td>1.20</td><td>0.047</td><td>0.357</td><td>1.000</td><td>1677</td><td>tags=18%, list=13%, signal=21%</td></tr><tr><td class='lessen'>949</td><td>LUI_THYROID_CANCER_PAX8_PPARG_UP</td><td></td><td>36</td><td>0.38</td><td>1.20</td><td>0.163</td><td>0.357</td><td>1.000</td><td>2124</td><td>tags=22%, list=16%, signal=27%</td></tr><tr><td class='lessen'>950</td><td>LEE_AGING_CEREBELLUM_DN</td><td></td><td>77</td><td>0.32</td><td>1.20</td><td>0.123</td><td>0.357</td><td>1.000</td><td>1006</td><td>tags=21%, list=8%, signal=22%</td></tr><tr><td class='lessen'>951</td><td>BROWNE_HCMV_INFECTION_48HR_DN</td><td></td><td>421</td><td>0.30</td><td>1.20</td><td>0.000</td><td>0.358</td><td>1.000</td><td>2011</td><td>tags=25%, list=16%, signal=29%</td></tr><tr><td class='lessen'>952</td><td>SENESE_HDAC1_TARGETS_DN</td><td></td><td>187</td><td>0.29</td><td>1.20</td><td>0.029</td><td>0.358</td><td>1.000</td><td>2502</td><td>tags=29%, list=19%, signal=35%</td></tr><tr><td class='lessen'>953</td><td>TERAO_AOX4_TARGETS_SKIN_DN</td><td></td><td>14</td><td>0.47</td><td>1.19</td><td>0.199</td><td>0.359</td><td>1.000</td><td>1432</td><td>tags=36%, list=11%, signal=40%</td></tr><tr><td class='lessen'>954</td><td>XU_CREBBP_TARGETS_DN</td><td></td><td>36</td><td>0.38</td><td>1.19</td><td>0.181</td><td>0.359</td><td>1.000</td><td>1429</td><td>tags=19%, list=11%, signal=22%</td></tr><tr><td class='lessen'>955</td><td>LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS</td><td></td><td>20</td><td>0.43</td><td>1.19</td><td>0.231</td><td>0.360</td><td>1.000</td><td>2574</td><td>tags=55%, list=20%, signal=69%</td></tr><tr><td class='lessen'>956</td><td>BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP</td><td></td><td>153</td><td>0.29</td><td>1.19</td><td>0.042</td><td>0.360</td><td>1.000</td><td>2493</td><td>tags=28%, list=19%, signal=34%</td></tr><tr><td class='lessen'>957</td><td>SU_PLACENTA</td><td></td><td>23</td><td>0.42</td><td>1.19</td><td>0.208</td><td>0.363</td><td>1.000</td><td>1119</td><td>tags=26%, list=9%, signal=29%</td></tr><tr><td class='lessen'>958</td><td>STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP</td><td></td><td>164</td><td>0.29</td><td>1.19</td><td>0.000</td><td>0.363</td><td>1.000</td><td>2661</td><td>tags=27%, list=21%, signal=33%</td></tr><tr><td class='lessen'>959</td><td>TARTE_PLASMA_CELL_VS_PLASMABLAST_UP</td><td></td><td>315</td><td>0.28</td><td>1.19</td><td>0.000</td><td>0.364</td><td>1.000</td><td>2141</td><td>tags=29%, list=17%, signal=34%</td></tr><tr><td class='lessen'>960</td><td>SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE</td><td></td><td>91</td><td>0.31</td><td>1.19</td><td>0.087</td><td>0.365</td><td>1.000</td><td>2470</td><td>tags=21%, list=19%, signal=26%</td></tr><tr><td class='lessen'>961</td><td>BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN</td><td></td><td>99</td><td>0.30</td><td>1.19</td><td>0.063</td><td>0.365</td><td>1.000</td><td>2536</td><td>tags=32%, list=20%, signal=40%</td></tr><tr><td class='lessen'>962</td><td>HAN_SATB1_TARGETS_UP</td><td></td><td>305</td><td>0.27</td><td>1.19</td><td>0.000</td><td>0.366</td><td>1.000</td><td>1975</td><td>tags=22%, list=15%, signal=26%</td></tr><tr><td class='lessen'>963</td><td>HARRIS_HYPOXIA</td><td></td><td>68</td><td>0.33</td><td>1.19</td><td>0.127</td><td>0.365</td><td>1.000</td><td>2204</td><td>tags=40%, list=17%, signal=48%</td></tr><tr><td class='lessen'>964</td><td>HAHTOLA_MYCOSIS_FUNGOIDES_DN</td><td></td><td>11</td><td>0.50</td><td>1.19</td><td>0.262</td><td>0.365</td><td>1.000</td><td>3434</td><td>tags=55%, list=27%, signal=74%</td></tr><tr><td class='lessen'>965</td><td>AMIT_SERUM_RESPONSE_60_MCF10A</td><td></td><td>47</td><td>0.35</td><td>1.19</td><td>0.153</td><td>0.367</td><td>1.000</td><td>2518</td><td>tags=40%, list=19%, signal=50%</td></tr><tr><td class='lessen'>966</td><td>JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN</td><td></td><td>53</td><td>0.35</td><td>1.19</td><td>0.153</td><td>0.370</td><td>1.000</td><td>1157</td><td>tags=25%, list=9%, signal=27%</td></tr><tr><td class='lessen'>967</td><td>HOUSTIS_ROS</td><td></td><td>31</td><td>0.39</td><td>1.19</td><td>0.200</td><td>0.370</td><td>1.000</td><td>1875</td><td>tags=26%, list=14%, signal=30%</td></tr><tr><td class='lessen'>968</td><td>CHASSOT_SKIN_WOUND</td><td></td><td>10</td><td>0.50</td><td>1.19</td><td>0.237</td><td>0.370</td><td>1.000</td><td>2473</td><td>tags=60%, list=19%, signal=74%</td></tr><tr><td class='lessen'>969</td><td>BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN</td><td></td><td>36</td><td>0.37</td><td>1.19</td><td>0.223</td><td>0.370</td><td>1.000</td><td>2399</td><td>tags=31%, list=19%, signal=37%</td></tr><tr><td class='lessen'>970</td><td>DAIRKEE_TERT_TARGETS_DN</td><td></td><td>87</td><td>0.31</td><td>1.18</td><td>0.125</td><td>0.373</td><td>1.000</td><td>2220</td><td>tags=28%, list=17%, signal=33%</td></tr><tr><td class='lessen'>971</td><td>BURTON_ADIPOGENESIS_10</td><td></td><td>26</td><td>0.40</td><td>1.18</td><td>0.198</td><td>0.374</td><td>1.000</td><td>2425</td><td>tags=38%, list=19%, signal=47%</td></tr><tr><td class='lessen'>972</td><td>URS_ADIPOCYTE_DIFFERENTIATION_UP</td><td></td><td>66</td><td>0.33</td><td>1.18</td><td>0.147</td><td>0.375</td><td>1.000</td><td>833</td><td>tags=18%, list=6%, signal=19%</td></tr><tr><td class='lessen'>973</td><td>VANTVEER_BREAST_CANCER_BRCA1_UP</td><td></td><td>28</td><td>0.39</td><td>1.18</td><td>0.195</td><td>0.375</td><td>1.000</td><td>1294</td><td>tags=18%, list=10%, signal=20%</td></tr><tr><td class='lessen'>974</td><td>BERNARD_PPAPDC1B_TARGETS_UP</td><td></td><td>31</td><td>0.37</td><td>1.18</td><td>0.191</td><td>0.375</td><td>1.000</td><td>3418</td><td>tags=42%, list=26%, signal=57%</td></tr><tr><td class='lessen'>975</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5</td><td></td><td>360</td><td>0.26</td><td>1.18</td><td>0.000</td><td>0.375</td><td>1.000</td><td>2669</td><td>tags=24%, list=21%, signal=30%</td></tr><tr><td class='lessen'>976</td><td>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL</td><td></td><td>14</td><td>0.47</td><td>1.18</td><td>0.265</td><td>0.375</td><td>1.000</td><td>1147</td><td>tags=29%, list=9%, signal=31%</td></tr><tr><td class='lessen'>977</td><td>JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP</td><td></td><td>47</td><td>0.35</td><td>1.18</td><td>0.190</td><td>0.375</td><td>1.000</td><td>1660</td><td>tags=28%, list=13%, signal=32%</td></tr><tr><td class='lessen'>978</td><td>BAKKER_FOXO3_TARGETS_UP</td><td></td><td>49</td><td>0.35</td><td>1.18</td><td>0.179</td><td>0.375</td><td>1.000</td><td>3098</td><td>tags=31%, list=24%, signal=40%</td></tr><tr><td class='lessen'>979</td><td>SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN</td><td></td><td>19</td><td>0.44</td><td>1.18</td><td>0.236</td><td>0.374</td><td>1.000</td><td>489</td><td>tags=21%, list=4%, signal=22%</td></tr><tr><td class='lessen'>980</td><td>CORRE_MULTIPLE_MYELOMA_DN</td><td></td><td>54</td><td>0.34</td><td>1.18</td><td>0.174</td><td>0.374</td><td>1.000</td><td>1902</td><td>tags=37%, list=15%, signal=43%</td></tr><tr><td class='lessen'>981</td><td>BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN</td><td></td><td>495</td><td>0.26</td><td>1.18</td><td>0.000</td><td>0.378</td><td>1.000</td><td>2374</td><td>tags=21%, list=18%, signal=25%</td></tr><tr><td class='lessen'>982</td><td>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4</td><td></td><td>84</td><td>0.32</td><td>1.18</td><td>0.162</td><td>0.377</td><td>1.000</td><td>1229</td><td>tags=20%, list=10%, signal=22%</td></tr><tr><td class='lessen'>983</td><td>HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN</td><td></td><td>14</td><td>0.47</td><td>1.18</td><td>0.265</td><td>0.380</td><td>1.000</td><td>1845</td><td>tags=36%, list=14%, signal=42%</td></tr><tr><td class='lessen'>984</td><td>IKEDA_MIR133_TARGETS_UP</td><td></td><td>42</td><td>0.35</td><td>1.18</td><td>0.160</td><td>0.382</td><td>1.000</td><td>3651</td><td>tags=40%, list=28%, signal=56%</td></tr><tr><td class='lessen'>985</td><td>FERNANDEZ_BOUND_BY_MYC</td><td></td><td>168</td><td>0.29</td><td>1.17</td><td>0.081</td><td>0.382</td><td>1.000</td><td>2368</td><td>tags=24%, list=18%, signal=29%</td></tr><tr><td class='lessen'>986</td><td>GARY_CD5_TARGETS_UP</td><td></td><td>400</td><td>0.26</td><td>1.17</td><td>0.000</td><td>0.383</td><td>1.000</td><td>3043</td><td>tags=28%, list=24%, signal=35%</td></tr><tr><td class='lessen'>987</td><td>GYORFFY_DOXORUBICIN_RESISTANCE</td><td></td><td>38</td><td>0.37</td><td>1.17</td><td>0.213</td><td>0.382</td><td>1.000</td><td>1589</td><td>tags=29%, list=12%, signal=33%</td></tr><tr><td class='lessen'>988</td><td>PILON_KLF1_TARGETS_UP</td><td></td><td>419</td><td>0.25</td><td>1.17</td><td>0.000</td><td>0.384</td><td>1.000</td><td>1902</td><td>tags=21%, list=15%, signal=24%</td></tr><tr><td class='lessen'>989</td><td>ZHOU_TNF_SIGNALING_4HR</td><td></td><td>47</td><td>0.35</td><td>1.17</td><td>0.194</td><td>0.384</td><td>1.000</td><td>3149</td><td>tags=28%, list=24%, signal=36%</td></tr><tr><td class='lessen'>990</td><td>KYNG_DNA_DAMAGE_BY_4NQO</td><td></td><td>32</td><td>0.38</td><td>1.17</td><td>0.237</td><td>0.386</td><td>1.000</td><td>2390</td><td>tags=34%, list=18%, signal=42%</td></tr><tr><td class='lessen'>991</td><td>TERAMOTO_OPN_TARGETS_CLUSTER_4</td><td></td><td>11</td><td>0.48</td><td>1.17</td><td>0.265</td><td>0.387</td><td>1.000</td><td>482</td><td>tags=18%, list=4%, signal=19%</td></tr><tr><td class='lessen'>992</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP</td><td></td><td>14</td><td>0.46</td><td>1.17</td><td>0.249</td><td>0.387</td><td>1.000</td><td>2388</td><td>tags=43%, list=18%, signal=53%</td></tr><tr><td class='lessen'>993</td><td>JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN</td><td></td><td>57</td><td>0.33</td><td>1.17</td><td>0.154</td><td>0.388</td><td>1.000</td><td>2502</td><td>tags=33%, list=19%, signal=41%</td></tr><tr><td class='lessen'>994</td><td>LIU_VMYB_TARGETS_UP</td><td></td><td>106</td><td>0.30</td><td>1.17</td><td>0.122</td><td>0.388</td><td>1.000</td><td>1433</td><td>tags=16%, list=11%, signal=18%</td></tr><tr><td class='lessen'>995</td><td>LEIN_OLIGODENDROCYTE_MARKERS</td><td></td><td>55</td><td>0.34</td><td>1.17</td><td>0.189</td><td>0.389</td><td>1.000</td><td>1415</td><td>tags=24%, list=11%, signal=26%</td></tr><tr><td class='lessen'>996</td><td>KAAB_FAILED_HEART_ATRIUM_DN</td><td></td><td>119</td><td>0.30</td><td>1.17</td><td>0.096</td><td>0.389</td><td>1.000</td><td>1844</td><td>tags=13%, list=14%, signal=16%</td></tr><tr><td class='lessen'>997</td><td>TANG_SENESCENCE_TP53_TARGETS_UP</td><td></td><td>27</td><td>0.39</td><td>1.17</td><td>0.191</td><td>0.389</td><td>1.000</td><td>1966</td><td>tags=37%, list=15%, signal=44%</td></tr><tr><td class='lessen'>998</td><td>BROWNE_HCMV_INFECTION_4HR_UP</td><td></td><td>47</td><td>0.35</td><td>1.17</td><td>0.173</td><td>0.389</td><td>1.000</td><td>2362</td><td>tags=36%, list=18%, signal=44%</td></tr><tr><td class='lessen'>999</td><td>NAKAJIMA_EOSINOPHIL</td><td></td><td>23</td><td>0.41</td><td>1.17</td><td>0.248</td><td>0.390</td><td>1.000</td><td>1315</td><td>tags=39%, list=10%, signal=43%</td></tr><tr><td class='lessen'>1000</td><td>JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN</td><td></td><td>44</td><td>0.35</td><td>1.17</td><td>0.188</td><td>0.391</td><td>1.000</td><td>2122</td><td>tags=27%, list=16%, signal=33%</td></tr><tr><td class='lessen'>1001</td><td>MANN_RESPONSE_TO_AMIFOSTINE_UP</td><td></td><td>20</td><td>0.42</td><td>1.17</td><td>0.213</td><td>0.391</td><td>1.000</td><td>2854</td><td>tags=35%, list=22%, signal=45%</td></tr><tr><td class='lessen'>1002</td><td>BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP</td><td></td><td>12</td><td>0.47</td><td>1.17</td><td>0.288</td><td>0.392</td><td>1.000</td><td>484</td><td>tags=17%, list=4%, signal=17%</td></tr><tr><td class='lessen'>1003</td><td>HAHTOLA_CTCL_PATHOGENESIS</td><td></td><td>15</td><td>0.46</td><td>1.17</td><td>0.246</td><td>0.392</td><td>1.000</td><td>2658</td><td>tags=60%, list=21%, signal=75%</td></tr><tr><td class='lessen'>1004</td><td>SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP</td><td></td><td>29</td><td>0.38</td><td>1.17</td><td>0.189</td><td>0.392</td><td>1.000</td><td>3000</td><td>tags=38%, list=23%, signal=49%</td></tr><tr><td class='lessen'>1005</td><td>HAHTOLA_SEZARY_SYNDROM_UP</td><td></td><td>79</td><td>0.32</td><td>1.16</td><td>0.154</td><td>0.393</td><td>1.000</td><td>2576</td><td>tags=30%, list=20%, signal=38%</td></tr><tr><td class='lessen'>1006</td><td>SASSON_RESPONSE_TO_FORSKOLIN_DN</td><td></td><td>79</td><td>0.31</td><td>1.16</td><td>0.171</td><td>0.393</td><td>1.000</td><td>2161</td><td>tags=22%, list=17%, signal=26%</td></tr><tr><td class='lessen'>1007</td><td>SABATES_COLORECTAL_ADENOMA_SIZE_DN</td><td></td><td>11</td><td>0.49</td><td>1.16</td><td>0.262</td><td>0.394</td><td>1.000</td><td>1980</td><td>tags=36%, list=15%, signal=43%</td></tr><tr><td class='lessen'>1008</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN</td><td></td><td>42</td><td>0.35</td><td>1.16</td><td>0.177</td><td>0.394</td><td>1.000</td><td>2392</td><td>tags=29%, list=18%, signal=35%</td></tr><tr><td class='lessen'>1009</td><td>SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A</td><td></td><td>19</td><td>0.41</td><td>1.16</td><td>0.235</td><td>0.396</td><td>1.000</td><td>2204</td><td>tags=47%, list=17%, signal=57%</td></tr><tr><td class='lessen'>1010</td><td>MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3</td><td></td><td>52</td><td>0.34</td><td>1.16</td><td>0.170</td><td>0.396</td><td>1.000</td><td>1073</td><td>tags=25%, list=8%, signal=27%</td></tr><tr><td class='lessen'>1011</td><td>PENG_GLUTAMINE_DEPRIVATION_UP</td><td></td><td>36</td><td>0.37</td><td>1.16</td><td>0.218</td><td>0.399</td><td>1.000</td><td>1287</td><td>tags=17%, list=10%, signal=18%</td></tr><tr><td class='lessen'>1012</td><td>SERVITJA_LIVER_HNF1A_TARGETS_UP</td><td></td><td>126</td><td>0.29</td><td>1.16</td><td>0.089</td><td>0.399</td><td>1.000</td><td>1589</td><td>tags=27%, list=12%, signal=30%</td></tr><tr><td class='lessen'>1013</td><td>DOANE_BREAST_CANCER_CLASSES_DN</td><td></td><td>31</td><td>0.38</td><td>1.16</td><td>0.209</td><td>0.399</td><td>1.000</td><td>2710</td><td>tags=45%, list=21%, signal=57%</td></tr><tr><td class='lessen'>1014</td><td>MARSHALL_VIRAL_INFECTION_RESPONSE_DN</td><td></td><td>25</td><td>0.40</td><td>1.16</td><td>0.248</td><td>0.400</td><td>1.000</td><td>883</td><td>tags=20%, list=7%, signal=21%</td></tr><tr><td class='lessen'>1015</td><td>YAGI_AML_WITH_T_9_11_TRANSLOCATION</td><td></td><td>110</td><td>0.30</td><td>1.16</td><td>0.091</td><td>0.400</td><td>1.000</td><td>1722</td><td>tags=15%, list=13%, signal=18%</td></tr><tr><td class='lessen'>1016</td><td>MCCLUNG_DELTA_FOSB_TARGETS_8WK</td><td></td><td>44</td><td>0.35</td><td>1.16</td><td>0.197</td><td>0.400</td><td>1.000</td><td>2886</td><td>tags=32%, list=22%, signal=41%</td></tr><tr><td class='lessen'>1017</td><td>SASSON_RESPONSE_TO_GONADOTROPHINS_DN</td><td></td><td>78</td><td>0.32</td><td>1.16</td><td>0.147</td><td>0.400</td><td>1.000</td><td>2636</td><td>tags=27%, list=20%, signal=34%</td></tr><tr><td class='lessen'>1018</td><td>ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN</td><td></td><td>30</td><td>0.38</td><td>1.16</td><td>0.246</td><td>0.400</td><td>1.000</td><td>3002</td><td>tags=40%, list=23%, signal=52%</td></tr><tr><td class='lessen'>1019</td><td>WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP</td><td></td><td>10</td><td>0.51</td><td>1.16</td><td>0.277</td><td>0.401</td><td>1.000</td><td>2076</td><td>tags=30%, list=16%, signal=36%</td></tr><tr><td class='lessen'>1020</td><td>CAIRO_HEPATOBLASTOMA_UP</td><td></td><td>171</td><td>0.28</td><td>1.16</td><td>0.059</td><td>0.402</td><td>1.000</td><td>2191</td><td>tags=20%, list=17%, signal=24%</td></tr><tr><td class='lessen'>1021</td><td>SEMENZA_HIF1_TARGETS</td><td></td><td>30</td><td>0.38</td><td>1.16</td><td>0.202</td><td>0.402</td><td>1.000</td><td>2052</td><td>tags=33%, list=16%, signal=40%</td></tr><tr><td class='lessen'>1022</td><td>CHANDRAN_METASTASIS_TOP50_DN</td><td></td><td>43</td><td>0.35</td><td>1.16</td><td>0.221</td><td>0.402</td><td>1.000</td><td>1734</td><td>tags=19%, list=13%, signal=21%</td></tr><tr><td class='lessen'>1023</td><td>GNATENKO_PLATELET_SIGNATURE</td><td></td><td>36</td><td>0.36</td><td>1.16</td><td>0.195</td><td>0.402</td><td>1.000</td><td>2652</td><td>tags=28%, list=21%, signal=35%</td></tr><tr><td class='lessen'>1024</td><td>GUO_HEX_TARGETS_UP</td><td></td><td>69</td><td>0.33</td><td>1.16</td><td>0.209</td><td>0.402</td><td>1.000</td><td>2502</td><td>tags=25%, list=19%, signal=30%</td></tr><tr><td class='lessen'>1025</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_3_DN</td><td></td><td>28</td><td>0.38</td><td>1.15</td><td>0.245</td><td>0.404</td><td>1.000</td><td>3191</td><td>tags=54%, list=25%, signal=71%</td></tr><tr><td class='lessen'>1026</td><td>BROWNE_HCMV_INFECTION_30MIN_DN</td><td></td><td>114</td><td>0.31</td><td>1.15</td><td>0.128</td><td>0.406</td><td>1.000</td><td>2297</td><td>tags=29%, list=18%, signal=35%</td></tr><tr><td class='lessen'>1027</td><td>GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB</td><td></td><td>107</td><td>0.30</td><td>1.15</td><td>0.181</td><td>0.406</td><td>1.000</td><td>2971</td><td>tags=34%, list=23%, signal=43%</td></tr><tr><td class='lessen'>1028</td><td>AMIT_EGF_RESPONSE_40_MCF10A</td><td></td><td>18</td><td>0.43</td><td>1.15</td><td>0.261</td><td>0.406</td><td>1.000</td><td>2152</td><td>tags=50%, list=17%, signal=60%</td></tr><tr><td class='lessen'>1029</td><td>SHIN_B_CELL_LYMPHOMA_CLUSTER_2</td><td></td><td>29</td><td>0.37</td><td>1.15</td><td>0.251</td><td>0.406</td><td>1.000</td><td>1402</td><td>tags=24%, list=11%, signal=27%</td></tr><tr><td class='lessen'>1030</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN</td><td></td><td>63</td><td>0.32</td><td>1.15</td><td>0.182</td><td>0.409</td><td>1.000</td><td>2274</td><td>tags=25%, list=18%, signal=31%</td></tr><tr><td class='lessen'>1031</td><td>SESTO_RESPONSE_TO_UV_C8</td><td></td><td>68</td><td>0.32</td><td>1.15</td><td>0.149</td><td>0.409</td><td>1.000</td><td>1300</td><td>tags=18%, list=10%, signal=20%</td></tr><tr><td class='lessen'>1032</td><td>LEE_DOUBLE_POLAR_THYMOCYTE</td><td></td><td>21</td><td>0.41</td><td>1.15</td><td>0.245</td><td>0.410</td><td>1.000</td><td>3105</td><td>tags=48%, list=24%, signal=63%</td></tr><tr><td class='lessen'>1033</td><td>GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN</td><td></td><td>47</td><td>0.34</td><td>1.15</td><td>0.253</td><td>0.412</td><td>1.000</td><td>2093</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>1034</td><td>LIM_MAMMARY_LUMINAL_PROGENITOR_DN</td><td></td><td>12</td><td>0.48</td><td>1.15</td><td>0.287</td><td>0.413</td><td>1.000</td><td>2262</td><td>tags=50%, list=17%, signal=61%</td></tr><tr><td class='lessen'>1035</td><td>HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN</td><td></td><td>18</td><td>0.43</td><td>1.15</td><td>0.261</td><td>0.414</td><td>1.000</td><td>1484</td><td>tags=17%, list=11%, signal=19%</td></tr><tr><td class='lessen'>1036</td><td>SCHEIDEREIT_IKK_INTERACTING_PROTEINS</td><td></td><td>53</td><td>0.33</td><td>1.15</td><td>0.194</td><td>0.414</td><td>1.000</td><td>2740</td><td>tags=28%, list=21%, signal=36%</td></tr><tr><td class='lessen'>1037</td><td>CERVERA_SDHB_TARGETS_1_UP</td><td></td><td>91</td><td>0.30</td><td>1.14</td><td>0.163</td><td>0.417</td><td>1.000</td><td>2032</td><td>tags=31%, list=16%, signal=36%</td></tr><tr><td class='lessen'>1038</td><td>MILI_PSEUDOPODIA_HAPTOTAXIS_DN</td><td></td><td>539</td><td>0.27</td><td>1.14</td><td>0.000</td><td>0.418</td><td>1.000</td><td>2482</td><td>tags=19%, list=19%, signal=22%</td></tr><tr><td class='lessen'>1039</td><td>HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN</td><td></td><td>24</td><td>0.40</td><td>1.14</td><td>0.271</td><td>0.420</td><td>1.000</td><td>1891</td><td>tags=21%, list=15%, signal=24%</td></tr><tr><td class='lessen'>1040</td><td>ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF</td><td></td><td>389</td><td>0.26</td><td>1.14</td><td>0.000</td><td>0.424</td><td>1.000</td><td>2851</td><td>tags=30%, list=22%, signal=37%</td></tr><tr><td class='lessen'>1041</td><td>HANSON_HRAS_SIGNALING_VIA_NFKB</td><td></td><td>19</td><td>0.42</td><td>1.14</td><td>0.265</td><td>0.424</td><td>1.000</td><td>957</td><td>tags=26%, list=7%, signal=28%</td></tr><tr><td class='lessen'>1042</td><td>ALCALAY_AML_BY_NPM1_LOCALIZATION_UP</td><td></td><td>121</td><td>0.28</td><td>1.14</td><td>0.203</td><td>0.425</td><td>1.000</td><td>2757</td><td>tags=35%, list=21%, signal=44%</td></tr><tr><td class='lessen'>1043</td><td>XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN</td><td></td><td>12</td><td>0.47</td><td>1.14</td><td>0.319</td><td>0.427</td><td>1.000</td><td>663</td><td>tags=17%, list=5%, signal=18%</td></tr><tr><td class='lessen'>1044</td><td>KAN_RESPONSE_TO_ARSENIC_TRIOXIDE</td><td></td><td>95</td><td>0.31</td><td>1.14</td><td>0.160</td><td>0.428</td><td>1.000</td><td>2412</td><td>tags=35%, list=19%, signal=42%</td></tr><tr><td class='lessen'>1045</td><td>DITTMER_PTHLH_TARGETS_DN</td><td></td><td>64</td><td>0.32</td><td>1.14</td><td>0.204</td><td>0.429</td><td>1.000</td><td>2801</td><td>tags=31%, list=22%, signal=40%</td></tr><tr><td class='lessen'>1046</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP</td><td></td><td>144</td><td>0.27</td><td>1.13</td><td>0.102</td><td>0.432</td><td>1.000</td><td>2374</td><td>tags=22%, list=18%, signal=27%</td></tr><tr><td class='lessen'>1047</td><td>LE_SKI_TARGETS_UP</td><td></td><td>16</td><td>0.43</td><td>1.13</td><td>0.277</td><td>0.432</td><td>1.000</td><td>1531</td><td>tags=38%, list=12%, signal=42%</td></tr><tr><td class='lessen'>1048</td><td>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6</td><td></td><td>24</td><td>0.38</td><td>1.13</td><td>0.241</td><td>0.432</td><td>1.000</td><td>1464</td><td>tags=33%, list=11%, signal=38%</td></tr><tr><td class='lessen'>1049</td><td>RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2</td><td></td><td>23</td><td>0.39</td><td>1.13</td><td>0.239</td><td>0.432</td><td>1.000</td><td>1267</td><td>tags=30%, list=10%, signal=34%</td></tr><tr><td class='lessen'>1050</td><td>MORI_SMALL_PRE_BII_LYMPHOCYTE_DN</td><td></td><td>69</td><td>0.31</td><td>1.13</td><td>0.193</td><td>0.433</td><td>1.000</td><td>1652</td><td>tags=17%, list=13%, signal=20%</td></tr><tr><td class='lessen'>1051</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN</td><td></td><td>44</td><td>0.34</td><td>1.13</td><td>0.220</td><td>0.434</td><td>1.000</td><td>2895</td><td>tags=39%, list=22%, signal=50%</td></tr><tr><td class='lessen'>1052</td><td>ALONSO_METASTASIS_EMT_UP</td><td></td><td>27</td><td>0.38</td><td>1.13</td><td>0.249</td><td>0.438</td><td>1.000</td><td>1475</td><td>tags=37%, list=11%, signal=42%</td></tr><tr><td class='lessen'>1053</td><td>KIM_GERMINAL_CENTER_T_HELPER_DN</td><td></td><td>16</td><td>0.43</td><td>1.13</td><td>0.295</td><td>0.439</td><td>1.000</td><td>4065</td><td>tags=50%, list=31%, signal=73%</td></tr><tr><td class='lessen'>1054</td><td>WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2</td><td></td><td>39</td><td>0.35</td><td>1.13</td><td>0.239</td><td>0.441</td><td>1.000</td><td>2438</td><td>tags=31%, list=19%, signal=38%</td></tr><tr><td class='lessen'>1055</td><td>MANTOVANI_NFKB_TARGETS_UP</td><td></td><td>38</td><td>0.35</td><td>1.13</td><td>0.224</td><td>0.445</td><td>1.000</td><td>2268</td><td>tags=34%, list=18%, signal=41%</td></tr><tr><td class='lessen'>1056</td><td>WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP</td><td></td><td>247</td><td>0.26</td><td>1.13</td><td>0.118</td><td>0.446</td><td>1.000</td><td>2665</td><td>tags=28%, list=21%, signal=35%</td></tr><tr><td class='lessen'>1057</td><td>HOEBEKE_LYMPHOID_STEM_CELL_UP</td><td></td><td>77</td><td>0.32</td><td>1.12</td><td>0.205</td><td>0.448</td><td>1.000</td><td>2931</td><td>tags=35%, list=23%, signal=45%</td></tr><tr><td class='lessen'>1058</td><td>DUTTA_APOPTOSIS_VIA_NFKB</td><td></td><td>26</td><td>0.39</td><td>1.12</td><td>0.283</td><td>0.448</td><td>1.000</td><td>3157</td><td>tags=50%, list=24%, signal=66%</td></tr><tr><td class='lessen'>1059</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN</td><td></td><td>70</td><td>0.30</td><td>1.12</td><td>0.180</td><td>0.449</td><td>1.000</td><td>2468</td><td>tags=24%, list=19%, signal=30%</td></tr><tr><td class='lessen'>1060</td><td>JI_RESPONSE_TO_FSH_DN</td><td></td><td>53</td><td>0.33</td><td>1.12</td><td>0.224</td><td>0.451</td><td>1.000</td><td>1422</td><td>tags=15%, list=11%, signal=17%</td></tr><tr><td class='lessen'>1061</td><td>KRIEG_KDM3A_TARGETS_NOT_HYPOXIA</td><td></td><td>148</td><td>0.28</td><td>1.12</td><td>0.185</td><td>0.453</td><td>1.000</td><td>3317</td><td>tags=32%, list=26%, signal=43%</td></tr><tr><td class='lessen'>1062</td><td>JAATINEN_HEMATOPOIETIC_STEM_CELL_UP</td><td></td><td>246</td><td>0.26</td><td>1.12</td><td>0.095</td><td>0.453</td><td>1.000</td><td>2283</td><td>tags=24%, list=18%, signal=29%</td></tr><tr><td class='lessen'>1063</td><td>BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP</td><td></td><td>26</td><td>0.38</td><td>1.12</td><td>0.302</td><td>0.454</td><td>1.000</td><td>2138</td><td>tags=31%, list=17%, signal=37%</td></tr><tr><td class='lessen'>1064</td><td>WELCH_GATA1_TARGETS</td><td></td><td>19</td><td>0.41</td><td>1.12</td><td>0.315</td><td>0.454</td><td>1.000</td><td>3065</td><td>tags=37%, list=24%, signal=48%</td></tr><tr><td class='lessen'>1065</td><td>PLASARI_TGFB1_TARGETS_1HR_UP</td><td></td><td>31</td><td>0.36</td><td>1.12</td><td>0.269</td><td>0.455</td><td>1.000</td><td>3154</td><td>tags=55%, list=24%, signal=72%</td></tr><tr><td class='lessen'>1066</td><td>GENTILE_UV_HIGH_DOSE_DN</td><td></td><td>263</td><td>0.26</td><td>1.12</td><td>0.042</td><td>0.454</td><td>1.000</td><td>2384</td><td>tags=22%, list=18%, signal=26%</td></tr><tr><td class='lessen'>1067</td><td>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3</td><td></td><td>13</td><td>0.46</td><td>1.12</td><td>0.322</td><td>0.454</td><td>1.000</td><td>3233</td><td>tags=54%, list=25%, signal=72%</td></tr><tr><td class='lessen'>1068</td><td>JOHNSTONE_PARVB_TARGETS_1_DN</td><td></td><td>40</td><td>0.34</td><td>1.12</td><td>0.224</td><td>0.454</td><td>1.000</td><td>2116</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>1069</td><td>SU_KIDNEY</td><td></td><td>14</td><td>0.43</td><td>1.12</td><td>0.298</td><td>0.454</td><td>1.000</td><td>895</td><td>tags=29%, list=7%, signal=31%</td></tr><tr><td class='lessen'>1070</td><td>CHEBOTAEV_GR_TARGETS_UP</td><td></td><td>66</td><td>0.30</td><td>1.12</td><td>0.219</td><td>0.455</td><td>1.000</td><td>2287</td><td>tags=32%, list=18%, signal=38%</td></tr><tr><td class='lessen'>1071</td><td>HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP</td><td></td><td>53</td><td>0.33</td><td>1.12</td><td>0.238</td><td>0.455</td><td>1.000</td><td>2771</td><td>tags=38%, list=21%, signal=48%</td></tr><tr><td class='lessen'>1072</td><td>DOUGLAS_BMI1_TARGETS_UP</td><td></td><td>459</td><td>0.27</td><td>1.12</td><td>0.000</td><td>0.457</td><td>1.000</td><td>2146</td><td>tags=22%, list=17%, signal=26%</td></tr><tr><td class='lessen'>1073</td><td>MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN</td><td></td><td>14</td><td>0.42</td><td>1.12</td><td>0.284</td><td>0.456</td><td>1.000</td><td>825</td><td>tags=21%, list=6%, signal=23%</td></tr><tr><td class='lessen'>1074</td><td>VANDESLUIS_NORMAL_EMBRYOS_DN</td><td></td><td>19</td><td>0.40</td><td>1.12</td><td>0.312</td><td>0.457</td><td>1.000</td><td>1109</td><td>tags=21%, list=9%, signal=23%</td></tr><tr><td class='lessen'>1075</td><td>MA_PITUITARY_FETAL_VS_ADULT_UP</td><td></td><td>23</td><td>0.40</td><td>1.12</td><td>0.305</td><td>0.459</td><td>1.000</td><td>1183</td><td>tags=26%, list=9%, signal=29%</td></tr><tr><td class='lessen'>1076</td><td>XU_RESPONSE_TO_TRETINOIN_DN</td><td></td><td>10</td><td>0.48</td><td>1.11</td><td>0.318</td><td>0.461</td><td>1.000</td><td>3596</td><td>tags=60%, list=28%, signal=83%</td></tr><tr><td class='lessen'>1077</td><td>MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP</td><td></td><td>69</td><td>0.31</td><td>1.11</td><td>0.201</td><td>0.461</td><td>1.000</td><td>1792</td><td>tags=28%, list=14%, signal=32%</td></tr><tr><td class='lessen'>1078</td><td>MANTOVANI_VIRAL_GPCR_SIGNALING_UP</td><td></td><td>76</td><td>0.30</td><td>1.11</td><td>0.198</td><td>0.462</td><td>1.000</td><td>767</td><td>tags=17%, list=6%, signal=18%</td></tr><tr><td class='lessen'>1079</td><td>ZHENG_FOXP3_TARGETS_UP</td><td></td><td>23</td><td>0.38</td><td>1.11</td><td>0.320</td><td>0.462</td><td>1.000</td><td>1803</td><td>tags=30%, list=14%, signal=35%</td></tr><tr><td class='lessen'>1080</td><td>DELPUECH_FOXO3_TARGETS_UP</td><td></td><td>61</td><td>0.32</td><td>1.11</td><td>0.255</td><td>0.462</td><td>1.000</td><td>1642</td><td>tags=26%, list=13%, signal=30%</td></tr><tr><td class='lessen'>1081</td><td>KAAB_FAILED_HEART_ATRIUM_UP</td><td></td><td>30</td><td>0.36</td><td>1.11</td><td>0.270</td><td>0.463</td><td>1.000</td><td>1922</td><td>tags=30%, list=15%, signal=35%</td></tr><tr><td class='lessen'>1082</td><td>DIRMEIER_LMP1_RESPONSE_LATE_DN</td><td></td><td>28</td><td>0.36</td><td>1.11</td><td>0.300</td><td>0.463</td><td>1.000</td><td>1776</td><td>tags=18%, list=14%, signal=21%</td></tr><tr><td class='lessen'>1083</td><td>GROSS_HIF1A_TARGETS_DN</td><td></td><td>22</td><td>0.39</td><td>1.11</td><td>0.287</td><td>0.463</td><td>1.000</td><td>1214</td><td>tags=27%, list=9%, signal=30%</td></tr><tr><td class='lessen'>1084</td><td>IKEDA_MIR1_TARGETS_UP</td><td></td><td>49</td><td>0.33</td><td>1.11</td><td>0.262</td><td>0.463</td><td>1.000</td><td>3357</td><td>tags=33%, list=26%, signal=44%</td></tr><tr><td class='lessen'>1085</td><td>TAVOR_CEBPA_TARGETS_UP</td><td></td><td>41</td><td>0.34</td><td>1.11</td><td>0.277</td><td>0.463</td><td>1.000</td><td>2255</td><td>tags=37%, list=17%, signal=44%</td></tr><tr><td class='lessen'>1086</td><td>AMIT_DELAYED_EARLY_GENES</td><td></td><td>17</td><td>0.41</td><td>1.11</td><td>0.313</td><td>0.462</td><td>1.000</td><td>2152</td><td>tags=47%, list=17%, signal=56%</td></tr><tr><td class='lessen'>1087</td><td>KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN</td><td></td><td>64</td><td>0.32</td><td>1.11</td><td>0.240</td><td>0.465</td><td>1.000</td><td>2469</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>1088</td><td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS</td><td></td><td>95</td><td>0.29</td><td>1.11</td><td>0.236</td><td>0.465</td><td>1.000</td><td>2837</td><td>tags=26%, list=22%, signal=33%</td></tr><tr><td class='lessen'>1089</td><td>APPIERTO_RESPONSE_TO_FENRETINIDE_UP</td><td></td><td>34</td><td>0.35</td><td>1.11</td><td>0.259</td><td>0.464</td><td>1.000</td><td>1476</td><td>tags=18%, list=11%, signal=20%</td></tr><tr><td class='lessen'>1090</td><td>JACKSON_DNMT1_TARGETS_UP</td><td></td><td>73</td><td>0.31</td><td>1.11</td><td>0.204</td><td>0.464</td><td>1.000</td><td>2419</td><td>tags=30%, list=19%, signal=37%</td></tr><tr><td class='lessen'>1091</td><td>JAEGER_METASTASIS_DN</td><td></td><td>210</td><td>0.25</td><td>1.11</td><td>0.133</td><td>0.466</td><td>1.000</td><td>554</td><td>tags=10%, list=4%, signal=11%</td></tr><tr><td class='lessen'>1092</td><td>VILIMAS_NOTCH1_TARGETS_UP</td><td></td><td>49</td><td>0.33</td><td>1.11</td><td>0.254</td><td>0.470</td><td>1.000</td><td>2320</td><td>tags=37%, list=18%, signal=45%</td></tr><tr><td class='lessen'>1093</td><td>RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN</td><td></td><td>401</td><td>0.25</td><td>1.11</td><td>0.000</td><td>0.472</td><td>1.000</td><td>2513</td><td>tags=23%, list=19%, signal=28%</td></tr><tr><td class='lessen'>1094</td><td>MCBRYAN_PUBERTAL_BREAST_3_4WK_UP</td><td></td><td>183</td><td>0.27</td><td>1.10</td><td>0.184</td><td>0.473</td><td>1.000</td><td>2136</td><td>tags=26%, list=17%, signal=30%</td></tr><tr><td class='lessen'>1095</td><td>PHONG_TNF_RESPONSE_VIA_P38_COMPLETE</td><td></td><td>187</td><td>0.28</td><td>1.10</td><td>0.158</td><td>0.474</td><td>1.000</td><td>3147</td><td>tags=31%, list=24%, signal=40%</td></tr><tr><td class='lessen'>1096</td><td>HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP</td><td></td><td>29</td><td>0.36</td><td>1.10</td><td>0.284</td><td>0.473</td><td>1.000</td><td>1759</td><td>tags=41%, list=14%, signal=48%</td></tr><tr><td class='lessen'>1097</td><td>CHEN_HOXA5_TARGETS_9HR_DN</td><td></td><td>35</td><td>0.35</td><td>1.10</td><td>0.295</td><td>0.473</td><td>1.000</td><td>1239</td><td>tags=17%, list=10%, signal=19%</td></tr><tr><td class='lessen'>1098</td><td>HADDAD_B_LYMPHOCYTE_PROGENITOR</td><td></td><td>215</td><td>0.26</td><td>1.10</td><td>0.135</td><td>0.476</td><td>1.000</td><td>2234</td><td>tags=26%, list=17%, signal=31%</td></tr><tr><td class='lessen'>1099</td><td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP</td><td></td><td>49</td><td>0.32</td><td>1.10</td><td>0.257</td><td>0.476</td><td>1.000</td><td>3290</td><td>tags=39%, list=25%, signal=52%</td></tr><tr><td class='lessen'>1100</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_5_DN</td><td></td><td>38</td><td>0.34</td><td>1.10</td><td>0.239</td><td>0.477</td><td>1.000</td><td>1789</td><td>tags=32%, list=14%, signal=37%</td></tr><tr><td class='lessen'>1101</td><td>FUJII_YBX1_TARGETS_UP</td><td></td><td>34</td><td>0.34</td><td>1.10</td><td>0.290</td><td>0.478</td><td>1.000</td><td>1521</td><td>tags=26%, list=12%, signal=30%</td></tr><tr><td class='lessen'>1102</td><td>WANG_SMARCE1_TARGETS_DN</td><td></td><td>292</td><td>0.26</td><td>1.10</td><td>0.154</td><td>0.478</td><td>1.000</td><td>2099</td><td>tags=21%, list=16%, signal=24%</td></tr><tr><td class='lessen'>1103</td><td>ZHAN_MULTIPLE_MYELOMA_UP</td><td></td><td>55</td><td>0.31</td><td>1.10</td><td>0.248</td><td>0.479</td><td>1.000</td><td>3325</td><td>tags=40%, list=26%, signal=54%</td></tr><tr><td class='lessen'>1104</td><td>TIEN_INTESTINE_PROBIOTICS_6HR_DN</td><td></td><td>137</td><td>0.28</td><td>1.10</td><td>0.212</td><td>0.479</td><td>1.000</td><td>3114</td><td>tags=30%, list=24%, signal=39%</td></tr><tr><td class='lessen'>1105</td><td>GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN</td><td></td><td>33</td><td>0.36</td><td>1.10</td><td>0.323</td><td>0.479</td><td>1.000</td><td>1578</td><td>tags=30%, list=12%, signal=34%</td></tr><tr><td class='lessen'>1106</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5</td><td></td><td>26</td><td>0.38</td><td>1.10</td><td>0.312</td><td>0.479</td><td>1.000</td><td>1038</td><td>tags=23%, list=8%, signal=25%</td></tr><tr><td class='lessen'>1107</td><td>WEINMANN_ADAPTATION_TO_HYPOXIA_UP</td><td></td><td>27</td><td>0.36</td><td>1.10</td><td>0.279</td><td>0.480</td><td>1.000</td><td>2021</td><td>tags=37%, list=16%, signal=44%</td></tr><tr><td class='lessen'>1108</td><td>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN</td><td></td><td>37</td><td>0.35</td><td>1.10</td><td>0.291</td><td>0.481</td><td>1.000</td><td>1607</td><td>tags=14%, list=12%, signal=15%</td></tr><tr><td class='lessen'>1109</td><td>LA_MEN1_TARGETS</td><td></td><td>22</td><td>0.38</td><td>1.10</td><td>0.313</td><td>0.481</td><td>1.000</td><td>1268</td><td>tags=45%, list=10%, signal=50%</td></tr><tr><td class='lessen'>1110</td><td>KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION</td><td></td><td>80</td><td>0.31</td><td>1.10</td><td>0.276</td><td>0.481</td><td>1.000</td><td>1129</td><td>tags=14%, list=9%, signal=15%</td></tr><tr><td class='lessen'>1111</td><td>DURCHDEWALD_SKIN_CARCINOGENESIS_DN</td><td></td><td>218</td><td>0.25</td><td>1.10</td><td>0.200</td><td>0.481</td><td>1.000</td><td>2060</td><td>tags=22%, list=16%, signal=25%</td></tr><tr><td class='lessen'>1112</td><td>ZHANG_BREAST_CANCER_PROGENITORS_DN</td><td></td><td>126</td><td>0.28</td><td>1.10</td><td>0.188</td><td>0.481</td><td>1.000</td><td>2718</td><td>tags=25%, list=21%, signal=31%</td></tr><tr><td class='lessen'>1113</td><td>MISSIAGLIA_REGULATED_BY_METHYLATION_UP</td><td></td><td>102</td><td>0.28</td><td>1.10</td><td>0.223</td><td>0.481</td><td>1.000</td><td>2412</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>1114</td><td>LI_INDUCED_T_TO_NATURAL_KILLER_DN</td><td></td><td>101</td><td>0.29</td><td>1.10</td><td>0.264</td><td>0.480</td><td>1.000</td><td>1834</td><td>tags=22%, list=14%, signal=25%</td></tr><tr><td class='lessen'>1115</td><td>CROMER_METASTASIS_DN</td><td></td><td>70</td><td>0.30</td><td>1.10</td><td>0.263</td><td>0.480</td><td>1.000</td><td>2509</td><td>tags=23%, list=19%, signal=28%</td></tr><tr><td class='lessen'>1116</td><td>MODY_HIPPOCAMPUS_POSTNATAL</td><td></td><td>58</td><td>0.31</td><td>1.10</td><td>0.260</td><td>0.481</td><td>1.000</td><td>3316</td><td>tags=33%, list=26%, signal=44%</td></tr><tr><td class='lessen'>1117</td><td>MATZUK_CENTRAL_FOR_FEMALE_FERTILITY</td><td></td><td>27</td><td>0.37</td><td>1.10</td><td>0.275</td><td>0.481</td><td>1.000</td><td>928</td><td>tags=26%, list=7%, signal=28%</td></tr><tr><td class='lessen'>1118</td><td>AMUNDSON_DNA_DAMAGE_RESPONSE_TP53</td><td></td><td>14</td><td>0.43</td><td>1.10</td><td>0.330</td><td>0.482</td><td>1.000</td><td>1773</td><td>tags=36%, list=14%, signal=41%</td></tr><tr><td class='lessen'>1119</td><td>JACKSON_DNMT1_TARGETS_DN</td><td></td><td>23</td><td>0.39</td><td>1.10</td><td>0.333</td><td>0.482</td><td>1.000</td><td>1916</td><td>tags=30%, list=15%, signal=36%</td></tr><tr><td class='lessen'>1120</td><td>SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS</td><td></td><td>33</td><td>0.35</td><td>1.10</td><td>0.288</td><td>0.481</td><td>1.000</td><td>3175</td><td>tags=42%, list=25%, signal=56%</td></tr><tr><td class='lessen'>1121</td><td>ROSS_AML_WITH_AML1_ETO_FUSION</td><td></td><td>63</td><td>0.31</td><td>1.10</td><td>0.266</td><td>0.481</td><td>1.000</td><td>1358</td><td>tags=21%, list=10%, signal=23%</td></tr><tr><td class='lessen'>1122</td><td>JIANG_HYPOXIA_NORMAL</td><td></td><td>263</td><td>0.25</td><td>1.09</td><td>0.250</td><td>0.484</td><td>1.000</td><td>2320</td><td>tags=23%, list=18%, signal=27%</td></tr><tr><td class='lessen'>1123</td><td>RASHI_NFKB1_TARGETS</td><td></td><td>18</td><td>0.39</td><td>1.09</td><td>0.314</td><td>0.487</td><td>1.000</td><td>3080</td><td>tags=44%, list=24%, signal=58%</td></tr><tr><td class='lessen'>1124</td><td>QI_HYPOXIA</td><td></td><td>117</td><td>0.27</td><td>1.09</td><td>0.184</td><td>0.493</td><td>1.000</td><td>2289</td><td>tags=26%, list=18%, signal=32%</td></tr><tr><td class='lessen'>1125</td><td>BROWNE_HCMV_INFECTION_10HR_DN</td><td></td><td>46</td><td>0.32</td><td>1.09</td><td>0.277</td><td>0.493</td><td>1.000</td><td>1427</td><td>tags=22%, list=11%, signal=24%</td></tr><tr><td class='lessen'>1126</td><td>SWEET_KRAS_ONCOGENIC_SIGNATURE</td><td></td><td>78</td><td>0.30</td><td>1.09</td><td>0.233</td><td>0.494</td><td>1.000</td><td>2504</td><td>tags=28%, list=19%, signal=35%</td></tr><tr><td class='lessen'>1127</td><td>OHGUCHI_LIVER_HNF4A_TARGETS_UP</td><td></td><td>38</td><td>0.34</td><td>1.09</td><td>0.321</td><td>0.494</td><td>1.000</td><td>1121</td><td>tags=24%, list=9%, signal=26%</td></tr><tr><td class='lessen'>1128</td><td>UEDA_CENTRAL_CLOCK</td><td></td><td>76</td><td>0.29</td><td>1.09</td><td>0.250</td><td>0.496</td><td>1.000</td><td>1939</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>1129</td><td>SMITH_TERT_TARGETS_DN</td><td></td><td>79</td><td>0.29</td><td>1.09</td><td>0.244</td><td>0.497</td><td>1.000</td><td>1488</td><td>tags=23%, list=12%, signal=26%</td></tr><tr><td class='lessen'>1130</td><td>SCHAVOLT_TARGETS_OF_TP53_AND_TP63</td><td></td><td>13</td><td>0.44</td><td>1.09</td><td>0.342</td><td>0.497</td><td>1.000</td><td>2008</td><td>tags=31%, list=16%, signal=36%</td></tr><tr><td class='lessen'>1131</td><td>KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP</td><td></td><td>48</td><td>0.32</td><td>1.09</td><td>0.299</td><td>0.498</td><td>1.000</td><td>1894</td><td>tags=29%, list=15%, signal=34%</td></tr><tr><td class='lessen'>1132</td><td>SU_THYMUS</td><td></td><td>16</td><td>0.42</td><td>1.09</td><td>0.343</td><td>0.498</td><td>1.000</td><td>2208</td><td>tags=44%, list=17%, signal=53%</td></tr><tr><td class='lessen'>1133</td><td>HOWLIN_CITED1_TARGETS_1_UP</td><td></td><td>27</td><td>0.36</td><td>1.08</td><td>0.317</td><td>0.499</td><td>1.000</td><td>1648</td><td>tags=30%, list=13%, signal=34%</td></tr><tr><td class='lessen'>1134</td><td>DURAND_STROMA_NS_UP</td><td></td><td>128</td><td>0.28</td><td>1.08</td><td>0.219</td><td>0.500</td><td>1.000</td><td>1619</td><td>tags=23%, list=13%, signal=27%</td></tr><tr><td class='lessen'>1135</td><td>KOINUMA_COLON_CANCER_MSI_UP</td><td></td><td>14</td><td>0.43</td><td>1.08</td><td>0.333</td><td>0.501</td><td>1.000</td><td>444</td><td>tags=14%, list=3%, signal=15%</td></tr><tr><td class='lessen'>1136</td><td>OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP</td><td></td><td>197</td><td>0.27</td><td>1.08</td><td>0.222</td><td>0.502</td><td>1.000</td><td>2434</td><td>tags=30%, list=19%, signal=36%</td></tr><tr><td class='lessen'>1137</td><td>PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN</td><td></td><td>87</td><td>0.29</td><td>1.08</td><td>0.214</td><td>0.503</td><td>1.000</td><td>1876</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>1138</td><td>PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP</td><td></td><td>25</td><td>0.37</td><td>1.08</td><td>0.343</td><td>0.506</td><td>1.000</td><td>2122</td><td>tags=32%, list=16%, signal=38%</td></tr><tr><td class='lessen'>1139</td><td>CHOI_ATL_CHRONIC_VS_ACUTE_DN</td><td></td><td>17</td><td>0.40</td><td>1.08</td><td>0.355</td><td>0.505</td><td>1.000</td><td>2185</td><td>tags=18%, list=17%, signal=21%</td></tr><tr><td class='lessen'>1140</td><td>MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP</td><td></td><td>137</td><td>0.27</td><td>1.08</td><td>0.284</td><td>0.505</td><td>1.000</td><td>2225</td><td>tags=28%, list=17%, signal=33%</td></tr><tr><td class='lessen'>1141</td><td>SUNG_METASTASIS_STROMA_DN</td><td></td><td>37</td><td>0.34</td><td>1.08</td><td>0.302</td><td>0.506</td><td>1.000</td><td>1340</td><td>tags=14%, list=10%, signal=15%</td></tr><tr><td class='lessen'>1142</td><td>KYNG_RESPONSE_TO_H2O2</td><td></td><td>61</td><td>0.30</td><td>1.08</td><td>0.318</td><td>0.508</td><td>1.000</td><td>2771</td><td>tags=33%, list=21%, signal=42%</td></tr><tr><td class='lessen'>1143</td><td>FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN</td><td></td><td>59</td><td>0.31</td><td>1.08</td><td>0.277</td><td>0.509</td><td>1.000</td><td>2388</td><td>tags=37%, list=18%, signal=46%</td></tr><tr><td class='lessen'>1144</td><td>HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP</td><td></td><td>36</td><td>0.33</td><td>1.08</td><td>0.322</td><td>0.509</td><td>1.000</td><td>2007</td><td>tags=36%, list=16%, signal=43%</td></tr><tr><td class='lessen'>1145</td><td>BASSO_B_LYMPHOCYTE_NETWORK</td><td></td><td>117</td><td>0.27</td><td>1.08</td><td>0.244</td><td>0.510</td><td>1.000</td><td>2538</td><td>tags=19%, list=20%, signal=23%</td></tr><tr><td class='lessen'>1146</td><td>KIM_MYCN_AMPLIFICATION_TARGETS_DN</td><td></td><td>80</td><td>0.29</td><td>1.08</td><td>0.295</td><td>0.510</td><td>1.000</td><td>2355</td><td>tags=25%, list=18%, signal=30%</td></tr><tr><td class='lessen'>1147</td><td>HOQUE_METHYLATED_IN_CANCER</td><td></td><td>52</td><td>0.32</td><td>1.08</td><td>0.305</td><td>0.509</td><td>1.000</td><td>1330</td><td>tags=25%, list=10%, signal=28%</td></tr><tr><td class='lessen'>1148</td><td>FRIDMAN_SENESCENCE_DN</td><td></td><td>12</td><td>0.44</td><td>1.08</td><td>0.345</td><td>0.509</td><td>1.000</td><td>1239</td><td>tags=33%, list=10%, signal=37%</td></tr><tr><td class='lessen'>1149</td><td>ROZANOV_MMP14_TARGETS_DN</td><td></td><td>25</td><td>0.36</td><td>1.08</td><td>0.330</td><td>0.509</td><td>1.000</td><td>1955</td><td>tags=36%, list=15%, signal=42%</td></tr><tr><td class='lessen'>1150</td><td>JEPSEN_SMRT_TARGETS</td><td></td><td>30</td><td>0.34</td><td>1.08</td><td>0.293</td><td>0.509</td><td>1.000</td><td>2492</td><td>tags=30%, list=19%, signal=37%</td></tr><tr><td class='lessen'>1151</td><td>BROWNE_HCMV_INFECTION_14HR_DN</td><td></td><td>247</td><td>0.25</td><td>1.08</td><td>0.190</td><td>0.510</td><td>1.000</td><td>1882</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>1152</td><td>GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN</td><td></td><td>198</td><td>0.26</td><td>1.08</td><td>0.250</td><td>0.512</td><td>1.000</td><td>2682</td><td>tags=32%, list=21%, signal=40%</td></tr><tr><td class='lessen'>1153</td><td>MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN</td><td></td><td>21</td><td>0.40</td><td>1.07</td><td>0.370</td><td>0.517</td><td>1.000</td><td>2753</td><td>tags=33%, list=21%, signal=42%</td></tr><tr><td class='lessen'>1154</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_1_DN</td><td></td><td>315</td><td>0.25</td><td>1.07</td><td>0.133</td><td>0.518</td><td>1.000</td><td>1905</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>1155</td><td>ROZANOV_MMP14_CORRELATED</td><td></td><td>11</td><td>0.46</td><td>1.07</td><td>0.390</td><td>0.519</td><td>1.000</td><td>2144</td><td>tags=36%, list=17%, signal=44%</td></tr><tr><td class='lessen'>1156</td><td>SUBTIL_PROGESTIN_TARGETS</td><td></td><td>33</td><td>0.34</td><td>1.07</td><td>0.371</td><td>0.519</td><td>1.000</td><td>2127</td><td>tags=30%, list=16%, signal=36%</td></tr><tr><td class='lessen'>1157</td><td>BRACHAT_RESPONSE_TO_METHOTREXATE_DN</td><td></td><td>22</td><td>0.37</td><td>1.07</td><td>0.332</td><td>0.520</td><td>1.000</td><td>3827</td><td>tags=50%, list=30%, signal=71%</td></tr><tr><td class='lessen'>1158</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3</td><td></td><td>63</td><td>0.30</td><td>1.07</td><td>0.269</td><td>0.521</td><td>1.000</td><td>2104</td><td>tags=37%, list=16%, signal=43%</td></tr><tr><td class='lessen'>1159</td><td>LEE_CALORIE_RESTRICTION_NEOCORTEX_UP</td><td></td><td>71</td><td>0.30</td><td>1.07</td><td>0.333</td><td>0.522</td><td>1.000</td><td>1832</td><td>tags=23%, list=14%, signal=26%</td></tr><tr><td class='lessen'>1160</td><td>BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN</td><td></td><td>28</td><td>0.34</td><td>1.07</td><td>0.319</td><td>0.522</td><td>1.000</td><td>1655</td><td>tags=29%, list=13%, signal=33%</td></tr><tr><td class='lessen'>1161</td><td>CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE</td><td></td><td>27</td><td>0.35</td><td>1.07</td><td>0.373</td><td>0.524</td><td>1.000</td><td>1873</td><td>tags=26%, list=14%, signal=30%</td></tr><tr><td class='lessen'>1162</td><td>ROSS_AML_WITH_PML_RARA_FUSION</td><td></td><td>66</td><td>0.30</td><td>1.07</td><td>0.266</td><td>0.525</td><td>1.000</td><td>1811</td><td>tags=29%, list=14%, signal=33%</td></tr><tr><td class='lessen'>1163</td><td>KOYAMA_SEMA3B_TARGETS_UP</td><td></td><td>210</td><td>0.26</td><td>1.07</td><td>0.286</td><td>0.527</td><td>1.000</td><td>2347</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>1164</td><td>GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN</td><td></td><td>192</td><td>0.27</td><td>1.07</td><td>0.259</td><td>0.527</td><td>1.000</td><td>2516</td><td>tags=22%, list=19%, signal=27%</td></tr><tr><td class='lessen'>1165</td><td>CAIRO_PML_TARGETS_BOUND_BY_MYC_UP</td><td></td><td>22</td><td>0.37</td><td>1.07</td><td>0.357</td><td>0.526</td><td>1.000</td><td>738</td><td>tags=14%, list=6%, signal=14%</td></tr><tr><td class='lessen'>1166</td><td>LIANG_SILENCED_BY_METHYLATION_2</td><td></td><td>41</td><td>0.32</td><td>1.07</td><td>0.327</td><td>0.526</td><td>1.000</td><td>1846</td><td>tags=37%, list=14%, signal=43%</td></tr><tr><td class='lessen'>1167</td><td>CHANG_IMMORTALIZED_BY_HPV31_DN</td><td></td><td>52</td><td>0.31</td><td>1.07</td><td>0.318</td><td>0.526</td><td>1.000</td><td>1373</td><td>tags=17%, list=11%, signal=19%</td></tr><tr><td class='lessen'>1168</td><td>GENTLES_LEUKEMIC_STEM_CELL_DN</td><td></td><td>10</td><td>0.47</td><td>1.07</td><td>0.363</td><td>0.527</td><td>1.000</td><td>1356</td><td>tags=60%, list=10%, signal=67%</td></tr><tr><td class='lessen'>1169</td><td>LAU_APOPTOSIS_CDKN2A_UP</td><td></td><td>51</td><td>0.31</td><td>1.07</td><td>0.306</td><td>0.527</td><td>1.000</td><td>3096</td><td>tags=37%, list=24%, signal=49%</td></tr><tr><td class='lessen'>1170</td><td>CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP</td><td></td><td>197</td><td>0.26</td><td>1.07</td><td>0.172</td><td>0.527</td><td>1.000</td><td>2165</td><td>tags=23%, list=17%, signal=27%</td></tr><tr><td class='lessen'>1171</td><td>XU_GH1_EXOGENOUS_TARGETS_UP</td><td></td><td>55</td><td>0.31</td><td>1.06</td><td>0.303</td><td>0.527</td><td>1.000</td><td>1936</td><td>tags=25%, list=15%, signal=30%</td></tr><tr><td class='lessen'>1172</td><td>WANG_HCP_PROSTATE_CANCER</td><td></td><td>88</td><td>0.28</td><td>1.06</td><td>0.292</td><td>0.527</td><td>1.000</td><td>2434</td><td>tags=32%, list=19%, signal=39%</td></tr><tr><td class='lessen'>1173</td><td>HOLLMANN_APOPTOSIS_VIA_CD40_UP</td><td></td><td>166</td><td>0.26</td><td>1.06</td><td>0.300</td><td>0.527</td><td>1.000</td><td>3191</td><td>tags=34%, list=25%, signal=45%</td></tr><tr><td class='lessen'>1174</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3</td><td></td><td>13</td><td>0.42</td><td>1.06</td><td>0.366</td><td>0.527</td><td>1.000</td><td>3168</td><td>tags=54%, list=24%, signal=71%</td></tr><tr><td class='lessen'>1175</td><td>LIN_MELANOMA_COPY_NUMBER_UP</td><td></td><td>57</td><td>0.30</td><td>1.06</td><td>0.291</td><td>0.527</td><td>1.000</td><td>2135</td><td>tags=18%, list=17%, signal=21%</td></tr><tr><td class='lessen'>1176</td><td>LEE_AGING_NEOCORTEX_UP</td><td></td><td>82</td><td>0.29</td><td>1.06</td><td>0.283</td><td>0.527</td><td>1.000</td><td>2384</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>1177</td><td>LIAO_HAVE_SOX4_BINDING_SITES</td><td></td><td>38</td><td>0.34</td><td>1.06</td><td>0.353</td><td>0.526</td><td>1.000</td><td>1501</td><td>tags=21%, list=12%, signal=24%</td></tr><tr><td class='lessen'>1178</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13</td><td></td><td>142</td><td>0.27</td><td>1.06</td><td>0.291</td><td>0.526</td><td>1.000</td><td>3415</td><td>tags=26%, list=26%, signal=35%</td></tr><tr><td class='lessen'>1179</td><td>KAYO_AGING_MUSCLE_UP</td><td></td><td>200</td><td>0.25</td><td>1.06</td><td>0.250</td><td>0.527</td><td>1.000</td><td>2211</td><td>tags=27%, list=17%, signal=32%</td></tr><tr><td class='lessen'>1180</td><td>MASSARWEH_TAMOXIFEN_RESISTANCE_UP</td><td></td><td>434</td><td>0.23</td><td>1.06</td><td>0.333</td><td>0.529</td><td>1.000</td><td>2467</td><td>tags=23%, list=19%, signal=27%</td></tr><tr><td class='lessen'>1181</td><td>ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN</td><td></td><td>80</td><td>0.29</td><td>1.06</td><td>0.324</td><td>0.529</td><td>1.000</td><td>1710</td><td>tags=19%, list=13%, signal=21%</td></tr><tr><td class='lessen'>1182</td><td>NADLER_HYPERGLYCEMIA_AT_OBESITY</td><td></td><td>54</td><td>0.31</td><td>1.06</td><td>0.322</td><td>0.529</td><td>1.000</td><td>1720</td><td>tags=20%, list=13%, signal=23%</td></tr><tr><td class='lessen'>1183</td><td>ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION</td><td></td><td>73</td><td>0.30</td><td>1.06</td><td>0.293</td><td>0.532</td><td>1.000</td><td>2451</td><td>tags=33%, list=19%, signal=40%</td></tr><tr><td class='lessen'>1184</td><td>STEIN_ESRRA_TARGETS_DN</td><td></td><td>78</td><td>0.29</td><td>1.06</td><td>0.295</td><td>0.538</td><td>1.000</td><td>2955</td><td>tags=27%, list=23%, signal=35%</td></tr><tr><td class='lessen'>1185</td><td>KAMIKUBO_MYELOID_MN1_NETWORK</td><td></td><td>18</td><td>0.39</td><td>1.06</td><td>0.357</td><td>0.538</td><td>1.000</td><td>3079</td><td>tags=39%, list=24%, signal=51%</td></tr><tr><td class='lessen'>1186</td><td>MCCLUNG_CREB1_TARGETS_DN</td><td></td><td>47</td><td>0.31</td><td>1.06</td><td>0.333</td><td>0.538</td><td>1.000</td><td>1118</td><td>tags=15%, list=9%, signal=16%</td></tr><tr><td class='lessen'>1187</td><td>LEE_LIVER_CANCER_MYC_E2F1_UP</td><td></td><td>52</td><td>0.31</td><td>1.06</td><td>0.342</td><td>0.538</td><td>1.000</td><td>2302</td><td>tags=31%, list=18%, signal=37%</td></tr><tr><td class='lessen'>1188</td><td>BROWNE_HCMV_INFECTION_6HR_UP</td><td></td><td>59</td><td>0.30</td><td>1.06</td><td>0.310</td><td>0.539</td><td>1.000</td><td>1625</td><td>tags=22%, list=13%, signal=25%</td></tr><tr><td class='lessen'>1189</td><td>ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP</td><td></td><td>372</td><td>0.24</td><td>1.06</td><td>0.333</td><td>0.539</td><td>1.000</td><td>2062</td><td>tags=27%, list=16%, signal=31%</td></tr><tr><td class='lessen'>1190</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN</td><td></td><td>107</td><td>0.27</td><td>1.06</td><td>0.281</td><td>0.540</td><td>1.000</td><td>2405</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>1191</td><td>HOOI_ST7_TARGETS_UP</td><td></td><td>64</td><td>0.30</td><td>1.05</td><td>0.304</td><td>0.541</td><td>1.000</td><td>2763</td><td>tags=30%, list=21%, signal=38%</td></tr><tr><td class='lessen'>1192</td><td>BASAKI_YBX1_TARGETS_DN</td><td></td><td>294</td><td>0.23</td><td>1.05</td><td>0.154</td><td>0.543</td><td>1.000</td><td>1840</td><td>tags=19%, list=14%, signal=22%</td></tr><tr><td class='lessen'>1193</td><td>LU_TUMOR_VASCULATURE_DN</td><td></td><td>12</td><td>0.44</td><td>1.05</td><td>0.373</td><td>0.542</td><td>1.000</td><td>2408</td><td>tags=50%, list=19%, signal=61%</td></tr><tr><td class='lessen'>1194</td><td>PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP</td><td></td><td>42</td><td>0.33</td><td>1.05</td><td>0.328</td><td>0.543</td><td>1.000</td><td>1158</td><td>tags=24%, list=9%, signal=26%</td></tr><tr><td class='lessen'>1195</td><td>BECKER_TAMOXIFEN_RESISTANCE_DN</td><td></td><td>44</td><td>0.32</td><td>1.05</td><td>0.371</td><td>0.544</td><td>1.000</td><td>1448</td><td>tags=16%, list=11%, signal=18%</td></tr><tr><td class='lessen'>1196</td><td>HAHTOLA_MYCOSIS_FUNGOIDES_UP</td><td></td><td>14</td><td>0.43</td><td>1.05</td><td>0.374</td><td>0.544</td><td>1.000</td><td>960</td><td>tags=29%, list=7%, signal=31%</td></tr><tr><td class='lessen'>1197</td><td>ENK_UV_RESPONSE_EPIDERMIS_DN</td><td></td><td>444</td><td>0.25</td><td>1.05</td><td>0.000</td><td>0.544</td><td>1.000</td><td>2855</td><td>tags=28%, list=22%, signal=35%</td></tr><tr><td class='lessen'>1198</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP</td><td></td><td>113</td><td>0.27</td><td>1.05</td><td>0.326</td><td>0.545</td><td>1.000</td><td>1998</td><td>tags=20%, list=15%, signal=24%</td></tr><tr><td class='lessen'>1199</td><td>WANG_CLIM2_TARGETS_DN</td><td></td><td>138</td><td>0.26</td><td>1.05</td><td>0.282</td><td>0.545</td><td>1.000</td><td>3115</td><td>tags=27%, list=24%, signal=35%</td></tr><tr><td class='lessen'>1200</td><td>ONDER_CDH1_TARGETS_2_DN</td><td></td><td>371</td><td>0.25</td><td>1.05</td><td>0.167</td><td>0.545</td><td>1.000</td><td>1892</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>1201</td><td>AMIT_EGF_RESPONSE_240_MCF10A</td><td></td><td>17</td><td>0.40</td><td>1.05</td><td>0.351</td><td>0.546</td><td>1.000</td><td>3228</td><td>tags=59%, list=25%, signal=78%</td></tr><tr><td class='lessen'>1202</td><td>GHANDHI_BYSTANDER_IRRADIATION_UP</td><td></td><td>64</td><td>0.30</td><td>1.05</td><td>0.351</td><td>0.548</td><td>1.000</td><td>2121</td><td>tags=27%, list=16%, signal=32%</td></tr><tr><td class='lessen'>1203</td><td>GUILLAUMOND_KLF10_TARGETS_UP</td><td></td><td>45</td><td>0.31</td><td>1.05</td><td>0.345</td><td>0.548</td><td>1.000</td><td>2368</td><td>tags=36%, list=18%, signal=43%</td></tr><tr><td class='lessen'>1204</td><td>MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3</td><td></td><td>102</td><td>0.27</td><td>1.05</td><td>0.333</td><td>0.549</td><td>1.000</td><td>1996</td><td>tags=29%, list=15%, signal=35%</td></tr><tr><td class='lessen'>1205</td><td>MCCLUNG_CREB1_TARGETS_UP</td><td></td><td>86</td><td>0.28</td><td>1.05</td><td>0.330</td><td>0.549</td><td>1.000</td><td>1430</td><td>tags=21%, list=11%, signal=23%</td></tr><tr><td class='lessen'>1206</td><td>FINETTI_BREAST_CANCER_KINOME_GREEN</td><td></td><td>15</td><td>0.40</td><td>1.05</td><td>0.374</td><td>0.548</td><td>1.000</td><td>2834</td><td>tags=53%, list=22%, signal=68%</td></tr><tr><td class='lessen'>1207</td><td>BROWNE_HCMV_INFECTION_6HR_DN</td><td></td><td>131</td><td>0.26</td><td>1.05</td><td>0.299</td><td>0.549</td><td>1.000</td><td>2977</td><td>tags=32%, list=23%, signal=41%</td></tr><tr><td class='lessen'>1208</td><td>NAGASHIMA_EGF_SIGNALING_UP</td><td></td><td>51</td><td>0.31</td><td>1.05</td><td>0.314</td><td>0.550</td><td>1.000</td><td>2152</td><td>tags=35%, list=17%, signal=42%</td></tr><tr><td class='lessen'>1209</td><td>ABE_INNER_EAR</td><td></td><td>42</td><td>0.31</td><td>1.05</td><td>0.369</td><td>0.552</td><td>1.000</td><td>2123</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>1210</td><td>YANG_BREAST_CANCER_ESR1_BULK_UP</td><td></td><td>19</td><td>0.38</td><td>1.05</td><td>0.347</td><td>0.552</td><td>1.000</td><td>1888</td><td>tags=26%, list=15%, signal=31%</td></tr><tr><td class='lessen'>1211</td><td>CHIBA_RESPONSE_TO_TSA_DN</td><td></td><td>20</td><td>0.37</td><td>1.05</td><td>0.379</td><td>0.552</td><td>1.000</td><td>3252</td><td>tags=40%, list=25%, signal=53%</td></tr><tr><td class='lessen'>1212</td><td>SENESE_HDAC1_AND_HDAC2_TARGETS_UP</td><td></td><td>184</td><td>0.25</td><td>1.04</td><td>0.370</td><td>0.564</td><td>1.000</td><td>2101</td><td>tags=24%, list=16%, signal=29%</td></tr><tr><td class='lessen'>1213</td><td>ROETH_TERT_TARGETS_UP</td><td></td><td>11</td><td>0.45</td><td>1.04</td><td>0.414</td><td>0.564</td><td>1.000</td><td>3524</td><td>tags=64%, list=27%, signal=87%</td></tr><tr><td class='lessen'>1214</td><td>SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP</td><td></td><td>19</td><td>0.39</td><td>1.04</td><td>0.396</td><td>0.567</td><td>1.000</td><td>2021</td><td>tags=42%, list=16%, signal=50%</td></tr><tr><td class='lessen'>1215</td><td>FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP</td><td></td><td>17</td><td>0.39</td><td>1.04</td><td>0.397</td><td>0.568</td><td>1.000</td><td>525</td><td>tags=12%, list=4%, signal=12%</td></tr><tr><td class='lessen'>1216</td><td>COLINA_TARGETS_OF_4EBP1_AND_4EBP2</td><td></td><td>316</td><td>0.25</td><td>1.04</td><td>0.571</td><td>0.568</td><td>1.000</td><td>2602</td><td>tags=28%, list=20%, signal=34%</td></tr><tr><td class='lessen'>1217</td><td>BILD_E2F3_ONCOGENIC_SIGNATURE</td><td></td><td>183</td><td>0.25</td><td>1.04</td><td>0.294</td><td>0.568</td><td>1.000</td><td>2118</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>1218</td><td>NAGASHIMA_NRG1_SIGNALING_UP</td><td></td><td>150</td><td>0.25</td><td>1.04</td><td>0.347</td><td>0.568</td><td>1.000</td><td>2473</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>1219</td><td>BROWN_MYELOID_CELL_DEVELOPMENT_DN</td><td></td><td>108</td><td>0.27</td><td>1.04</td><td>0.312</td><td>0.572</td><td>1.000</td><td>1280</td><td>tags=11%, list=10%, signal=12%</td></tr><tr><td class='lessen'>1220</td><td>OUYANG_PROSTATE_CANCER_PROGRESSION_DN</td><td></td><td>20</td><td>0.38</td><td>1.04</td><td>0.409</td><td>0.572</td><td>1.000</td><td>2387</td><td>tags=30%, list=18%, signal=37%</td></tr><tr><td class='lessen'>1221</td><td>PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN</td><td></td><td>112</td><td>0.27</td><td>1.04</td><td>0.333</td><td>0.571</td><td>1.000</td><td>1799</td><td>tags=14%, list=14%, signal=16%</td></tr><tr><td class='lessen'>1222</td><td>KAYO_AGING_MUSCLE_DN</td><td></td><td>105</td><td>0.28</td><td>1.04</td><td>0.342</td><td>0.571</td><td>1.000</td><td>1627</td><td>tags=15%, list=13%, signal=17%</td></tr><tr><td class='lessen'>1223</td><td>PETRETTO_HEART_MASS_QTL_CIS_UP</td><td></td><td>20</td><td>0.36</td><td>1.04</td><td>0.381</td><td>0.571</td><td>1.000</td><td>2119</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>1224</td><td>HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY</td><td></td><td>20</td><td>0.37</td><td>1.04</td><td>0.396</td><td>0.572</td><td>1.000</td><td>3059</td><td>tags=35%, list=24%, signal=46%</td></tr><tr><td class='lessen'>1225</td><td>BILD_SRC_ONCOGENIC_SIGNATURE</td><td></td><td>53</td><td>0.30</td><td>1.03</td><td>0.342</td><td>0.573</td><td>1.000</td><td>2366</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>1226</td><td>VANASSE_BCL2_TARGETS_DN</td><td></td><td>61</td><td>0.30</td><td>1.03</td><td>0.393</td><td>0.573</td><td>1.000</td><td>2195</td><td>tags=30%, list=17%, signal=35%</td></tr><tr><td class='lessen'>1227</td><td>BALDWIN_PRKCI_TARGETS_UP</td><td></td><td>33</td><td>0.33</td><td>1.03</td><td>0.402</td><td>0.573</td><td>1.000</td><td>3237</td><td>tags=39%, list=25%, signal=52%</td></tr><tr><td class='lessen'>1228</td><td>HAMAI_APOPTOSIS_VIA_TRAIL_DN</td><td></td><td>151</td><td>0.26</td><td>1.03</td><td>0.386</td><td>0.573</td><td>1.000</td><td>2368</td><td>tags=29%, list=18%, signal=35%</td></tr><tr><td class='lessen'>1229</td><td>HENDRICKS_SMARCA4_TARGETS_DN</td><td></td><td>44</td><td>0.31</td><td>1.03</td><td>0.383</td><td>0.573</td><td>1.000</td><td>1536</td><td>tags=27%, list=12%, signal=31%</td></tr><tr><td class='lessen'>1230</td><td>VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN</td><td></td><td>34</td><td>0.33</td><td>1.03</td><td>0.395</td><td>0.573</td><td>1.000</td><td>815</td><td>tags=24%, list=6%, signal=25%</td></tr><tr><td class='lessen'>1231</td><td>BILD_MYC_ONCOGENIC_SIGNATURE</td><td></td><td>153</td><td>0.26</td><td>1.03</td><td>0.298</td><td>0.573</td><td>1.000</td><td>2718</td><td>tags=24%, list=21%, signal=30%</td></tr><tr><td class='lessen'>1232</td><td>ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE</td><td></td><td>14</td><td>0.41</td><td>1.03</td><td>0.373</td><td>0.573</td><td>1.000</td><td>1922</td><td>tags=36%, list=15%, signal=42%</td></tr><tr><td class='lessen'>1233</td><td>WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP</td><td></td><td>18</td><td>0.38</td><td>1.03</td><td>0.409</td><td>0.575</td><td>1.000</td><td>711</td><td>tags=11%, list=5%, signal=12%</td></tr><tr><td class='lessen'>1234</td><td>BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN</td><td></td><td>30</td><td>0.34</td><td>1.03</td><td>0.386</td><td>0.575</td><td>1.000</td><td>575</td><td>tags=17%, list=4%, signal=17%</td></tr><tr><td class='lessen'>1235</td><td>MCCABE_HOXC6_TARGETS_DN</td><td></td><td>19</td><td>0.37</td><td>1.03</td><td>0.404</td><td>0.580</td><td>1.000</td><td>2082</td><td>tags=32%, list=16%, signal=38%</td></tr><tr><td class='lessen'>1236</td><td>KIM_WT1_TARGETS_12HR_DN</td><td></td><td>173</td><td>0.25</td><td>1.03</td><td>0.368</td><td>0.579</td><td>1.000</td><td>2282</td><td>tags=21%, list=18%, signal=25%</td></tr><tr><td class='lessen'>1237</td><td>AMIT_EGF_RESPONSE_20_MCF10A</td><td></td><td>13</td><td>0.42</td><td>1.03</td><td>0.429</td><td>0.579</td><td>1.000</td><td>109</td><td>tags=8%, list=1%, signal=8%</td></tr><tr><td class='lessen'>1238</td><td>OUYANG_PROSTATE_CANCER_PROGRESSION_UP</td><td></td><td>18</td><td>0.38</td><td>1.03</td><td>0.389</td><td>0.580</td><td>1.000</td><td>2687</td><td>tags=33%, list=21%, signal=42%</td></tr><tr><td class='lessen'>1239</td><td>ASTON_MAJOR_DEPRESSIVE_DISORDER_DN</td><td></td><td>138</td><td>0.26</td><td>1.03</td><td>0.387</td><td>0.583</td><td>1.000</td><td>1812</td><td>tags=17%, list=14%, signal=19%</td></tr><tr><td class='lessen'>1240</td><td>SU_PANCREAS</td><td></td><td>39</td><td>0.32</td><td>1.03</td><td>0.387</td><td>0.585</td><td>1.000</td><td>1516</td><td>tags=26%, list=12%, signal=29%</td></tr><tr><td class='lessen'>1241</td><td>JOHNSTONE_PARVB_TARGETS_2_DN</td><td></td><td>267</td><td>0.23</td><td>1.03</td><td>0.308</td><td>0.586</td><td>1.000</td><td>2294</td><td>tags=17%, list=18%, signal=20%</td></tr><tr><td class='lessen'>1242</td><td>MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN</td><td></td><td>287</td><td>0.25</td><td>1.03</td><td>0.308</td><td>0.585</td><td>1.000</td><td>2507</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>1243</td><td>SHIN_B_CELL_LYMPHOMA_CLUSTER_7</td><td></td><td>27</td><td>0.34</td><td>1.03</td><td>0.407</td><td>0.587</td><td>1.000</td><td>3420</td><td>tags=52%, list=26%, signal=70%</td></tr><tr><td class='lessen'>1244</td><td>AFFAR_YY1_TARGETS_UP</td><td></td><td>194</td><td>0.25</td><td>1.02</td><td>0.400</td><td>0.589</td><td>1.000</td><td>2099</td><td>tags=31%, list=16%, signal=36%</td></tr><tr><td class='lessen'>1245</td><td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD</td><td></td><td>20</td><td>0.36</td><td>1.02</td><td>0.408</td><td>0.589</td><td>1.000</td><td>2755</td><td>tags=35%, list=21%, signal=44%</td></tr><tr><td class='lessen'>1246</td><td>BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION</td><td></td><td>10</td><td>0.43</td><td>1.02</td><td>0.432</td><td>0.592</td><td>1.000</td><td>2509</td><td>tags=40%, list=19%, signal=50%</td></tr><tr><td class='lessen'>1247</td><td>WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2</td><td></td><td>30</td><td>0.34</td><td>1.02</td><td>0.413</td><td>0.592</td><td>1.000</td><td>2502</td><td>tags=33%, list=19%, signal=41%</td></tr><tr><td class='lessen'>1248</td><td>SCHEIDEREIT_IKK_TARGETS</td><td></td><td>15</td><td>0.40</td><td>1.02</td><td>0.411</td><td>0.592</td><td>1.000</td><td>3630</td><td>tags=40%, list=28%, signal=56%</td></tr><tr><td class='lessen'>1249</td><td>KOBAYASHI_EGFR_SIGNALING_24HR_UP</td><td></td><td>77</td><td>0.28</td><td>1.02</td><td>0.430</td><td>0.597</td><td>1.000</td><td>1875</td><td>tags=22%, list=14%, signal=26%</td></tr><tr><td class='lessen'>1250</td><td>FARDIN_HYPOXIA_11</td><td></td><td>25</td><td>0.36</td><td>1.02</td><td>0.439</td><td>0.597</td><td>1.000</td><td>2117</td><td>tags=32%, list=16%, signal=38%</td></tr><tr><td class='lessen'>1251</td><td>DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2</td><td></td><td>104</td><td>0.27</td><td>1.02</td><td>0.406</td><td>0.598</td><td>1.000</td><td>1147</td><td>tags=12%, list=9%, signal=13%</td></tr><tr><td class='lessen'>1252</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN</td><td></td><td>21</td><td>0.37</td><td>1.02</td><td>0.427</td><td>0.598</td><td>1.000</td><td>2513</td><td>tags=38%, list=19%, signal=47%</td></tr><tr><td class='lessen'>1253</td><td>LEIN_PONS_MARKERS</td><td></td><td>79</td><td>0.28</td><td>1.02</td><td>0.441</td><td>0.603</td><td>1.000</td><td>1779</td><td>tags=27%, list=14%, signal=31%</td></tr><tr><td class='lessen'>1254</td><td>BILANGES_SERUM_SENSITIVE_VIA_TSC1</td><td></td><td>21</td><td>0.36</td><td>1.02</td><td>0.443</td><td>0.603</td><td>1.000</td><td>1825</td><td>tags=38%, list=14%, signal=44%</td></tr><tr><td class='lessen'>1255</td><td>FORTSCHEGGER_PHF8_TARGETS_UP</td><td></td><td>206</td><td>0.24</td><td>1.02</td><td>0.379</td><td>0.604</td><td>1.000</td><td>2729</td><td>tags=27%, list=21%, signal=33%</td></tr><tr><td class='lessen'>1256</td><td>DORN_ADENOVIRUS_INFECTION_24HR_UP</td><td></td><td>11</td><td>0.43</td><td>1.02</td><td>0.411</td><td>0.604</td><td>1.000</td><td>2135</td><td>tags=36%, list=17%, signal=44%</td></tr><tr><td class='lessen'>1257</td><td>TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP</td><td></td><td>215</td><td>0.25</td><td>1.02</td><td>0.458</td><td>0.603</td><td>1.000</td><td>1885</td><td>tags=20%, list=15%, signal=24%</td></tr><tr><td class='lessen'>1258</td><td>FINAK_BREAST_CANCER_SDPP_SIGNATURE</td><td></td><td>22</td><td>0.36</td><td>1.02</td><td>0.419</td><td>0.604</td><td>1.000</td><td>1292</td><td>tags=32%, list=10%, signal=35%</td></tr><tr><td class='lessen'>1259</td><td>WHITESIDE_CISPLATIN_RESISTANCE_UP</td><td></td><td>11</td><td>0.44</td><td>1.02</td><td>0.446</td><td>0.604</td><td>1.000</td><td>1581</td><td>tags=27%, list=12%, signal=31%</td></tr><tr><td class='lessen'>1260</td><td>ABBUD_LIF_SIGNALING_2_UP</td><td></td><td>12</td><td>0.41</td><td>1.02</td><td>0.450</td><td>0.603</td><td>1.000</td><td>731</td><td>tags=33%, list=6%, signal=35%</td></tr><tr><td class='lessen'>1261</td><td>BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP</td><td></td><td>43</td><td>0.31</td><td>1.02</td><td>0.371</td><td>0.603</td><td>1.000</td><td>2709</td><td>tags=35%, list=21%, signal=44%</td></tr><tr><td class='lessen'>1262</td><td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS</td><td></td><td>32</td><td>0.32</td><td>1.01</td><td>0.396</td><td>0.607</td><td>1.000</td><td>3113</td><td>tags=41%, list=24%, signal=53%</td></tr><tr><td class='lessen'>1263</td><td>ONGUSAHA_TP53_TARGETS</td><td></td><td>35</td><td>0.32</td><td>1.01</td><td>0.394</td><td>0.608</td><td>1.000</td><td>3022</td><td>tags=37%, list=23%, signal=48%</td></tr><tr><td class='lessen'>1264</td><td>SENESE_HDAC2_TARGETS_DN</td><td></td><td>102</td><td>0.27</td><td>1.01</td><td>0.355</td><td>0.608</td><td>1.000</td><td>1363</td><td>tags=19%, list=11%, signal=21%</td></tr><tr><td class='lessen'>1265</td><td>TSENG_IRS1_TARGETS_UP</td><td></td><td>99</td><td>0.27</td><td>1.01</td><td>0.384</td><td>0.610</td><td>1.000</td><td>1512</td><td>tags=17%, list=12%, signal=19%</td></tr><tr><td class='lessen'>1266</td><td>TAKAO_RESPONSE_TO_UVB_RADIATION_UP</td><td></td><td>76</td><td>0.27</td><td>1.01</td><td>0.391</td><td>0.609</td><td>1.000</td><td>1530</td><td>tags=12%, list=12%, signal=13%</td></tr><tr><td class='lessen'>1267</td><td>FRASOR_RESPONSE_TO_ESTRADIOL_UP</td><td></td><td>34</td><td>0.32</td><td>1.01</td><td>0.445</td><td>0.609</td><td>1.000</td><td>2079</td><td>tags=35%, list=16%, signal=42%</td></tr><tr><td class='lessen'>1268</td><td>ZAMORA_NOS2_TARGETS_DN</td><td></td><td>86</td><td>0.28</td><td>1.01</td><td>0.385</td><td>0.610</td><td>1.000</td><td>1966</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>1269</td><td>LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP</td><td></td><td>102</td><td>0.27</td><td>1.01</td><td>0.376</td><td>0.610</td><td>1.000</td><td>1456</td><td>tags=21%, list=11%, signal=23%</td></tr><tr><td class='lessen'>1270</td><td>YANG_MUC2_TARGETS_DUODENUM_6MO_DN</td><td></td><td>14</td><td>0.41</td><td>1.01</td><td>0.460</td><td>0.611</td><td>1.000</td><td>2159</td><td>tags=36%, list=17%, signal=43%</td></tr><tr><td class='lessen'>1271</td><td>KRIGE_AMINO_ACID_DEPRIVATION</td><td></td><td>27</td><td>0.33</td><td>1.01</td><td>0.446</td><td>0.613</td><td>1.000</td><td>2785</td><td>tags=37%, list=22%, signal=47%</td></tr><tr><td class='lessen'>1272</td><td>JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP</td><td></td><td>95</td><td>0.26</td><td>1.01</td><td>0.406</td><td>0.614</td><td>1.000</td><td>2840</td><td>tags=24%, list=22%, signal=31%</td></tr><tr><td class='lessen'>1273</td><td>ODONNELL_METASTASIS_UP</td><td></td><td>62</td><td>0.28</td><td>1.01</td><td>0.425</td><td>0.615</td><td>1.000</td><td>1842</td><td>tags=27%, list=14%, signal=32%</td></tr><tr><td class='lessen'>1274</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP</td><td></td><td>79</td><td>0.27</td><td>1.01</td><td>0.427</td><td>0.615</td><td>1.000</td><td>2500</td><td>tags=37%, list=19%, signal=45%</td></tr><tr><td class='lessen'>1275</td><td>VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN</td><td></td><td>13</td><td>0.40</td><td>1.01</td><td>0.403</td><td>0.617</td><td>1.000</td><td>1898</td><td>tags=38%, list=15%, signal=45%</td></tr><tr><td class='lessen'>1276</td><td>MATZUK_EARLY_ANTRAL_FOLLICLE</td><td></td><td>13</td><td>0.40</td><td>1.01</td><td>0.449</td><td>0.618</td><td>1.000</td><td>1432</td><td>tags=31%, list=11%, signal=35%</td></tr><tr><td class='lessen'>1277</td><td>KESHELAVA_MULTIPLE_DRUG_RESISTANCE</td><td></td><td>64</td><td>0.28</td><td>1.01</td><td>0.431</td><td>0.621</td><td>1.000</td><td>1965</td><td>tags=25%, list=15%, signal=29%</td></tr><tr><td class='lessen'>1278</td><td>TSENG_ADIPOGENIC_POTENTIAL_UP</td><td></td><td>28</td><td>0.33</td><td>1.01</td><td>0.452</td><td>0.621</td><td>1.000</td><td>1364</td><td>tags=18%, list=11%, signal=20%</td></tr><tr><td class='lessen'>1279</td><td>LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP</td><td></td><td>28</td><td>0.33</td><td>1.00</td><td>0.419</td><td>0.621</td><td>1.000</td><td>1876</td><td>tags=29%, list=15%, signal=33%</td></tr><tr><td class='lessen'>1280</td><td>YAGI_AML_SURVIVAL</td><td></td><td>106</td><td>0.26</td><td>1.00</td><td>0.481</td><td>0.623</td><td>1.000</td><td>2504</td><td>tags=22%, list=19%, signal=27%</td></tr><tr><td class='lessen'>1281</td><td>KANG_DOXORUBICIN_RESISTANCE_DN</td><td></td><td>16</td><td>0.39</td><td>1.00</td><td>0.458</td><td>0.625</td><td>1.000</td><td>2932</td><td>tags=25%, list=23%, signal=32%</td></tr><tr><td class='lessen'>1282</td><td>ZHOU_TNF_SIGNALING_30MIN</td><td></td><td>46</td><td>0.30</td><td>1.00</td><td>0.443</td><td>0.625</td><td>1.000</td><td>2703</td><td>tags=26%, list=21%, signal=33%</td></tr><tr><td class='lessen'>1283</td><td>WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN</td><td></td><td>11</td><td>0.42</td><td>1.00</td><td>0.459</td><td>0.626</td><td>1.000</td><td>1814</td><td>tags=55%, list=14%, signal=63%</td></tr><tr><td class='lessen'>1284</td><td>GRANDVAUX_IRF3_TARGETS_DN</td><td></td><td>16</td><td>0.39</td><td>1.00</td><td>0.463</td><td>0.626</td><td>1.000</td><td>2948</td><td>tags=31%, list=23%, signal=40%</td></tr><tr><td class='lessen'>1285</td><td>BYSTROEM_CORRELATED_WITH_IL5_UP</td><td></td><td>48</td><td>0.30</td><td>1.00</td><td>0.450</td><td>0.626</td><td>1.000</td><td>2493</td><td>tags=23%, list=19%, signal=28%</td></tr><tr><td class='lessen'>1286</td><td>HUMMEL_BURKITTS_LYMPHOMA_UP</td><td></td><td>33</td><td>0.32</td><td>1.00</td><td>0.454</td><td>0.625</td><td>1.000</td><td>2283</td><td>tags=24%, list=18%, signal=29%</td></tr><tr><td class='lessen'>1287</td><td>SABATES_COLORECTAL_ADENOMA_UP</td><td></td><td>103</td><td>0.26</td><td>1.00</td><td>0.471</td><td>0.626</td><td>1.000</td><td>837</td><td>tags=15%, list=6%, signal=15%</td></tr><tr><td class='lessen'>1288</td><td>NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON</td><td></td><td>12</td><td>0.41</td><td>1.00</td><td>0.428</td><td>0.632</td><td>1.000</td><td>1125</td><td>tags=25%, list=9%, signal=27%</td></tr><tr><td class='lessen'>1289</td><td>LIU_COMMON_CANCER_GENES</td><td></td><td>54</td><td>0.29</td><td>1.00</td><td>0.454</td><td>0.632</td><td>1.000</td><td>1519</td><td>tags=13%, list=12%, signal=15%</td></tr><tr><td class='lessen'>1290</td><td>CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN</td><td></td><td>28</td><td>0.33</td><td>1.00</td><td>0.453</td><td>0.633</td><td>1.000</td><td>8671</td><td>tags=100%, list=67%, signal=303%</td></tr><tr><td class='lessen'>1291</td><td>CHIBA_RESPONSE_TO_TSA</td><td></td><td>42</td><td>0.31</td><td>1.00</td><td>0.462</td><td>0.633</td><td>1.000</td><td>2382</td><td>tags=26%, list=18%, signal=32%</td></tr><tr><td class='lessen'>1292</td><td>BAUS_TFF2_TARGETS_UP</td><td></td><td>29</td><td>0.33</td><td>1.00</td><td>0.442</td><td>0.632</td><td>1.000</td><td>2069</td><td>tags=38%, list=16%, signal=45%</td></tr><tr><td class='lessen'>1293</td><td>FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN</td><td></td><td>78</td><td>0.28</td><td>1.00</td><td>0.459</td><td>0.633</td><td>1.000</td><td>1735</td><td>tags=22%, list=13%, signal=25%</td></tr><tr><td class='lessen'>1294</td><td>CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN</td><td></td><td>21</td><td>0.36</td><td>1.00</td><td>0.424</td><td>0.632</td><td>1.000</td><td>1555</td><td>tags=24%, list=12%, signal=27%</td></tr><tr><td class='lessen'>1295</td><td>ROME_INSULIN_TARGETS_IN_MUSCLE_UP</td><td></td><td>343</td><td>0.24</td><td>1.00</td><td>0.500</td><td>0.638</td><td>1.000</td><td>3135</td><td>tags=23%, list=24%, signal=30%</td></tr><tr><td class='lessen'>1296</td><td>MCCLUNG_COCAINE_REWARD_5D</td><td></td><td>75</td><td>0.27</td><td>0.99</td><td>0.505</td><td>0.639</td><td>1.000</td><td>752</td><td>tags=12%, list=6%, signal=13%</td></tr><tr><td class='lessen'>1297</td><td>JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN</td><td></td><td>73</td><td>0.27</td><td>0.99</td><td>0.430</td><td>0.639</td><td>1.000</td><td>2680</td><td>tags=19%, list=21%, signal=24%</td></tr><tr><td class='lessen'>1298</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8</td><td></td><td>41</td><td>0.30</td><td>0.99</td><td>0.436</td><td>0.639</td><td>1.000</td><td>713</td><td>tags=12%, list=6%, signal=13%</td></tr><tr><td class='lessen'>1299</td><td>ALONSO_METASTASIS_NEURAL_UP</td><td></td><td>17</td><td>0.38</td><td>0.99</td><td>0.437</td><td>0.639</td><td>1.000</td><td>1354</td><td>tags=29%, list=10%, signal=33%</td></tr><tr><td class='lessen'>1300</td><td>BOYLAN_MULTIPLE_MYELOMA_PCA3_UP</td><td></td><td>62</td><td>0.28</td><td>0.99</td><td>0.463</td><td>0.640</td><td>1.000</td><td>2121</td><td>tags=24%, list=16%, signal=29%</td></tr><tr><td class='lessen'>1301</td><td>RODRIGUES_NTN1_TARGETS_DN</td><td></td><td>132</td><td>0.25</td><td>0.99</td><td>0.412</td><td>0.643</td><td>1.000</td><td>2946</td><td>tags=32%, list=23%, signal=41%</td></tr><tr><td class='lessen'>1302</td><td>RIZ_ERYTHROID_DIFFERENTIATION_12HR</td><td></td><td>41</td><td>0.30</td><td>0.99</td><td>0.448</td><td>0.645</td><td>1.000</td><td>2062</td><td>tags=34%, list=16%, signal=40%</td></tr><tr><td class='lessen'>1303</td><td>EHLERS_ANEUPLOIDY_UP</td><td></td><td>33</td><td>0.31</td><td>0.99</td><td>0.477</td><td>0.648</td><td>1.000</td><td>2569</td><td>tags=27%, list=20%, signal=34%</td></tr><tr><td class='lessen'>1304</td><td>WEI_MIR34A_TARGETS</td><td></td><td>122</td><td>0.25</td><td>0.99</td><td>0.500</td><td>0.648</td><td>1.000</td><td>1558</td><td>tags=13%, list=12%, signal=15%</td></tr><tr><td class='lessen'>1305</td><td>BILANGES_SERUM_SENSITIVE_GENES</td><td></td><td>73</td><td>0.27</td><td>0.99</td><td>0.504</td><td>0.649</td><td>1.000</td><td>1865</td><td>tags=23%, list=14%, signal=27%</td></tr><tr><td class='lessen'>1306</td><td>ZHAN_EARLY_DIFFERENTIATION_GENES_DN</td><td></td><td>37</td><td>0.30</td><td>0.99</td><td>0.459</td><td>0.649</td><td>1.000</td><td>2473</td><td>tags=32%, list=19%, signal=40%</td></tr><tr><td class='lessen'>1307</td><td>RASHI_RESPONSE_TO_IONIZING_RADIATION_4</td><td></td><td>45</td><td>0.30</td><td>0.99</td><td>0.471</td><td>0.648</td><td>1.000</td><td>1442</td><td>tags=20%, list=11%, signal=22%</td></tr><tr><td class='lessen'>1308</td><td>MAHADEVAN_RESPONSE_TO_MP470_DN</td><td></td><td>17</td><td>0.38</td><td>0.99</td><td>0.482</td><td>0.649</td><td>1.000</td><td>2135</td><td>tags=29%, list=17%, signal=35%</td></tr><tr><td class='lessen'>1309</td><td>APPIERTO_RESPONSE_TO_FENRETINIDE_DN</td><td></td><td>40</td><td>0.31</td><td>0.99</td><td>0.477</td><td>0.648</td><td>1.000</td><td>1772</td><td>tags=15%, list=14%, signal=17%</td></tr><tr><td class='lessen'>1310</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP</td><td></td><td>66</td><td>0.27</td><td>0.99</td><td>0.482</td><td>0.649</td><td>1.000</td><td>2438</td><td>tags=38%, list=19%, signal=46%</td></tr><tr><td class='lessen'>1311</td><td>SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP</td><td></td><td>67</td><td>0.28</td><td>0.99</td><td>0.472</td><td>0.649</td><td>1.000</td><td>2302</td><td>tags=16%, list=18%, signal=20%</td></tr><tr><td class='lessen'>1312</td><td>JIANG_AGING_CEREBRAL_CORTEX_UP</td><td></td><td>33</td><td>0.32</td><td>0.99</td><td>0.452</td><td>0.649</td><td>1.000</td><td>1239</td><td>tags=12%, list=10%, signal=13%</td></tr><tr><td class='lessen'>1313</td><td>BLUM_RESPONSE_TO_SALIRASIB_UP</td><td></td><td>208</td><td>0.23</td><td>0.99</td><td>0.576</td><td>0.649</td><td>1.000</td><td>2621</td><td>tags=18%, list=20%, signal=23%</td></tr><tr><td class='lessen'>1314</td><td>GENTILE_UV_RESPONSE_CLUSTER_D7</td><td></td><td>35</td><td>0.31</td><td>0.99</td><td>0.459</td><td>0.649</td><td>1.000</td><td>2692</td><td>tags=34%, list=21%, signal=43%</td></tr><tr><td class='lessen'>1315</td><td>AMUNDSON_RESPONSE_TO_ARSENITE</td><td></td><td>175</td><td>0.24</td><td>0.99</td><td>0.564</td><td>0.649</td><td>1.000</td><td>2350</td><td>tags=22%, list=18%, signal=26%</td></tr><tr><td class='lessen'>1316</td><td>GENTILE_UV_RESPONSE_CLUSTER_D5</td><td></td><td>31</td><td>0.32</td><td>0.99</td><td>0.457</td><td>0.649</td><td>1.000</td><td>1721</td><td>tags=13%, list=13%, signal=15%</td></tr><tr><td class='lessen'>1317</td><td>HUI_MAPK14_TARGETS_UP</td><td></td><td>20</td><td>0.35</td><td>0.98</td><td>0.458</td><td>0.655</td><td>1.000</td><td>2893</td><td>tags=45%, list=22%, signal=58%</td></tr><tr><td class='lessen'>1318</td><td>ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN</td><td></td><td>62</td><td>0.28</td><td>0.98</td><td>0.496</td><td>0.656</td><td>1.000</td><td>2106</td><td>tags=26%, list=16%, signal=31%</td></tr><tr><td class='lessen'>1319</td><td>DAZARD_UV_RESPONSE_CLUSTER_G1</td><td></td><td>59</td><td>0.28</td><td>0.98</td><td>0.506</td><td>0.657</td><td>1.000</td><td>2675</td><td>tags=22%, list=21%, signal=28%</td></tr><tr><td class='lessen'>1320</td><td>KAAB_HEART_ATRIUM_VS_VENTRICLE_DN</td><td></td><td>229</td><td>0.24</td><td>0.98</td><td>0.500</td><td>0.658</td><td>1.000</td><td>2408</td><td>tags=26%, list=19%, signal=31%</td></tr><tr><td class='lessen'>1321</td><td>LEE_LIVER_CANCER_E2F1_UP</td><td></td><td>58</td><td>0.28</td><td>0.98</td><td>0.528</td><td>0.659</td><td>1.000</td><td>2343</td><td>tags=34%, list=18%, signal=42%</td></tr><tr><td class='lessen'>1322</td><td>FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN</td><td></td><td>45</td><td>0.30</td><td>0.98</td><td>0.506</td><td>0.659</td><td>1.000</td><td>3411</td><td>tags=36%, list=26%, signal=48%</td></tr><tr><td class='lessen'>1323</td><td>WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH</td><td></td><td>54</td><td>0.29</td><td>0.98</td><td>0.503</td><td>0.659</td><td>1.000</td><td>2761</td><td>tags=35%, list=21%, signal=45%</td></tr><tr><td class='lessen'>1324</td><td>WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT</td><td></td><td>49</td><td>0.29</td><td>0.98</td><td>0.424</td><td>0.661</td><td>1.000</td><td>2443</td><td>tags=29%, list=19%, signal=35%</td></tr><tr><td class='lessen'>1325</td><td>VALK_AML_CLUSTER_15</td><td></td><td>27</td><td>0.33</td><td>0.98</td><td>0.470</td><td>0.665</td><td>1.000</td><td>2413</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>1326</td><td>GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN</td><td></td><td>848</td><td>0.21</td><td>0.98</td><td>1.000</td><td>0.665</td><td>1.000</td><td>2564</td><td>tags=22%, list=20%, signal=26%</td></tr><tr><td class='lessen'>1327</td><td>HUPER_BREAST_BASAL_VS_LUMINAL_DN</td><td></td><td>49</td><td>0.28</td><td>0.98</td><td>0.468</td><td>0.667</td><td>1.000</td><td>2052</td><td>tags=27%, list=16%, signal=31%</td></tr><tr><td class='lessen'>1328</td><td>ZHU_CMV_8_HR_UP</td><td></td><td>39</td><td>0.31</td><td>0.98</td><td>0.492</td><td>0.667</td><td>1.000</td><td>3524</td><td>tags=49%, list=27%, signal=67%</td></tr><tr><td class='lessen'>1329</td><td>DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP</td><td></td><td>247</td><td>0.23</td><td>0.98</td><td>0.556</td><td>0.668</td><td>1.000</td><td>3212</td><td>tags=30%, list=25%, signal=39%</td></tr><tr><td class='lessen'>1330</td><td>IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP</td><td></td><td>18</td><td>0.35</td><td>0.98</td><td>0.461</td><td>0.668</td><td>1.000</td><td>2206</td><td>tags=33%, list=17%, signal=40%</td></tr><tr><td class='lessen'>1331</td><td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN</td><td></td><td>90</td><td>0.26</td><td>0.98</td><td>0.522</td><td>0.669</td><td>1.000</td><td>2049</td><td>tags=24%, list=16%, signal=29%</td></tr><tr><td class='lessen'>1332</td><td>LEE_AGING_MUSCLE_DN</td><td></td><td>39</td><td>0.30</td><td>0.98</td><td>0.485</td><td>0.669</td><td>1.000</td><td>2356</td><td>tags=31%, list=18%, signal=38%</td></tr><tr><td class='lessen'>1333</td><td>MAHADEVAN_IMATINIB_RESISTANCE_UP</td><td></td><td>17</td><td>0.38</td><td>0.98</td><td>0.479</td><td>0.671</td><td>1.000</td><td>2161</td><td>tags=35%, list=17%, signal=42%</td></tr><tr><td class='lessen'>1334</td><td>CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN</td><td></td><td>23</td><td>0.33</td><td>0.97</td><td>0.483</td><td>0.682</td><td>1.000</td><td>902</td><td>tags=22%, list=7%, signal=23%</td></tr><tr><td class='lessen'>1335</td><td>CHIN_BREAST_CANCER_COPY_NUMBER_DN</td><td></td><td>12</td><td>0.40</td><td>0.97</td><td>0.479</td><td>0.681</td><td>1.000</td><td>1475</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>1336</td><td>HOLLEMAN_DAUNORUBICIN_B_ALL_DN</td><td></td><td>10</td><td>0.43</td><td>0.97</td><td>0.510</td><td>0.682</td><td>1.000</td><td>2570</td><td>tags=30%, list=20%, signal=37%</td></tr><tr><td class='lessen'>1337</td><td>OKUMURA_INFLAMMATORY_RESPONSE_LPS</td><td></td><td>148</td><td>0.24</td><td>0.97</td><td>0.628</td><td>0.683</td><td>1.000</td><td>2028</td><td>tags=22%, list=16%, signal=26%</td></tr><tr><td class='lessen'>1338</td><td>GEISS_RESPONSE_TO_DSRNA_DN</td><td></td><td>13</td><td>0.39</td><td>0.97</td><td>0.491</td><td>0.684</td><td>1.000</td><td>2493</td><td>tags=38%, list=19%, signal=48%</td></tr><tr><td class='lessen'>1339</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN</td><td></td><td>362</td><td>0.22</td><td>0.97</td><td>0.750</td><td>0.686</td><td>1.000</td><td>2364</td><td>tags=22%, list=18%, signal=27%</td></tr><tr><td class='lessen'>1340</td><td>GENTILE_UV_RESPONSE_CLUSTER_D9</td><td></td><td>17</td><td>0.36</td><td>0.97</td><td>0.493</td><td>0.688</td><td>1.000</td><td>2730</td><td>tags=41%, list=21%, signal=52%</td></tr><tr><td class='lessen'>1341</td><td>BAE_BRCA1_TARGETS_DN</td><td></td><td>29</td><td>0.31</td><td>0.97</td><td>0.508</td><td>0.688</td><td>1.000</td><td>2906</td><td>tags=34%, list=22%, signal=44%</td></tr><tr><td class='lessen'>1342</td><td>CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY</td><td></td><td>22</td><td>0.35</td><td>0.97</td><td>0.540</td><td>0.689</td><td>1.000</td><td>2170</td><td>tags=27%, list=17%, signal=33%</td></tr><tr><td class='lessen'>1343</td><td>FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP</td><td></td><td>56</td><td>0.28</td><td>0.97</td><td>0.516</td><td>0.688</td><td>1.000</td><td>3082</td><td>tags=27%, list=24%, signal=35%</td></tr><tr><td class='lessen'>1344</td><td>YE_METASTATIC_LIVER_CANCER</td><td></td><td>21</td><td>0.34</td><td>0.97</td><td>0.507</td><td>0.689</td><td>1.000</td><td>1533</td><td>tags=24%, list=12%, signal=27%</td></tr><tr><td class='lessen'>1345</td><td>MCCABE_HOXC6_TARGETS_CANCER_UP</td><td></td><td>26</td><td>0.32</td><td>0.96</td><td>0.541</td><td>0.692</td><td>1.000</td><td>2688</td><td>tags=35%, list=21%, signal=44%</td></tr><tr><td class='lessen'>1346</td><td>PLASARI_NFIC_TARGETS_BASAL_UP</td><td></td><td>25</td><td>0.32</td><td>0.96</td><td>0.506</td><td>0.697</td><td>1.000</td><td>623</td><td>tags=24%, list=5%, signal=25%</td></tr><tr><td class='lessen'>1347</td><td>ZHANG_GATA6_TARGETS_DN</td><td></td><td>58</td><td>0.28</td><td>0.96</td><td>0.538</td><td>0.697</td><td>1.000</td><td>1475</td><td>tags=19%, list=11%, signal=21%</td></tr><tr><td class='lessen'>1348</td><td>MA_MYELOID_DIFFERENTIATION_DN</td><td></td><td>42</td><td>0.29</td><td>0.96</td><td>0.506</td><td>0.700</td><td>1.000</td><td>2113</td><td>tags=26%, list=16%, signal=31%</td></tr><tr><td class='lessen'>1349</td><td>BENPORATH_MYC_TARGETS_WITH_EBOX</td><td></td><td>208</td><td>0.23</td><td>0.96</td><td>0.654</td><td>0.700</td><td>1.000</td><td>2770</td><td>tags=25%, list=21%, signal=31%</td></tr><tr><td class='lessen'>1350</td><td>CROMER_METASTASIS_UP</td><td></td><td>64</td><td>0.27</td><td>0.96</td><td>0.574</td><td>0.701</td><td>1.000</td><td>1776</td><td>tags=14%, list=14%, signal=16%</td></tr><tr><td class='lessen'>1351</td><td>NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON</td><td></td><td>88</td><td>0.25</td><td>0.96</td><td>0.578</td><td>0.701</td><td>1.000</td><td>1559</td><td>tags=19%, list=12%, signal=22%</td></tr><tr><td class='lessen'>1352</td><td>CAMPS_COLON_CANCER_COPY_NUMBER_DN</td><td></td><td>27</td><td>0.33</td><td>0.96</td><td>0.519</td><td>0.703</td><td>1.000</td><td>892</td><td>tags=22%, list=7%, signal=24%</td></tr><tr><td class='lessen'>1353</td><td>ZHAN_MULTIPLE_MYELOMA_HP_DN</td><td></td><td>37</td><td>0.30</td><td>0.96</td><td>0.517</td><td>0.704</td><td>1.000</td><td>1427</td><td>tags=22%, list=11%, signal=24%</td></tr><tr><td class='lessen'>1354</td><td>MOOTHA_PGC</td><td></td><td>362</td><td>0.22</td><td>0.96</td><td>0.857</td><td>0.706</td><td>1.000</td><td>2580</td><td>tags=21%, list=20%, signal=25%</td></tr><tr><td class='lessen'>1355</td><td>GRADE_COLON_CANCER_DN</td><td></td><td>23</td><td>0.33</td><td>0.96</td><td>0.531</td><td>0.706</td><td>1.000</td><td>2247</td><td>tags=26%, list=17%, signal=32%</td></tr><tr><td class='lessen'>1356</td><td>ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR</td><td></td><td>10</td><td>0.41</td><td>0.96</td><td>0.483</td><td>0.706</td><td>1.000</td><td>487</td><td>tags=20%, list=4%, signal=21%</td></tr><tr><td class='lessen'>1357</td><td>LOPEZ_EPITHELIOID_MESOTHELIOMA</td><td></td><td>15</td><td>0.37</td><td>0.96</td><td>0.512</td><td>0.706</td><td>1.000</td><td>337</td><td>tags=20%, list=3%, signal=21%</td></tr><tr><td class='lessen'>1358</td><td>CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY</td><td></td><td>27</td><td>0.33</td><td>0.96</td><td>0.514</td><td>0.707</td><td>1.000</td><td>1080</td><td>tags=19%, list=8%, signal=20%</td></tr><tr><td class='lessen'>1359</td><td>STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP</td><td></td><td>62</td><td>0.27</td><td>0.96</td><td>0.543</td><td>0.708</td><td>1.000</td><td>1502</td><td>tags=19%, list=12%, signal=22%</td></tr><tr><td class='lessen'>1360</td><td>IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP</td><td></td><td>10</td><td>0.40</td><td>0.96</td><td>0.510</td><td>0.707</td><td>1.000</td><td>3597</td><td>tags=90%, list=28%, signal=125%</td></tr><tr><td class='lessen'>1361</td><td>CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN</td><td></td><td>18</td><td>0.35</td><td>0.96</td><td>0.500</td><td>0.707</td><td>1.000</td><td>1804</td><td>tags=22%, list=14%, signal=26%</td></tr><tr><td class='lessen'>1362</td><td>BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP</td><td></td><td>177</td><td>0.23</td><td>0.96</td><td>0.619</td><td>0.708</td><td>1.000</td><td>2099</td><td>tags=22%, list=16%, signal=26%</td></tr><tr><td class='lessen'>1363</td><td>HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2</td><td></td><td>138</td><td>0.25</td><td>0.95</td><td>0.662</td><td>0.710</td><td>1.000</td><td>3079</td><td>tags=24%, list=24%, signal=31%</td></tr><tr><td class='lessen'>1364</td><td>ONGUSAHA_BRCA1_TARGETS_UP</td><td></td><td>13</td><td>0.39</td><td>0.95</td><td>0.502</td><td>0.710</td><td>1.000</td><td>2785</td><td>tags=46%, list=22%, signal=59%</td></tr><tr><td class='lessen'>1365</td><td>MITSIADES_RESPONSE_TO_APLIDIN_UP</td><td></td><td>336</td><td>0.22</td><td>0.95</td><td>0.833</td><td>0.711</td><td>1.000</td><td>2451</td><td>tags=22%, list=19%, signal=26%</td></tr><tr><td class='lessen'>1366</td><td>VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP</td><td></td><td>11</td><td>0.40</td><td>0.95</td><td>0.485</td><td>0.711</td><td>1.000</td><td>1803</td><td>tags=27%, list=14%, signal=32%</td></tr><tr><td class='lessen'>1367</td><td>ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS</td><td></td><td>13</td><td>0.39</td><td>0.95</td><td>0.500</td><td>0.711</td><td>1.000</td><td>2234</td><td>tags=38%, list=17%, signal=46%</td></tr><tr><td class='lessen'>1368</td><td>LINDVALL_IMMORTALIZED_BY_TERT_UP</td><td></td><td>70</td><td>0.27</td><td>0.95</td><td>0.488</td><td>0.716</td><td>1.000</td><td>2934</td><td>tags=36%, list=23%, signal=46%</td></tr><tr><td class='lessen'>1369</td><td>MOREIRA_RESPONSE_TO_TSA_UP</td><td></td><td>26</td><td>0.32</td><td>0.95</td><td>0.519</td><td>0.716</td><td>1.000</td><td>2394</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>1370</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP</td><td></td><td>57</td><td>0.27</td><td>0.95</td><td>0.552</td><td>0.716</td><td>1.000</td><td>2382</td><td>tags=19%, list=18%, signal=24%</td></tr><tr><td class='lessen'>1371</td><td>KANG_FLUOROURACIL_RESISTANCE_DN</td><td></td><td>15</td><td>0.37</td><td>0.95</td><td>0.532</td><td>0.716</td><td>1.000</td><td>275</td><td>tags=13%, list=2%, signal=14%</td></tr><tr><td class='lessen'>1372</td><td>VERHAAK_GLIOBLASTOMA_NEURAL</td><td></td><td>108</td><td>0.25</td><td>0.95</td><td>0.564</td><td>0.720</td><td>1.000</td><td>1394</td><td>tags=17%, list=11%, signal=19%</td></tr><tr><td class='lessen'>1373</td><td>VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN</td><td></td><td>33</td><td>0.31</td><td>0.95</td><td>0.466</td><td>0.721</td><td>1.000</td><td>1228</td><td>tags=15%, list=9%, signal=17%</td></tr><tr><td class='lessen'>1374</td><td>NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS</td><td></td><td>10</td><td>0.42</td><td>0.95</td><td>0.517</td><td>0.723</td><td>1.000</td><td>1507</td><td>tags=40%, list=12%, signal=45%</td></tr><tr><td class='lessen'>1375</td><td>DALESSIO_TSA_RESPONSE</td><td></td><td>19</td><td>0.35</td><td>0.95</td><td>0.545</td><td>0.724</td><td>1.000</td><td>2120</td><td>tags=42%, list=16%, signal=50%</td></tr><tr><td class='lessen'>1376</td><td>AMUNDSON_GENOTOXIC_SIGNATURE</td><td></td><td>91</td><td>0.25</td><td>0.95</td><td>0.578</td><td>0.724</td><td>1.000</td><td>2161</td><td>tags=23%, list=17%, signal=28%</td></tr><tr><td class='lessen'>1377</td><td>XU_GH1_AUTOCRINE_TARGETS_DN</td><td></td><td>115</td><td>0.24</td><td>0.95</td><td>0.635</td><td>0.725</td><td>1.000</td><td>1648</td><td>tags=17%, list=13%, signal=19%</td></tr><tr><td class='lessen'>1378</td><td>AMIT_EGF_RESPONSE_480_MCF10A</td><td></td><td>38</td><td>0.29</td><td>0.95</td><td>0.545</td><td>0.726</td><td>1.000</td><td>1501</td><td>tags=24%, list=12%, signal=27%</td></tr><tr><td class='lessen'>1379</td><td>WEIGEL_OXIDATIVE_STRESS_RESPONSE</td><td></td><td>31</td><td>0.31</td><td>0.94</td><td>0.492</td><td>0.726</td><td>1.000</td><td>2898</td><td>tags=32%, list=22%, signal=41%</td></tr><tr><td class='lessen'>1380</td><td>CHICAS_RB1_TARGETS_SENESCENT</td><td></td><td>454</td><td>0.23</td><td>0.94</td><td>0.667</td><td>0.729</td><td>1.000</td><td>2168</td><td>tags=22%, list=17%, signal=26%</td></tr><tr><td class='lessen'>1381</td><td>ONDER_CDH1_TARGETS_3_UP</td><td></td><td>16</td><td>0.36</td><td>0.94</td><td>0.507</td><td>0.730</td><td>1.000</td><td>2413</td><td>tags=31%, list=19%, signal=38%</td></tr><tr><td class='lessen'>1382</td><td>SYED_ESTRADIOL_RESPONSE</td><td></td><td>18</td><td>0.34</td><td>0.94</td><td>0.529</td><td>0.730</td><td>1.000</td><td>1839</td><td>tags=22%, list=14%, signal=26%</td></tr><tr><td class='lessen'>1383</td><td>ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN</td><td></td><td>14</td><td>0.38</td><td>0.94</td><td>0.521</td><td>0.731</td><td>1.000</td><td>1674</td><td>tags=36%, list=13%, signal=41%</td></tr><tr><td class='lessen'>1384</td><td>WELCSH_BRCA1_TARGETS_UP</td><td></td><td>167</td><td>0.23</td><td>0.94</td><td>0.667</td><td>0.731</td><td>1.000</td><td>2225</td><td>tags=19%, list=17%, signal=22%</td></tr><tr><td class='lessen'>1385</td><td>HAHTOLA_SEZARY_SYNDROM_DN</td><td></td><td>32</td><td>0.30</td><td>0.94</td><td>0.542</td><td>0.731</td><td>1.000</td><td>1444</td><td>tags=31%, list=11%, signal=35%</td></tr><tr><td class='lessen'>1386</td><td>DITTMER_PTHLH_TARGETS_UP</td><td></td><td>99</td><td>0.25</td><td>0.94</td><td>0.615</td><td>0.733</td><td>1.000</td><td>3009</td><td>tags=27%, list=23%, signal=35%</td></tr><tr><td class='lessen'>1387</td><td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP</td><td></td><td>76</td><td>0.26</td><td>0.94</td><td>0.606</td><td>0.732</td><td>1.000</td><td>2567</td><td>tags=28%, list=20%, signal=34%</td></tr><tr><td class='lessen'>1388</td><td>KYNG_DNA_DAMAGE_BY_4NQO_OR_UV</td><td></td><td>57</td><td>0.27</td><td>0.94</td><td>0.599</td><td>0.732</td><td>1.000</td><td>1726</td><td>tags=19%, list=13%, signal=22%</td></tr><tr><td class='lessen'>1389</td><td>KOHOUTEK_CCNT1_TARGETS</td><td></td><td>43</td><td>0.28</td><td>0.94</td><td>0.558</td><td>0.733</td><td>1.000</td><td>2284</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>1390</td><td>ZHU_CMV_ALL_UP</td><td></td><td>103</td><td>0.25</td><td>0.94</td><td>0.642</td><td>0.732</td><td>1.000</td><td>3600</td><td>tags=37%, list=28%, signal=51%</td></tr><tr><td class='lessen'>1391</td><td>KORKOLA_YOLK_SAC_TUMOR_UP</td><td></td><td>17</td><td>0.36</td><td>0.94</td><td>0.540</td><td>0.732</td><td>1.000</td><td>968</td><td>tags=18%, list=7%, signal=19%</td></tr><tr><td class='lessen'>1392</td><td>KRIEG_HYPOXIA_VIA_KDM3A</td><td></td><td>47</td><td>0.29</td><td>0.94</td><td>0.604</td><td>0.733</td><td>1.000</td><td>2099</td><td>tags=32%, list=16%, signal=38%</td></tr><tr><td class='lessen'>1393</td><td>BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP</td><td></td><td>23</td><td>0.33</td><td>0.94</td><td>0.543</td><td>0.735</td><td>1.000</td><td>1925</td><td>tags=22%, list=15%, signal=25%</td></tr><tr><td class='lessen'>1394</td><td>NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON</td><td></td><td>22</td><td>0.33</td><td>0.94</td><td>0.534</td><td>0.735</td><td>1.000</td><td>315</td><td>tags=9%, list=2%, signal=9%</td></tr><tr><td class='lessen'>1395</td><td>PIEPOLI_LGI1_TARGETS_UP</td><td></td><td>14</td><td>0.38</td><td>0.94</td><td>0.516</td><td>0.735</td><td>1.000</td><td>1812</td><td>tags=43%, list=14%, signal=50%</td></tr><tr><td class='lessen'>1396</td><td>TIAN_TNF_SIGNALING_NOT_VIA_NFKB</td><td></td><td>21</td><td>0.34</td><td>0.94</td><td>0.542</td><td>0.736</td><td>1.000</td><td>3154</td><td>tags=38%, list=24%, signal=50%</td></tr><tr><td class='lessen'>1397</td><td>COLLER_MYC_TARGETS_UP</td><td></td><td>22</td><td>0.34</td><td>0.94</td><td>0.583</td><td>0.736</td><td>1.000</td><td>738</td><td>tags=14%, list=6%, signal=14%</td></tr><tr><td class='lessen'>1398</td><td>NICK_RESPONSE_TO_PROC_TREATMENT_DN</td><td></td><td>20</td><td>0.34</td><td>0.94</td><td>0.570</td><td>0.736</td><td>1.000</td><td>8605</td><td>tags=100%, list=67%, signal=298%</td></tr><tr><td class='lessen'>1399</td><td>KERLEY_RESPONSE_TO_CISPLATIN_UP</td><td></td><td>37</td><td>0.30</td><td>0.94</td><td>0.597</td><td>0.739</td><td>1.000</td><td>1547</td><td>tags=22%, list=12%, signal=24%</td></tr><tr><td class='lessen'>1400</td><td>SUZUKI_AMPLIFIED_IN_ORAL_CANCER</td><td></td><td>12</td><td>0.39</td><td>0.94</td><td>0.546</td><td>0.740</td><td>1.000</td><td>1671</td><td>tags=33%, list=13%, signal=38%</td></tr><tr><td class='lessen'>1401</td><td>BURTON_ADIPOGENESIS_PEAK_AT_8HR</td><td></td><td>35</td><td>0.30</td><td>0.94</td><td>0.599</td><td>0.739</td><td>1.000</td><td>2586</td><td>tags=29%, list=20%, signal=36%</td></tr><tr><td class='lessen'>1402</td><td>FUNG_IL2_SIGNALING_2</td><td></td><td>11</td><td>0.40</td><td>0.93</td><td>0.550</td><td>0.741</td><td>1.000</td><td>113</td><td>tags=18%, list=1%, signal=18%</td></tr><tr><td class='lessen'>1403</td><td>SANA_RESPONSE_TO_IFNG_DN</td><td></td><td>76</td><td>0.26</td><td>0.93</td><td>0.608</td><td>0.741</td><td>1.000</td><td>2251</td><td>tags=22%, list=17%, signal=27%</td></tr><tr><td class='lessen'>1404</td><td>NAKAYAMA_FRA2_TARGETS</td><td></td><td>37</td><td>0.29</td><td>0.93</td><td>0.576</td><td>0.741</td><td>1.000</td><td>1187</td><td>tags=16%, list=9%, signal=18%</td></tr><tr><td class='lessen'>1405</td><td>DAIRKEE_TERT_TARGETS_UP</td><td></td><td>292</td><td>0.23</td><td>0.93</td><td>0.857</td><td>0.745</td><td>1.000</td><td>2295</td><td>tags=17%, list=18%, signal=20%</td></tr><tr><td class='lessen'>1406</td><td>HSIAO_HOUSEKEEPING_GENES</td><td></td><td>352</td><td>0.21</td><td>0.93</td><td>0.750</td><td>0.744</td><td>1.000</td><td>2528</td><td>tags=13%, list=20%, signal=16%</td></tr><tr><td class='lessen'>1407</td><td>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN</td><td></td><td>40</td><td>0.29</td><td>0.93</td><td>0.557</td><td>0.744</td><td>1.000</td><td>2118</td><td>tags=30%, list=16%, signal=36%</td></tr><tr><td class='lessen'>1408</td><td>PARK_APL_PATHOGENESIS_UP</td><td></td><td>14</td><td>0.36</td><td>0.93</td><td>0.537</td><td>0.744</td><td>1.000</td><td>2120</td><td>tags=36%, list=16%, signal=43%</td></tr><tr><td class='lessen'>1409</td><td>ZHENG_FOXP3_TARGETS_IN_THYMUS_DN</td><td></td><td>10</td><td>0.41</td><td>0.93</td><td>0.528</td><td>0.745</td><td>1.000</td><td>2274</td><td>tags=40%, list=18%, signal=48%</td></tr><tr><td class='lessen'>1410</td><td>SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP</td><td></td><td>20</td><td>0.33</td><td>0.93</td><td>0.558</td><td>0.749</td><td>1.000</td><td>1463</td><td>tags=20%, list=11%, signal=23%</td></tr><tr><td class='lessen'>1411</td><td>KRIEG_HYPOXIA_NOT_VIA_KDM3A</td><td></td><td>575</td><td>0.22</td><td>0.93</td><td>1.000</td><td>0.749</td><td>1.000</td><td>2143</td><td>tags=20%, list=17%, signal=23%</td></tr><tr><td class='lessen'>1412</td><td>BOYLAN_MULTIPLE_MYELOMA_PCA3_DN</td><td></td><td>56</td><td>0.27</td><td>0.93</td><td>0.660</td><td>0.749</td><td>1.000</td><td>2100</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>1413</td><td>SENGUPTA_EBNA1_ANTICORRELATED</td><td></td><td>117</td><td>0.24</td><td>0.93</td><td>0.620</td><td>0.748</td><td>1.000</td><td>1940</td><td>tags=22%, list=15%, signal=26%</td></tr><tr><td class='lessen'>1414</td><td>LIU_LIVER_CANCER</td><td></td><td>26</td><td>0.32</td><td>0.93</td><td>0.552</td><td>0.749</td><td>1.000</td><td>1091</td><td>tags=23%, list=8%, signal=25%</td></tr><tr><td class='lessen'>1415</td><td>NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON</td><td></td><td>11</td><td>0.39</td><td>0.93</td><td>0.567</td><td>0.749</td><td>1.000</td><td>305</td><td>tags=18%, list=2%, signal=19%</td></tr><tr><td class='lessen'>1416</td><td>LIU_SOX4_TARGETS_UP</td><td></td><td>107</td><td>0.24</td><td>0.93</td><td>0.702</td><td>0.749</td><td>1.000</td><td>2307</td><td>tags=20%, list=18%, signal=24%</td></tr><tr><td class='lessen'>1417</td><td>CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN</td><td></td><td>41</td><td>0.28</td><td>0.93</td><td>0.601</td><td>0.749</td><td>1.000</td><td>3127</td><td>tags=41%, list=24%, signal=55%</td></tr><tr><td class='lessen'>1418</td><td>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP</td><td></td><td>225</td><td>0.22</td><td>0.93</td><td>0.758</td><td>0.750</td><td>1.000</td><td>2382</td><td>tags=25%, list=18%, signal=31%</td></tr><tr><td class='lessen'>1419</td><td>TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP</td><td></td><td>16</td><td>0.36</td><td>0.93</td><td>0.516</td><td>0.750</td><td>1.000</td><td>863</td><td>tags=25%, list=7%, signal=27%</td></tr><tr><td class='lessen'>1420</td><td>BROWNE_HCMV_INFECTION_48HR_UP</td><td></td><td>153</td><td>0.23</td><td>0.93</td><td>0.766</td><td>0.750</td><td>1.000</td><td>1540</td><td>tags=15%, list=12%, signal=17%</td></tr><tr><td class='lessen'>1421</td><td>SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN</td><td></td><td>38</td><td>0.29</td><td>0.93</td><td>0.596</td><td>0.751</td><td>1.000</td><td>2255</td><td>tags=34%, list=17%, signal=41%</td></tr><tr><td class='lessen'>1422</td><td>COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN</td><td></td><td>114</td><td>0.24</td><td>0.92</td><td>0.645</td><td>0.755</td><td>1.000</td><td>2425</td><td>tags=32%, list=19%, signal=39%</td></tr><tr><td class='lessen'>1423</td><td>TURJANSKI_MAPK1_AND_MAPK2_TARGETS</td><td></td><td>11</td><td>0.39</td><td>0.92</td><td>0.540</td><td>0.755</td><td>1.000</td><td>3757</td><td>tags=55%, list=29%, signal=77%</td></tr><tr><td class='lessen'>1424</td><td>HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP</td><td></td><td>15</td><td>0.36</td><td>0.92</td><td>0.508</td><td>0.755</td><td>1.000</td><td>8309</td><td>tags=100%, list=64%, signal=279%</td></tr><tr><td class='lessen'>1425</td><td>PROVENZANI_METASTASIS_DN</td><td></td><td>116</td><td>0.24</td><td>0.92</td><td>0.694</td><td>0.757</td><td>1.000</td><td>2652</td><td>tags=27%, list=21%, signal=33%</td></tr><tr><td class='lessen'>1426</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8</td><td></td><td>12</td><td>0.37</td><td>0.92</td><td>0.546</td><td>0.758</td><td>1.000</td><td>2451</td><td>tags=25%, list=19%, signal=31%</td></tr><tr><td class='lessen'>1427</td><td>SASAKI_ADULT_T_CELL_LEUKEMIA</td><td></td><td>153</td><td>0.23</td><td>0.92</td><td>0.739</td><td>0.757</td><td>1.000</td><td>1294</td><td>tags=15%, list=10%, signal=17%</td></tr><tr><td class='lessen'>1428</td><td>LOPEZ_TRANSLATION_VIA_FN1_SIGNALING</td><td></td><td>34</td><td>0.30</td><td>0.92</td><td>0.572</td><td>0.758</td><td>1.000</td><td>3366</td><td>tags=32%, list=26%, signal=44%</td></tr><tr><td class='lessen'>1429</td><td>NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON</td><td></td><td>15</td><td>0.36</td><td>0.92</td><td>0.560</td><td>0.758</td><td>1.000</td><td>1194</td><td>tags=20%, list=9%, signal=22%</td></tr><tr><td class='lessen'>1430</td><td>WOOD_EBV_EBNA1_TARGETS_UP</td><td></td><td>98</td><td>0.24</td><td>0.92</td><td>0.753</td><td>0.758</td><td>1.000</td><td>2382</td><td>tags=22%, list=18%, signal=27%</td></tr><tr><td class='lessen'>1431</td><td>DELLA_RESPONSE_TO_TSA_AND_BUTYRATE</td><td></td><td>21</td><td>0.32</td><td>0.92</td><td>0.589</td><td>0.761</td><td>1.000</td><td>3133</td><td>tags=52%, list=24%, signal=69%</td></tr><tr><td class='lessen'>1432</td><td>ZUCCHI_METASTASIS_DN</td><td></td><td>36</td><td>0.29</td><td>0.92</td><td>0.607</td><td>0.762</td><td>1.000</td><td>2369</td><td>tags=25%, list=18%, signal=31%</td></tr><tr><td class='lessen'>1433</td><td>LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED</td><td></td><td>16</td><td>0.35</td><td>0.92</td><td>0.586</td><td>0.765</td><td>1.000</td><td>2726</td><td>tags=44%, list=21%, signal=55%</td></tr><tr><td class='lessen'>1434</td><td>RIGGINS_TAMOXIFEN_RESISTANCE_DN</td><td></td><td>179</td><td>0.22</td><td>0.92</td><td>0.629</td><td>0.765</td><td>1.000</td><td>2425</td><td>tags=26%, list=19%, signal=31%</td></tr><tr><td class='lessen'>1435</td><td>WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR</td><td></td><td>26</td><td>0.30</td><td>0.92</td><td>0.610</td><td>0.766</td><td>1.000</td><td>1901</td><td>tags=27%, list=15%, signal=31%</td></tr><tr><td class='lessen'>1436</td><td>PARENT_MTOR_SIGNALING_DN</td><td></td><td>35</td><td>0.29</td><td>0.92</td><td>0.608</td><td>0.768</td><td>1.000</td><td>1534</td><td>tags=31%, list=12%, signal=36%</td></tr><tr><td class='lessen'>1437</td><td>MALIK_REPRESSED_BY_ESTROGEN</td><td></td><td>12</td><td>0.38</td><td>0.92</td><td>0.571</td><td>0.768</td><td>1.000</td><td>1979</td><td>tags=33%, list=15%, signal=39%</td></tr><tr><td class='lessen'>1438</td><td>HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER</td><td></td><td>23</td><td>0.32</td><td>0.92</td><td>0.569</td><td>0.769</td><td>1.000</td><td>1975</td><td>tags=26%, list=15%, signal=31%</td></tr><tr><td class='lessen'>1439</td><td>NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP</td><td></td><td>17</td><td>0.34</td><td>0.91</td><td>0.583</td><td>0.770</td><td>1.000</td><td>1334</td><td>tags=18%, list=10%, signal=20%</td></tr><tr><td class='lessen'>1440</td><td>DORN_ADENOVIRUS_INFECTION_12HR_UP</td><td></td><td>26</td><td>0.32</td><td>0.91</td><td>0.603</td><td>0.771</td><td>1.000</td><td>2145</td><td>tags=35%, list=17%, signal=41%</td></tr><tr><td class='lessen'>1441</td><td>CARD_MIR302A_TARGETS</td><td></td><td>69</td><td>0.25</td><td>0.91</td><td>0.728</td><td>0.773</td><td>1.000</td><td>3548</td><td>tags=35%, list=27%, signal=48%</td></tr><tr><td class='lessen'>1442</td><td>BHAT_ESR1_TARGETS_VIA_AKT1_UP</td><td></td><td>225</td><td>0.22</td><td>0.91</td><td>0.920</td><td>0.773</td><td>1.000</td><td>2099</td><td>tags=18%, list=16%, signal=21%</td></tr><tr><td class='lessen'>1443</td><td>HOFMANN_CELL_LYMPHOMA_UP</td><td></td><td>40</td><td>0.29</td><td>0.91</td><td>0.585</td><td>0.773</td><td>1.000</td><td>2733</td><td>tags=30%, list=21%, signal=38%</td></tr><tr><td class='lessen'>1444</td><td>ALFANO_MYC_TARGETS</td><td></td><td>206</td><td>0.23</td><td>0.91</td><td>0.667</td><td>0.772</td><td>1.000</td><td>2146</td><td>tags=21%, list=17%, signal=25%</td></tr><tr><td class='lessen'>1445</td><td>LI_CISPLATIN_RESISTANCE_UP</td><td></td><td>21</td><td>0.32</td><td>0.91</td><td>0.573</td><td>0.773</td><td>1.000</td><td>1875</td><td>tags=24%, list=14%, signal=28%</td></tr><tr><td class='lessen'>1446</td><td>RIZKI_TUMOR_INVASIVENESS_2D_UP</td><td></td><td>59</td><td>0.26</td><td>0.91</td><td>0.620</td><td>0.773</td><td>1.000</td><td>2624</td><td>tags=24%, list=20%, signal=30%</td></tr><tr><td class='lessen'>1447</td><td>WIERENGA_STAT5A_TARGETS_GROUP1</td><td></td><td>100</td><td>0.24</td><td>0.91</td><td>0.758</td><td>0.779</td><td>1.000</td><td>2099</td><td>tags=30%, list=16%, signal=36%</td></tr><tr><td class='lessen'>1448</td><td>CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP</td><td></td><td>19</td><td>0.34</td><td>0.91</td><td>0.631</td><td>0.781</td><td>1.000</td><td>2612</td><td>tags=47%, list=20%, signal=59%</td></tr><tr><td class='lessen'>1449</td><td>ALONSO_METASTASIS_UP</td><td></td><td>156</td><td>0.23</td><td>0.91</td><td>0.767</td><td>0.782</td><td>1.000</td><td>2350</td><td>tags=19%, list=18%, signal=22%</td></tr><tr><td class='lessen'>1450</td><td>DAZARD_RESPONSE_TO_UV_SCC_UP</td><td></td><td>102</td><td>0.24</td><td>0.91</td><td>0.712</td><td>0.784</td><td>1.000</td><td>3025</td><td>tags=28%, list=23%, signal=37%</td></tr><tr><td class='lessen'>1451</td><td>WU_HBX_TARGETS_1_UP</td><td></td><td>14</td><td>0.37</td><td>0.91</td><td>0.603</td><td>0.785</td><td>1.000</td><td>1008</td><td>tags=21%, list=8%, signal=23%</td></tr><tr><td class='lessen'>1452</td><td>CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY</td><td></td><td>25</td><td>0.31</td><td>0.90</td><td>0.633</td><td>0.788</td><td>1.000</td><td>1099</td><td>tags=16%, list=8%, signal=17%</td></tr><tr><td class='lessen'>1453</td><td>SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC</td><td></td><td>86</td><td>0.24</td><td>0.90</td><td>0.697</td><td>0.788</td><td>1.000</td><td>241</td><td>tags=3%, list=2%, signal=4%</td></tr><tr><td class='lessen'>1454</td><td>CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP</td><td></td><td>61</td><td>0.25</td><td>0.90</td><td>0.711</td><td>0.788</td><td>1.000</td><td>2576</td><td>tags=28%, list=20%, signal=35%</td></tr><tr><td class='lessen'>1455</td><td>GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP</td><td></td><td>510</td><td>0.21</td><td>0.90</td><td>1.000</td><td>0.791</td><td>1.000</td><td>2439</td><td>tags=23%, list=19%, signal=27%</td></tr><tr><td class='lessen'>1456</td><td>HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN</td><td></td><td>45</td><td>0.27</td><td>0.90</td><td>0.657</td><td>0.794</td><td>1.000</td><td>1528</td><td>tags=18%, list=12%, signal=20%</td></tr><tr><td class='lessen'>1457</td><td>HILLION_HMGA1B_TARGETS</td><td></td><td>88</td><td>0.25</td><td>0.90</td><td>0.689</td><td>0.794</td><td>1.000</td><td>2320</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>1458</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN</td><td></td><td>30</td><td>0.29</td><td>0.90</td><td>0.623</td><td>0.793</td><td>1.000</td><td>1642</td><td>tags=20%, list=13%, signal=23%</td></tr><tr><td class='lessen'>1459</td><td>ZHAN_MULTIPLE_MYELOMA_CD2_DN</td><td></td><td>38</td><td>0.29</td><td>0.90</td><td>0.638</td><td>0.794</td><td>1.000</td><td>2675</td><td>tags=37%, list=21%, signal=46%</td></tr><tr><td class='lessen'>1460</td><td>STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP</td><td></td><td>20</td><td>0.33</td><td>0.90</td><td>0.613</td><td>0.794</td><td>1.000</td><td>1934</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>1461</td><td>BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN</td><td></td><td>29</td><td>0.30</td><td>0.90</td><td>0.645</td><td>0.795</td><td>1.000</td><td>1112</td><td>tags=21%, list=9%, signal=23%</td></tr><tr><td class='lessen'>1462</td><td>ONKEN_UVEAL_MELANOMA_DN</td><td></td><td>438</td><td>0.21</td><td>0.90</td><td>1.000</td><td>0.796</td><td>1.000</td><td>2505</td><td>tags=20%, list=19%, signal=24%</td></tr><tr><td class='lessen'>1463</td><td>GAL_LEUKEMIC_STEM_CELL_UP</td><td></td><td>105</td><td>0.23</td><td>0.90</td><td>0.839</td><td>0.796</td><td>1.000</td><td>2572</td><td>tags=26%, list=20%, signal=32%</td></tr><tr><td class='lessen'>1464</td><td>NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN</td><td></td><td>455</td><td>0.21</td><td>0.90</td><td>1.000</td><td>0.795</td><td>1.000</td><td>2158</td><td>tags=18%, list=17%, signal=21%</td></tr><tr><td class='lessen'>1465</td><td>NIELSEN_LIPOSARCOMA_DN</td><td></td><td>19</td><td>0.33</td><td>0.90</td><td>0.580</td><td>0.796</td><td>1.000</td><td>1902</td><td>tags=26%, list=15%, signal=31%</td></tr><tr><td class='lessen'>1466</td><td>IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR</td><td></td><td>416</td><td>0.20</td><td>0.90</td><td>1.000</td><td>0.803</td><td>1.000</td><td>2352</td><td>tags=20%, list=18%, signal=24%</td></tr><tr><td class='lessen'>1467</td><td>BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN</td><td></td><td>47</td><td>0.27</td><td>0.89</td><td>0.685</td><td>0.803</td><td>1.000</td><td>858</td><td>tags=9%, list=7%, signal=9%</td></tr><tr><td class='lessen'>1468</td><td>MARKEY_RB1_CHRONIC_LOF_UP</td><td></td><td>106</td><td>0.23</td><td>0.89</td><td>0.785</td><td>0.804</td><td>1.000</td><td>2604</td><td>tags=25%, list=20%, signal=32%</td></tr><tr><td class='lessen'>1469</td><td>HASLINGER_B_CLL_WITH_MUTATED_VH_GENES</td><td></td><td>16</td><td>0.33</td><td>0.89</td><td>0.578</td><td>0.804</td><td>1.000</td><td>1090</td><td>tags=13%, list=8%, signal=14%</td></tr><tr><td class='lessen'>1470</td><td>SENESE_HDAC1_TARGETS_UP</td><td></td><td>359</td><td>0.20</td><td>0.89</td><td>0.800</td><td>0.804</td><td>1.000</td><td>2399</td><td>tags=20%, list=19%, signal=24%</td></tr><tr><td class='lessen'>1471</td><td>SANCHEZ_MDM2_TARGETS</td><td></td><td>10</td><td>0.39</td><td>0.89</td><td>0.563</td><td>0.804</td><td>1.000</td><td>1533</td><td>tags=30%, list=12%, signal=34%</td></tr><tr><td class='lessen'>1472</td><td>ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE</td><td></td><td>15</td><td>0.35</td><td>0.89</td><td>0.560</td><td>0.804</td><td>1.000</td><td>1917</td><td>tags=33%, list=15%, signal=39%</td></tr><tr><td class='lessen'>1473</td><td>ZHAN_MULTIPLE_MYELOMA_DN</td><td></td><td>34</td><td>0.28</td><td>0.89</td><td>0.659</td><td>0.807</td><td>1.000</td><td>1775</td><td>tags=29%, list=14%, signal=34%</td></tr><tr><td class='lessen'>1474</td><td>CUI_TCF21_TARGETS_DN</td><td></td><td>27</td><td>0.30</td><td>0.89</td><td>0.619</td><td>0.808</td><td>1.000</td><td>2758</td><td>tags=41%, list=21%, signal=52%</td></tr><tr><td class='lessen'>1475</td><td>YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN</td><td></td><td>49</td><td>0.26</td><td>0.89</td><td>0.728</td><td>0.807</td><td>1.000</td><td>942</td><td>tags=12%, list=7%, signal=13%</td></tr><tr><td class='lessen'>1476</td><td>BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP</td><td></td><td>12</td><td>0.36</td><td>0.89</td><td>0.598</td><td>0.807</td><td>1.000</td><td>2707</td><td>tags=33%, list=21%, signal=42%</td></tr><tr><td class='lessen'>1477</td><td>VANTVEER_BREAST_CANCER_ESR1_DN</td><td></td><td>197</td><td>0.21</td><td>0.89</td><td>0.875</td><td>0.807</td><td>1.000</td><td>2389</td><td>tags=27%, list=18%, signal=33%</td></tr><tr><td class='lessen'>1478</td><td>MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN</td><td></td><td>20</td><td>0.32</td><td>0.89</td><td>0.647</td><td>0.807</td><td>1.000</td><td>2597</td><td>tags=45%, list=20%, signal=56%</td></tr><tr><td class='lessen'>1479</td><td>BOYLAN_MULTIPLE_MYELOMA_C_UP</td><td></td><td>36</td><td>0.28</td><td>0.89</td><td>0.677</td><td>0.807</td><td>1.000</td><td>1612</td><td>tags=22%, list=12%, signal=25%</td></tr><tr><td class='lessen'>1480</td><td>KYNG_DNA_DAMAGE_BY_UV</td><td></td><td>57</td><td>0.26</td><td>0.89</td><td>0.693</td><td>0.807</td><td>1.000</td><td>2512</td><td>tags=32%, list=19%, signal=39%</td></tr><tr><td class='lessen'>1481</td><td>ROESSLER_LIVER_CANCER_METASTASIS_UP</td><td></td><td>96</td><td>0.23</td><td>0.89</td><td>0.789</td><td>0.807</td><td>1.000</td><td>1810</td><td>tags=18%, list=14%, signal=20%</td></tr><tr><td class='lessen'>1482</td><td>IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP</td><td></td><td>95</td><td>0.24</td><td>0.89</td><td>0.726</td><td>0.808</td><td>1.000</td><td>2847</td><td>tags=32%, list=22%, signal=40%</td></tr><tr><td class='lessen'>1483</td><td>PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN</td><td></td><td>17</td><td>0.34</td><td>0.89</td><td>0.642</td><td>0.808</td><td>1.000</td><td>36</td><td>tags=6%, list=0%, signal=6%</td></tr><tr><td class='lessen'>1484</td><td>HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP</td><td></td><td>18</td><td>0.31</td><td>0.89</td><td>0.576</td><td>0.809</td><td>1.000</td><td>8873</td><td>tags=100%, list=69%, signal=318%</td></tr><tr><td class='lessen'>1485</td><td>NAM_FXYD5_TARGETS_DN</td><td></td><td>16</td><td>0.34</td><td>0.89</td><td>0.618</td><td>0.809</td><td>1.000</td><td>3301</td><td>tags=50%, list=26%, signal=67%</td></tr><tr><td class='lessen'>1486</td><td>JIANG_VHL_TARGETS</td><td></td><td>105</td><td>0.23</td><td>0.89</td><td>0.793</td><td>0.811</td><td>1.000</td><td>3381</td><td>tags=30%, list=26%, signal=40%</td></tr><tr><td class='lessen'>1487</td><td>OUILLETTE_CLL_13Q14_DELETION_DN</td><td></td><td>50</td><td>0.26</td><td>0.89</td><td>0.782</td><td>0.811</td><td>1.000</td><td>2754</td><td>tags=34%, list=21%, signal=43%</td></tr><tr><td class='lessen'>1488</td><td>BROWNE_HCMV_INFECTION_2HR_DN</td><td></td><td>44</td><td>0.27</td><td>0.89</td><td>0.678</td><td>0.813</td><td>1.000</td><td>1275</td><td>tags=16%, list=10%, signal=18%</td></tr><tr><td class='lessen'>1489</td><td>FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP</td><td></td><td>132</td><td>0.22</td><td>0.89</td><td>0.788</td><td>0.812</td><td>1.000</td><td>2358</td><td>tags=16%, list=18%, signal=19%</td></tr><tr><td class='lessen'>1490</td><td>WILLERT_WNT_SIGNALING</td><td></td><td>19</td><td>0.33</td><td>0.88</td><td>0.620</td><td>0.813</td><td>1.000</td><td>1988</td><td>tags=21%, list=15%, signal=25%</td></tr><tr><td class='lessen'>1491</td><td>AMIT_EGF_RESPONSE_60_HELA</td><td></td><td>39</td><td>0.28</td><td>0.88</td><td>0.675</td><td>0.814</td><td>1.000</td><td>3352</td><td>tags=44%, list=26%, signal=59%</td></tr><tr><td class='lessen'>1492</td><td>CHANG_IMMORTALIZED_BY_HPV31_UP</td><td></td><td>59</td><td>0.25</td><td>0.88</td><td>0.758</td><td>0.815</td><td>1.000</td><td>1908</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>1493</td><td>ELLWOOD_MYC_TARGETS_UP</td><td></td><td>12</td><td>0.36</td><td>0.88</td><td>0.614</td><td>0.815</td><td>1.000</td><td>3587</td><td>tags=58%, list=28%, signal=81%</td></tr><tr><td class='lessen'>1494</td><td>WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP</td><td></td><td>86</td><td>0.24</td><td>0.88</td><td>0.794</td><td>0.814</td><td>1.000</td><td>2057</td><td>tags=14%, list=16%, signal=16%</td></tr><tr><td class='lessen'>1495</td><td>GROSS_ELK3_TARGETS_DN</td><td></td><td>29</td><td>0.30</td><td>0.88</td><td>0.680</td><td>0.814</td><td>1.000</td><td>1832</td><td>tags=34%, list=14%, signal=40%</td></tr><tr><td class='lessen'>1496</td><td>GHANDHI_DIRECT_IRRADIATION_UP</td><td></td><td>78</td><td>0.24</td><td>0.88</td><td>0.763</td><td>0.814</td><td>1.000</td><td>2034</td><td>tags=26%, list=16%, signal=30%</td></tr><tr><td class='lessen'>1497</td><td>MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP</td><td></td><td>21</td><td>0.32</td><td>0.88</td><td>0.625</td><td>0.817</td><td>1.000</td><td>852</td><td>tags=14%, list=7%, signal=15%</td></tr><tr><td class='lessen'>1498</td><td>STARK_HYPPOCAMPUS_22Q11_DELETION_DN</td><td></td><td>16</td><td>0.34</td><td>0.88</td><td>0.618</td><td>0.817</td><td>1.000</td><td>247</td><td>tags=6%, list=2%, signal=6%</td></tr><tr><td class='lessen'>1499</td><td>VALK_AML_CLUSTER_3</td><td></td><td>30</td><td>0.29</td><td>0.88</td><td>0.658</td><td>0.818</td><td>1.000</td><td>2119</td><td>tags=23%, list=16%, signal=28%</td></tr><tr><td class='lessen'>1500</td><td>KARAKAS_TGFB1_SIGNALING</td><td></td><td>16</td><td>0.33</td><td>0.88</td><td>0.644</td><td>0.818</td><td>1.000</td><td>481</td><td>tags=19%, list=4%, signal=19%</td></tr><tr><td class='lessen'>1501</td><td>PHESSE_TARGETS_OF_APC_AND_MBD2_UP</td><td></td><td>14</td><td>0.34</td><td>0.88</td><td>0.631</td><td>0.818</td><td>1.000</td><td>374</td><td>tags=14%, list=3%, signal=15%</td></tr><tr><td class='lessen'>1502</td><td>YANG_BREAST_CANCER_ESR1_LASER_DN</td><td></td><td>44</td><td>0.26</td><td>0.88</td><td>0.720</td><td>0.818</td><td>1.000</td><td>1772</td><td>tags=23%, list=14%, signal=26%</td></tr><tr><td class='lessen'>1503</td><td>WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN</td><td></td><td>21</td><td>0.32</td><td>0.88</td><td>0.636</td><td>0.818</td><td>1.000</td><td>2002</td><td>tags=43%, list=15%, signal=51%</td></tr><tr><td class='lessen'>1504</td><td>PENG_LEUCINE_DEPRIVATION_UP</td><td></td><td>120</td><td>0.23</td><td>0.88</td><td>0.821</td><td>0.818</td><td>1.000</td><td>1547</td><td>tags=16%, list=12%, signal=18%</td></tr><tr><td class='lessen'>1505</td><td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD</td><td></td><td>11</td><td>0.38</td><td>0.88</td><td>0.607</td><td>0.819</td><td>1.000</td><td>2755</td><td>tags=45%, list=21%, signal=58%</td></tr><tr><td class='lessen'>1506</td><td>KANNAN_TP53_TARGETS_UP</td><td></td><td>49</td><td>0.26</td><td>0.88</td><td>0.748</td><td>0.820</td><td>1.000</td><td>2151</td><td>tags=24%, list=17%, signal=29%</td></tr><tr><td class='lessen'>1507</td><td>ITO_PTTG1_TARGETS_UP</td><td></td><td>10</td><td>0.39</td><td>0.88</td><td>0.615</td><td>0.822</td><td>1.000</td><td>109</td><td>tags=10%, list=1%, signal=10%</td></tr><tr><td class='lessen'>1508</td><td>WONG_IFNA2_RESISTANCE_DN</td><td></td><td>27</td><td>0.29</td><td>0.88</td><td>0.650</td><td>0.824</td><td>1.000</td><td>2159</td><td>tags=22%, list=17%, signal=27%</td></tr><tr><td class='lessen'>1509</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN</td><td></td><td>30</td><td>0.29</td><td>0.88</td><td>0.683</td><td>0.824</td><td>1.000</td><td>3000</td><td>tags=40%, list=23%, signal=52%</td></tr><tr><td class='lessen'>1510</td><td>WANG_TUMOR_INVASIVENESS_UP</td><td></td><td>318</td><td>0.20</td><td>0.88</td><td>1.000</td><td>0.824</td><td>1.000</td><td>2724</td><td>tags=19%, list=21%, signal=23%</td></tr><tr><td class='lessen'>1511</td><td>SANDERSON_PPARA_TARGETS</td><td></td><td>14</td><td>0.35</td><td>0.87</td><td>0.598</td><td>0.824</td><td>1.000</td><td>1784</td><td>tags=29%, list=14%, signal=33%</td></tr><tr><td class='lessen'>1512</td><td>HOOI_ST7_TARGETS_DN</td><td></td><td>88</td><td>0.23</td><td>0.87</td><td>0.792</td><td>0.826</td><td>1.000</td><td>2276</td><td>tags=27%, list=18%, signal=33%</td></tr><tr><td class='lessen'>1513</td><td>ASTIER_INTEGRIN_SIGNALING</td><td></td><td>50</td><td>0.25</td><td>0.87</td><td>0.763</td><td>0.826</td><td>1.000</td><td>1577</td><td>tags=16%, list=12%, signal=18%</td></tr><tr><td class='lessen'>1514</td><td>ZHAN_MULTIPLE_MYELOMA_PR_DN</td><td></td><td>37</td><td>0.27</td><td>0.87</td><td>0.710</td><td>0.826</td><td>1.000</td><td>2296</td><td>tags=22%, list=18%, signal=26%</td></tr><tr><td class='lessen'>1515</td><td>PEREZ_TP53_AND_TP63_TARGETS</td><td></td><td>169</td><td>0.21</td><td>0.87</td><td>0.857</td><td>0.828</td><td>1.000</td><td>2136</td><td>tags=22%, list=17%, signal=27%</td></tr><tr><td class='lessen'>1516</td><td>BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN</td><td></td><td>79</td><td>0.24</td><td>0.87</td><td>0.762</td><td>0.828</td><td>1.000</td><td>2827</td><td>tags=27%, list=22%, signal=34%</td></tr><tr><td class='lessen'>1517</td><td>KAAB_FAILED_HEART_VENTRICLE_DN</td><td></td><td>35</td><td>0.28</td><td>0.87</td><td>0.745</td><td>0.828</td><td>1.000</td><td>1502</td><td>tags=14%, list=12%, signal=16%</td></tr><tr><td class='lessen'>1518</td><td>STEINER_ERYTHROCYTE_MEMBRANE_GENES</td><td></td><td>12</td><td>0.36</td><td>0.87</td><td>0.630</td><td>0.827</td><td>1.000</td><td>35</td><td>tags=8%, list=0%, signal=8%</td></tr><tr><td class='lessen'>1519</td><td>NAKAMURA_METASTASIS_MODEL_UP</td><td></td><td>36</td><td>0.27</td><td>0.87</td><td>0.652</td><td>0.827</td><td>1.000</td><td>1406</td><td>tags=19%, list=11%, signal=22%</td></tr><tr><td class='lessen'>1520</td><td>OSADA_ASCL1_TARGETS_DN</td><td></td><td>22</td><td>0.31</td><td>0.87</td><td>0.618</td><td>0.832</td><td>1.000</td><td>2371</td><td>tags=45%, list=18%, signal=56%</td></tr><tr><td class='lessen'>1521</td><td>HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN</td><td></td><td>32</td><td>0.27</td><td>0.87</td><td>0.716</td><td>0.833</td><td>1.000</td><td>2707</td><td>tags=31%, list=21%, signal=39%</td></tr><tr><td class='lessen'>1522</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP</td><td></td><td>62</td><td>0.24</td><td>0.87</td><td>0.736</td><td>0.834</td><td>1.000</td><td>1860</td><td>tags=21%, list=14%, signal=24%</td></tr><tr><td class='lessen'>1523</td><td>STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP</td><td></td><td>102</td><td>0.23</td><td>0.87</td><td>0.795</td><td>0.833</td><td>1.000</td><td>3094</td><td>tags=29%, list=24%, signal=38%</td></tr><tr><td class='lessen'>1524</td><td>VALK_AML_CLUSTER_7</td><td></td><td>23</td><td>0.30</td><td>0.87</td><td>0.701</td><td>0.837</td><td>1.000</td><td>1795</td><td>tags=22%, list=14%, signal=25%</td></tr><tr><td class='lessen'>1525</td><td>MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN</td><td></td><td>99</td><td>0.22</td><td>0.87</td><td>0.886</td><td>0.836</td><td>1.000</td><td>2726</td><td>tags=28%, list=21%, signal=36%</td></tr><tr><td class='lessen'>1526</td><td>RAMASWAMY_METASTASIS_DN</td><td></td><td>48</td><td>0.26</td><td>0.87</td><td>0.733</td><td>0.837</td><td>1.000</td><td>1563</td><td>tags=19%, list=12%, signal=21%</td></tr><tr><td class='lessen'>1527</td><td>SESTO_RESPONSE_TO_UV_C6</td><td></td><td>36</td><td>0.27</td><td>0.86</td><td>0.701</td><td>0.839</td><td>1.000</td><td>2900</td><td>tags=39%, list=22%, signal=50%</td></tr><tr><td class='lessen'>1528</td><td>HOLLMANN_APOPTOSIS_VIA_CD40_DN</td><td></td><td>202</td><td>0.20</td><td>0.86</td><td>0.848</td><td>0.838</td><td>1.000</td><td>2675</td><td>tags=25%, list=21%, signal=31%</td></tr><tr><td class='lessen'>1529</td><td>DASU_IL6_SIGNALING_SCAR_UP</td><td></td><td>27</td><td>0.30</td><td>0.86</td><td>0.691</td><td>0.841</td><td>1.000</td><td>2757</td><td>tags=33%, list=21%, signal=42%</td></tr><tr><td class='lessen'>1530</td><td>JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP</td><td></td><td>27</td><td>0.29</td><td>0.86</td><td>0.686</td><td>0.841</td><td>1.000</td><td>2232</td><td>tags=19%, list=17%, signal=22%</td></tr><tr><td class='lessen'>1531</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN</td><td></td><td>26</td><td>0.28</td><td>0.86</td><td>0.725</td><td>0.842</td><td>1.000</td><td>9280</td><td>tags=100%, list=72%, signal=353%</td></tr><tr><td class='lessen'>1532</td><td>ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM</td><td></td><td>58</td><td>0.24</td><td>0.86</td><td>0.858</td><td>0.844</td><td>1.000</td><td>1936</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>1533</td><td>GILMORE_CORE_NFKB_PATHWAY</td><td></td><td>14</td><td>0.35</td><td>0.86</td><td>0.625</td><td>0.847</td><td>1.000</td><td>3630</td><td>tags=43%, list=28%, signal=60%</td></tr><tr><td class='lessen'>1534</td><td>DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN</td><td></td><td>74</td><td>0.23</td><td>0.86</td><td>0.818</td><td>0.849</td><td>1.000</td><td>2758</td><td>tags=34%, list=21%, signal=43%</td></tr><tr><td class='lessen'>1535</td><td>STAEGE_EWING_FAMILY_TUMOR</td><td></td><td>26</td><td>0.30</td><td>0.86</td><td>0.695</td><td>0.852</td><td>1.000</td><td>868</td><td>tags=15%, list=7%, signal=16%</td></tr><tr><td class='lessen'>1536</td><td>OSADA_ASCL1_TARGETS_UP</td><td></td><td>43</td><td>0.26</td><td>0.86</td><td>0.746</td><td>0.853</td><td>1.000</td><td>2204</td><td>tags=33%, list=17%, signal=39%</td></tr><tr><td class='lessen'>1537</td><td>IGARASHI_ATF4_TARGETS_DN</td><td></td><td>74</td><td>0.23</td><td>0.86</td><td>0.836</td><td>0.853</td><td>1.000</td><td>2419</td><td>tags=23%, list=19%, signal=28%</td></tr><tr><td class='lessen'>1538</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP</td><td></td><td>20</td><td>0.31</td><td>0.85</td><td>0.695</td><td>0.854</td><td>1.000</td><td>2072</td><td>tags=30%, list=16%, signal=36%</td></tr><tr><td class='lessen'>1539</td><td>STANELLE_E2F1_TARGETS</td><td></td><td>24</td><td>0.29</td><td>0.85</td><td>0.711</td><td>0.856</td><td>1.000</td><td>2394</td><td>tags=29%, list=19%, signal=36%</td></tr><tr><td class='lessen'>1540</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1</td><td></td><td>197</td><td>0.20</td><td>0.85</td><td>0.963</td><td>0.858</td><td>1.000</td><td>2528</td><td>tags=26%, list=20%, signal=32%</td></tr><tr><td class='lessen'>1541</td><td>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN</td><td></td><td>510</td><td>0.18</td><td>0.85</td><td>1.000</td><td>0.860</td><td>1.000</td><td>3408</td><td>tags=26%, list=26%, signal=35%</td></tr><tr><td class='lessen'>1542</td><td>CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN</td><td></td><td>34</td><td>0.27</td><td>0.85</td><td>0.723</td><td>0.860</td><td>1.000</td><td>652</td><td>tags=12%, list=5%, signal=12%</td></tr><tr><td class='lessen'>1543</td><td>ZHAN_MULTIPLE_MYELOMA_MS_DN</td><td></td><td>30</td><td>0.27</td><td>0.85</td><td>0.694</td><td>0.859</td><td>1.000</td><td>2925</td><td>tags=23%, list=23%, signal=30%</td></tr><tr><td class='lessen'>1544</td><td>UROSEVIC_RESPONSE_TO_IMIQUIMOD</td><td></td><td>16</td><td>0.33</td><td>0.85</td><td>0.695</td><td>0.861</td><td>1.000</td><td>2439</td><td>tags=38%, list=19%, signal=46%</td></tr><tr><td class='lessen'>1545</td><td>GENTILE_RESPONSE_CLUSTER_D3</td><td></td><td>56</td><td>0.24</td><td>0.85</td><td>0.811</td><td>0.861</td><td>1.000</td><td>1905</td><td>tags=21%, list=15%, signal=25%</td></tr><tr><td class='lessen'>1546</td><td>KORKOLA_TERATOMA</td><td></td><td>35</td><td>0.26</td><td>0.85</td><td>0.755</td><td>0.861</td><td>1.000</td><td>1466</td><td>tags=20%, list=11%, signal=22%</td></tr><tr><td class='lessen'>1547</td><td>MEDINA_SMARCA4_TARGETS</td><td></td><td>37</td><td>0.27</td><td>0.85</td><td>0.735</td><td>0.861</td><td>1.000</td><td>2572</td><td>tags=22%, list=20%, signal=27%</td></tr><tr><td class='lessen'>1548</td><td>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN</td><td></td><td>22</td><td>0.29</td><td>0.85</td><td>0.713</td><td>0.860</td><td>1.000</td><td>2135</td><td>tags=18%, list=17%, signal=22%</td></tr><tr><td class='lessen'>1549</td><td>BROWNE_HCMV_INFECTION_8HR_DN</td><td></td><td>37</td><td>0.26</td><td>0.85</td><td>0.759</td><td>0.861</td><td>1.000</td><td>2502</td><td>tags=32%, list=19%, signal=40%</td></tr><tr><td class='lessen'>1550</td><td>BROWNE_HCMV_INFECTION_8HR_UP</td><td></td><td>87</td><td>0.22</td><td>0.85</td><td>0.896</td><td>0.861</td><td>1.000</td><td>1666</td><td>tags=13%, list=13%, signal=14%</td></tr><tr><td class='lessen'>1551</td><td>GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3</td><td></td><td>11</td><td>0.36</td><td>0.85</td><td>0.672</td><td>0.861</td><td>1.000</td><td>3277</td><td>tags=36%, list=25%, signal=49%</td></tr><tr><td class='lessen'>1552</td><td>HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN</td><td></td><td>81</td><td>0.23</td><td>0.85</td><td>0.836</td><td>0.861</td><td>1.000</td><td>1488</td><td>tags=14%, list=12%, signal=15%</td></tr><tr><td class='lessen'>1553</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP</td><td></td><td>29</td><td>0.28</td><td>0.85</td><td>0.732</td><td>0.862</td><td>1.000</td><td>1715</td><td>tags=28%, list=13%, signal=32%</td></tr><tr><td class='lessen'>1554</td><td>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7</td><td></td><td>310</td><td>0.20</td><td>0.85</td><td>1.000</td><td>0.863</td><td>1.000</td><td>2119</td><td>tags=22%, list=16%, signal=26%</td></tr><tr><td class='lessen'>1555</td><td>LU_TUMOR_VASCULATURE_UP</td><td></td><td>23</td><td>0.30</td><td>0.84</td><td>0.705</td><td>0.865</td><td>1.000</td><td>1305</td><td>tags=22%, list=10%, signal=24%</td></tr><tr><td class='lessen'>1556</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_7_UP</td><td></td><td>80</td><td>0.23</td><td>0.84</td><td>0.822</td><td>0.865</td><td>1.000</td><td>2000</td><td>tags=20%, list=15%, signal=24%</td></tr><tr><td class='lessen'>1557</td><td>FERRARI_RESPONSE_TO_FENRETINIDE_UP</td><td></td><td>17</td><td>0.31</td><td>0.84</td><td>0.654</td><td>0.865</td><td>1.000</td><td>3147</td><td>tags=53%, list=24%, signal=70%</td></tr><tr><td class='lessen'>1558</td><td>GHO_ATF5_TARGETS_DN</td><td></td><td>14</td><td>0.33</td><td>0.84</td><td>0.688</td><td>0.865</td><td>1.000</td><td>1825</td><td>tags=36%, list=14%, signal=42%</td></tr><tr><td class='lessen'>1559</td><td>MELLMAN_TUT1_TARGETS_DN</td><td></td><td>44</td><td>0.25</td><td>0.84</td><td>0.793</td><td>0.864</td><td>1.000</td><td>2413</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>1560</td><td>NAKAMURA_METASTASIS</td><td></td><td>38</td><td>0.25</td><td>0.84</td><td>0.798</td><td>0.868</td><td>1.000</td><td>2970</td><td>tags=39%, list=23%, signal=51%</td></tr><tr><td class='lessen'>1561</td><td>WU_HBX_TARGETS_3_DN</td><td></td><td>12</td><td>0.35</td><td>0.84</td><td>0.678</td><td>0.867</td><td>1.000</td><td>2353</td><td>tags=33%, list=18%, signal=41%</td></tr><tr><td class='lessen'>1562</td><td>MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP</td><td></td><td>18</td><td>0.31</td><td>0.84</td><td>0.677</td><td>0.867</td><td>1.000</td><td>2122</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>1563</td><td>LUI_THYROID_CANCER_PAX8_PPARG_DN</td><td></td><td>38</td><td>0.26</td><td>0.84</td><td>0.780</td><td>0.868</td><td>1.000</td><td>1996</td><td>tags=16%, list=15%, signal=19%</td></tr><tr><td class='lessen'>1564</td><td>HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN</td><td></td><td>19</td><td>0.31</td><td>0.84</td><td>0.718</td><td>0.869</td><td>1.000</td><td>1239</td><td>tags=11%, list=10%, signal=12%</td></tr><tr><td class='lessen'>1565</td><td>CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP</td><td></td><td>48</td><td>0.25</td><td>0.84</td><td>0.783</td><td>0.869</td><td>1.000</td><td>2135</td><td>tags=17%, list=17%, signal=20%</td></tr><tr><td class='lessen'>1566</td><td>SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP</td><td></td><td>61</td><td>0.24</td><td>0.84</td><td>0.786</td><td>0.870</td><td>1.000</td><td>2671</td><td>tags=25%, list=21%, signal=31%</td></tr><tr><td class='lessen'>1567</td><td>NEMETH_INFLAMMATORY_RESPONSE_LPS_DN</td><td></td><td>29</td><td>0.28</td><td>0.84</td><td>0.724</td><td>0.870</td><td>1.000</td><td>1757</td><td>tags=31%, list=14%, signal=36%</td></tr><tr><td class='lessen'>1568</td><td>BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN</td><td></td><td>36</td><td>0.27</td><td>0.84</td><td>0.786</td><td>0.870</td><td>1.000</td><td>2190</td><td>tags=22%, list=17%, signal=27%</td></tr><tr><td class='lessen'>1569</td><td>HALMOS_CEBPA_TARGETS_DN</td><td></td><td>41</td><td>0.26</td><td>0.84</td><td>0.770</td><td>0.870</td><td>1.000</td><td>3241</td><td>tags=46%, list=25%, signal=62%</td></tr><tr><td class='lessen'>1570</td><td>LIU_IL13_PRIMING_MODEL</td><td></td><td>11</td><td>0.35</td><td>0.84</td><td>0.661</td><td>0.870</td><td>1.000</td><td>1373</td><td>tags=27%, list=11%, signal=30%</td></tr><tr><td class='lessen'>1571</td><td>ZHU_CMV_24_HR_UP</td><td></td><td>79</td><td>0.22</td><td>0.84</td><td>0.856</td><td>0.869</td><td>1.000</td><td>3600</td><td>tags=34%, list=28%, signal=47%</td></tr><tr><td class='lessen'>1572</td><td>BORLAK_LIVER_CANCER_EGF_UP</td><td></td><td>49</td><td>0.24</td><td>0.84</td><td>0.745</td><td>0.870</td><td>1.000</td><td>2188</td><td>tags=27%, list=17%, signal=32%</td></tr><tr><td class='lessen'>1573</td><td>MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP</td><td></td><td>313</td><td>0.20</td><td>0.84</td><td>1.000</td><td>0.872</td><td>1.000</td><td>1819</td><td>tags=12%, list=14%, signal=13%</td></tr><tr><td class='lessen'>1574</td><td>YIH_RESPONSE_TO_ARSENITE_C2</td><td></td><td>17</td><td>0.31</td><td>0.83</td><td>0.728</td><td>0.873</td><td>1.000</td><td>3454</td><td>tags=41%, list=27%, signal=56%</td></tr><tr><td class='lessen'>1575</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN</td><td></td><td>13</td><td>0.33</td><td>0.83</td><td>0.652</td><td>0.874</td><td>1.000</td><td>1530</td><td>tags=23%, list=12%, signal=26%</td></tr><tr><td class='lessen'>1576</td><td>GRATIAS_RETINOBLASTOMA_16Q24</td><td></td><td>13</td><td>0.33</td><td>0.83</td><td>0.699</td><td>0.878</td><td>1.000</td><td>8659</td><td>tags=100%, list=67%, signal=302%</td></tr><tr><td class='lessen'>1577</td><td>TSUNODA_CISPLATIN_RESISTANCE_DN</td><td></td><td>38</td><td>0.26</td><td>0.83</td><td>0.748</td><td>0.880</td><td>1.000</td><td>1559</td><td>tags=24%, list=12%, signal=27%</td></tr><tr><td class='lessen'>1578</td><td>RIGGINS_TAMOXIFEN_RESISTANCE_UP</td><td></td><td>63</td><td>0.23</td><td>0.83</td><td>0.819</td><td>0.882</td><td>1.000</td><td>2637</td><td>tags=33%, list=20%, signal=42%</td></tr><tr><td class='lessen'>1579</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN</td><td></td><td>18</td><td>0.31</td><td>0.83</td><td>0.712</td><td>0.883</td><td>1.000</td><td>1397</td><td>tags=22%, list=11%, signal=25%</td></tr><tr><td class='lessen'>1580</td><td>HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP</td><td></td><td>31</td><td>0.27</td><td>0.83</td><td>0.818</td><td>0.884</td><td>1.000</td><td>3082</td><td>tags=35%, list=24%, signal=46%</td></tr><tr><td class='lessen'>1581</td><td>GRESHOCK_CANCER_COPY_NUMBER_UP</td><td></td><td>294</td><td>0.19</td><td>0.83</td><td>1.000</td><td>0.885</td><td>1.000</td><td>2473</td><td>tags=19%, list=19%, signal=23%</td></tr><tr><td class='lessen'>1582</td><td>XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP</td><td></td><td>12</td><td>0.34</td><td>0.83</td><td>0.712</td><td>0.885</td><td>1.000</td><td>715</td><td>tags=17%, list=6%, signal=18%</td></tr><tr><td class='lessen'>1583</td><td>DAZARD_RESPONSE_TO_UV_SCC_DN</td><td></td><td>100</td><td>0.21</td><td>0.83</td><td>0.937</td><td>0.885</td><td>1.000</td><td>3181</td><td>tags=33%, list=25%, signal=43%</td></tr><tr><td class='lessen'>1584</td><td>WINTER_HYPOXIA_UP</td><td></td><td>74</td><td>0.23</td><td>0.82</td><td>0.843</td><td>0.886</td><td>1.000</td><td>2509</td><td>tags=20%, list=19%, signal=25%</td></tr><tr><td class='lessen'>1585</td><td>GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN</td><td></td><td>70</td><td>0.22</td><td>0.82</td><td>0.891</td><td>0.888</td><td>1.000</td><td>1842</td><td>tags=19%, list=14%, signal=22%</td></tr><tr><td class='lessen'>1586</td><td>YANAGIHARA_ESX1_TARGETS</td><td></td><td>27</td><td>0.28</td><td>0.82</td><td>0.793</td><td>0.891</td><td>1.000</td><td>3177</td><td>tags=37%, list=25%, signal=49%</td></tr><tr><td class='lessen'>1587</td><td>PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP</td><td></td><td>241</td><td>0.19</td><td>0.82</td><td>1.000</td><td>0.892</td><td>1.000</td><td>2106</td><td>tags=16%, list=16%, signal=19%</td></tr><tr><td class='lessen'>1588</td><td>ZWANG_EGF_INTERVAL_DN</td><td></td><td>165</td><td>0.19</td><td>0.82</td><td>0.975</td><td>0.892</td><td>1.000</td><td>2152</td><td>tags=21%, list=17%, signal=24%</td></tr><tr><td class='lessen'>1589</td><td>JISON_SICKLE_CELL_DISEASE_DN</td><td></td><td>140</td><td>0.21</td><td>0.82</td><td>0.926</td><td>0.893</td><td>1.000</td><td>860</td><td>tags=6%, list=7%, signal=7%</td></tr><tr><td class='lessen'>1590</td><td>BROWNE_HCMV_INFECTION_18HR_UP</td><td></td><td>152</td><td>0.20</td><td>0.82</td><td>0.981</td><td>0.893</td><td>1.000</td><td>1884</td><td>tags=13%, list=15%, signal=15%</td></tr><tr><td class='lessen'>1591</td><td>GABRIELY_MIR21_TARGETS</td><td></td><td>240</td><td>0.19</td><td>0.82</td><td>0.958</td><td>0.894</td><td>1.000</td><td>3180</td><td>tags=27%, list=25%, signal=35%</td></tr><tr><td class='lessen'>1592</td><td>FORTSCHEGGER_PHF8_TARGETS_DN</td><td></td><td>602</td><td>0.19</td><td>0.82</td><td>1.000</td><td>0.894</td><td>1.000</td><td>3115</td><td>tags=27%, list=24%, signal=34%</td></tr><tr><td class='lessen'>1593</td><td>BROWNE_HCMV_INFECTION_1HR_DN</td><td></td><td>180</td><td>0.20</td><td>0.82</td><td>0.972</td><td>0.896</td><td>1.000</td><td>2196</td><td>tags=18%, list=17%, signal=22%</td></tr><tr><td class='lessen'>1594</td><td>ELVIDGE_HIF1A_TARGETS_UP</td><td></td><td>54</td><td>0.23</td><td>0.82</td><td>0.841</td><td>0.896</td><td>1.000</td><td>3199</td><td>tags=30%, list=25%, signal=39%</td></tr><tr><td class='lessen'>1595</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN</td><td></td><td>418</td><td>0.19</td><td>0.82</td><td>1.000</td><td>0.895</td><td>1.000</td><td>2709</td><td>tags=18%, list=21%, signal=22%</td></tr><tr><td class='lessen'>1596</td><td>CHENG_IMPRINTED_BY_ESTRADIOL</td><td></td><td>81</td><td>0.22</td><td>0.82</td><td>0.923</td><td>0.896</td><td>1.000</td><td>1958</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>1597</td><td>ROVERSI_GLIOMA_LOH_REGIONS</td><td></td><td>39</td><td>0.25</td><td>0.82</td><td>0.841</td><td>0.895</td><td>1.000</td><td>2507</td><td>tags=31%, list=19%, signal=38%</td></tr><tr><td class='lessen'>1598</td><td>GOLDRATH_HOMEOSTATIC_PROLIFERATION</td><td></td><td>143</td><td>0.20</td><td>0.81</td><td>0.985</td><td>0.898</td><td>1.000</td><td>3287</td><td>tags=23%, list=25%, signal=31%</td></tr><tr><td class='lessen'>1599</td><td>SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER</td><td></td><td>20</td><td>0.29</td><td>0.81</td><td>0.746</td><td>0.899</td><td>1.000</td><td>2296</td><td>tags=40%, list=18%, signal=49%</td></tr><tr><td class='lessen'>1600</td><td>MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN</td><td></td><td>440</td><td>0.18</td><td>0.81</td><td>1.000</td><td>0.898</td><td>1.000</td><td>1925</td><td>tags=13%, list=15%, signal=15%</td></tr><tr><td class='lessen'>1601</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_P2</td><td></td><td>60</td><td>0.23</td><td>0.81</td><td>0.899</td><td>0.898</td><td>1.000</td><td>1936</td><td>tags=22%, list=15%, signal=25%</td></tr><tr><td class='lessen'>1602</td><td>ONDER_CDH1_TARGETS_1_UP</td><td></td><td>104</td><td>0.21</td><td>0.81</td><td>0.926</td><td>0.899</td><td>1.000</td><td>1875</td><td>tags=18%, list=14%, signal=21%</td></tr><tr><td class='lessen'>1603</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN</td><td></td><td>42</td><td>0.25</td><td>0.81</td><td>0.883</td><td>0.899</td><td>1.000</td><td>1795</td><td>tags=19%, list=14%, signal=22%</td></tr><tr><td class='lessen'>1604</td><td>EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN</td><td></td><td>36</td><td>0.25</td><td>0.81</td><td>0.781</td><td>0.899</td><td>1.000</td><td>1591</td><td>tags=19%, list=12%, signal=22%</td></tr><tr><td class='lessen'>1605</td><td>RODRIGUES_NTN1_AND_DCC_TARGETS</td><td></td><td>28</td><td>0.27</td><td>0.81</td><td>0.790</td><td>0.901</td><td>1.000</td><td>2483</td><td>tags=32%, list=19%, signal=40%</td></tr><tr><td class='lessen'>1606</td><td>FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP</td><td></td><td>31</td><td>0.26</td><td>0.81</td><td>0.764</td><td>0.904</td><td>1.000</td><td>748</td><td>tags=13%, list=6%, signal=14%</td></tr><tr><td class='lessen'>1607</td><td>KYNG_DNA_DAMAGE_UP</td><td></td><td>201</td><td>0.20</td><td>0.81</td><td>0.963</td><td>0.905</td><td>1.000</td><td>1347</td><td>tags=13%, list=10%, signal=15%</td></tr><tr><td class='lessen'>1608</td><td>STEIN_ESRRA_TARGETS</td><td></td><td>413</td><td>0.17</td><td>0.81</td><td>1.000</td><td>0.904</td><td>1.000</td><td>2563</td><td>tags=20%, list=20%, signal=24%</td></tr><tr><td class='lessen'>1609</td><td>GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP</td><td></td><td>59</td><td>0.23</td><td>0.81</td><td>0.885</td><td>0.905</td><td>1.000</td><td>3374</td><td>tags=27%, list=26%, signal=37%</td></tr><tr><td class='lessen'>1610</td><td>CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP</td><td></td><td>22</td><td>0.28</td><td>0.80</td><td>0.779</td><td>0.909</td><td>1.000</td><td>1819</td><td>tags=36%, list=14%, signal=42%</td></tr><tr><td class='lessen'>1611</td><td>SCHLESINGER_METHYLATED_IN_COLON_CANCER</td><td></td><td>10</td><td>0.35</td><td>0.80</td><td>0.712</td><td>0.910</td><td>1.000</td><td>740</td><td>tags=20%, list=6%, signal=21%</td></tr><tr><td class='lessen'>1612</td><td>NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP</td><td></td><td>220</td><td>0.19</td><td>0.80</td><td>1.000</td><td>0.910</td><td>1.000</td><td>1170</td><td>tags=11%, list=9%, signal=12%</td></tr><tr><td class='lessen'>1613</td><td>MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN</td><td></td><td>61</td><td>0.22</td><td>0.80</td><td>0.907</td><td>0.911</td><td>1.000</td><td>1962</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>1614</td><td>ZEMBUTSU_SENSITIVITY_TO_CISPLATIN</td><td></td><td>17</td><td>0.30</td><td>0.80</td><td>0.763</td><td>0.916</td><td>1.000</td><td>1425</td><td>tags=24%, list=11%, signal=26%</td></tr><tr><td class='lessen'>1615</td><td>LAMB_CCND1_TARGETS</td><td></td><td>18</td><td>0.30</td><td>0.80</td><td>0.747</td><td>0.916</td><td>1.000</td><td>1991</td><td>tags=22%, list=15%, signal=26%</td></tr><tr><td class='lessen'>1616</td><td>FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP</td><td></td><td>47</td><td>0.24</td><td>0.80</td><td>0.871</td><td>0.915</td><td>1.000</td><td>2279</td><td>tags=21%, list=18%, signal=26%</td></tr><tr><td class='lessen'>1617</td><td>BONCI_TARGETS_OF_MIR15A_AND_MIR16_1</td><td></td><td>81</td><td>0.22</td><td>0.80</td><td>0.907</td><td>0.916</td><td>1.000</td><td>1547</td><td>tags=15%, list=12%, signal=17%</td></tr><tr><td class='lessen'>1618</td><td>GALLUZZI_PERMEABILIZE_MITOCHONDRIA</td><td></td><td>40</td><td>0.25</td><td>0.80</td><td>0.815</td><td>0.918</td><td>1.000</td><td>2767</td><td>tags=28%, list=21%, signal=35%</td></tr><tr><td class='lessen'>1619</td><td>MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>12</td><td>0.33</td><td>0.80</td><td>0.720</td><td>0.918</td><td>1.000</td><td>974</td><td>tags=25%, list=8%, signal=27%</td></tr><tr><td class='lessen'>1620</td><td>AMIT_SERUM_RESPONSE_480_MCF10A</td><td></td><td>30</td><td>0.26</td><td>0.79</td><td>0.779</td><td>0.919</td><td>1.000</td><td>816</td><td>tags=10%, list=6%, signal=11%</td></tr><tr><td class='lessen'>1621</td><td>DORN_ADENOVIRUS_INFECTION_32HR_UP</td><td></td><td>11</td><td>0.33</td><td>0.79</td><td>0.750</td><td>0.919</td><td>1.000</td><td>2135</td><td>tags=45%, list=17%, signal=54%</td></tr><tr><td class='lessen'>1622</td><td>SMIRNOV_RESPONSE_TO_IR_2HR_UP</td><td></td><td>43</td><td>0.25</td><td>0.79</td><td>0.860</td><td>0.920</td><td>1.000</td><td>2062</td><td>tags=26%, list=16%, signal=30%</td></tr><tr><td class='lessen'>1623</td><td>OZEN_MIR125B1_TARGETS</td><td></td><td>21</td><td>0.29</td><td>0.79</td><td>0.774</td><td>0.920</td><td>1.000</td><td>1601</td><td>tags=14%, list=12%, signal=16%</td></tr><tr><td class='lessen'>1624</td><td>HOSHIDA_LIVER_CANCER_SURVIVAL_DN</td><td></td><td>95</td><td>0.21</td><td>0.79</td><td>0.949</td><td>0.920</td><td>1.000</td><td>1860</td><td>tags=17%, list=14%, signal=20%</td></tr><tr><td class='lessen'>1625</td><td>KARLSSON_TGFB1_TARGETS_UP</td><td></td><td>100</td><td>0.20</td><td>0.79</td><td>0.976</td><td>0.921</td><td>1.000</td><td>2873</td><td>tags=24%, list=22%, signal=31%</td></tr><tr><td class='lessen'>1626</td><td>HUANG_GATA2_TARGETS_DN</td><td></td><td>63</td><td>0.23</td><td>0.79</td><td>0.901</td><td>0.921</td><td>1.000</td><td>1652</td><td>tags=17%, list=13%, signal=20%</td></tr><tr><td class='lessen'>1627</td><td>VALK_AML_CLUSTER_12</td><td></td><td>29</td><td>0.26</td><td>0.79</td><td>0.823</td><td>0.923</td><td>1.000</td><td>2279</td><td>tags=28%, list=18%, signal=33%</td></tr><tr><td class='lessen'>1628</td><td>BOYLAN_MULTIPLE_MYELOMA_C_D_UP</td><td></td><td>111</td><td>0.21</td><td>0.79</td><td>0.963</td><td>0.926</td><td>1.000</td><td>1815</td><td>tags=14%, list=14%, signal=17%</td></tr><tr><td class='lessen'>1629</td><td>CHENG_RESPONSE_TO_NICKEL_ACETATE</td><td></td><td>33</td><td>0.25</td><td>0.79</td><td>0.894</td><td>0.926</td><td>1.000</td><td>2770</td><td>tags=24%, list=21%, signal=31%</td></tr><tr><td class='lessen'>1630</td><td>HOWLIN_CITED1_TARGETS_2_UP</td><td></td><td>15</td><td>0.31</td><td>0.79</td><td>0.755</td><td>0.926</td><td>1.000</td><td>787</td><td>tags=13%, list=6%, signal=14%</td></tr><tr><td class='lessen'>1631</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22</td><td></td><td>10</td><td>0.34</td><td>0.79</td><td>0.736</td><td>0.926</td><td>1.000</td><td>8548</td><td>tags=100%, list=66%, signal=295%</td></tr><tr><td class='lessen'>1632</td><td>GRABARCZYK_BCL11B_TARGETS_DN</td><td></td><td>46</td><td>0.24</td><td>0.78</td><td>0.874</td><td>0.929</td><td>1.000</td><td>1321</td><td>tags=15%, list=10%, signal=17%</td></tr><tr><td class='lessen'>1633</td><td>ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE</td><td></td><td>16</td><td>0.30</td><td>0.78</td><td>0.766</td><td>0.932</td><td>1.000</td><td>976</td><td>tags=19%, list=8%, signal=20%</td></tr><tr><td class='lessen'>1634</td><td>GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION</td><td></td><td>36</td><td>0.25</td><td>0.78</td><td>0.883</td><td>0.933</td><td>1.000</td><td>2048</td><td>tags=19%, list=16%, signal=23%</td></tr><tr><td class='lessen'>1635</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN</td><td></td><td>390</td><td>0.18</td><td>0.78</td><td>1.000</td><td>0.934</td><td>1.000</td><td>3171</td><td>tags=24%, list=25%, signal=30%</td></tr><tr><td class='lessen'>1636</td><td>HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN</td><td></td><td>13</td><td>0.31</td><td>0.78</td><td>0.756</td><td>0.934</td><td>1.000</td><td>905</td><td>tags=31%, list=7%, signal=33%</td></tr><tr><td class='lessen'>1637</td><td>CHESLER_BRAIN_HIGHEST_EXPRESSION</td><td></td><td>36</td><td>0.24</td><td>0.78</td><td>0.873</td><td>0.934</td><td>1.000</td><td>3756</td><td>tags=42%, list=29%, signal=59%</td></tr><tr><td class='lessen'>1638</td><td>ENK_UV_RESPONSE_KERATINOCYTE_UP</td><td></td><td>465</td><td>0.17</td><td>0.78</td><td>1.000</td><td>0.937</td><td>1.000</td><td>2099</td><td>tags=16%, list=16%, signal=18%</td></tr><tr><td class='lessen'>1639</td><td>NGO_MALIGNANT_GLIOMA_1P_LOH</td><td></td><td>16</td><td>0.30</td><td>0.77</td><td>0.792</td><td>0.937</td><td>1.000</td><td>2675</td><td>tags=25%, list=21%, signal=31%</td></tr><tr><td class='lessen'>1640</td><td>ZWANG_EGF_PERSISTENTLY_DN</td><td></td><td>42</td><td>0.23</td><td>0.77</td><td>0.878</td><td>0.937</td><td>1.000</td><td>2667</td><td>tags=29%, list=21%, signal=36%</td></tr><tr><td class='lessen'>1641</td><td>KIM_MYCL1_AMPLIFICATION_TARGETS_DN</td><td></td><td>17</td><td>0.29</td><td>0.77</td><td>0.782</td><td>0.940</td><td>1.000</td><td>2811</td><td>tags=41%, list=22%, signal=53%</td></tr><tr><td class='lessen'>1642</td><td>LIU_CMYB_TARGETS_UP</td><td></td><td>134</td><td>0.19</td><td>0.77</td><td>1.000</td><td>0.941</td><td>1.000</td><td>2116</td><td>tags=17%, list=16%, signal=20%</td></tr><tr><td class='lessen'>1643</td><td>SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN</td><td></td><td>26</td><td>0.26</td><td>0.77</td><td>0.836</td><td>0.946</td><td>1.000</td><td>2411</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>1644</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6</td><td></td><td>37</td><td>0.24</td><td>0.77</td><td>0.878</td><td>0.947</td><td>1.000</td><td>303</td><td>tags=8%, list=2%, signal=8%</td></tr><tr><td class='lessen'>1645</td><td>ZHENG_RESPONSE_TO_ARSENITE_UP</td><td></td><td>10</td><td>0.33</td><td>0.77</td><td>0.762</td><td>0.947</td><td>1.000</td><td>63</td><td>tags=10%, list=0%, signal=10%</td></tr><tr><td class='lessen'>1646</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP</td><td></td><td>63</td><td>0.22</td><td>0.76</td><td>0.921</td><td>0.947</td><td>1.000</td><td>2036</td><td>tags=19%, list=16%, signal=22%</td></tr><tr><td class='lessen'>1647</td><td>AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN</td><td></td><td>14</td><td>0.30</td><td>0.76</td><td>0.760</td><td>0.950</td><td>1.000</td><td>1716</td><td>tags=21%, list=13%, signal=25%</td></tr><tr><td class='lessen'>1648</td><td>HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP</td><td></td><td>19</td><td>0.28</td><td>0.76</td><td>0.823</td><td>0.950</td><td>1.000</td><td>2234</td><td>tags=26%, list=17%, signal=32%</td></tr><tr><td class='lessen'>1649</td><td>LU_EZH2_TARGETS_DN</td><td></td><td>295</td><td>0.18</td><td>0.76</td><td>1.000</td><td>0.951</td><td>1.000</td><td>2519</td><td>tags=20%, list=19%, signal=25%</td></tr><tr><td class='lessen'>1650</td><td>WARTERS_IR_RESPONSE_5GY</td><td></td><td>35</td><td>0.25</td><td>0.76</td><td>0.897</td><td>0.950</td><td>1.000</td><td>2034</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>1651</td><td>ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST</td><td></td><td>118</td><td>0.19</td><td>0.76</td><td>0.952</td><td>0.951</td><td>1.000</td><td>2153</td><td>tags=15%, list=17%, signal=18%</td></tr><tr><td class='lessen'>1652</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G2</td><td></td><td>24</td><td>0.26</td><td>0.76</td><td>0.828</td><td>0.951</td><td>1.000</td><td>2376</td><td>tags=29%, list=18%, signal=36%</td></tr><tr><td class='lessen'>1653</td><td>POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP</td><td></td><td>37</td><td>0.23</td><td>0.75</td><td>0.897</td><td>0.957</td><td>1.000</td><td>801</td><td>tags=11%, list=6%, signal=11%</td></tr><tr><td class='lessen'>1654</td><td>QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2</td><td></td><td>32</td><td>0.24</td><td>0.75</td><td>0.880</td><td>0.957</td><td>1.000</td><td>1988</td><td>tags=22%, list=15%, signal=26%</td></tr><tr><td class='lessen'>1655</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_3_DN</td><td></td><td>178</td><td>0.19</td><td>0.75</td><td>1.000</td><td>0.960</td><td>1.000</td><td>2583</td><td>tags=22%, list=20%, signal=28%</td></tr><tr><td class='lessen'>1656</td><td>BRUINS_UVC_RESPONSE_EARLY_LATE</td><td></td><td>241</td><td>0.18</td><td>0.75</td><td>1.000</td><td>0.961</td><td>1.000</td><td>2127</td><td>tags=14%, list=16%, signal=17%</td></tr><tr><td class='lessen'>1657</td><td>DORN_ADENOVIRUS_INFECTION_48HR_UP</td><td></td><td>14</td><td>0.30</td><td>0.75</td><td>0.834</td><td>0.961</td><td>1.000</td><td>2135</td><td>tags=36%, list=17%, signal=43%</td></tr><tr><td class='lessen'>1658</td><td>BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN</td><td></td><td>16</td><td>0.29</td><td>0.75</td><td>0.812</td><td>0.961</td><td>1.000</td><td>1524</td><td>tags=13%, list=12%, signal=14%</td></tr><tr><td class='lessen'>1659</td><td>KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN</td><td></td><td>681</td><td>0.15</td><td>0.74</td><td>1.000</td><td>0.968</td><td>1.000</td><td>1724</td><td>tags=11%, list=13%, signal=12%</td></tr><tr><td class='lessen'>1660</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP</td><td></td><td>15</td><td>0.29</td><td>0.74</td><td>0.814</td><td>0.971</td><td>1.000</td><td>2785</td><td>tags=33%, list=22%, signal=42%</td></tr><tr><td class='lessen'>1661</td><td>HEDENFALK_BREAST_CANCER_BRACX_DN</td><td></td><td>18</td><td>0.27</td><td>0.74</td><td>0.875</td><td>0.972</td><td>1.000</td><td>3453</td><td>tags=33%, list=27%, signal=45%</td></tr><tr><td class='lessen'>1662</td><td>BARIS_THYROID_CANCER_DN</td><td></td><td>57</td><td>0.21</td><td>0.73</td><td>0.966</td><td>0.974</td><td>1.000</td><td>1834</td><td>tags=18%, list=14%, signal=20%</td></tr><tr><td class='lessen'>1663</td><td>LEE_RECENT_THYMIC_EMIGRANT</td><td></td><td>173</td><td>0.18</td><td>0.73</td><td>1.000</td><td>0.974</td><td>1.000</td><td>1675</td><td>tags=14%, list=13%, signal=16%</td></tr><tr><td class='lessen'>1664</td><td>VANTVEER_BREAST_CANCER_BRCA1_DN</td><td></td><td>30</td><td>0.24</td><td>0.73</td><td>0.898</td><td>0.975</td><td>1.000</td><td>2878</td><td>tags=37%, list=22%, signal=47%</td></tr><tr><td class='lessen'>1665</td><td>BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN</td><td></td><td>20</td><td>0.26</td><td>0.73</td><td>0.865</td><td>0.975</td><td>1.000</td><td>2509</td><td>tags=30%, list=19%, signal=37%</td></tr><tr><td class='lessen'>1666</td><td>MACLACHLAN_BRCA1_TARGETS_UP</td><td></td><td>20</td><td>0.26</td><td>0.73</td><td>0.871</td><td>0.976</td><td>1.000</td><td>2221</td><td>tags=30%, list=17%, signal=36%</td></tr><tr><td class='lessen'>1667</td><td>SMIRNOV_RESPONSE_TO_IR_6HR_UP</td><td></td><td>119</td><td>0.19</td><td>0.73</td><td>1.000</td><td>0.976</td><td>1.000</td><td>3154</td><td>tags=31%, list=24%, signal=41%</td></tr><tr><td class='lessen'>1668</td><td>JI_RESPONSE_TO_FSH_UP</td><td></td><td>61</td><td>0.21</td><td>0.73</td><td>0.988</td><td>0.976</td><td>1.000</td><td>2321</td><td>tags=21%, list=18%, signal=26%</td></tr><tr><td class='lessen'>1669</td><td>VICENT_METASTASIS_UP</td><td></td><td>13</td><td>0.30</td><td>0.73</td><td>0.837</td><td>0.975</td><td>1.000</td><td>1129</td><td>tags=15%, list=9%, signal=17%</td></tr><tr><td class='lessen'>1670</td><td>KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN</td><td></td><td>174</td><td>0.18</td><td>0.73</td><td>1.000</td><td>0.975</td><td>1.000</td><td>2652</td><td>tags=21%, list=21%, signal=26%</td></tr><tr><td class='lessen'>1671</td><td>YAMASHITA_LIVER_CANCER_STEM_CELL_UP</td><td></td><td>45</td><td>0.23</td><td>0.73</td><td>0.947</td><td>0.975</td><td>1.000</td><td>1432</td><td>tags=18%, list=11%, signal=20%</td></tr><tr><td class='lessen'>1672</td><td>RADAEVA_RESPONSE_TO_IFNA1_UP</td><td></td><td>44</td><td>0.22</td><td>0.73</td><td>0.940</td><td>0.975</td><td>1.000</td><td>3624</td><td>tags=43%, list=28%, signal=60%</td></tr><tr><td class='lessen'>1673</td><td>WONG_MITOCHONDRIA_GENE_MODULE</td><td></td><td>205</td><td>0.17</td><td>0.73</td><td>1.000</td><td>0.977</td><td>1.000</td><td>3776</td><td>tags=34%, list=29%, signal=47%</td></tr><tr><td class='lessen'>1674</td><td>KASLER_HDAC7_TARGETS_2_DN</td><td></td><td>28</td><td>0.24</td><td>0.72</td><td>0.909</td><td>0.978</td><td>1.000</td><td>3892</td><td>tags=64%, list=30%, signal=92%</td></tr><tr><td class='lessen'>1675</td><td>PARK_HSC_AND_MULTIPOTENT_PROGENITORS</td><td></td><td>41</td><td>0.22</td><td>0.72</td><td>0.957</td><td>0.978</td><td>1.000</td><td>1331</td><td>tags=10%, list=10%, signal=11%</td></tr><tr><td class='lessen'>1676</td><td>LIU_PROSTATE_CANCER_UP</td><td></td><td>72</td><td>0.20</td><td>0.72</td><td>0.985</td><td>0.980</td><td>1.000</td><td>2662</td><td>tags=22%, list=21%, signal=28%</td></tr><tr><td class='lessen'>1677</td><td>ELVIDGE_HYPOXIA_BY_DMOG_DN</td><td></td><td>50</td><td>0.22</td><td>0.72</td><td>0.956</td><td>0.983</td><td>1.000</td><td>3199</td><td>tags=34%, list=25%, signal=45%</td></tr><tr><td class='lessen'>1678</td><td>ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP</td><td></td><td>35</td><td>0.22</td><td>0.71</td><td>0.915</td><td>0.985</td><td>1.000</td><td>3088</td><td>tags=31%, list=24%, signal=41%</td></tr><tr><td class='lessen'>1679</td><td>HOLLEMAN_DAUNORUBICIN_B_ALL_UP</td><td></td><td>10</td><td>0.31</td><td>0.71</td><td>0.834</td><td>0.985</td><td>1.000</td><td>1294</td><td>tags=20%, list=10%, signal=22%</td></tr><tr><td class='lessen'>1680</td><td>SESTO_RESPONSE_TO_UV_C2</td><td></td><td>43</td><td>0.21</td><td>0.71</td><td>0.954</td><td>0.985</td><td>1.000</td><td>3357</td><td>tags=37%, list=26%, signal=50%</td></tr><tr><td class='lessen'>1681</td><td>MARSON_FOXP3_TARGETS_STIMULATED_UP</td><td></td><td>25</td><td>0.24</td><td>0.71</td><td>0.883</td><td>0.991</td><td>1.000</td><td>3079</td><td>tags=44%, list=24%, signal=58%</td></tr><tr><td class='lessen'>1682</td><td>WORSCHECH_TUMOR_REJECTION_DN</td><td></td><td>10</td><td>0.31</td><td>0.70</td><td>0.827</td><td>0.991</td><td>1.000</td><td>8977</td><td>tags=100%, list=69%, signal=327%</td></tr><tr><td class='lessen'>1683</td><td>XU_CREBBP_TARGETS_UP</td><td></td><td>22</td><td>0.25</td><td>0.70</td><td>0.896</td><td>0.991</td><td>1.000</td><td>1660</td><td>tags=14%, list=13%, signal=16%</td></tr><tr><td class='lessen'>1684</td><td>CAFFAREL_RESPONSE_TO_THC_24HR_3_DN</td><td></td><td>12</td><td>0.28</td><td>0.70</td><td>0.864</td><td>0.991</td><td>1.000</td><td>2687</td><td>tags=42%, list=21%, signal=53%</td></tr><tr><td class='lessen'>1685</td><td>PROVENZANI_METASTASIS_UP</td><td></td><td>159</td><td>0.17</td><td>0.70</td><td>1.000</td><td>0.992</td><td>1.000</td><td>2505</td><td>tags=19%, list=19%, signal=24%</td></tr><tr><td class='lessen'>1686</td><td>LEE_NAIVE_T_LYMPHOCYTE</td><td></td><td>12</td><td>0.29</td><td>0.70</td><td>0.845</td><td>0.992</td><td>1.000</td><td>1292</td><td>tags=25%, list=10%, signal=28%</td></tr><tr><td class='lessen'>1687</td><td>IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN</td><td></td><td>11</td><td>0.29</td><td>0.70</td><td>0.836</td><td>0.992</td><td>1.000</td><td>9126</td><td>tags=100%, list=71%, signal=339%</td></tr><tr><td class='lessen'>1688</td><td>CHUNG_BLISTER_CYTOTOXICITY_UP</td><td></td><td>104</td><td>0.18</td><td>0.70</td><td>1.000</td><td>0.993</td><td>1.000</td><td>2621</td><td>tags=19%, list=20%, signal=24%</td></tr><tr><td class='lessen'>1689</td><td>SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP</td><td></td><td>18</td><td>0.26</td><td>0.70</td><td>0.889</td><td>0.993</td><td>1.000</td><td>672</td><td>tags=11%, list=5%, signal=12%</td></tr><tr><td class='lessen'>1690</td><td>MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA</td><td></td><td>11</td><td>0.30</td><td>0.70</td><td>0.818</td><td>0.993</td><td>1.000</td><td>340</td><td>tags=9%, list=3%, signal=9%</td></tr><tr><td class='lessen'>1691</td><td>CHICAS_RB1_TARGETS_LOW_SERUM</td><td></td><td>66</td><td>0.20</td><td>0.70</td><td>0.993</td><td>0.993</td><td>1.000</td><td>1658</td><td>tags=11%, list=13%, signal=12%</td></tr><tr><td class='lessen'>1692</td><td>COLLIS_PRKDC_SUBSTRATES</td><td></td><td>19</td><td>0.25</td><td>0.70</td><td>0.884</td><td>0.993</td><td>1.000</td><td>9673</td><td>tags=100%, list=75%, signal=396%</td></tr><tr><td class='lessen'>1693</td><td>DORN_ADENOVIRUS_INFECTION_48HR_DN</td><td></td><td>34</td><td>0.22</td><td>0.70</td><td>0.928</td><td>0.993</td><td>1.000</td><td>2320</td><td>tags=24%, list=18%, signal=29%</td></tr><tr><td class='lessen'>1694</td><td>NELSON_RESPONSE_TO_ANDROGEN_DN</td><td></td><td>18</td><td>0.26</td><td>0.69</td><td>0.916</td><td>0.995</td><td>1.000</td><td>2135</td><td>tags=22%, list=17%, signal=27%</td></tr><tr><td class='lessen'>1695</td><td>LI_CYTIDINE_ANALOGS_CYCTOTOXICITY</td><td></td><td>14</td><td>0.27</td><td>0.69</td><td>0.861</td><td>0.997</td><td>1.000</td><td>9388</td><td>tags=100%, list=73%, signal=364%</td></tr><tr><td class='lessen'>1696</td><td>GALE_APL_WITH_FLT3_MUTATED_DN</td><td></td><td>12</td><td>0.28</td><td>0.69</td><td>0.848</td><td>0.997</td><td>1.000</td><td>9285</td><td>tags=100%, list=72%, signal=354%</td></tr><tr><td class='lessen'>1697</td><td>MA_PITUITARY_FETAL_VS_ADULT_DN</td><td></td><td>14</td><td>0.27</td><td>0.68</td><td>0.891</td><td>0.998</td><td>1.000</td><td>398</td><td>tags=7%, list=3%, signal=7%</td></tr><tr><td class='lessen'>1698</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10</td><td></td><td>56</td><td>0.19</td><td>0.68</td><td>0.993</td><td>0.999</td><td>1.000</td><td>10452</td><td>tags=100%, list=81%, signal=519%</td></tr><tr><td class='lessen'>1699</td><td>LEE_LIVER_CANCER_MYC_TGFA_UP</td><td></td><td>57</td><td>0.20</td><td>0.68</td><td>0.982</td><td>1.000</td><td>1.000</td><td>2188</td><td>tags=25%, list=17%, signal=29%</td></tr><tr><td class='lessen'>1700</td><td>KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP</td><td></td><td>10</td><td>0.30</td><td>0.68</td><td>0.859</td><td>0.999</td><td>1.000</td><td>1226</td><td>tags=20%, list=9%, signal=22%</td></tr><tr><td class='lessen'>1701</td><td>GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN</td><td></td><td>87</td><td>0.18</td><td>0.68</td><td>1.000</td><td>0.999</td><td>1.000</td><td>3433</td><td>tags=34%, list=27%, signal=47%</td></tr><tr><td class='lessen'>1702</td><td>BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN</td><td></td><td>147</td><td>0.17</td><td>0.68</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2442</td><td>tags=16%, list=19%, signal=20%</td></tr><tr><td class='lessen'>1703</td><td>LUCAS_HNF4A_TARGETS_UP</td><td></td><td>48</td><td>0.20</td><td>0.68</td><td>0.982</td><td>1.000</td><td>1.000</td><td>421</td><td>tags=6%, list=3%, signal=6%</td></tr><tr><td class='lessen'>1704</td><td>BARRIER_COLON_CANCER_RECURRENCE_DN</td><td></td><td>15</td><td>0.26</td><td>0.68</td><td>0.882</td><td>1.000</td><td>1.000</td><td>1988</td><td>tags=13%, list=15%, signal=16%</td></tr><tr><td class='lessen'>1705</td><td>NGUYEN_NOTCH1_TARGETS_DN</td><td></td><td>76</td><td>0.18</td><td>0.68</td><td>0.991</td><td>0.999</td><td>1.000</td><td>2555</td><td>tags=25%, list=20%, signal=31%</td></tr><tr><td class='lessen'>1706</td><td>DORN_ADENOVIRUS_INFECTION_32HR_DN</td><td></td><td>33</td><td>0.21</td><td>0.68</td><td>0.948</td><td>0.999</td><td>1.000</td><td>3179</td><td>tags=33%, list=25%, signal=44%</td></tr><tr><td class='lessen'>1707</td><td>SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN</td><td></td><td>47</td><td>0.20</td><td>0.68</td><td>0.972</td><td>0.999</td><td>1.000</td><td>2048</td><td>tags=17%, list=16%, signal=20%</td></tr><tr><td class='lessen'>1708</td><td>YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP</td><td></td><td>28</td><td>0.22</td><td>0.68</td><td>0.946</td><td>0.999</td><td>1.000</td><td>2189</td><td>tags=18%, list=17%, signal=21%</td></tr><tr><td class='lessen'>1709</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_UP</td><td></td><td>260</td><td>0.16</td><td>0.67</td><td>1.000</td><td>0.999</td><td>1.000</td><td>2523</td><td>tags=18%, list=20%, signal=22%</td></tr><tr><td class='lessen'>1710</td><td>CHOI_ATL_STAGE_PREDICTOR</td><td></td><td>33</td><td>0.22</td><td>0.67</td><td>0.951</td><td>0.999</td><td>1.000</td><td>2272</td><td>tags=15%, list=18%, signal=18%</td></tr><tr><td class='lessen'>1711</td><td>IKEDA_MIR30_TARGETS_DN</td><td></td><td>23</td><td>0.23</td><td>0.67</td><td>0.929</td><td>0.998</td><td>1.000</td><td>1383</td><td>tags=13%, list=11%, signal=15%</td></tr><tr><td class='lessen'>1712</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP</td><td></td><td>10</td><td>0.29</td><td>0.67</td><td>0.863</td><td>0.998</td><td>1.000</td><td>3547</td><td>tags=40%, list=27%, signal=55%</td></tr><tr><td class='lessen'>1713</td><td>FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP</td><td></td><td>56</td><td>0.19</td><td>0.67</td><td>0.983</td><td>0.999</td><td>1.000</td><td>2260</td><td>tags=16%, list=17%, signal=19%</td></tr><tr><td class='lessen'>1714</td><td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN</td><td></td><td>16</td><td>0.25</td><td>0.67</td><td>0.914</td><td>0.999</td><td>1.000</td><td>2896</td><td>tags=38%, list=22%, signal=48%</td></tr><tr><td class='lessen'>1715</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP</td><td></td><td>24</td><td>0.23</td><td>0.67</td><td>0.947</td><td>0.999</td><td>1.000</td><td>379</td><td>tags=8%, list=3%, signal=9%</td></tr><tr><td class='lessen'>1716</td><td>MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP</td><td></td><td>61</td><td>0.19</td><td>0.67</td><td>0.987</td><td>0.999</td><td>1.000</td><td>10517</td><td>tags=100%, list=81%, signal=532%</td></tr><tr><td class='lessen'>1717</td><td>FARMER_BREAST_CANCER_CLUSTER_4</td><td></td><td>14</td><td>0.27</td><td>0.67</td><td>0.915</td><td>0.999</td><td>1.000</td><td>3099</td><td>tags=50%, list=24%, signal=66%</td></tr><tr><td class='lessen'>1718</td><td>KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION</td><td></td><td>14</td><td>0.27</td><td>0.66</td><td>0.884</td><td>1.000</td><td>1.000</td><td>882</td><td>tags=14%, list=7%, signal=15%</td></tr><tr><td class='lessen'>1719</td><td>SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN</td><td></td><td>39</td><td>0.21</td><td>0.66</td><td>0.968</td><td>1.000</td><td>1.000</td><td>3446</td><td>tags=38%, list=27%, signal=52%</td></tr><tr><td class='lessen'>1720</td><td>WOOD_EBV_EBNA1_TARGETS_DN</td><td></td><td>40</td><td>0.20</td><td>0.66</td><td>0.965</td><td>1.000</td><td>1.000</td><td>1981</td><td>tags=18%, list=15%, signal=21%</td></tr><tr><td class='lessen'>1721</td><td>PARENT_MTOR_SIGNALING_UP</td><td></td><td>453</td><td>0.15</td><td>0.66</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2513</td><td>tags=17%, list=19%, signal=20%</td></tr><tr><td class='lessen'>1722</td><td>PENG_RAPAMYCIN_RESPONSE_DN</td><td></td><td>212</td><td>0.15</td><td>0.66</td><td>1.000</td><td>1.000</td><td>1.000</td><td>1830</td><td>tags=8%, list=14%, signal=10%</td></tr><tr><td class='lessen'>1723</td><td>STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN</td><td></td><td>36</td><td>0.21</td><td>0.65</td><td>0.972</td><td>1.000</td><td>1.000</td><td>3534</td><td>tags=36%, list=27%, signal=50%</td></tr><tr><td class='lessen'>1724</td><td>HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP</td><td></td><td>22</td><td>0.23</td><td>0.65</td><td>0.948</td><td>1.000</td><td>1.000</td><td>172</td><td>tags=5%, list=1%, signal=5%</td></tr><tr><td class='lessen'>1725</td><td>ZAMORA_NOS2_TARGETS_UP</td><td></td><td>62</td><td>0.19</td><td>0.65</td><td>1.000</td><td>1.000</td><td>1.000</td><td>1244</td><td>tags=8%, list=10%, signal=9%</td></tr><tr><td class='lessen'>1726</td><td>MOOTHA_MITOCHONDRIA</td><td></td><td>399</td><td>0.14</td><td>0.65</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3319</td><td>tags=26%, list=26%, signal=34%</td></tr><tr><td class='lessen'>1727</td><td>KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP</td><td></td><td>31</td><td>0.20</td><td>0.65</td><td>0.972</td><td>1.000</td><td>1.000</td><td>874</td><td>tags=6%, list=7%, signal=7%</td></tr><tr><td class='lessen'>1728</td><td>WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN</td><td></td><td>93</td><td>0.17</td><td>0.65</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2501</td><td>tags=22%, list=19%, signal=26%</td></tr><tr><td class='lessen'>1729</td><td>BOYLAN_MULTIPLE_MYELOMA_C_DN</td><td></td><td>45</td><td>0.19</td><td>0.64</td><td>0.974</td><td>1.000</td><td>1.000</td><td>3084</td><td>tags=33%, list=24%, signal=44%</td></tr><tr><td class='lessen'>1730</td><td>LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER</td><td></td><td>174</td><td>0.16</td><td>0.64</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3229</td><td>tags=23%, list=25%, signal=30%</td></tr><tr><td class='lessen'>1731</td><td>LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES</td><td></td><td>13</td><td>0.26</td><td>0.64</td><td>0.898</td><td>1.000</td><td>1.000</td><td>1205</td><td>tags=15%, list=9%, signal=17%</td></tr><tr><td class='lessen'>1732</td><td>TCGA_GLIOBLASTOMA_COPY_NUMBER_DN</td><td></td><td>24</td><td>0.22</td><td>0.64</td><td>0.961</td><td>1.000</td><td>1.000</td><td>3010</td><td>tags=38%, list=23%, signal=49%</td></tr><tr><td class='lessen'>1733</td><td>CHANDRAN_METASTASIS_UP</td><td></td><td>155</td><td>0.16</td><td>0.64</td><td>1.000</td><td>1.000</td><td>1.000</td><td>1508</td><td>tags=8%, list=12%, signal=9%</td></tr><tr><td class='lessen'>1734</td><td>CHUANG_OXIDATIVE_STRESS_RESPONSE_DN</td><td></td><td>10</td><td>0.28</td><td>0.64</td><td>0.915</td><td>1.000</td><td>1.000</td><td>1162</td><td>tags=20%, list=9%, signal=22%</td></tr><tr><td class='lessen'>1735</td><td>LIN_APC_TARGETS</td><td></td><td>63</td><td>0.18</td><td>0.63</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2100</td><td>tags=14%, list=16%, signal=17%</td></tr><tr><td class='lessen'>1736</td><td>GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP</td><td></td><td>85</td><td>0.17</td><td>0.63</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2446</td><td>tags=15%, list=19%, signal=19%</td></tr><tr><td class='lessen'>1737</td><td>CAFFAREL_RESPONSE_TO_THC_8HR_5_UP</td><td></td><td>11</td><td>0.27</td><td>0.63</td><td>0.907</td><td>1.000</td><td>1.000</td><td>2854</td><td>tags=27%, list=22%, signal=35%</td></tr><tr><td class='lessen'>1738</td><td>FRASOR_TAMOXIFEN_RESPONSE_DN</td><td></td><td>10</td><td>0.27</td><td>0.63</td><td>0.896</td><td>1.000</td><td>1.000</td><td>9443</td><td>tags=100%, list=73%, signal=370%</td></tr><tr><td class='lessen'>1739</td><td>MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP</td><td></td><td>38</td><td>0.20</td><td>0.63</td><td>0.990</td><td>1.000</td><td>1.000</td><td>1820</td><td>tags=13%, list=14%, signal=15%</td></tr><tr><td class='lessen'>1740</td><td>KOBAYASHI_EGFR_SIGNALING_6HR_DN</td><td></td><td>16</td><td>0.24</td><td>0.63</td><td>0.935</td><td>1.000</td><td>1.000</td><td>2062</td><td>tags=31%, list=16%, signal=37%</td></tr><tr><td class='lessen'>1741</td><td>YIH_RESPONSE_TO_ARSENITE_C3</td><td></td><td>33</td><td>0.20</td><td>0.63</td><td>0.982</td><td>1.000</td><td>1.000</td><td>2572</td><td>tags=33%, list=20%, signal=42%</td></tr><tr><td class='lessen'>1742</td><td>HASLINGER_B_CLL_WITH_13Q14_DELETION</td><td></td><td>18</td><td>0.23</td><td>0.63</td><td>0.949</td><td>1.000</td><td>1.000</td><td>2419</td><td>tags=28%, list=19%, signal=34%</td></tr><tr><td class='lessen'>1743</td><td>DOUGLAS_BMI1_TARGETS_DN</td><td></td><td>241</td><td>0.15</td><td>0.62</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2626</td><td>tags=18%, list=20%, signal=22%</td></tr><tr><td class='lessen'>1744</td><td>SESTO_RESPONSE_TO_UV_C5</td><td></td><td>42</td><td>0.19</td><td>0.62</td><td>1.000</td><td>1.000</td><td>1.000</td><td>10488</td><td>tags=100%, list=81%, signal=527%</td></tr><tr><td class='lessen'>1745</td><td>FAELT_B_CLL_WITH_VH3_21_DN</td><td></td><td>43</td><td>0.19</td><td>0.62</td><td>0.989</td><td>1.000</td><td>1.000</td><td>1256</td><td>tags=9%, list=10%, signal=10%</td></tr><tr><td class='lessen'>1746</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7</td><td></td><td>63</td><td>0.17</td><td>0.62</td><td>1.000</td><td>1.000</td><td>1.000</td><td>1848</td><td>tags=10%, list=14%, signal=11%</td></tr><tr><td class='lessen'>1747</td><td>OSMAN_BLADDER_CANCER_DN</td><td></td><td>290</td><td>0.14</td><td>0.62</td><td>1.000</td><td>1.000</td><td>1.000</td><td>1532</td><td>tags=8%, list=12%, signal=8%</td></tr><tr><td class='lessen'>1748</td><td>UDAYAKUMAR_MED1_TARGETS_UP</td><td></td><td>115</td><td>0.16</td><td>0.62</td><td>1.000</td><td>1.000</td><td>1.000</td><td>1928</td><td>tags=11%, list=15%, signal=13%</td></tr><tr><td class='lessen'>1749</td><td>AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN</td><td></td><td>187</td><td>0.15</td><td>0.61</td><td>1.000</td><td>1.000</td><td>1.000</td><td>1856</td><td>tags=11%, list=14%, signal=12%</td></tr><tr><td class='lessen'>1750</td><td>CHEN_HOXA5_TARGETS_9HR_UP</td><td></td><td>154</td><td>0.15</td><td>0.61</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2429</td><td>tags=16%, list=19%, signal=20%</td></tr><tr><td class='lessen'>1751</td><td>ENK_UV_RESPONSE_KERATINOCYTE_DN</td><td></td><td>417</td><td>0.14</td><td>0.61</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3414</td><td>tags=24%, list=26%, signal=31%</td></tr><tr><td class='lessen'>1752</td><td>DAZARD_UV_RESPONSE_CLUSTER_G28</td><td></td><td>15</td><td>0.24</td><td>0.60</td><td>0.959</td><td>1.000</td><td>1.000</td><td>3154</td><td>tags=47%, list=24%, signal=62%</td></tr><tr><td class='lessen'>1753</td><td>CHANGOLKAR_H2AFY_TARGETS_UP</td><td></td><td>38</td><td>0.18</td><td>0.60</td><td>0.995</td><td>1.000</td><td>1.000</td><td>3051</td><td>tags=21%, list=24%, signal=27%</td></tr><tr><td class='lessen'>1754</td><td>TIEN_INTESTINE_PROBIOTICS_2HR_DN</td><td></td><td>71</td><td>0.17</td><td>0.60</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2272</td><td>tags=15%, list=18%, signal=19%</td></tr><tr><td class='lessen'>1755</td><td>SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN</td><td></td><td>25</td><td>0.21</td><td>0.59</td><td>0.972</td><td>1.000</td><td>1.000</td><td>10243</td><td>tags=100%, list=79%, signal=480%</td></tr><tr><td class='lessen'>1756</td><td>NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP</td><td></td><td>28</td><td>0.19</td><td>0.59</td><td>0.984</td><td>1.000</td><td>1.000</td><td>3546</td><td>tags=43%, list=27%, signal=59%</td></tr><tr><td class='lessen'>1757</td><td>BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN</td><td></td><td>32</td><td>0.19</td><td>0.59</td><td>0.980</td><td>1.000</td><td>1.000</td><td>1988</td><td>tags=13%, list=15%, signal=15%</td></tr><tr><td class='lessen'>1758</td><td>WALLACE_JAK2_TARGETS_UP</td><td></td><td>20</td><td>0.22</td><td>0.59</td><td>0.992</td><td>1.000</td><td>1.000</td><td>2295</td><td>tags=20%, list=18%, signal=24%</td></tr><tr><td class='lessen'>1759</td><td>AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP</td><td></td><td>234</td><td>0.14</td><td>0.59</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2753</td><td>tags=19%, list=21%, signal=24%</td></tr><tr><td class='lessen'>1760</td><td>MILI_PSEUDOPODIA_HAPTOTAXIS_UP</td><td></td><td>395</td><td>0.13</td><td>0.59</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2547</td><td>tags=13%, list=20%, signal=15%</td></tr><tr><td class='lessen'>1761</td><td>TOMIDA_METASTASIS_DN</td><td></td><td>16</td><td>0.22</td><td>0.58</td><td>0.965</td><td>1.000</td><td>1.000</td><td>2470</td><td>tags=25%, list=19%, signal=31%</td></tr><tr><td class='lessen'>1762</td><td>BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN</td><td></td><td>35</td><td>0.18</td><td>0.58</td><td>0.995</td><td>1.000</td><td>1.000</td><td>3937</td><td>tags=37%, list=30%, signal=53%</td></tr><tr><td class='lessen'>1763</td><td>LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP</td><td></td><td>141</td><td>0.15</td><td>0.58</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2889</td><td>tags=21%, list=22%, signal=26%</td></tr><tr><td class='lessen'>1764</td><td>RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP</td><td></td><td>13</td><td>0.23</td><td>0.58</td><td>0.960</td><td>1.000</td><td>1.000</td><td>2280</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>1765</td><td>WHITESIDE_CISPLATIN_RESISTANCE_DN</td><td></td><td>11</td><td>0.25</td><td>0.58</td><td>0.947</td><td>1.000</td><td>1.000</td><td>9757</td><td>tags=100%, list=75%, signal=407%</td></tr><tr><td class='lessen'>1766</td><td>TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN</td><td></td><td>15</td><td>0.22</td><td>0.57</td><td>0.955</td><td>1.000</td><td>1.000</td><td>1900</td><td>tags=13%, list=15%, signal=16%</td></tr><tr><td class='lessen'>1767</td><td>JAIN_NFKB_SIGNALING</td><td></td><td>65</td><td>0.16</td><td>0.57</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2329</td><td>tags=15%, list=18%, signal=19%</td></tr><tr><td class='lessen'>1768</td><td>JIANG_HYPOXIA_VIA_VHL</td><td></td><td>29</td><td>0.18</td><td>0.57</td><td>0.988</td><td>1.000</td><td>1.000</td><td>10555</td><td>tags=100%, list=82%, signal=542%</td></tr><tr><td class='lessen'>1769</td><td>KAUFFMANN_DNA_REPLICATION_GENES</td><td></td><td>121</td><td>0.15</td><td>0.57</td><td>1.000</td><td>1.000</td><td>1.000</td><td>1919</td><td>tags=10%, list=15%, signal=12%</td></tr><tr><td class='lessen'>1770</td><td>MCCABE_HOXC6_TARGETS_CANCER_DN</td><td></td><td>17</td><td>0.21</td><td>0.57</td><td>0.977</td><td>1.000</td><td>1.000</td><td>10203</td><td>tags=100%, list=79%, signal=473%</td></tr><tr><td class='lessen'>1771</td><td>MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN</td><td></td><td>19</td><td>0.21</td><td>0.57</td><td>0.982</td><td>1.000</td><td>1.000</td><td>1799</td><td>tags=21%, list=14%, signal=24%</td></tr><tr><td class='lessen'>1772</td><td>LAIHO_COLORECTAL_CANCER_SERRATED_DN</td><td></td><td>62</td><td>0.16</td><td>0.57</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3420</td><td>tags=29%, list=26%, signal=39%</td></tr><tr><td class='lessen'>1773</td><td>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN</td><td></td><td>16</td><td>0.21</td><td>0.57</td><td>0.979</td><td>1.000</td><td>1.000</td><td>2557</td><td>tags=38%, list=20%, signal=47%</td></tr><tr><td class='lessen'>1774</td><td>LUND_SILENCED_BY_METHYLATION</td><td></td><td>16</td><td>0.21</td><td>0.57</td><td>0.966</td><td>1.000</td><td>1.000</td><td>10221</td><td>tags=100%, list=79%, signal=476%</td></tr><tr><td class='lessen'>1775</td><td>FINETTI_BREAST_CANCERS_KINOME_GRAY</td><td></td><td>13</td><td>0.22</td><td>0.56</td><td>0.963</td><td>1.000</td><td>1.000</td><td>942</td><td>tags=8%, list=7%, signal=8%</td></tr><tr><td class='lessen'>1776</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17</td><td></td><td>155</td><td>0.14</td><td>0.56</td><td>1.000</td><td>1.000</td><td>1.000</td><td>11151</td><td>tags=100%, list=86%, signal=716%</td></tr><tr><td class='lessen'>1777</td><td>ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP</td><td></td><td>645</td><td>0.13</td><td>0.56</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2316</td><td>tags=12%, list=18%, signal=14%</td></tr><tr><td class='lessen'>1778</td><td>RODRIGUES_THYROID_CARCINOMA_UP</td><td></td><td>12</td><td>0.23</td><td>0.55</td><td>0.981</td><td>1.000</td><td>1.000</td><td>3180</td><td>tags=33%, list=25%, signal=44%</td></tr><tr><td class='lessen'>1779</td><td>MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN</td><td></td><td>40</td><td>0.17</td><td>0.55</td><td>0.990</td><td>1.000</td><td>1.000</td><td>4027</td><td>tags=45%, list=31%, signal=65%</td></tr><tr><td class='lessen'>1780</td><td>TOMLINS_PROSTATE_CANCER_UP</td><td></td><td>34</td><td>0.18</td><td>0.55</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2374</td><td>tags=21%, list=18%, signal=25%</td></tr><tr><td class='lessen'>1781</td><td>FU_INTERACT_WITH_ALKBH8</td><td></td><td>12</td><td>0.23</td><td>0.55</td><td>0.954</td><td>1.000</td><td>1.000</td><td>793</td><td>tags=8%, list=6%, signal=9%</td></tr><tr><td class='lessen'>1782</td><td>CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB</td><td></td><td>14</td><td>0.22</td><td>0.55</td><td>0.971</td><td>1.000</td><td>1.000</td><td>3065</td><td>tags=29%, list=24%, signal=37%</td></tr><tr><td class='lessen'>1783</td><td>FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN</td><td></td><td>37</td><td>0.17</td><td>0.55</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2201</td><td>tags=16%, list=17%, signal=19%</td></tr><tr><td class='lessen'>1784</td><td>RAMALHO_STEMNESS_UP</td><td></td><td>174</td><td>0.13</td><td>0.55</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2977</td><td>tags=16%, list=23%, signal=21%</td></tr><tr><td class='lessen'>1785</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP</td><td></td><td>19</td><td>0.20</td><td>0.54</td><td>0.990</td><td>1.000</td><td>1.000</td><td>2127</td><td>tags=16%, list=16%, signal=19%</td></tr><tr><td class='lessen'>1786</td><td>TOOKER_GEMCITABINE_RESISTANCE_UP</td><td></td><td>65</td><td>0.15</td><td>0.53</td><td>1.000</td><td>1.000</td><td>1.000</td><td>1467</td><td>tags=9%, list=11%, signal=10%</td></tr><tr><td class='lessen'>1787</td><td>WENG_POR_TARGETS_GLOBAL_DN</td><td></td><td>20</td><td>0.19</td><td>0.53</td><td>1.000</td><td>1.000</td><td>1.000</td><td>1096</td><td>tags=10%, list=8%, signal=11%</td></tr><tr><td class='lessen'>1788</td><td>MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4</td><td></td><td>16</td><td>0.20</td><td>0.53</td><td>0.984</td><td>1.000</td><td>1.000</td><td>2992</td><td>tags=25%, list=23%, signal=32%</td></tr><tr><td class='lessen'>1789</td><td>SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN</td><td></td><td>44</td><td>0.16</td><td>0.53</td><td>0.995</td><td>1.000</td><td>1.000</td><td>2863</td><td>tags=20%, list=22%, signal=26%</td></tr><tr><td class='lessen'>1790</td><td>PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN</td><td></td><td>44</td><td>0.16</td><td>0.52</td><td>0.995</td><td>1.000</td><td>1.000</td><td>10895</td><td>tags=100%, list=84%, signal=632%</td></tr><tr><td class='lessen'>1791</td><td>WENDT_COHESIN_TARGETS_UP</td><td></td><td>26</td><td>0.17</td><td>0.52</td><td>0.992</td><td>1.000</td><td>1.000</td><td>10683</td><td>tags=100%, list=83%, signal=573%</td></tr><tr><td class='lessen'>1792</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP</td><td></td><td>89</td><td>0.14</td><td>0.52</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2792</td><td>tags=18%, list=22%, signal=23%</td></tr><tr><td class='lessen'>1793</td><td>HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN</td><td></td><td>100</td><td>0.14</td><td>0.52</td><td>1.000</td><td>1.000</td><td>1.000</td><td>11182</td><td>tags=100%, list=86%, signal=732%</td></tr><tr><td class='lessen'>1794</td><td>SINGH_NFE2L2_TARGETS</td><td></td><td>13</td><td>0.21</td><td>0.51</td><td>0.991</td><td>1.000</td><td>1.000</td><td>2597</td><td>tags=31%, list=20%, signal=38%</td></tr><tr><td class='lessen'>1795</td><td>GOLUB_ALL_VS_AML_UP</td><td></td><td>23</td><td>0.18</td><td>0.51</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3397</td><td>tags=30%, list=26%, signal=41%</td></tr><tr><td class='lessen'>1796</td><td>RAHMAN_TP53_TARGETS_PHOSPHORYLATED</td><td></td><td>19</td><td>0.19</td><td>0.51</td><td>0.986</td><td>1.000</td><td>1.000</td><td>3790</td><td>tags=42%, list=29%, signal=59%</td></tr><tr><td class='lessen'>1797</td><td>NOJIMA_SFRP2_TARGETS_DN</td><td></td><td>23</td><td>0.18</td><td>0.50</td><td>0.992</td><td>1.000</td><td>1.000</td><td>3099</td><td>tags=35%, list=24%, signal=46%</td></tr><tr><td class='lessen'>1798</td><td>KOBAYASHI_RESPONSE_TO_ROMIDEPSIN</td><td></td><td>14</td><td>0.20</td><td>0.50</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3011</td><td>tags=36%, list=23%, signal=46%</td></tr><tr><td class='lessen'>1799</td><td>YIH_RESPONSE_TO_ARSENITE_C4</td><td></td><td>17</td><td>0.18</td><td>0.50</td><td>0.990</td><td>1.000</td><td>1.000</td><td>10548</td><td>tags=100%, list=82%, signal=541%</td></tr><tr><td class='lessen'>1800</td><td>ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN</td><td></td><td>28</td><td>0.17</td><td>0.50</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3167</td><td>tags=29%, list=24%, signal=38%</td></tr><tr><td class='lessen'>1801</td><td>OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP</td><td></td><td>63</td><td>0.14</td><td>0.50</td><td>1.000</td><td>1.000</td><td>1.000</td><td>1645</td><td>tags=8%, list=13%, signal=9%</td></tr><tr><td class='lessen'>1802</td><td>FAELT_B_CLL_WITH_VH3_21_UP</td><td></td><td>38</td><td>0.15</td><td>0.49</td><td>1.000</td><td>1.000</td><td>1.000</td><td>11015</td><td>tags=100%, list=85%, signal=672%</td></tr><tr><td class='lessen'>1803</td><td>LINSLEY_MIR16_TARGETS</td><td></td><td>169</td><td>0.12</td><td>0.49</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2559</td><td>tags=15%, list=20%, signal=18%</td></tr><tr><td class='lessen'>1804</td><td>SESTO_RESPONSE_TO_UV_C4</td><td></td><td>16</td><td>0.19</td><td>0.49</td><td>0.997</td><td>1.000</td><td>1.000</td><td>588</td><td>tags=6%, list=5%, signal=7%</td></tr><tr><td class='lessen'>1805</td><td>TOMIDA_METASTASIS_UP</td><td></td><td>19</td><td>0.18</td><td>0.49</td><td>1.000</td><td>1.000</td><td>1.000</td><td>8816</td><td>tags=95%, list=68%, signal=297%</td></tr><tr><td class='lessen'>1806</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP</td><td></td><td>21</td><td>0.18</td><td>0.49</td><td>0.996</td><td>1.000</td><td>1.000</td><td>2530</td><td>tags=24%, list=20%, signal=30%</td></tr><tr><td class='lessen'>1807</td><td>MURAKAMI_UV_RESPONSE_6HR_UP</td><td></td><td>33</td><td>0.16</td><td>0.49</td><td>0.995</td><td>1.000</td><td>1.000</td><td>3583</td><td>tags=33%, list=28%, signal=46%</td></tr><tr><td class='lessen'>1808</td><td>HEDENFALK_BREAST_CANCER_BRACX_UP</td><td></td><td>18</td><td>0.18</td><td>0.48</td><td>1.000</td><td>1.000</td><td>1.000</td><td>1650</td><td>tags=11%, list=13%, signal=13%</td></tr><tr><td class='lessen'>1809</td><td>FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN</td><td></td><td>40</td><td>0.14</td><td>0.48</td><td>1.000</td><td>1.000</td><td>1.000</td><td>11100</td><td>tags=100%, list=86%, signal=703%</td></tr><tr><td class='lessen'>1810</td><td>MMS_MOUSE_LYMPH_HIGH_4HRS_UP</td><td></td><td>33</td><td>0.15</td><td>0.47</td><td>1.000</td><td>1.000</td><td>1.000</td><td>11028</td><td>tags=100%, list=85%, signal=677%</td></tr><tr><td class='lessen'>1811</td><td>CHOW_RASSF1_TARGETS_UP</td><td></td><td>22</td><td>0.17</td><td>0.47</td><td>1.000</td><td>1.000</td><td>1.000</td><td>10785</td><td>tags=100%, list=83%, signal=601%</td></tr><tr><td class='lessen'>1812</td><td>SHEN_SMARCA2_TARGETS_UP</td><td></td><td>335</td><td>0.11</td><td>0.47</td><td>1.000</td><td>1.000</td><td>1.000</td><td>4124</td><td>tags=32%, list=32%, signal=45%</td></tr><tr><td class='lessen'>1813</td><td>JIANG_AGING_HYPOTHALAMUS_UP</td><td></td><td>42</td><td>0.14</td><td>0.46</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3859</td><td>tags=29%, list=30%, signal=41%</td></tr><tr><td class='lessen'>1814</td><td>KYNG_WERNER_SYNDROM_UP</td><td></td><td>14</td><td>0.18</td><td>0.45</td><td>0.987</td><td>1.000</td><td>1.000</td><td>2819</td><td>tags=36%, list=22%, signal=46%</td></tr><tr><td class='lessen'>1815</td><td>HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP</td><td></td><td>10</td><td>0.19</td><td>0.44</td><td>0.989</td><td>1.000</td><td>1.000</td><td>2211</td><td>tags=20%, list=17%, signal=24%</td></tr><tr><td class='lessen'>1816</td><td>GUTIERREZ_MULTIPLE_MYELOMA_DN</td><td></td><td>30</td><td>0.13</td><td>0.41</td><td>1.000</td><td>1.000</td><td>1.000</td><td>4077</td><td>tags=33%, list=32%, signal=49%</td></tr><tr><td class='lessen'>1817</td><td>VANOEVELEN_MYOGENESIS_SIN3A_TARGETS</td><td></td><td>167</td><td>0.10</td><td>0.40</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2201</td><td>tags=10%, list=17%, signal=12%</td></tr><tr><td class='lessen'>1818</td><td>JIANG_AGING_HYPOTHALAMUS_DN</td><td></td><td>40</td><td>0.12</td><td>0.39</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2528</td><td>tags=13%, list=20%, signal=15%</td></tr><tr><td class='lessen'>1819</td><td>ONKEN_UVEAL_MELANOMA_UP</td><td></td><td>611</td><td>0.27</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2382</td><td>tags=22%, list=18%, signal=25%</td></tr><tr><td class='lessen'>1820</td><td>FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP</td><td></td><td>447</td><td>0.35</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2746</td><td>tags=34%, list=21%, signal=41%</td></tr><tr><td class='lessen'>1821</td><td>DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP</td><td></td><td>1209</td><td>0.15</td><td></td><td></td><td>1.000</td><td>0.000</td><td>3083</td><td>tags=18%, list=24%, signal=22%</td></tr><tr><td class='lessen'>1822</td><td>SENESE_HDAC3_TARGETS_UP</td><td></td><td>408</td><td>0.27</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2329</td><td>tags=24%, list=18%, signal=28%</td></tr><tr><td class='lessen'>1823</td><td>DODD_NASOPHARYNGEAL_CARCINOMA_DN</td><td></td><td>1023</td><td>0.17</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2382</td><td>tags=17%, list=18%, signal=19%</td></tr><tr><td class='lessen'>1824</td><td>GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP</td><td></td><td>928</td><td>0.19</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2439</td><td>tags=21%, list=19%, signal=24%</td></tr><tr><td class='lessen'>1825</td><td>GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN</td><td></td><td>1426</td><td>0.21</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2876</td><td>tags=19%, list=22%, signal=22%</td></tr><tr><td class='lessen'>1826</td><td>GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN</td><td></td><td>598</td><td>0.08</td><td></td><td></td><td>1.000</td><td>0.000</td><td>1563</td><td>tags=6%, list=12%, signal=7%</td></tr><tr><td class='lessen'>1827</td><td>SCHLOSSER_SERUM_RESPONSE_DN</td><td></td><td>579</td><td>0.21</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2419</td><td>tags=16%, list=19%, signal=18%</td></tr><tr><td class='lessen'>1828</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_DN</td><td></td><td>700</td><td>0.20</td><td></td><td></td><td>1.000</td><td>0.000</td><td>3210</td><td>tags=25%, list=25%, signal=32%</td></tr><tr><td class='lessen'>1829</td><td>PUJANA_ATM_PCC_NETWORK</td><td></td><td>1157</td><td>0.18</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2551</td><td>tags=20%, list=20%, signal=22%</td></tr><tr><td class='lessen'>1830</td><td>NUYTTEN_NIPP1_TARGETS_UP</td><td></td><td>567</td><td>0.22</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2213</td><td>tags=21%, list=17%, signal=24%</td></tr><tr><td class='lessen'>1831</td><td>NUYTTEN_NIPP1_TARGETS_DN</td><td></td><td>682</td><td>0.19</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2661</td><td>tags=21%, list=21%, signal=25%</td></tr><tr><td class='lessen'>1832</td><td>NUYTTEN_EZH2_TARGETS_UP</td><td></td><td>828</td><td>0.29</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2448</td><td>tags=26%, list=19%, signal=30%</td></tr><tr><td class='lessen'>1833</td><td>BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP</td><td></td><td>651</td><td>0.21</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2453</td><td>tags=19%, list=19%, signal=23%</td></tr><tr><td class='lessen'>1834</td><td>LOPEZ_MBD_TARGETS</td><td></td><td>765</td><td>0.22</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2324</td><td>tags=19%, list=18%, signal=22%</td></tr><tr><td class='lessen'>1835</td><td>CUI_TCF21_TARGETS_2_DN</td><td></td><td>680</td><td>0.45</td><td></td><td></td><td>1.000</td><td>0.000</td><td>3064</td><td>tags=43%, list=24%, signal=53%</td></tr><tr><td class='lessen'>1836</td><td>BLALOCK_ALZHEIMERS_DISEASE_UP</td><td></td><td>1391</td><td>0.25</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2507</td><td>tags=22%, list=19%, signal=25%</td></tr><tr><td class='lessen'>1837</td><td>KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP</td><td></td><td>672</td><td>0.27</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2809</td><td>tags=26%, list=22%, signal=31%</td></tr><tr><td class='lessen'>1838</td><td>ZHENG_BOUND_BY_FOXP3</td><td></td><td>402</td><td>0.26</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2579</td><td>tags=29%, list=20%, signal=35%</td></tr><tr><td class='lessen'>1839</td><td>MARTINEZ_RB1_TARGETS_DN</td><td></td><td>435</td><td>0.21</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2479</td><td>tags=22%, list=19%, signal=27%</td></tr><tr><td class='lessen'>1840</td><td>ACEVEDO_LIVER_CANCER_UP</td><td></td><td>735</td><td>0.20</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2345</td><td>tags=17%, list=18%, signal=19%</td></tr><tr><td class='lessen'>1841</td><td>CHEN_METABOLIC_SYNDROM_NETWORK</td><td></td><td>991</td><td>0.40</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2145</td><td>tags=33%, list=17%, signal=37%</td></tr><tr><td class='lessen'>1842</td><td>DANG_BOUND_BY_MYC</td><td></td><td>931</td><td>0.14</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2394</td><td>tags=14%, list=19%, signal=16%</td></tr><tr><td class='lessen'>1843</td><td>WONG_ADULT_TISSUE_STEM_MODULE</td><td></td><td>633</td><td>0.41</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2512</td><td>tags=38%, list=19%, signal=45%</td></tr><tr><td class='lessen'>1844</td><td>PILON_KLF1_TARGETS_DN</td><td></td><td>1548</td><td>0.23</td><td></td><td></td><td>1.000</td><td>0.000</td><td>3181</td><td>tags=23%, list=25%, signal=27%</td></tr><tr><td class='lessen'>1845</td><td>BRUINS_UVC_RESPONSE_LATE</td><td></td><td>891</td><td>0.26</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2307</td><td>tags=20%, list=18%, signal=23%</td></tr><tr><td class='lessen'>1846</td><td>KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3</td><td></td><td>677</td><td>0.24</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2880</td><td>tags=26%, list=22%, signal=31%</td></tr><tr><td class='lessen'>1847</td><td>WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D</td><td></td><td>690</td><td>0.38</td><td></td><td></td><td>1.000</td><td>0.000</td><td>2778</td><td>tags=34%, list=21%, signal=41%</td></tr><tr><td class='lessen'>1848</td><td>WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D</td><td></td><td>540</td><td>0.30</td><td></td><td></td><td>1.000</td><td>0.000</td><td>3008</td><td>tags=32%, list=23%, signal=40%</td></tr><caption class='table'>Table: Gene sets enriched in phenotype <b>na<b>&nbsp<a href='gsea_report_for_na_pos_1439144934464.xls'>[plain text format]</a></caption></table></div><br></body></html>